id	sid	tid	token	lemma	pos
aiua-11120	1	1	stesura	stesura	PROPN
aiua-11120	1	2	seveso	seveso	PROPN
aiua-11120	1	3	archivio	archivio	PROPN
aiua-11120	1	4	italiano	italiano	X
aiua-11120	1	5	di	di	X
aiua-11120	1	6	urologia	urologia	PROPN
aiua-11120	1	7	e	e	PROPN
aiua-11120	1	8	andrologia	andrologia	PROPN
aiua-11120	1	9	2022	2022	NUM
aiua-11120	1	10	;	;	PUNCT
aiua-11120	1	11	94	94	NUM
aiua-11120	1	12	,	,	PUNCT
aiua-11120	1	13	4492	4492	NUM
aiua-11120	1	14	review	review	VERB
aiua-11120	1	15	no	no	DET
aiua-11120	1	16	conflict	conflict	NOUN
aiua-11120	1	17	of	of	ADP
aiua-11120	1	18	interest	interest	NOUN
aiua-11120	1	19	declared	declare	VERB
aiua-11120	1	20	.	.	PUNCT
aiua-11120	2	1	background	background	NOUN
aiua-11120	2	2	:	:	PUNCT
aiua-11120	2	3	overactive	overactive	ADJ
aiua-11120	2	4	bladder	bladder	NOUN
aiua-11120	2	5	(	(	PUNCT
aiua-11120	2	6	oab	oab	PROPN
aiua-11120	2	7	)	)	PUNCT
aiua-11120	2	8	symptoms	symptom	NOUN
aiua-11120	2	9	of	of	ADP
aiua-11120	2	10	frequency	frequency	NOUN
aiua-11120	2	11	,	,	PUNCT
aiua-11120	2	12	urgency	urgency	NOUN
aiua-11120	2	13	and	and	CCONJ
aiua-11120	2	14	urge	urge	VERB
aiua-11120	2	15	incontinence	incontinence	NOUN
aiua-11120	2	16	are	be	AUX
aiua-11120	2	17	frequently	frequently	ADV
aiua-11120	2	18	associated	associate	VERB
aiua-11120	2	19	with	with	ADP
aiua-11120	2	20	known	know	VERB
aiua-11120	2	21	neurological	neurological	ADJ
aiua-11120	2	22	diseases	disease	NOUN
aiua-11120	2	23	like	like	ADP
aiua-11120	2	24	multiple	multiple	ADJ
aiua-11120	2	25	sclerosis	sclerosis	NOUN
aiua-11120	2	26	(	(	PUNCT
aiua-11120	2	27	ms	ms	NOUN
aiua-11120	2	28	)	)	PUNCT
aiua-11120	2	29	,	,	PUNCT
aiua-11120	2	30	spinal	spinal	NOUN
aiua-11120	2	31	cord	cord	NOUN
aiua-11120	2	32	injury	injury	NOUN
aiua-11120	2	33	(	(	PUNCT
aiua-11120	2	34	sci	sci	PROPN
aiua-11120	2	35	)	)	PUNCT
aiua-11120	2	36	,	,	PUNCT
aiua-11120	2	37	parkinson	parkinson	NOUN
aiua-11120	2	38	’s	’s	PART
aiua-11120	2	39	disease	disease	NOUN
aiua-11120	2	40	(	(	PUNCT
aiua-11120	2	41	pd	pd	NOUN
aiua-11120	2	42	)	)	PUNCT
aiua-11120	2	43	,	,	PUNCT
aiua-11120	2	44	stroke	stroke	NOUN
aiua-11120	2	45	.	.	PUNCT
aiua-11120	3	1	objective	objective	NOUN
aiua-11120	3	2	:	:	PUNCT
aiua-11120	3	3	the	the	DET
aiua-11120	3	4	aim	aim	NOUN
aiua-11120	3	5	of	of	ADP
aiua-11120	3	6	our	our	PRON
aiua-11120	3	7	study	study	NOUN
aiua-11120	3	8	was	be	AUX
aiua-11120	3	9	to	to	PART
aiua-11120	3	10	review	review	VERB
aiua-11120	3	11	the	the	DET
aiua-11120	3	12	efficacy	efficacy	NOUN
aiua-11120	3	13	of	of	ADP
aiua-11120	3	14	pharmacological	pharmacological	NOUN
aiua-11120	3	15	and	and	CCONJ
aiua-11120	3	16	non	non	ADJ
aiua-11120	3	17	-	-	ADJ
aiua-11120	3	18	pharmacological	pharmacological	ADJ
aiua-11120	3	19	treatments	treatment	NOUN
aiua-11120	3	20	for	for	ADP
aiua-11120	3	21	neurogenic	neurogenic	ADJ
aiua-11120	3	22	overactive	overactive	ADJ
aiua-11120	3	23	bladder	bladder	NOUN
aiua-11120	3	24	.	.	PUNCT
aiua-11120	4	1	materials	material	NOUN
aiua-11120	4	2	and	and	CCONJ
aiua-11120	4	3	methods	method	NOUN
aiua-11120	4	4	:	:	PUNCT
aiua-11120	4	5	we	we	PRON
aiua-11120	4	6	searched	search	VERB
aiua-11120	4	7	two	two	NUM
aiua-11120	4	8	electronic	electronic	ADJ
aiua-11120	4	9	databases	database	NOUN
aiua-11120	4	10	(	(	PUNCT
aiua-11120	4	11	pubmed	pubmed	NOUN
aiua-11120	4	12	and	and	CCONJ
aiua-11120	4	13	embase	embase	NOUN
aiua-11120	4	14	)	)	PUNCT
aiua-11120	4	15	for	for	ADP
aiua-11120	4	16	randomized	randomized	ADJ
aiua-11120	4	17	controlled	control	VERB
aiua-11120	4	18	trials	trial	NOUN
aiua-11120	4	19	focusing	focus	VERB
aiua-11120	4	20	on	on	ADP
aiua-11120	4	21	pharmacological	pharmacological	ADJ
aiua-11120	4	22	and	and	CCONJ
aiua-11120	4	23	non	non	ADJ
aiua-11120	4	24	-	-	ADJ
aiua-11120	4	25	pharmacological	pharmacological	ADJ
aiua-11120	4	26	medical	medical	ADJ
aiua-11120	4	27	treatments	treatment	NOUN
aiua-11120	4	28	for	for	ADP
aiua-11120	4	29	overactive	overactive	ADJ
aiua-11120	4	30	bladder	bladder	NOUN
aiua-11120	4	31	symptoms	symptom	NOUN
aiua-11120	4	32	associated	associate	VERB
aiua-11120	4	33	with	with	ADP
aiua-11120	4	34	neurological	neurological	ADJ
aiua-11120	4	35	diseases	disease	NOUN
aiua-11120	4	36	published	publish	VERB
aiua-11120	4	37	up	up	ADP
aiua-11120	4	38	to	to	PART
aiua-11120	4	39	30	30	NUM
aiua-11120	4	40	april	april	PROPN
aiua-11120	4	41	2022	2022	NUM
aiua-11120	4	42	.	.	PUNCT
aiua-11120	5	1	results	result	NOUN
aiua-11120	5	2	:	:	PUNCT
aiua-11120	5	3	a	a	DET
aiua-11120	5	4	total	total	NOUN
aiua-11120	5	5	of	of	ADP
aiua-11120	5	6	157	157	NUM
aiua-11120	5	7	articles	article	NOUN
aiua-11120	5	8	were	be	AUX
aiua-11120	5	9	retrieved	retrieve	VERB
aiua-11120	5	10	;	;	PUNCT
aiua-11120	5	11	94	94	NUM
aiua-11120	5	12	were	be	AUX
aiua-11120	5	13	selected	select	VERB
aiua-11120	5	14	by	by	ADP
aiua-11120	5	15	title	title	NOUN
aiua-11120	5	16	and	and	CCONJ
aiua-11120	5	17	abstract	abstract	ADJ
aiua-11120	5	18	screening	screening	NOUN
aiua-11120	5	19	;	;	PUNCT
aiua-11120	5	20	after	after	ADP
aiua-11120	5	21	removal	removal	NOUN
aiua-11120	5	22	of	of	ADP
aiua-11120	5	23	17	17	NUM
aiua-11120	5	24	duplicates	duplicate	NOUN
aiua-11120	5	25	,	,	PUNCT
aiua-11120	5	26	77	77	NUM
aiua-11120	5	27	records	record	NOUN
aiua-11120	5	28	were	be	AUX
aiua-11120	5	29	evaluated	evaluate	VERB
aiua-11120	5	30	by	by	ADP
aiua-11120	5	31	full	full	ADJ
aiua-11120	5	32	-	-	PUNCT
aiua-11120	5	33	text	text	NOUN
aiua-11120	5	34	examination	examination	NOUN
aiua-11120	5	35	.	.	PUNCT
aiua-11120	6	1	sixty	sixty	NUM
aiua-11120	6	2	-	-	PUNCT
aiua-11120	6	3	two	two	NUM
aiua-11120	6	4	studies	study	NOUN
aiua-11120	6	5	were	be	AUX
aiua-11120	6	6	finally	finally	ADV
aiua-11120	6	7	selected	select	VERB
aiua-11120	6	8	.	.	PUNCT
aiua-11120	7	1	the	the	DET
aiua-11120	7	2	articles	article	NOUN
aiua-11120	7	3	selected	select	VERB
aiua-11120	7	4	for	for	ADP
aiua-11120	7	5	review	review	NOUN
aiua-11120	7	6	focused	focus	VERB
aiua-11120	7	7	on	on	ADP
aiua-11120	7	8	the	the	DET
aiua-11120	7	9	following	following	ADJ
aiua-11120	7	10	interventions	intervention	NOUN
aiua-11120	7	11	:	:	PUNCT
aiua-11120	7	12	anticholinergics	anticholinergic	NOUN
aiua-11120	7	13	(	(	PUNCT
aiua-11120	7	14	n	n	NOUN
aiua-11120	7	15	=	=	NOUN
aiua-11120	7	16	9	9	NUM
aiua-11120	7	17	)	)	PUNCT
aiua-11120	7	18	,	,	PUNCT
aiua-11120	7	19	mirabegron	mirabegron	PROPN
aiua-11120	7	20	(	(	PUNCT
aiua-11120	7	21	n	n	NOUN
aiua-11120	7	22	=	=	SYM
aiua-11120	7	23	5	5	NUM
aiua-11120	7	24	)	)	PUNCT
aiua-11120	7	25	,	,	PUNCT
aiua-11120	7	26	comparison	comparison	NOUN
aiua-11120	7	27	of	of	ADP
aiua-11120	7	28	different	different	ADJ
aiua-11120	7	29	drugs	drug	NOUN
aiua-11120	7	30	(	(	PUNCT
aiua-11120	7	31	n	n	NOUN
aiua-11120	7	32	=	=	SYM
aiua-11120	7	33	3	3	NUM
aiua-11120	7	34	)	)	PUNCT
aiua-11120	7	35	,	,	PUNCT
aiua-11120	7	36	cannabinoids	cannabinoid	NOUN
aiua-11120	7	37	(	(	PUNCT
aiua-11120	7	38	n	n	NOUN
aiua-11120	7	39	=	=	SYM
aiua-11120	7	40	2	2	NUM
aiua-11120	7	41	)	)	PUNCT
aiua-11120	7	42	,	,	PUNCT
aiua-11120	7	43	intravesical	intravesical	ADJ
aiua-11120	7	44	instillations	instillation	NOUN
aiua-11120	7	45	(	(	PUNCT
aiua-11120	7	46	n	n	NOUN
aiua-11120	7	47	=	=	SYM
aiua-11120	7	48	3	3	NUM
aiua-11120	7	49	)	)	PUNCT
aiua-11120	7	50	,	,	PUNCT
aiua-11120	7	51	botulinum	botulinum	ADJ
aiua-11120	7	52	toxin	toxin	NOUN
aiua-11120	7	53	(	(	PUNCT
aiua-11120	7	54	n	n	NOUN
aiua-11120	7	55	=	=	SYM
aiua-11120	7	56	16	16	NUM
aiua-11120	7	57	)	)	PUNCT
aiua-11120	7	58	,	,	PUNCT
aiua-11120	7	59	transcutaneous	transcutaneous	ADJ
aiua-11120	7	60	tibial	tibial	ADJ
aiua-11120	7	61	nerve	nerve	NOUN
aiua-11120	7	62	stimulation	stimulation	NOUN
aiua-11120	7	63	(	(	PUNCT
aiua-11120	7	64	ttns	ttns	NOUN
aiua-11120	7	65	)	)	PUNCT
aiua-11120	7	66	(	(	PUNCT
aiua-11120	7	67	n	n	NOUN
aiua-11120	7	68	=	=	SYM
aiua-11120	7	69	6	6	NUM
aiua-11120	7	70	)	)	PUNCT
aiua-11120	7	71	,	,	PUNCT
aiua-11120	7	72	acupuncture	acupuncture	NOUN
aiua-11120	7	73	(	(	PUNCT
aiua-11120	7	74	n	n	NOUN
aiua-11120	7	75	=	=	SYM
aiua-11120	7	76	2	2	NUM
aiua-11120	7	77	)	)	PUNCT
aiua-11120	7	78	,	,	PUNCT
aiua-11120	7	79	transcutaneous	transcutaneous	ADJ
aiua-11120	7	80	electrical	electrical	ADJ
aiua-11120	7	81	nerve	nerve	NOUN
aiua-11120	7	82	stimulation	stimulation	NOUN
aiua-11120	7	83	tens	ten	NOUN
aiua-11120	7	84	(	(	PUNCT
aiua-11120	7	85	n	n	NOUN
aiua-11120	7	86	=	=	SYM
aiua-11120	7	87	4	4	NUM
aiua-11120	7	88	)	)	PUNCT
aiua-11120	7	89	,	,	PUNCT
aiua-11120	7	90	pelvic	pelvic	ADJ
aiua-11120	7	91	floor	floor	NOUN
aiua-11120	7	92	muscle	muscle	NOUN
aiua-11120	7	93	training	training	NOUN
aiua-11120	7	94	(	(	PUNCT
aiua-11120	7	95	pfmt	pfmt	NOUN
aiua-11120	7	96	)	)	PUNCT
aiua-11120	7	97	(	(	PUNCT
aiua-11120	7	98	n	n	NOUN
aiua-11120	7	99	=	=	SYM
aiua-11120	7	100	10	10	NUM
aiua-11120	7	101	)	)	PUNCT
aiua-11120	7	102	,	,	PUNCT
aiua-11120	7	103	others	other	NOUN
aiua-11120	7	104	(	(	PUNCT
aiua-11120	7	105	n	n	NOUN
aiua-11120	7	106	=	=	SYM
aiua-11120	7	107	2	2	NUM
aiua-11120	7	108	)	)	PUNCT
aiua-11120	7	109	.	.	PUNCT
aiua-11120	8	1	anticholinergics	anticholinergic	NOUN
aiua-11120	8	2	were	be	AUX
aiua-11120	8	3	more	more	ADV
aiua-11120	8	4	effective	effective	ADJ
aiua-11120	8	5	than	than	ADP
aiua-11120	8	6	placebo	placebo	NOUN
aiua-11120	8	7	in	in	ADP
aiua-11120	8	8	decreasing	decrease	VERB
aiua-11120	8	9	the	the	DET
aiua-11120	8	10	number	number	NOUN
aiua-11120	8	11	of	of	ADP
aiua-11120	8	12	daily	daily	ADJ
aiua-11120	8	13	voids	voids	NOUN
aiua-11120	8	14	in	in	ADP
aiua-11120	8	15	patients	patient	NOUN
aiua-11120	8	16	with	with	ADP
aiua-11120	8	17	pd	pd	PROPN
aiua-11120	8	18	(	(	PUNCT
aiua-11120	8	19	mean	mean	INTJ
aiua-11120	8	20	difference	difference	NOUN
aiua-11120	9	1	[	[	X
aiua-11120	9	2	md]1.16	md]1.16	NOUN
aiua-11120	9	3	,	,	PUNCT
aiua-11120	9	4	95	95	NUM
aiua-11120	9	5	%	%	NOUN
aiua-11120	9	6	ci	ci	NOUN
aiua-11120	9	7	1.80	1.80	NUM
aiua-11120	9	8	to	to	ADP
aiua-11120	9	9	0.52	0.52	NUM
aiua-11120	9	10	,	,	PUNCT
aiua-11120	9	11	2	2	NUM
aiua-11120	9	12	trials	trial	NOUN
aiua-11120	9	13	,	,	PUNCT
aiua-11120	9	14	86	86	NUM
aiua-11120	9	15	patients	patient	NOUN
aiua-11120	9	16	,	,	PUNCT
aiua-11120	9	17	p	p	X
aiua-11120	9	18	<	<	X
aiua-11120	9	19	0.004	0.004	NUM
aiua-11120	9	20	)	)	PUNCT
aiua-11120	9	21	,	,	PUNCT
aiua-11120	9	22	but	but	CCONJ
aiua-11120	9	23	no	no	DET
aiua-11120	9	24	significant	significant	ADJ
aiua-11120	9	25	difference	difference	NOUN
aiua-11120	9	26	from	from	ADP
aiua-11120	9	27	baseline	baseline	NOUN
aiua-11120	9	28	was	be	AUX
aiua-11120	9	29	found	find	VERB
aiua-11120	9	30	for	for	ADP
aiua-11120	9	31	incontinence	incontinence	NOUN
aiua-11120	9	32	episodes	episode	NOUN
aiua-11120	9	33	and	and	CCONJ
aiua-11120	9	34	nocturia	nocturia	PROPN
aiua-11120	9	35	.	.	PUNCT
aiua-11120	10	1	mirabegron	mirabegron	PROPN
aiua-11120	10	2	was	be	AUX
aiua-11120	10	3	more	more	ADJ
aiua-11120	10	4	efficacy	efficacy	NOUN
aiua-11120	10	5	of	of	ADP
aiua-11120	10	6	overactive	overactive	ADJ
aiua-11120	10	7	neurogenic	neurogenic	ADJ
aiua-11120	10	8	bladder	bladder	NOUN
aiua-11120	10	9	treatment	treatment	NOUN
aiua-11120	10	10	:	:	PUNCT
aiua-11120	10	11	a	a	DET
aiua-11120	10	12	systematic	systematic	ADJ
aiua-11120	10	13	review	review	NOUN
aiua-11120	10	14	of	of	ADP
aiua-11120	10	15	randomized	randomized	ADJ
aiua-11120	10	16	controlled	control	VERB
aiua-11120	10	17	trials	trial	NOUN
aiua-11120	10	18	rawa	rawa	PROPN
aiua-11120	10	19	bapir	bapir	VERB
aiua-11120	10	20	1	1	NUM
aiua-11120	10	21	,	,	PUNCT
aiua-11120	10	22	14	14	NUM
aiua-11120	10	23	,	,	PUNCT
aiua-11120	10	24	kamran	kamran	PROPN
aiua-11120	10	25	hassan	hassan	PROPN
aiua-11120	10	26	bhatti	bhatti	PROPN
aiua-11120	10	27	2	2	NUM
aiua-11120	10	28	,	,	PUNCT
aiua-11120	10	29	14	14	NUM
aiua-11120	10	30	,	,	PUNCT
aiua-11120	10	31	ahmed	ahmed	PROPN
aiua-11120	10	32	eliwa	eliwa	VERB
aiua-11120	10	33	3	3	NUM
aiua-11120	10	34	,	,	PUNCT
aiua-11120	10	35	14	14	NUM
aiua-11120	10	36	,	,	PUNCT
aiua-11120	10	37	herney	herney	PROPN
aiua-11120	10	38	andrés	andrés	PROPN
aiua-11120	10	39	garcía	garcía	PROPN
aiua-11120	10	40	-	-	PUNCT
aiua-11120	10	41	perdomo	perdomo	NOUN
aiua-11120	10	42	4	4	NUM
aiua-11120	10	43	,	,	PUNCT
aiua-11120	10	44	14	14	NUM
aiua-11120	10	45	,	,	PUNCT
aiua-11120	10	46	nazim	nazim	PROPN
aiua-11120	10	47	gherabi	gherabi	PROPN
aiua-11120	10	48	5	5	NUM
aiua-11120	10	49	,	,	PUNCT
aiua-11120	10	50	14	14	NUM
aiua-11120	10	51	,	,	PUNCT
aiua-11120	10	52	derek	derek	PROPN
aiua-11120	10	53	hennessey	hennessey	PROPN
aiua-11120	10	54	6	6	NUM
aiua-11120	10	55	,	,	PUNCT
aiua-11120	10	56	14	14	NUM
aiua-11120	10	57	,	,	PUNCT
aiua-11120	10	58	vittorio	vittorio	NOUN
aiua-11120	10	59	magri	magri	VERB
aiua-11120	10	60	7	7	NUM
aiua-11120	10	61	,	,	PUNCT
aiua-11120	10	62	14	14	NUM
aiua-11120	10	63	,	,	PUNCT
aiua-11120	10	64	panagiotis	panagiotis	NOUN
aiua-11120	10	65	mourmouris	mourmouris	VERB
aiua-11120	10	66	8	8	NUM
aiua-11120	10	67	,	,	PUNCT
aiua-11120	10	68	14	14	NUM
aiua-11120	10	69	,	,	PUNCT
aiua-11120	10	70	adama	adama	PROPN
aiua-11120	10	71	ouattara	ouattara	NOUN
aiua-11120	10	72	9	9	NUM
aiua-11120	10	73	,	,	PUNCT
aiua-11120	10	74	14	14	NUM
aiua-11120	10	75	,	,	PUNCT
aiua-11120	10	76	gianpaolo	gianpaolo	NOUN
aiua-11120	10	77	perletti	perletti	NOUN
aiua-11120	10	78	10	10	NUM
aiua-11120	10	79	,	,	PUNCT
aiua-11120	10	80	14	14	NUM
aiua-11120	10	81	,	,	PUNCT
aiua-11120	10	82	joseph	joseph	PROPN
aiua-11120	10	83	philipraj	philipraj	PROPN
aiua-11120	10	84	11	11	NUM
aiua-11120	10	85	,	,	PUNCT
aiua-11120	10	86	14	14	NUM
aiua-11120	10	87	,	,	PUNCT
aiua-11120	10	88	konstantinos	konstantinos	PROPN
aiua-11120	10	89	stamatiou	stamatiou	PROPN
aiua-11120	10	90	12	12	NUM
aiua-11120	10	91	,	,	PUNCT
aiua-11120	10	92	14	14	NUM
aiua-11120	10	93	,	,	PUNCT
aiua-11120	10	94	alberto	alberto	PROPN
aiua-11120	10	95	trinchieri	trinchieri	ADJ
aiua-11120	10	96	13	13	NUM
aiua-11120	10	97	,	,	PUNCT
aiua-11120	10	98	14	14	NUM
aiua-11120	10	99	,	,	PUNCT
aiua-11120	10	100	noor	noor	PROPN
aiua-11120	10	101	buchholz	buchholz	PROPN
aiua-11120	10	102	14	14	NUM
aiua-11120	10	103	1	1	NUM
aiua-11120	10	104	smart	smart	ADJ
aiua-11120	10	105	health	health	NOUN
aiua-11120	10	106	tower	tower	NOUN
aiua-11120	10	107	,	,	PUNCT
aiua-11120	10	108	sulaymaniyah	sulaymaniyah	NOUN
aiua-11120	10	109	,	,	PUNCT
aiua-11120	10	110	kurdistan	kurdistan	PROPN
aiua-11120	10	111	region	region	NOUN
aiua-11120	10	112	,	,	PUNCT
aiua-11120	10	113	iraq	iraq	PROPN
aiua-11120	10	114	;	;	PUNCT
aiua-11120	10	115	2	2	NUM
aiua-11120	10	116	urology	urology	NOUN
aiua-11120	10	117	department	department	NOUN
aiua-11120	10	118	,	,	PUNCT
aiua-11120	10	119	hmc	hmc	PROPN
aiua-11120	10	120	,	,	PUNCT
aiua-11120	10	121	hamad	hamad	PROPN
aiua-11120	10	122	medical	medical	PROPN
aiua-11120	10	123	corporation	corporation	PROPN
aiua-11120	10	124	,	,	PUNCT
aiua-11120	10	125	qatar	qatar	PROPN
aiua-11120	10	126	;	;	PUNCT
aiua-11120	10	127	3	3	NUM
aiua-11120	10	128	department	department	NOUN
aiua-11120	10	129	of	of	ADP
aiua-11120	10	130	urology	urology	NOUN
aiua-11120	10	131	,	,	PUNCT
aiua-11120	10	132	zagazig	zagazig	PROPN
aiua-11120	10	133	university	university	PROPN
aiua-11120	10	134	,	,	PUNCT
aiua-11120	10	135	zagazig	zagazig	PROPN
aiua-11120	10	136	,	,	PUNCT
aiua-11120	10	137	sharkia	sharkia	PROPN
aiua-11120	10	138	,	,	PUNCT
aiua-11120	10	139	egypt	egypt	PROPN
aiua-11120	10	140	;	;	PUNCT
aiua-11120	10	141	4	4	NUM
aiua-11120	10	142	universidad	universidad	PROPN
aiua-11120	10	143	del	del	PROPN
aiua-11120	10	144	valle	valle	PROPN
aiua-11120	10	145	,	,	PUNCT
aiua-11120	10	146	cali	cali	PROPN
aiua-11120	10	147	,	,	PUNCT
aiua-11120	10	148	colombia	colombia	PROPN
aiua-11120	10	149	;	;	PUNCT
aiua-11120	10	150	5	5	NUM
aiua-11120	10	151	faculty	faculty	NOUN
aiua-11120	10	152	of	of	ADP
aiua-11120	10	153	medicine	medicine	NOUN
aiua-11120	10	154	algiers	algiers	PROPN
aiua-11120	10	155	1	1	NUM
aiua-11120	10	156	,	,	PUNCT
aiua-11120	10	157	algiers	algiers	PROPN
aiua-11120	10	158	,	,	PUNCT
aiua-11120	10	159	algeria	algeria	PROPN
aiua-11120	10	160	;	;	PUNCT
aiua-11120	10	161	6	6	NUM
aiua-11120	10	162	department	department	NOUN
aiua-11120	10	163	of	of	ADP
aiua-11120	10	164	urology	urology	NOUN
aiua-11120	10	165	,	,	PUNCT
aiua-11120	10	166	mercy	mercy	NOUN
aiua-11120	10	167	university	university	NOUN
aiua-11120	10	168	hospital	hospital	NOUN
aiua-11120	10	169	,	,	PUNCT
aiua-11120	10	170	cork	cork	NOUN
aiua-11120	10	171	,	,	PUNCT
aiua-11120	10	172	ireland	ireland	NOUN
aiua-11120	10	173	;	;	PUNCT
aiua-11120	10	174	7	7	NUM
aiua-11120	10	175	asst	asst	NOUN
aiua-11120	10	176	nord	nord	PROPN
aiua-11120	10	177	milano	milano	PROPN
aiua-11120	10	178	,	,	PUNCT
aiua-11120	10	179	milan	milan	PROPN
aiua-11120	10	180	,	,	PUNCT
aiua-11120	10	181	italy	italy	PROPN
aiua-11120	10	182	;	;	PUNCT
aiua-11120	10	183	8	8	NUM
aiua-11120	10	184	2nd	2nd	ADJ
aiua-11120	10	185	department	department	NOUN
aiua-11120	10	186	of	of	ADP
aiua-11120	10	187	urology	urology	NOUN
aiua-11120	10	188	,	,	PUNCT
aiua-11120	10	189	national	national	ADJ
aiua-11120	10	190	and	and	CCONJ
aiua-11120	10	191	kapodistrian	kapodistrian	ADJ
aiua-11120	10	192	university	university	PROPN
aiua-11120	10	193	of	of	ADP
aiua-11120	10	194	athens	athens	PROPN
aiua-11120	10	195	,	,	PUNCT
aiua-11120	10	196	sismanoglio	sismanoglio	PROPN
aiua-11120	10	197	hospital	hospital	PROPN
aiua-11120	10	198	,	,	PUNCT
aiua-11120	10	199	athens	athens	PROPN
aiua-11120	10	200	,	,	PUNCT
aiua-11120	10	201	greece	greece	PROPN
aiua-11120	10	202	;	;	PUNCT
aiua-11120	10	203	9	9	NUM
aiua-11120	10	204	division	division	NOUN
aiua-11120	10	205	of	of	ADP
aiua-11120	10	206	urology	urology	NOUN
aiua-11120	10	207	,	,	PUNCT
aiua-11120	10	208	souro	souro	NOUN
aiua-11120	10	209	sanou	sanou	PROPN
aiua-11120	10	210	university	university	NOUN
aiua-11120	10	211	teaching	teaching	NOUN
aiua-11120	10	212	hospital	hospital	NOUN
aiua-11120	10	213	,	,	PUNCT
aiua-11120	10	214	bobo	bobo	NOUN
aiua-11120	10	215	-	-	PUNCT
aiua-11120	10	216	dioulasso	dioulasso	PROPN
aiua-11120	10	217	,	,	PUNCT
aiua-11120	10	218	burkina	burkina	PROPN
aiua-11120	10	219	faso	faso	PROPN
aiua-11120	10	220	;	;	PUNCT
aiua-11120	10	221	10	10	NUM
aiua-11120	10	222	department	department	NOUN
aiua-11120	10	223	of	of	ADP
aiua-11120	10	224	biotechnology	biotechnology	NOUN
aiua-11120	10	225	and	and	CCONJ
aiua-11120	10	226	life	life	NOUN
aiua-11120	10	227	sciences	science	NOUN
aiua-11120	10	228	,	,	PUNCT
aiua-11120	10	229	section	section	NOUN
aiua-11120	10	230	of	of	ADP
aiua-11120	10	231	medical	medical	ADJ
aiua-11120	10	232	and	and	CCONJ
aiua-11120	10	233	surgical	surgical	ADJ
aiua-11120	10	234	sciences	science	NOUN
aiua-11120	10	235	,	,	PUNCT
aiua-11120	10	236	university	university	NOUN
aiua-11120	10	237	of	of	ADP
aiua-11120	10	238	insubria	insubria	PROPN
aiua-11120	10	239	,	,	PUNCT
aiua-11120	10	240	varese	varese	PROPN
aiua-11120	10	241	,	,	PUNCT
aiua-11120	10	242	italy	italy	PROPN
aiua-11120	10	243	;	;	PUNCT
aiua-11120	10	244	11	11	NUM
aiua-11120	10	245	department	department	NOUN
aiua-11120	10	246	of	of	ADP
aiua-11120	10	247	urology	urology	NOUN
aiua-11120	10	248	,	,	PUNCT
aiua-11120	10	249	mahatma	mahatma	PROPN
aiua-11120	10	250	gandhi	gandhi	PROPN
aiua-11120	10	251	medical	medical	PROPN
aiua-11120	10	252	college	college	PROPN
aiua-11120	10	253	and	and	CCONJ
aiua-11120	10	254	research	research	PROPN
aiua-11120	10	255	institute	institute	PROPN
aiua-11120	10	256	,	,	PUNCT
aiua-11120	10	257	sri	sri	PROPN
aiua-11120	10	258	balaji	balaji	PROPN
aiua-11120	10	259	vidyapeeth	vidyapeeth	PROPN
aiua-11120	10	260	,	,	PUNCT
aiua-11120	10	261	puducherry	puducherry	PROPN
aiua-11120	10	262	,	,	PUNCT
aiua-11120	10	263	india	india	PROPN
aiua-11120	10	264	;	;	PUNCT
aiua-11120	10	265	12	12	NUM
aiua-11120	10	266	department	department	NOUN
aiua-11120	10	267	of	of	ADP
aiua-11120	10	268	urology	urology	NOUN
aiua-11120	10	269	,	,	PUNCT
aiua-11120	10	270	tzaneio	tzaneio	PROPN
aiua-11120	10	271	general	general	ADJ
aiua-11120	10	272	hospital	hospital	NOUN
aiua-11120	10	273	,	,	PUNCT
aiua-11120	10	274	18536	18536	NUM
aiua-11120	10	275	piraeus	piraeus	NOUN
aiua-11120	10	276	,	,	PUNCT
aiua-11120	10	277	greece	greece	PROPN
aiua-11120	10	278	;	;	PUNCT
aiua-11120	10	279	13	13	NUM
aiua-11120	10	280	urology	urology	NOUN
aiua-11120	10	281	school	school	NOUN
aiua-11120	10	282	,	,	PUNCT
aiua-11120	10	283	university	university	PROPN
aiua-11120	10	284	of	of	ADP
aiua-11120	10	285	milan	milan	PROPN
aiua-11120	10	286	,	,	PUNCT
aiua-11120	10	287	milan	milan	PROPN
aiua-11120	10	288	,	,	PUNCT
aiua-11120	10	289	italy	italy	PROPN
aiua-11120	10	290	;	;	PUNCT
aiua-11120	10	291	14	14	NUM
aiua-11120	10	292	u	u	NOUN
aiua-11120	10	293	-	-	ADJ
aiua-11120	10	294	merge	merge	ADJ
aiua-11120	10	295	ltd	ltd	PROPN
aiua-11120	10	296	.	.	PUNCT
aiua-11120	11	1	(	(	PUNCT
aiua-11120	11	2	urology	urology	NOUN
aiua-11120	11	3	for	for	ADP
aiua-11120	11	4	emerging	emerge	VERB
aiua-11120	11	5	countries	country	NOUN
aiua-11120	11	6	)	)	PUNCT
aiua-11120	11	7	,	,	PUNCT
aiua-11120	11	8	london	london	PROPN
aiua-11120	11	9	-	-	PUNCT
aiua-11120	11	10	athens	athens	PROPN
aiua-11120	11	11	-	-	PUNCT
aiua-11120	11	12	dubai	dubai	NOUN
aiua-11120	11	13	*	*	PUNCT
aiua-11120	11	14	authors	author	NOUN
aiua-11120	11	15	1	1	NUM
aiua-11120	11	16	-	-	SYM
aiua-11120	11	17	14	14	NUM
aiua-11120	11	18	have	have	AUX
aiua-11120	11	19	equally	equally	ADV
aiua-11120	11	20	contributed	contribute	VERB
aiua-11120	11	21	to	to	ADP
aiua-11120	11	22	the	the	DET
aiua-11120	11	23	paper	paper	NOUN
aiua-11120	11	24	and	and	CCONJ
aiua-11120	11	25	share	share	VERB
aiua-11120	11	26	first	first	ADJ
aiua-11120	11	27	authorship	authorship	NOUN
aiua-11120	11	28	.	.	PUNCT
aiua-11120	12	1	*	*	PUNCT
aiua-11120	12	2	u	u	ADJ
aiua-11120	12	3	-	-	ADJ
aiua-11120	12	4	merge	merge	PROPN
aiua-11120	12	5	ltd	ltd	PROPN
aiua-11120	12	6	.	.	PUNCT
aiua-11120	13	1	(	(	PUNCT
aiua-11120	13	2	urology	urology	NOUN
aiua-11120	13	3	for	for	ADP
aiua-11120	13	4	emerging	emerge	VERB
aiua-11120	13	5	countries	country	NOUN
aiua-11120	13	6	)	)	PUNCT
aiua-11120	13	7	is	be	AUX
aiua-11120	13	8	an	an	DET
aiua-11120	13	9	academic	academic	ADJ
aiua-11120	13	10	urological	urological	ADJ
aiua-11120	13	11	platform	platform	NOUN
aiua-11120	13	12	dedicated	dedicate	VERB
aiua-11120	13	13	to	to	PART
aiua-11120	13	14	facilitate	facilitate	VERB
aiua-11120	13	15	knowledge	knowledge	NOUN
aiua-11120	13	16	transfer	transfer	NOUN
aiua-11120	13	17	in	in	ADP
aiua-11120	13	18	urology	urology	NOUN
aiua-11120	13	19	on	on	ADP
aiua-11120	13	20	all	all	DET
aiua-11120	13	21	levels	level	NOUN
aiua-11120	13	22	from	from	ADP
aiua-11120	13	23	developed	develop	VERB
aiua-11120	13	24	to	to	ADP
aiua-11120	13	25	emerging	emerge	VERB
aiua-11120	13	26	countries	country	NOUN
aiua-11120	13	27	.	.	PUNCT
aiua-11120	14	1	u	u	ADJ
aiua-11120	14	2	-	-	ADJ
aiua-11120	14	3	merge	merge	PROPN
aiua-11120	14	4	ltd	ltd	PROPN
aiua-11120	14	5	.	.	PROPN
aiua-11120	14	6	is	be	AUX
aiua-11120	14	7	registered	register	VERB
aiua-11120	14	8	with	with	ADP
aiua-11120	14	9	the	the	DET
aiua-11120	14	10	companies	company	NOUN
aiua-11120	14	11	house	house	VERB
aiua-11120	14	12	in	in	ADP
aiua-11120	14	13	london/	london/	NUM
aiua-11120	14	14	uk	uk	PROPN
aiua-11120	14	15	.	.	PROPN
aiua-11120	14	16	www.u-merge.com	www.u-merge.com	PROPN
aiua-11120	14	17	doi	doi	PROPN
aiua-11120	14	18	:	:	PUNCT
aiua-11120	14	19	10.4081	10.4081	NUM
aiua-11120	14	20	/	/	SYM
aiua-11120	14	21	aiua.2022.4.492	aiua.2022.4.492	PROPN
aiua-11120	14	22	summary	summary	NOUN
aiua-11120	14	23	effective	effective	ADJ
aiua-11120	14	24	than	than	ADP
aiua-11120	14	25	placebo	placebo	NOUN
aiua-11120	14	26	in	in	ADP
aiua-11120	14	27	increasing	increase	VERB
aiua-11120	14	28	the	the	DET
aiua-11120	14	29	cystometric	cystometric	ADJ
aiua-11120	14	30	capacity	capacity	NOUN
aiua-11120	14	31	in	in	ADP
aiua-11120	14	32	patients	patient	NOUN
aiua-11120	14	33	with	with	ADP
aiua-11120	14	34	ms	ms	PROPN
aiua-11120	14	35	(	(	PUNCT
aiua-11120	14	36	mean	mean	INTJ
aiua-11120	14	37	difference	difference	NOUN
aiua-11120	14	38	[	[	X
aiua-11120	14	39	md	md	X
aiua-11120	14	40	]	]	X
aiua-11120	14	41	89.89	89.89	NUM
aiua-11120	14	42	ml	ml	NOUN
aiua-11120	14	43	,	,	PUNCT
aiua-11120	14	44	95	95	NUM
aiua-11120	14	45	%	%	NOUN
aiua-11120	14	46	ci	ci	NOUN
aiua-11120	14	47	29.76	29.76	NUM
aiua-11120	14	48	to	to	ADP
aiua-11120	14	49	150.01	150.01	NUM
aiua-11120	14	50	,	,	PUNCT
aiua-11120	14	51	2	2	NUM
aiua-11120	14	52	trials	trial	NOUN
aiua-11120	14	53	,	,	PUNCT
aiua-11120	14	54	98	98	NUM
aiua-11120	14	55	patients	patient	NOUN
aiua-11120	14	56	,	,	PUNCT
aiua-11120	14	57	p	p	X
aiua-11120	14	58	<	<	X
aiua-11120	14	59	0.003	0.003	NUM
aiua-11120	14	60	)	)	PUNCT
aiua-11120	14	61	but	but	CCONJ
aiua-11120	14	62	no	no	DET
aiua-11120	14	63	significant	significant	ADJ
aiua-11120	14	64	difference	difference	NOUN
aiua-11120	14	65	was	be	AUX
aiua-11120	14	66	observed	observe	VERB
aiua-11120	14	67	for	for	ADP
aiua-11120	14	68	symptom	symptom	NOUN
aiua-11120	14	69	scores	score	NOUN
aiua-11120	14	70	and	and	CCONJ
aiua-11120	14	71	bladder	bladder	NOUN
aiua-11120	14	72	diary	diary	NOUN
aiua-11120	14	73	parameters	parameter	NOUN
aiua-11120	14	74	.	.	PUNCT
aiua-11120	15	1	ttns	ttns	PROPN
aiua-11120	15	2	was	be	AUX
aiua-11120	15	3	more	more	ADV
aiua-11120	15	4	effective	effective	ADJ
aiua-11120	15	5	than	than	ADP
aiua-11120	15	6	its	its	PRON
aiua-11120	15	7	sham	sham	NOUN
aiua-11120	15	8	-	-	PUNCT
aiua-11120	15	9	control	control	NOUN
aiua-11120	15	10	in	in	ADP
aiua-11120	15	11	decreasing	decrease	VERB
aiua-11120	15	12	the	the	DET
aiua-11120	15	13	number	number	NOUN
aiua-11120	15	14	of	of	ADP
aiua-11120	15	15	nocturia	nocturia	PROPN
aiua-11120	15	16	episodes	episode	NOUN
aiua-11120	15	17	(	(	PUNCT
aiua-11120	15	18	md	md	PROPN
aiua-11120	15	19	-1.40	-1.40	NOUN
aiua-11120	15	20	,	,	PUNCT
aiua-11120	15	21	95	95	NUM
aiua-11120	15	22	%	%	NOUN
aiua-11120	15	23	ci	ci	NOUN
aiua-11120	15	24	-2.39	-2.39	NOUN
aiua-11120	15	25	to	to	ADP
aiua-11120	15	26	-0.42	-0.42	NUM
aiua-11120	15	27	,	,	PUNCT
aiua-11120	15	28	2	2	NUM
aiua-11120	15	29	trials	trial	NOUN
aiua-11120	15	30	,	,	PUNCT
aiua-11120	15	31	53	53	NUM
aiua-11120	15	32	patients	patient	NOUN
aiua-11120	15	33	,	,	PUNCT
aiua-11120	15	34	p	p	X
aiua-11120	15	35	<	<	X
aiua-11120	15	36	0.005	0.005	NUM
aiua-11120	15	37	)	)	PUNCT
aiua-11120	15	38	but	but	CCONJ
aiua-11120	15	39	no	no	DET
aiua-11120	15	40	significant	significant	ADJ
aiua-11120	15	41	changes	change	NOUN
aiua-11120	15	42	of	of	ADP
aiua-11120	15	43	oab	oab	PROPN
aiua-11120	15	44	symptom	symptom	NOUN
aiua-11120	15	45	scores	score	NOUN
aiua-11120	15	46	were	be	AUX
aiua-11120	15	47	reported	report	VERB
aiua-11120	15	48	.	.	PUNCT
aiua-11120	16	1	pfmt	pfmt	NOUN
aiua-11120	16	2	was	be	AUX
aiua-11120	16	3	more	more	ADV
aiua-11120	16	4	effective	effective	ADJ
aiua-11120	16	5	than	than	ADP
aiua-11120	16	6	conservative	conservative	ADJ
aiua-11120	16	7	advice	advice	NOUN
aiua-11120	16	8	in	in	ADP
aiua-11120	16	9	decreasing	decrease	VERB
aiua-11120	16	10	the	the	DET
aiua-11120	16	11	iciq	iciq	NOUN
aiua-11120	16	12	symptom	symptom	NOUN
aiua-11120	16	13	score	score	NOUN
aiua-11120	16	14	(	(	PUNCT
aiua-11120	16	15	md	md	PROPN
aiua-11120	16	16	,	,	PUNCT
aiua-11120	16	17	-1.12	-1.12	NOUN
aiua-11120	16	18	,	,	PUNCT
aiua-11120	16	19	95	95	NUM
aiua-11120	16	20	%	%	NOUN
aiua-11120	16	21	ci	ci	NOUN
aiua-11120	16	22	-2.13	-2.13	PRON
aiua-11120	16	23	to	to	ADP
aiua-11120	16	24	-0.11	-0.11	NUM
aiua-11120	16	25	,	,	PUNCT
aiua-11120	16	26	2	2	NUM
aiua-11120	16	27	trials	trial	NOUN
aiua-11120	16	28	,	,	PUNCT
aiua-11120	16	29	91	91	NUM
aiua-11120	16	30	patients	patient	NOUN
aiua-11120	16	31	,	,	PUNCT
aiua-11120	16	32	p	p	X
aiua-11120	16	33	=	=	NOUN
aiua-11120	16	34	0.03	0.03	NUM
aiua-11120	16	35	)	)	PUNCT
aiua-11120	16	36	,	,	PUNCT
aiua-11120	16	37	although	although	SCONJ
aiua-11120	16	38	the	the	DET
aiua-11120	16	39	number	number	NOUN
aiua-11120	16	40	of	of	ADP
aiua-11120	16	41	incontinence	incontinence	NOUN
aiua-11120	16	42	episodes	episode	NOUN
aiua-11120	16	43	was	be	AUX
aiua-11120	16	44	not	not	PART
aiua-11120	16	45	significantly	significantly	ADV
aiua-11120	16	46	different	different	ADJ
aiua-11120	16	47	between	between	ADP
aiua-11120	16	48	groups	group	NOUN
aiua-11120	16	49	.	.	PUNCT
aiua-11120	17	1	conclusions	conclusion	NOUN
aiua-11120	17	2	:	:	PUNCT
aiua-11120	17	3	the	the	DET
aiua-11120	17	4	results	result	NOUN
aiua-11120	17	5	of	of	ADP
aiua-11120	17	6	the	the	DET
aiua-11120	17	7	meta	meta	ADJ
aiua-11120	17	8	-	-	PUNCT
aiua-11120	17	9	analysis	analysis	NOUN
aiua-11120	17	10	demonstrate	demonstrate	VERB
aiua-11120	17	11	a	a	DET
aiua-11120	17	12	moderate	moderate	ADJ
aiua-11120	17	13	efficacy	efficacy	NOUN
aiua-11120	17	14	of	of	ADP
aiua-11120	17	15	all	all	DET
aiua-11120	17	16	considered	consider	VERB
aiua-11120	17	17	treatments	treatment	NOUN
aiua-11120	17	18	without	without	ADP
aiua-11120	17	19	proving	prove	VERB
aiua-11120	17	20	the	the	DET
aiua-11120	17	21	superiority	superiority	NOUN
aiua-11120	17	22	of	of	ADP
aiua-11120	17	23	one	one	NUM
aiua-11120	17	24	therapy	therapy	NOUN
aiua-11120	17	25	over	over	ADP
aiua-11120	17	26	the	the	DET
aiua-11120	17	27	others	other	NOUN
aiua-11120	17	28	.	.	PUNCT
aiua-11120	18	1	combination	combination	NOUN
aiua-11120	18	2	treatment	treatment	NOUN
aiua-11120	18	3	using	use	VERB
aiua-11120	18	4	different	different	ADJ
aiua-11120	18	5	pharmacological	pharmacological	NOUN
aiua-11120	18	6	and	and	CCONJ
aiua-11120	18	7	non	non	ADJ
aiua-11120	18	8	-	-	ADJ
aiua-11120	18	9	pharmacological	pharmacological	ADJ
aiua-11120	18	10	therapies	therapy	NOUN
aiua-11120	18	11	could	could	AUX
aiua-11120	18	12	achieve	achieve	VERB
aiua-11120	18	13	the	the	DET
aiua-11120	18	14	best	good	ADJ
aiua-11120	18	15	clinical	clinical	ADJ
aiua-11120	18	16	efficacy	efficacy	NOUN
aiua-11120	18	17	due	due	ADP
aiua-11120	18	18	to	to	ADP
aiua-11120	18	19	the	the	DET
aiua-11120	18	20	favorable	favorable	ADJ
aiua-11120	18	21	combination	combination	NOUN
aiua-11120	18	22	of	of	ADP
aiua-11120	18	23	the	the	DET
aiua-11120	18	24	different	different	ADJ
aiua-11120	18	25	mechanisms	mechanism	NOUN
aiua-11120	18	26	of	of	ADP
aiua-11120	18	27	action	action	NOUN
aiua-11120	18	28	.	.	PUNCT
aiua-11120	19	1	this	this	PRON
aiua-11120	19	2	could	could	AUX
aiua-11120	19	3	be	be	AUX
aiua-11120	19	4	associated	associate	VERB
aiua-11120	19	5	with	with	ADP
aiua-11120	19	6	fewer	few	ADJ
aiua-11120	19	7	side	side	ADJ
aiua-11120	19	8	effects	effect	NOUN
aiua-11120	19	9	due	due	ADJ
aiua-11120	19	10	to	to	ADP
aiua-11120	19	11	drug	drug	NOUN
aiua-11120	19	12	dosage	dosage	NOUN
aiua-11120	19	13	reduction	reduction	NOUN
aiua-11120	19	14	.	.	PUNCT
aiua-11120	20	1	these	these	DET
aiua-11120	20	2	data	datum	NOUN
aiua-11120	20	3	are	be	AUX
aiua-11120	20	4	only	only	ADV
aiua-11120	20	5	provisional	provisional	ADJ
aiua-11120	20	6	and	and	CCONJ
aiua-11120	20	7	should	should	AUX
aiua-11120	20	8	be	be	AUX
aiua-11120	20	9	considered	consider	VERB
aiua-11120	20	10	with	with	ADP
aiua-11120	20	11	caution	caution	NOUN
aiua-11120	20	12	,	,	PUNCT
aiua-11120	20	13	due	due	ADP
aiua-11120	20	14	to	to	ADP
aiua-11120	20	15	the	the	DET
aiua-11120	20	16	few	few	ADJ
aiua-11120	20	17	studies	study	NOUN
aiua-11120	20	18	included	include	VERB
aiua-11120	20	19	in	in	ADP
aiua-11120	20	20	metaanalysis	metaanalysis	NOUN
aiua-11120	20	21	and	and	CCONJ
aiua-11120	20	22	to	to	ADP
aiua-11120	20	23	the	the	DET
aiua-11120	20	24	small	small	ADJ
aiua-11120	20	25	number	number	NOUN
aiua-11120	20	26	of	of	ADP
aiua-11120	20	27	patients	patient	NOUN
aiua-11120	20	28	.	.	PUNCT
aiua-11120	21	1	key	key	ADJ
aiua-11120	21	2	words	word	NOUN
aiua-11120	21	3	:	:	PUNCT
aiua-11120	21	4	overactive	overactive	ADJ
aiua-11120	21	5	bladder	bladder	NOUN
aiua-11120	21	6	;	;	PUNCT
aiua-11120	21	7	urinary	urinary	ADJ
aiua-11120	21	8	incontinence	incontinence	NOUN
aiua-11120	21	9	,	,	PUNCT
aiua-11120	21	10	urge	urge	NOUN
aiua-11120	21	11	;	;	PUNCT
aiua-11120	21	12	multiple	multiple	ADJ
aiua-11120	21	13	sclerosis	sclerosis	NOUN
aiua-11120	21	14	;	;	PUNCT
aiua-11120	21	15	ischemic	ischemic	ADJ
aiua-11120	21	16	stroke	stroke	NOUN
aiua-11120	21	17	;	;	PUNCT
aiua-11120	21	18	parkinson	parkinson	NOUN
aiua-11120	21	19	disease	disease	NOUN
aiua-11120	21	20	;	;	PUNCT
aiua-11120	21	21	anticholinergics	anticholinergic	NOUN
aiua-11120	21	22	;	;	PUNCT
aiua-11120	21	23	mirabegron	mirabegron	PROPN
aiua-11120	21	24	;	;	PUNCT
aiua-11120	21	25	cannabinoids	cannabinoid	NOUN
aiua-11120	21	26	;	;	PUNCT
aiua-11120	21	27	transcutaneous	transcutaneous	ADJ
aiua-11120	21	28	tibial	tibial	ADJ
aiua-11120	21	29	nerve	nerve	NOUN
aiua-11120	21	30	stimulation	stimulation	NOUN
aiua-11120	21	31	(	(	PUNCT
aiua-11120	21	32	ttns	ttns	NOUN
aiua-11120	21	33	)	)	PUNCT
aiua-11120	21	34	;	;	PUNCT
aiua-11120	21	35	pelvic	pelvic	ADJ
aiua-11120	21	36	floor	floor	NOUN
aiua-11120	21	37	muscle	muscle	NOUN
aiua-11120	21	38	training	training	NOUN
aiua-11120	21	39	(	(	PUNCT
aiua-11120	21	40	pfmt	pfmt	NOUN
aiua-11120	21	41	)	)	PUNCT
aiua-11120	21	42	.	.	PUNCT
aiua-11120	21	43	submitted	submit	VERB
aiua-11120	21	44	5	5	NUM
aiua-11120	21	45	november	november	PROPN
aiua-11120	21	46	2022	2022	NUM
aiua-11120	21	47	;	;	PUNCT
aiua-11120	21	48	accepted	accept	VERB
aiua-11120	21	49	15	15	NUM
aiua-11120	21	50	november	november	NOUN
aiua-11120	21	51	2022	2022	NUM
aiua-11120	21	52	493archivio	493archivio	PROPN
aiua-11120	21	53	italiano	italiano	NOUN
aiua-11120	21	54	di	di	X
aiua-11120	21	55	urologia	urologia	PROPN
aiua-11120	21	56	e	e	PROPN
aiua-11120	21	57	andrologia	andrologia	PROPN
aiua-11120	21	58	2022	2022	NUM
aiua-11120	21	59	;	;	PUNCT
aiua-11120	21	60	94	94	NUM
aiua-11120	21	61	,	,	PUNCT
aiua-11120	21	62	4	4	NUM
aiua-11120	21	63	treatment	treatment	NOUN
aiua-11120	21	64	of	of	ADP
aiua-11120	21	65	overactive	overactive	ADJ
aiua-11120	21	66	neurogenic	neurogenic	ADJ
aiua-11120	21	67	bladder	bladder	NOUN
aiua-11120	21	68	introduction	introduction	NOUN
aiua-11120	21	69	voiding	void	VERB
aiua-11120	21	70	dysfunction	dysfunction	NOUN
aiua-11120	21	71	often	often	ADV
aiua-11120	21	72	develops	develop	VERB
aiua-11120	21	73	in	in	ADP
aiua-11120	21	74	patients	patient	NOUN
aiua-11120	21	75	with	with	ADP
aiua-11120	21	76	underlying	underlying	ADJ
aiua-11120	21	77	neurological	neurological	ADJ
aiua-11120	21	78	diseases	disease	NOUN
aiua-11120	21	79	.	.	PUNCT
aiua-11120	22	1	patients	patient	NOUN
aiua-11120	22	2	may	may	AUX
aiua-11120	22	3	present	present	VERB
aiua-11120	22	4	with	with	ADP
aiua-11120	22	5	overactive	overactive	ADJ
aiua-11120	22	6	bladder	bladder	NOUN
aiua-11120	22	7	(	(	PUNCT
aiua-11120	22	8	oab	oab	PROPN
aiua-11120	22	9	)	)	PUNCT
aiua-11120	22	10	symptoms	symptom	NOUN
aiua-11120	22	11	of	of	ADP
aiua-11120	22	12	frequency	frequency	NOUN
aiua-11120	22	13	,	,	PUNCT
aiua-11120	22	14	urgency	urgency	NOUN
aiua-11120	22	15	and	and	CCONJ
aiua-11120	22	16	urge	urge	ADJ
aiua-11120	22	17	incontinence	incontinence	NOUN
aiua-11120	22	18	.	.	PUNCT
aiua-11120	23	1	oab	oab	PROPN
aiua-11120	23	2	in	in	ADP
aiua-11120	23	3	patients	patient	NOUN
aiua-11120	23	4	with	with	ADP
aiua-11120	23	5	known	know	VERB
aiua-11120	23	6	neurological	neurological	ADJ
aiua-11120	23	7	diseases	disease	NOUN
aiua-11120	23	8	(	(	PUNCT
aiua-11120	23	9	neurogenic	neurogenic	ADJ
aiua-11120	23	10	overactive	overactive	ADJ
aiua-11120	23	11	bladder	bladder	NOUN
aiua-11120	23	12	)	)	PUNCT
aiua-11120	23	13	is	be	AUX
aiua-11120	23	14	related	relate	VERB
aiua-11120	23	15	to	to	ADP
aiua-11120	23	16	disturbances	disturbance	NOUN
aiua-11120	23	17	of	of	ADP
aiua-11120	23	18	the	the	DET
aiua-11120	23	19	neurological	neurological	ADJ
aiua-11120	23	20	control	control	NOUN
aiua-11120	23	21	of	of	ADP
aiua-11120	23	22	micturition	micturition	NOUN
aiua-11120	23	23	.	.	PUNCT
aiua-11120	24	1	oab	oab	PROPN
aiua-11120	24	2	symptoms	symptom	NOUN
aiua-11120	24	3	are	be	AUX
aiua-11120	24	4	highly	highly	ADV
aiua-11120	24	5	prevalent	prevalent	ADJ
aiua-11120	24	6	among	among	ADP
aiua-11120	24	7	patients	patient	NOUN
aiua-11120	24	8	with	with	ADP
aiua-11120	24	9	multiple	multiple	ADJ
aiua-11120	24	10	sclerosis	sclerosis	NOUN
aiua-11120	24	11	(	(	PUNCT
aiua-11120	24	12	ms	ms	NOUN
aiua-11120	24	13	)	)	PUNCT
aiua-11120	24	14	,	,	PUNCT
aiua-11120	24	15	spinal	spinal	NOUN
aiua-11120	24	16	cord	cord	NOUN
aiua-11120	24	17	injury	injury	NOUN
aiua-11120	24	18	(	(	PUNCT
aiua-11120	24	19	sci	sci	PROPN
aiua-11120	24	20	)	)	PUNCT
aiua-11120	24	21	,	,	PUNCT
aiua-11120	24	22	parkinson	parkinson	NOUN
aiua-11120	24	23	’s	’s	PART
aiua-11120	24	24	disease	disease	NOUN
aiua-11120	24	25	(	(	PUNCT
aiua-11120	24	26	pd	pd	PROPN
aiua-11120	24	27	)	)	PUNCT
aiua-11120	24	28	,	,	PUNCT
aiua-11120	24	29	various	various	ADJ
aiua-11120	24	30	neurological	neurological	ADJ
aiua-11120	24	31	diseases	disease	NOUN
aiua-11120	24	32	,	,	PUNCT
aiua-11120	24	33	and	and	CCONJ
aiua-11120	24	34	stroke	stroke	NOUN
aiua-11120	24	35	.	.	PUNCT
aiua-11120	25	1	this	this	PRON
aiua-11120	25	2	was	be	AUX
aiua-11120	25	3	shown	show	VERB
aiua-11120	25	4	by	by	ADP
aiua-11120	25	5	a	a	DET
aiua-11120	25	6	recent	recent	ADJ
aiua-11120	25	7	study	study	NOUN
aiua-11120	25	8	demonstrating	demonstrate	VERB
aiua-11120	25	9	oab	oab	PROPN
aiua-11120	25	10	symptoms	symptom	NOUN
aiua-11120	25	11	in	in	ADP
aiua-11120	25	12	over	over	ADP
aiua-11120	25	13	50	50	NUM
aiua-11120	25	14	%	%	NOUN
aiua-11120	25	15	of	of	ADP
aiua-11120	25	16	these	these	DET
aiua-11120	25	17	patients	patient	NOUN
aiua-11120	25	18	(	(	PUNCT
aiua-11120	25	19	1	1	NUM
aiua-11120	25	20	)	)	PUNCT
aiua-11120	25	21	.	.	PUNCT
aiua-11120	26	1	symptoms	symptom	NOUN
aiua-11120	26	2	vary	vary	VERB
aiua-11120	26	3	from	from	ADP
aiua-11120	26	4	mild	mild	ADJ
aiua-11120	26	5	lower	low	ADJ
aiua-11120	26	6	urinary	urinary	ADJ
aiua-11120	26	7	tract	tract	NOUN
aiua-11120	26	8	symptoms	symptom	NOUN
aiua-11120	26	9	(	(	PUNCT
aiua-11120	26	10	luts	luts	PROPN
aiua-11120	26	11	)	)	PUNCT
aiua-11120	26	12	,	,	PUNCT
aiua-11120	26	13	that	that	PRON
aiua-11120	26	14	are	be	AUX
aiua-11120	26	15	often	often	ADV
aiua-11120	26	16	poorly	poorly	ADV
aiua-11120	26	17	recognized	recognize	VERB
aiua-11120	26	18	or	or	CCONJ
aiua-11120	26	19	misdiagnosed	misdiagnose	VERB
aiua-11120	26	20	in	in	ADP
aiua-11120	26	21	men	man	NOUN
aiua-11120	26	22	as	as	ADP
aiua-11120	26	23	prostatic	prostatic	ADJ
aiua-11120	26	24	disease	disease	NOUN
aiua-11120	26	25	,	,	PUNCT
aiua-11120	26	26	to	to	ADP
aiua-11120	26	27	severe	severe	ADJ
aiua-11120	26	28	clinical	clinical	ADJ
aiua-11120	26	29	conditions	condition	NOUN
aiua-11120	26	30	like	like	ADP
aiua-11120	26	31	those	those	PRON
aiua-11120	26	32	observed	observe	VERB
aiua-11120	26	33	after	after	ADP
aiua-11120	26	34	spinal	spinal	PROPN
aiua-11120	26	35	cord	cord	NOUN
aiua-11120	26	36	injury	injury	NOUN
aiua-11120	26	37	(	(	PUNCT
aiua-11120	26	38	sci	sci	PROPN
aiua-11120	26	39	)	)	PUNCT
aiua-11120	26	40	.	.	PUNCT
aiua-11120	27	1	the	the	DET
aiua-11120	27	2	severity	severity	NOUN
aiua-11120	27	3	of	of	ADP
aiua-11120	27	4	symptoms	symptom	NOUN
aiua-11120	27	5	depends	depend	VERB
aiua-11120	27	6	on	on	ADP
aiua-11120	27	7	the	the	DET
aiua-11120	27	8	type	type	NOUN
aiua-11120	27	9	and	and	CCONJ
aiua-11120	27	10	degree	degree	NOUN
aiua-11120	27	11	of	of	ADP
aiua-11120	27	12	damage	damage	NOUN
aiua-11120	27	13	to	to	ADP
aiua-11120	27	14	the	the	DET
aiua-11120	27	15	nervous	nervous	ADJ
aiua-11120	27	16	system	system	NOUN
aiua-11120	27	17	.	.	PUNCT
aiua-11120	28	1	as	as	SCONJ
aiua-11120	28	2	the	the	DET
aiua-11120	28	3	neurological	neurological	ADJ
aiua-11120	28	4	condition	condition	NOUN
aiua-11120	28	5	progresses	progress	VERB
aiua-11120	28	6	,	,	PUNCT
aiua-11120	28	7	the	the	DET
aiua-11120	28	8	bladder	bladder	NOUN
aiua-11120	28	9	function	function	NOUN
aiua-11120	28	10	progressively	progressively	ADV
aiua-11120	28	11	deteriorates	deteriorate	VERB
aiua-11120	28	12	,	,	PUNCT
aiua-11120	28	13	and	and	CCONJ
aiua-11120	28	14	becomes	become	VERB
aiua-11120	28	15	more	more	ADV
aiua-11120	28	16	difficult	difficult	ADJ
aiua-11120	28	17	to	to	PART
aiua-11120	28	18	treat	treat	VERB
aiua-11120	28	19	.	.	PUNCT
aiua-11120	29	1	incontinence	incontinence	NOUN
aiua-11120	29	2	frequently	frequently	ADV
aiua-11120	29	3	develops	develop	VERB
aiua-11120	29	4	as	as	ADP
aiua-11120	29	5	a	a	DET
aiua-11120	29	6	consequence	consequence	NOUN
aiua-11120	29	7	of	of	ADP
aiua-11120	29	8	disease	disease	NOUN
aiua-11120	29	9	progression	progression	NOUN
aiua-11120	29	10	.	.	PUNCT
aiua-11120	30	1	conservative	conservative	ADJ
aiua-11120	30	2	management	management	NOUN
aiua-11120	30	3	includes	include	VERB
aiua-11120	30	4	pharmacological	pharmacological	ADJ
aiua-11120	30	5	treatment	treatment	NOUN
aiua-11120	30	6	to	to	PART
aiua-11120	30	7	reduce	reduce	VERB
aiua-11120	30	8	the	the	DET
aiua-11120	30	9	contractility	contractility	NOUN
aiua-11120	30	10	of	of	ADP
aiua-11120	30	11	the	the	DET
aiua-11120	30	12	detrusor	detrusor	NOUN
aiua-11120	30	13	muscle	muscle	NOUN
aiua-11120	30	14	,	,	PUNCT
aiua-11120	30	15	behavioral	behavioral	ADJ
aiua-11120	30	16	therapy	therapy	NOUN
aiua-11120	30	17	and	and	CCONJ
aiua-11120	30	18	biofeedback	biofeedback	NOUN
aiua-11120	30	19	,	,	PUNCT
aiua-11120	30	20	electrical	electrical	ADJ
aiua-11120	30	21	stimulation	stimulation	NOUN
aiua-11120	30	22	,	,	PUNCT
aiua-11120	30	23	or	or	CCONJ
aiua-11120	30	24	chemical	chemical	NOUN
aiua-11120	30	25	denervation	denervation	NOUN
aiua-11120	30	26	procedures	procedure	NOUN
aiua-11120	30	27	(	(	PUNCT
aiua-11120	30	28	instillation	instillation	NOUN
aiua-11120	30	29	of	of	ADP
aiua-11120	30	30	capsaicin	capsaicin	PROPN
aiua-11120	30	31	and	and	CCONJ
aiua-11120	30	32	resiniferatoxin	resiniferatoxin	NOUN
aiua-11120	30	33	or	or	CCONJ
aiua-11120	30	34	intradetrusorial	intradetrusorial	ADJ
aiua-11120	30	35	injection	injection	NOUN
aiua-11120	30	36	of	of	ADP
aiua-11120	30	37	botulinum	botulinum	ADJ
aiua-11120	30	38	toxin	toxin	NOUN
aiua-11120	30	39	)	)	PUNCT
aiua-11120	30	40	.	.	PUNCT
aiua-11120	31	1	no	no	DET
aiua-11120	31	2	single	single	ADJ
aiua-11120	31	3	treatment	treatment	NOUN
aiua-11120	31	4	exists	exist	VERB
aiua-11120	31	5	for	for	ADP
aiua-11120	31	6	neurogenic	neurogenic	ADJ
aiua-11120	31	7	oab	oab	PROPN
aiua-11120	31	8	due	due	ADP
aiua-11120	31	9	to	to	ADP
aiua-11120	31	10	the	the	DET
aiua-11120	31	11	complexity	complexity	NOUN
aiua-11120	31	12	and	and	CCONJ
aiua-11120	31	13	individual	individual	ADJ
aiua-11120	31	14	variability	variability	NOUN
aiua-11120	31	15	of	of	ADP
aiua-11120	31	16	the	the	DET
aiua-11120	31	17	underlying	underlying	ADJ
aiua-11120	31	18	neurological	neurological	ADJ
aiua-11120	31	19	diseases	disease	NOUN
aiua-11120	31	20	.	.	PUNCT
aiua-11120	32	1	treatment	treatment	NOUN
aiua-11120	32	2	should	should	AUX
aiua-11120	32	3	be	be	AUX
aiua-11120	32	4	tailored	tailor	VERB
aiua-11120	32	5	to	to	ADP
aiua-11120	32	6	the	the	DET
aiua-11120	32	7	individual	individual	ADJ
aiua-11120	32	8	patient	patient	NOUN
aiua-11120	32	9	,	,	PUNCT
aiua-11120	32	10	also	also	ADV
aiua-11120	32	11	considering	consider	VERB
aiua-11120	32	12	that	that	SCONJ
aiua-11120	32	13	conventional	conventional	ADJ
aiua-11120	32	14	treatment	treatment	NOUN
aiua-11120	32	15	programs	program	NOUN
aiua-11120	32	16	for	for	ADP
aiua-11120	32	17	non	non	ADJ
aiua-11120	32	18	-	-	ADJ
aiua-11120	32	19	neurogenic	neurogenic	ADJ
aiua-11120	32	20	oab	oab	PROPN
aiua-11120	32	21	could	could	AUX
aiua-11120	32	22	lack	lack	VERB
aiua-11120	32	23	clinical	clinical	ADJ
aiua-11120	32	24	efficacy	efficacy	NOUN
aiua-11120	32	25	in	in	ADP
aiua-11120	32	26	neurogenic	neurogenic	ADJ
aiua-11120	32	27	patients	patient	NOUN
aiua-11120	32	28	.	.	PUNCT
aiua-11120	33	1	several	several	ADJ
aiua-11120	33	2	systematic	systematic	ADJ
aiua-11120	33	3	reviews	review	NOUN
aiua-11120	33	4	have	have	AUX
aiua-11120	33	5	been	be	AUX
aiua-11120	33	6	published	publish	VERB
aiua-11120	33	7	in	in	ADP
aiua-11120	33	8	the	the	DET
aiua-11120	33	9	last	last	ADJ
aiua-11120	33	10	15	15	NUM
aiua-11120	33	11	years	year	NOUN
aiua-11120	33	12	to	to	PART
aiua-11120	33	13	evaluate	evaluate	VERB
aiua-11120	33	14	the	the	DET
aiua-11120	33	15	evidence	evidence	NOUN
aiua-11120	33	16	concerning	concern	VERB
aiua-11120	33	17	the	the	DET
aiua-11120	33	18	different	different	ADJ
aiua-11120	33	19	treatments	treatment	NOUN
aiua-11120	33	20	for	for	ADP
aiua-11120	33	21	neurogenic	neurogenic	ADJ
aiua-11120	33	22	oab	oab	PROPN
aiua-11120	33	23	(	(	PUNCT
aiua-11120	33	24	2	2	NUM
aiua-11120	33	25	-	-	SYM
aiua-11120	33	26	13	13	NUM
aiua-11120	33	27	)	)	PUNCT
aiua-11120	33	28	.	.	PUNCT
aiua-11120	34	1	in	in	ADP
aiua-11120	34	2	2012	2012	NUM
aiua-11120	34	3	,	,	PUNCT
aiua-11120	34	4	madhuvrata	madhuvrata	NOUN
aiua-11120	34	5	and	and	CCONJ
aiua-11120	34	6	coworkers	coworker	NOUN
aiua-11120	34	7	(	(	PUNCT
aiua-11120	34	8	2	2	NUM
aiua-11120	34	9	)	)	PUNCT
aiua-11120	34	10	published	publish	VERB
aiua-11120	34	11	a	a	DET
aiua-11120	34	12	systematic	systematic	ADJ
aiua-11120	34	13	review	review	NOUN
aiua-11120	34	14	and	and	CCONJ
aiua-11120	34	15	meta	meta	ADJ
aiua-11120	34	16	-	-	PUNCT
aiua-11120	34	17	analysis	analysis	NOUN
aiua-11120	34	18	on	on	ADP
aiua-11120	34	19	anticholinergic	anticholinergic	ADJ
aiua-11120	34	20	treatment	treatment	NOUN
aiua-11120	34	21	of	of	ADP
aiua-11120	34	22	adult	adult	NOUN
aiua-11120	34	23	neurogenic	neurogenic	ADJ
aiua-11120	34	24	oab	oab	PROPN
aiua-11120	34	25	,	,	PUNCT
aiua-11120	34	26	which	which	PRON
aiua-11120	34	27	updated	update	VERB
aiua-11120	34	28	and	and	CCONJ
aiua-11120	34	29	completed	complete	VERB
aiua-11120	34	30	a	a	DET
aiua-11120	34	31	previous	previous	ADJ
aiua-11120	34	32	systematic	systematic	ADJ
aiua-11120	34	33	review	review	NOUN
aiua-11120	34	34	assessing	assess	VERB
aiua-11120	34	35	the	the	DET
aiua-11120	34	36	efficacy	efficacy	NOUN
aiua-11120	34	37	and	and	CCONJ
aiua-11120	34	38	tolerability	tolerability	NOUN
aiua-11120	34	39	of	of	ADP
aiua-11120	34	40	anticholinergic	anticholinergic	ADJ
aiua-11120	34	41	agents	agent	NOUN
aiua-11120	34	42	in	in	ADP
aiua-11120	34	43	patients	patient	NOUN
aiua-11120	34	44	with	with	ADP
aiua-11120	34	45	oab	oab	PROPN
aiua-11120	34	46	associated	associate	VERB
aiua-11120	34	47	to	to	ADP
aiua-11120	34	48	multiple	multiple	ADJ
aiua-11120	34	49	sclerosis	sclerosis	NOUN
aiua-11120	34	50	(	(	PUNCT
aiua-11120	34	51	3	3	NUM
aiua-11120	34	52	)	)	PUNCT
aiua-11120	34	53	.	.	PUNCT
aiua-11120	35	1	a	a	DET
aiua-11120	35	2	more	more	ADV
aiua-11120	35	3	recent	recent	ADJ
aiua-11120	35	4	systematic	systematic	ADJ
aiua-11120	35	5	review	review	NOUN
aiua-11120	35	6	evaluated	evaluate	VERB
aiua-11120	35	7	the	the	DET
aiua-11120	35	8	effectiveness	effectiveness	NOUN
aiua-11120	35	9	and	and	CCONJ
aiua-11120	35	10	safety	safety	NOUN
aiua-11120	35	11	of	of	ADP
aiua-11120	35	12	intravesical	intravesical	ADJ
aiua-11120	35	13	oxybutynin	oxybutynin	PROPN
aiua-11120	35	14	therapy	therapy	NOUN
aiua-11120	35	15	for	for	ADP
aiua-11120	35	16	patients	patient	NOUN
aiua-11120	35	17	with	with	ADP
aiua-11120	35	18	neurogenic	neurogenic	ADJ
aiua-11120	35	19	oab	oab	PROPN
aiua-11120	35	20	(	(	PUNCT
aiua-11120	35	21	4	4	NUM
aiua-11120	35	22	)	)	PUNCT
aiua-11120	35	23	.	.	PUNCT
aiua-11120	36	1	two	two	NUM
aiua-11120	36	2	recent	recent	ADJ
aiua-11120	36	3	systematic	systematic	ADJ
aiua-11120	36	4	reviews	review	NOUN
aiua-11120	36	5	addressed	address	VERB
aiua-11120	36	6	the	the	DET
aiua-11120	36	7	results	result	NOUN
aiua-11120	36	8	of	of	ADP
aiua-11120	36	9	pelvic	pelvic	ADJ
aiua-11120	36	10	floor	floor	NOUN
aiua-11120	36	11	muscle	muscle	NOUN
aiua-11120	36	12	training	training	NOUN
aiua-11120	36	13	(	(	PUNCT
aiua-11120	36	14	pfmt	pfmt	NOUN
aiua-11120	36	15	)	)	PUNCT
aiua-11120	36	16	for	for	ADP
aiua-11120	36	17	bladder	bladder	NOUN
aiua-11120	36	18	dysfunction	dysfunction	NOUN
aiua-11120	36	19	in	in	ADP
aiua-11120	36	20	patients	patient	NOUN
aiua-11120	36	21	with	with	ADP
aiua-11120	36	22	multiple	multiple	ADJ
aiua-11120	36	23	sclerosis	sclerosis	NOUN
aiua-11120	36	24	(	(	PUNCT
aiua-11120	36	25	5	5	NUM
aiua-11120	36	26	,	,	PUNCT
aiua-11120	36	27	6	6	NUM
aiua-11120	36	28	)	)	PUNCT
aiua-11120	36	29	.	.	PUNCT
aiua-11120	37	1	one	one	NUM
aiua-11120	37	2	of	of	ADP
aiua-11120	37	3	these	these	DET
aiua-11120	37	4	systematic	systematic	ADJ
aiua-11120	37	5	reviews	review	NOUN
aiua-11120	37	6	extended	extend	VERB
aiua-11120	37	7	its	its	PRON
aiua-11120	37	8	analysis	analysis	NOUN
aiua-11120	37	9	to	to	ADP
aiua-11120	37	10	the	the	DET
aiua-11120	37	11	results	result	NOUN
aiua-11120	37	12	of	of	ADP
aiua-11120	37	13	peripheral	peripheral	ADJ
aiua-11120	37	14	tibial	tibial	ADJ
aiua-11120	37	15	nerve	nerve	NOUN
aiua-11120	37	16	stimulation	stimulation	NOUN
aiua-11120	37	17	(	(	PUNCT
aiua-11120	37	18	ptns	ptns	NOUN
aiua-11120	37	19	)	)	PUNCT
aiua-11120	37	20	(	(	PUNCT
aiua-11120	37	21	6	6	NUM
aiua-11120	37	22	)	)	PUNCT
aiua-11120	37	23	.	.	PUNCT
aiua-11120	38	1	a	a	DET
aiua-11120	38	2	systematic	systematic	ADJ
aiua-11120	38	3	review	review	NOUN
aiua-11120	38	4	addressed	address	VERB
aiua-11120	38	5	the	the	DET
aiua-11120	38	6	outcomes	outcome	NOUN
aiua-11120	38	7	of	of	ADP
aiua-11120	38	8	ptns	ptns	NOUN
aiua-11120	38	9	in	in	ADP
aiua-11120	38	10	the	the	DET
aiua-11120	38	11	treatment	treatment	NOUN
aiua-11120	38	12	of	of	ADP
aiua-11120	38	13	lower	low	ADJ
aiua-11120	38	14	urinary	urinary	ADJ
aiua-11120	38	15	tract	tract	NOUN
aiua-11120	38	16	dysfunction	dysfunction	NOUN
aiua-11120	38	17	including	include	VERB
aiua-11120	38	18	neurogenic	neurogenic	ADJ
aiua-11120	38	19	bladder	bladder	NOUN
aiua-11120	38	20	.	.	PUNCT
aiua-11120	39	1	ptns	ptns	NOUN
aiua-11120	39	2	was	be	AUX
aiua-11120	39	3	found	find	VERB
aiua-11120	39	4	to	to	PART
aiua-11120	39	5	be	be	AUX
aiua-11120	39	6	effective	effective	ADJ
aiua-11120	39	7	in	in	ADP
aiua-11120	39	8	up	up	ADP
aiua-11120	39	9	to	to	PART
aiua-11120	39	10	100	100	NUM
aiua-11120	39	11	%	%	NOUN
aiua-11120	39	12	of	of	ADP
aiua-11120	39	13	patients	patient	NOUN
aiua-11120	39	14	with	with	ADP
aiua-11120	39	15	neurological	neurological	ADJ
aiua-11120	39	16	pathologies	pathology	NOUN
aiua-11120	39	17	,	,	PUNCT
aiua-11120	39	18	although	although	SCONJ
aiua-11120	39	19	this	this	DET
aiua-11120	39	20	review	review	NOUN
aiua-11120	39	21	was	be	AUX
aiua-11120	39	22	based	base	VERB
aiua-11120	39	23	on	on	ADP
aiua-11120	39	24	non	non	ADJ
aiua-11120	39	25	-	-	ADJ
aiua-11120	39	26	randomized	randomized	ADJ
aiua-11120	39	27	studies	study	NOUN
aiua-11120	39	28	(	(	PUNCT
aiua-11120	39	29	7	7	NUM
aiua-11120	39	30	)	)	PUNCT
aiua-11120	39	31	.	.	PUNCT
aiua-11120	40	1	a	a	DET
aiua-11120	40	2	meta	meta	ADJ
aiua-11120	40	3	-	-	PUNCT
aiua-11120	40	4	analysis	analysis	NOUN
aiua-11120	40	5	evaluated	evaluate	VERB
aiua-11120	40	6	the	the	DET
aiua-11120	40	7	results	result	NOUN
aiua-11120	40	8	of	of	ADP
aiua-11120	40	9	studies	study	NOUN
aiua-11120	40	10	focusing	focus	VERB
aiua-11120	40	11	on	on	ADP
aiua-11120	40	12	sacral	sacral	ADJ
aiua-11120	40	13	neuromodulation	neuromodulation	NOUN
aiua-11120	40	14	(	(	PUNCT
aiua-11120	40	15	snm	snm	PROPN
aiua-11120	40	16	)	)	PUNCT
aiua-11120	40	17	in	in	ADP
aiua-11120	40	18	patients	patient	NOUN
aiua-11120	40	19	with	with	ADP
aiua-11120	40	20	neurogenic	neurogenic	ADJ
aiua-11120	40	21	lower	low	ADJ
aiua-11120	40	22	urinary	urinary	ADJ
aiua-11120	40	23	tract	tract	NOUN
aiua-11120	40	24	dysfunction	dysfunction	NOUN
aiua-11120	40	25	(	(	PUNCT
aiua-11120	40	26	8)	8)	NUM
aiua-11120	40	27	.	.	PUNCT
aiua-11120	41	1	finally	finally	ADV
aiua-11120	41	2	,	,	PUNCT
aiua-11120	41	3	several	several	ADJ
aiua-11120	41	4	systematic	systematic	ADJ
aiua-11120	41	5	reviews	review	NOUN
aiua-11120	41	6	with	with	ADP
aiua-11120	41	7	metanalysis	metanalysis	NOUN
aiua-11120	41	8	evaluated	evaluate	VERB
aiua-11120	41	9	the	the	DET
aiua-11120	41	10	treatment	treatment	NOUN
aiua-11120	41	11	of	of	ADP
aiua-11120	41	12	overactive	overactive	ADJ
aiua-11120	41	13	bladder	bladder	NOUN
aiua-11120	41	14	syndrome	syndrome	NOUN
aiua-11120	41	15	with	with	ADP
aiua-11120	41	16	botulinum	botulinum	ADJ
aiua-11120	41	17	toxin	toxin	NOUN
aiua-11120	41	18	injection	injection	NOUN
aiua-11120	41	19	(	(	PUNCT
aiua-11120	41	20	9	9	NUM
aiua-11120	41	21	-	-	SYM
aiua-11120	41	22	15	15	NUM
aiua-11120	41	23	)	)	PUNCT
aiua-11120	41	24	.	.	PUNCT
aiua-11120	42	1	although	although	SCONJ
aiua-11120	42	2	a	a	DET
aiua-11120	42	3	relevant	relevant	ADJ
aiua-11120	42	4	bulk	bulk	NOUN
aiua-11120	42	5	of	of	ADP
aiua-11120	42	6	information	information	NOUN
aiua-11120	42	7	from	from	ADP
aiua-11120	42	8	previous	previous	ADJ
aiua-11120	42	9	systematic	systematic	ADJ
aiua-11120	42	10	reviews	review	NOUN
aiua-11120	42	11	is	be	AUX
aiua-11120	42	12	available	available	ADJ
aiua-11120	42	13	,	,	PUNCT
aiua-11120	42	14	certain	certain	ADJ
aiua-11120	42	15	specific	specific	ADJ
aiua-11120	42	16	aspects	aspect	NOUN
aiua-11120	42	17	,	,	PUNCT
aiua-11120	42	18	such	such	ADJ
aiua-11120	42	19	as	as	ADP
aiua-11120	42	20	efficacy	efficacy	PROPN
aiua-11120	42	21	mirabegron	mirabegron	NOUN
aiua-11120	42	22	and	and	CCONJ
aiua-11120	42	23	new	new	ADJ
aiua-11120	42	24	anticholinergic	anticholinergic	ADJ
aiua-11120	42	25	agents	agent	NOUN
aiua-11120	42	26	in	in	ADP
aiua-11120	42	27	neurogenic	neurogenic	ADJ
aiua-11120	42	28	bladder	bladder	NOUN
aiua-11120	42	29	have	have	AUX
aiua-11120	42	30	not	not	PART
aiua-11120	42	31	yet	yet	ADV
aiua-11120	42	32	been	be	AUX
aiua-11120	42	33	addressed	address	VERB
aiua-11120	42	34	.	.	PUNCT
aiua-11120	43	1	other	other	ADJ
aiua-11120	43	2	issues	issue	NOUN
aiua-11120	43	3	,	,	PUNCT
aiua-11120	43	4	such	such	ADJ
aiua-11120	43	5	as	as	ADP
aiua-11120	43	6	efficacy	efficacy	NOUN
aiua-11120	43	7	of	of	ADP
aiua-11120	43	8	ptns	ptns	NOUN
aiua-11120	43	9	in	in	ADP
aiua-11120	43	10	neurogenic	neurogenic	ADJ
aiua-11120	43	11	bladder	bladder	NOUN
aiua-11120	43	12	,	,	PUNCT
aiua-11120	43	13	need	need	VERB
aiua-11120	43	14	to	to	PART
aiua-11120	43	15	be	be	AUX
aiua-11120	43	16	corroborated	corroborate	VERB
aiua-11120	43	17	by	by	ADP
aiua-11120	43	18	randomizes	randomize	NOUN
aiua-11120	43	19	studies	study	NOUN
aiua-11120	43	20	.	.	PUNCT
aiua-11120	44	1	the	the	DET
aiua-11120	44	2	aim	aim	NOUN
aiua-11120	44	3	of	of	ADP
aiua-11120	44	4	our	our	PRON
aiua-11120	44	5	study	study	NOUN
aiua-11120	44	6	was	be	AUX
aiua-11120	44	7	to	to	PART
aiua-11120	44	8	review	review	VERB
aiua-11120	44	9	the	the	DET
aiua-11120	44	10	efficacy	efficacy	NOUN
aiua-11120	44	11	of	of	ADP
aiua-11120	44	12	treatments	treatment	NOUN
aiua-11120	44	13	for	for	ADP
aiua-11120	44	14	neurogenic	neurogenic	ADJ
aiua-11120	44	15	oab	oab	PROPN
aiua-11120	44	16	focusing	focus	VERB
aiua-11120	44	17	on	on	ADP
aiua-11120	44	18	recent	recent	ADJ
aiua-11120	44	19	clinical	clinical	ADJ
aiua-11120	44	20	evidence	evidence	NOUN
aiua-11120	44	21	,	,	PUNCT
aiua-11120	44	22	including	include	VERB
aiua-11120	44	23	studies	study	NOUN
aiua-11120	44	24	focusing	focus	VERB
aiua-11120	44	25	on	on	ADP
aiua-11120	44	26	mirabegron	mirabegron	PROPN
aiua-11120	44	27	and	and	CCONJ
aiua-11120	44	28	on	on	ADP
aiua-11120	44	29	new	new	ADJ
aiua-11120	44	30	anticholinergic	anticholinergic	ADJ
aiua-11120	44	31	agents	agent	NOUN
aiua-11120	44	32	.	.	PUNCT
aiua-11120	45	1	materials	material	NOUN
aiua-11120	45	2	and	and	CCONJ
aiua-11120	45	3	methods	method	NOUN
aiua-11120	45	4	the	the	DET
aiua-11120	45	5	review	review	NOUN
aiua-11120	45	6	was	be	AUX
aiua-11120	45	7	conducted	conduct	VERB
aiua-11120	45	8	in	in	ADP
aiua-11120	45	9	accordance	accordance	NOUN
aiua-11120	45	10	with	with	ADP
aiua-11120	45	11	the	the	DET
aiua-11120	45	12	prisma	prisma	NOUN
aiua-11120	45	13	(	(	PUNCT
aiua-11120	45	14	preferred	prefer	VERB
aiua-11120	45	15	reporting	reporting	NOUN
aiua-11120	45	16	items	item	NOUN
aiua-11120	45	17	for	for	ADP
aiua-11120	45	18	systematic	systematic	ADJ
aiua-11120	45	19	reviews	review	NOUN
aiua-11120	45	20	and	and	CCONJ
aiua-11120	45	21	meta	meta	NOUN
aiua-11120	45	22	-	-	PUNCT
aiua-11120	45	23	analyses	analysis	NOUN
aiua-11120	45	24	)	)	PUNCT
aiua-11120	45	25	guidelines	guideline	NOUN
aiua-11120	45	26	(	(	PUNCT
aiua-11120	45	27	16	16	NUM
aiua-11120	45	28	)	)	PUNCT
aiua-11120	45	29	.	.	PUNCT
aiua-11120	46	1	it	it	PRON
aiua-11120	46	2	has	have	AUX
aiua-11120	46	3	been	be	AUX
aiua-11120	46	4	registered	register	VERB
aiua-11120	46	5	on	on	ADP
aiua-11120	46	6	the	the	DET
aiua-11120	46	7	prospero	prospero	NOUN
aiua-11120	46	8	platform	platform	NOUN
aiua-11120	46	9	(	(	PUNCT
aiua-11120	46	10	registration	registration	NOUN
aiua-11120	46	11	number	number	NOUN
aiua-11120	46	12	:	:	PUNCT
aiua-11120	46	13	crd42022347165	crd42022347165	NOUN
aiua-11120	46	14	)	)	PUNCT
aiua-11120	46	15	.	.	PUNCT
aiua-11120	47	1	types	type	NOUN
aiua-11120	47	2	of	of	ADP
aiua-11120	47	3	studies	study	NOUN
aiua-11120	47	4	,	,	PUNCT
aiua-11120	47	5	inclusion	inclusion	NOUN
aiua-11120	47	6	criteria	criterion	NOUN
aiua-11120	47	7	we	we	PRON
aiua-11120	47	8	considered	consider	VERB
aiua-11120	47	9	randomized	randomized	ADJ
aiua-11120	47	10	controlled	control	VERB
aiua-11120	47	11	trials	trial	NOUN
aiua-11120	47	12	(	(	PUNCT
aiua-11120	47	13	rcts	rct	NOUN
aiua-11120	47	14	)	)	PUNCT
aiua-11120	47	15	,	,	PUNCT
aiua-11120	47	16	with	with	ADP
aiua-11120	47	17	single	single	ADJ
aiua-11120	47	18	/	/	SYM
aiua-11120	47	19	double	double	ADJ
aiua-11120	47	20	blinded	blind	VERB
aiua-11120	47	21	design	design	NOUN
aiua-11120	47	22	without	without	ADP
aiua-11120	47	23	time	time	NOUN
aiua-11120	47	24	constraints	constraint	NOUN
aiua-11120	47	25	.	.	PUNCT
aiua-11120	48	1	we	we	PRON
aiua-11120	48	2	included	include	VERB
aiua-11120	48	3	studies	study	NOUN
aiua-11120	48	4	involving	involve	VERB
aiua-11120	48	5	adult	adult	NOUN
aiua-11120	48	6	patients	patient	NOUN
aiua-11120	48	7	of	of	ADP
aiua-11120	48	8	both	both	DET
aiua-11120	48	9	sexes	sex	NOUN
aiua-11120	48	10	subjected	subject	VERB
aiua-11120	48	11	to	to	ADP
aiua-11120	48	12	pharmacological	pharmacological	NOUN
aiua-11120	48	13	and	and	CCONJ
aiua-11120	48	14	non	non	ADJ
aiua-11120	48	15	-	-	ADJ
aiua-11120	48	16	pharmacological	pharmacological	ADJ
aiua-11120	48	17	medical	medical	ADJ
aiua-11120	48	18	treatment	treatment	NOUN
aiua-11120	48	19	for	for	ADP
aiua-11120	48	20	overactive	overactive	ADJ
aiua-11120	48	21	bladder	bladder	NOUN
aiua-11120	48	22	symptoms	symptom	NOUN
aiua-11120	48	23	associated	associate	VERB
aiua-11120	48	24	with	with	ADP
aiua-11120	48	25	neurological	neurological	ADJ
aiua-11120	48	26	diseases	disease	NOUN
aiua-11120	48	27	including	include	VERB
aiua-11120	48	28	post	post	ADJ
aiua-11120	48	29	-	-	ADJ
aiua-11120	48	30	ischemic	ischemic	ADJ
aiua-11120	48	31	stroke	stroke	NOUN
aiua-11120	48	32	,	,	PUNCT
aiua-11120	48	33	parkinson	parkinson	NOUN
aiua-11120	48	34	’s	’s	PART
aiua-11120	48	35	disease	disease	NOUN
aiua-11120	48	36	and	and	CCONJ
aiua-11120	48	37	multiple	multiple	ADJ
aiua-11120	48	38	sclerosis	sclerosis	NOUN
aiua-11120	48	39	.	.	PUNCT
aiua-11120	49	1	outcomes	outcome	NOUN
aiua-11120	49	2	the	the	DET
aiua-11120	49	3	following	follow	VERB
aiua-11120	49	4	outcomes	outcome	NOUN
aiua-11120	49	5	were	be	AUX
aiua-11120	49	6	considered	consider	VERB
aiua-11120	49	7	:	:	PUNCT
aiua-11120	49	8	number	number	NOUN
aiua-11120	49	9	of	of	ADP
aiua-11120	49	10	daytime	daytime	ADJ
aiua-11120	49	11	voids	voids	NOUN
aiua-11120	49	12	and	and	CCONJ
aiua-11120	49	13	night	night	NOUN
aiua-11120	49	14	-	-	PUNCT
aiua-11120	49	15	time	time	NOUN
aiua-11120	49	16	voids	voids	NOUN
aiua-11120	49	17	(	(	PUNCT
aiua-11120	49	18	nocturia	nocturia	PROPN
aiua-11120	49	19	)	)	PUNCT
aiua-11120	49	20	;	;	PUNCT
aiua-11120	49	21	number	number	NOUN
aiua-11120	49	22	of	of	ADP
aiua-11120	49	23	incontinence	incontinence	NOUN
aiua-11120	49	24	and	and	CCONJ
aiua-11120	49	25	urgency	urgency	NOUN
aiua-11120	49	26	episodes	episode	NOUN
aiua-11120	49	27	;	;	PUNCT
aiua-11120	49	28	modification	modification	NOUN
aiua-11120	49	29	of	of	ADP
aiua-11120	49	30	scores	score	NOUN
aiua-11120	49	31	measuring	measure	VERB
aiua-11120	49	32	urinary	urinary	ADJ
aiua-11120	49	33	symptoms	symptom	NOUN
aiua-11120	49	34	and	and	CCONJ
aiua-11120	49	35	quality	quality	NOUN
aiua-11120	49	36	of	of	ADP
aiua-11120	49	37	life	life	NOUN
aiua-11120	49	38	;	;	PUNCT
aiua-11120	49	39	change	change	NOUN
aiua-11120	49	40	of	of	ADP
aiua-11120	49	41	urodynamic	urodynamic	ADJ
aiua-11120	49	42	measurements	measurement	NOUN
aiua-11120	49	43	(	(	PUNCT
aiua-11120	49	44	cystometric	cystometric	ADJ
aiua-11120	49	45	capacity	capacity	NOUN
aiua-11120	49	46	,	,	PUNCT
aiua-11120	49	47	peak	peak	NOUN
aiua-11120	49	48	pressure	pressure	NOUN
aiua-11120	49	49	,	,	PUNCT
aiua-11120	49	50	volume	volume	NOUN
aiua-11120	49	51	at	at	ADP
aiua-11120	49	52	1st	1st	ADJ
aiua-11120	49	53	contraction	contraction	NOUN
aiua-11120	49	54	)	)	PUNCT
aiua-11120	49	55	.	.	PUNCT
aiua-11120	50	1	the	the	DET
aiua-11120	50	2	overactive	overactive	ADJ
aiua-11120	50	3	bladder	bladder	NOUN
aiua-11120	50	4	symptom	symptom	NOUN
aiua-11120	50	5	score	score	NOUN
aiua-11120	50	6	(	(	PUNCT
aiua-11120	50	7	oab	oab	PROPN
aiua-11120	50	8	-	-	PUNCT
aiua-11120	50	9	ss	ss	NOUN
aiua-11120	50	10	)	)	PUNCT
aiua-11120	50	11	is	be	AUX
aiua-11120	50	12	a	a	DET
aiua-11120	50	13	diagnostic	diagnostic	ADJ
aiua-11120	50	14	tool	tool	NOUN
aiua-11120	50	15	divided	divide	VERB
aiua-11120	50	16	in	in	ADP
aiua-11120	50	17	four	four	NUM
aiua-11120	50	18	domains	domain	NOUN
aiua-11120	50	19	,	,	PUNCT
aiua-11120	50	20	administered	administer	VERB
aiua-11120	50	21	to	to	ADP
aiua-11120	50	22	patients	patient	NOUN
aiua-11120	50	23	for	for	ADP
aiua-11120	50	24	self	self	NOUN
aiua-11120	50	25	-	-	PUNCT
aiua-11120	50	26	evaluation	evaluation	NOUN
aiua-11120	50	27	of	of	ADP
aiua-11120	50	28	voiding	void	VERB
aiua-11120	50	29	symptoms	symptom	NOUN
aiua-11120	50	30	.	.	PUNCT
aiua-11120	51	1	the	the	DET
aiua-11120	51	2	score	score	NOUN
aiua-11120	51	3	ranges	range	VERB
aiua-11120	51	4	between	between	ADP
aiua-11120	51	5	0	0	NUM
aiua-11120	51	6	and	and	CCONJ
aiua-11120	51	7	15	15	NUM
aiua-11120	51	8	(	(	PUNCT
aiua-11120	51	9	15	15	NUM
aiua-11120	51	10	=	=	SYM
aiua-11120	51	11	most	most	ADV
aiua-11120	51	12	severe	severe	ADJ
aiua-11120	51	13	symptoms	symptom	NOUN
aiua-11120	51	14	)	)	PUNCT
aiua-11120	51	15	.	.	PUNCT
aiua-11120	52	1	the	the	DET
aiua-11120	52	2	international	international	ADJ
aiua-11120	52	3	consultation	consultation	NOUN
aiua-11120	52	4	on	on	ADP
aiua-11120	52	5	incontinence	incontinence	NOUN
aiua-11120	52	6	questionnaire	questionnaire	NOUN
aiua-11120	52	7	overactive	overactive	ADJ
aiua-11120	52	8	bladder	bladder	NOUN
aiua-11120	52	9	(	(	PUNCT
aiua-11120	52	10	iciq	iciq	NOUN
aiua-11120	52	11	)	)	PUNCT
aiua-11120	52	12	is	be	AUX
aiua-11120	52	13	a	a	DET
aiua-11120	52	14	questionnaire	questionnaire	NOUN
aiua-11120	52	15	for	for	ADP
aiua-11120	52	16	evaluating	evaluate	VERB
aiua-11120	52	17	overactive	overactive	ADJ
aiua-11120	52	18	bladder	bladder	NOUN
aiua-11120	52	19	and	and	CCONJ
aiua-11120	52	20	related	relate	VERB
aiua-11120	52	21	impact	impact	NOUN
aiua-11120	52	22	on	on	ADP
aiua-11120	52	23	quality	quality	NOUN
aiua-11120	52	24	of	of	ADP
aiua-11120	52	25	life	life	NOUN
aiua-11120	52	26	(	(	PUNCT
aiua-11120	52	27	qol	qol	NOUN
aiua-11120	52	28	)	)	PUNCT
aiua-11120	52	29	and	and	CCONJ
aiua-11120	52	30	outcome	outcome	NOUN
aiua-11120	52	31	of	of	ADP
aiua-11120	52	32	treatment	treatment	NOUN
aiua-11120	52	33	in	in	ADP
aiua-11120	52	34	men	man	NOUN
aiua-11120	52	35	and	and	CCONJ
aiua-11120	52	36	women	woman	NOUN
aiua-11120	52	37	in	in	ADP
aiua-11120	52	38	research	research	NOUN
aiua-11120	52	39	and	and	CCONJ
aiua-11120	52	40	clinical	clinical	ADJ
aiua-11120	52	41	practice	practice	NOUN
aiua-11120	52	42	across	across	ADP
aiua-11120	52	43	the	the	DET
aiua-11120	52	44	world	world	NOUN
aiua-11120	52	45	.	.	PUNCT
aiua-11120	53	1	it	it	PRON
aiua-11120	53	2	is	be	AUX
aiua-11120	53	3	based	base	VERB
aiua-11120	53	4	on	on	ADP
aiua-11120	53	5	a	a	DET
aiua-11120	53	6	0	0	NUM
aiua-11120	53	7	-	-	SYM
aiua-11120	53	8	16	16	NUM
aiua-11120	53	9	overall	overall	ADJ
aiua-11120	53	10	score	score	NOUN
aiua-11120	53	11	with	with	ADP
aiua-11120	53	12	greater	great	ADJ
aiua-11120	53	13	values	value	NOUN
aiua-11120	53	14	indicating	indicate	VERB
aiua-11120	53	15	increased	increase	VERB
aiua-11120	53	16	symptom	symptom	NOUN
aiua-11120	53	17	severity	severity	NOUN
aiua-11120	53	18	.	.	PUNCT
aiua-11120	54	1	search	search	NOUN
aiua-11120	54	2	strategy	strategy	NOUN
aiua-11120	54	3	two	two	NUM
aiua-11120	54	4	electronic	electronic	ADJ
aiua-11120	54	5	databases	database	NOUN
aiua-11120	54	6	(	(	PUNCT
aiua-11120	54	7	pubmed	pubmed	NOUN
aiua-11120	54	8	and	and	CCONJ
aiua-11120	54	9	embase	embase	NOUN
aiua-11120	54	10	)	)	PUNCT
aiua-11120	54	11	were	be	AUX
aiua-11120	54	12	searched	search	VERB
aiua-11120	54	13	for	for	ADP
aiua-11120	54	14	articles	article	NOUN
aiua-11120	54	15	in	in	ADP
aiua-11120	54	16	english	english	PROPN
aiua-11120	54	17	,	,	PUNCT
aiua-11120	54	18	published	publish	VERB
aiua-11120	54	19	up	up	ADV
aiua-11120	54	20	to	to	PART
aiua-11120	54	21	30	30	NUM
aiua-11120	54	22	april	april	PROPN
aiua-11120	54	23	2022	2022	NUM
aiua-11120	54	24	.	.	PUNCT
aiua-11120	55	1	record	record	NOUN
aiua-11120	55	2	search	search	NOUN
aiua-11120	55	3	and	and	CCONJ
aiua-11120	55	4	retrieval	retrieval	NOUN
aiua-11120	55	5	was	be	AUX
aiua-11120	55	6	performed	perform	VERB
aiua-11120	55	7	using	use	VERB
aiua-11120	55	8	strings	string	NOUN
aiua-11120	55	9	based	base	VERB
aiua-11120	55	10	on	on	ADP
aiua-11120	55	11	the	the	DET
aiua-11120	55	12	combination	combination	NOUN
aiua-11120	55	13	of	of	ADP
aiua-11120	55	14	various	various	ADJ
aiua-11120	55	15	mesh	mesh	NOUN
aiua-11120	55	16	terms	term	NOUN
aiua-11120	55	17	:	:	PUNCT
aiua-11120	55	18	(	(	PUNCT
aiua-11120	55	19	urinary	urinary	ADJ
aiua-11120	55	20	bladder	bladder	NOUN
aiua-11120	55	21	,	,	PUNCT
aiua-11120	55	22	overactive	overactive	NOUN
aiua-11120	55	23	;	;	PUNCT
aiua-11120	55	24	urinary	urinary	ADJ
aiua-11120	55	25	incontinence	incontinence	NOUN
aiua-11120	55	26	,	,	PUNCT
aiua-11120	55	27	urge	urge	NOUN
aiua-11120	55	28	;	;	PUNCT
aiua-11120	55	29	multiple	multiple	ADJ
aiua-11120	55	30	sclerosis	sclerosis	NOUN
aiua-11120	55	31	;	;	PUNCT
aiua-11120	55	32	ischemic	ischemic	ADJ
aiua-11120	55	33	stroke	stroke	NOUN
aiua-11120	55	34	;	;	PUNCT
aiua-11120	55	35	parkinson	parkinson	NOUN
aiua-11120	55	36	disease	disease	NOUN
aiua-11120	55	37	):	):	PUNCT
aiua-11120	55	38	(	(	PUNCT
aiua-11120	55	39	treatment	treatment	NOUN
aiua-11120	55	40	)	)	PUNCT
aiua-11120	55	41	and	and	CCONJ
aiua-11120	55	42	(	(	PUNCT
aiua-11120	55	43	urge	urge	VERB
aiua-11120	55	44	urinary	urinary	ADJ
aiua-11120	55	45	incontinence	incontinence	NOUN
aiua-11120	55	46	or	or	CCONJ
aiua-11120	55	47	overactive	overactive	ADJ
aiua-11120	55	48	urinary	urinary	ADJ
aiua-11120	55	49	bladder	bladder	NOUN
aiua-11120	55	50	or	or	CCONJ
aiua-11120	55	51	detrusor	detrusor	NOUN
aiua-11120	55	52	overactivity	overactivity	NOUN
aiua-11120	55	53	)	)	PUNCT
aiua-11120	55	54	and	and	CCONJ
aiua-11120	55	55	(	(	PUNCT
aiua-11120	55	56	multiple	multiple	ADJ
aiua-11120	55	57	sclerosis	sclerosis	NOUN
aiua-11120	55	58	or	or	CCONJ
aiua-11120	55	59	parkinson	parkinson	NOUN
aiua-11120	55	60	disease	disease	NOUN
aiua-11120	55	61	or	or	CCONJ
aiua-11120	55	62	ischemic	ischemic	ADJ
aiua-11120	55	63	stroke	stroke	NOUN
aiua-11120	55	64	)	)	PUNCT
aiua-11120	55	65	.	.	PUNCT
aiua-11120	56	1	relevant	relevant	ADJ
aiua-11120	56	2	data	datum	NOUN
aiua-11120	56	3	were	be	AUX
aiua-11120	56	4	also	also	ADV
aiua-11120	56	5	hand	hand	AUX
aiua-11120	56	6	searched	search	VERB
aiua-11120	56	7	by	by	ADP
aiua-11120	56	8	browsing	browse	VERB
aiua-11120	56	9	various	various	ADJ
aiua-11120	56	10	sources	source	NOUN
aiua-11120	56	11	(	(	PUNCT
aiua-11120	56	12	e.g.	e.g.	ADV
aiua-11120	56	13	,	,	PUNCT
aiua-11120	56	14	reference	reference	NOUN
aiua-11120	56	15	lists	list	NOUN
aiua-11120	56	16	from	from	ADP
aiua-11120	56	17	reviews	review	NOUN
aiua-11120	56	18	and	and	CCONJ
aiua-11120	56	19	study	study	NOUN
aiua-11120	56	20	reports	report	NOUN
aiua-11120	56	21	,	,	PUNCT
aiua-11120	56	22	congress	congress	PROPN
aiua-11120	56	23	abstracts	abstract	VERB
aiua-11120	56	24	,	,	PUNCT
aiua-11120	56	25	clinical	clinical	ADJ
aiua-11120	56	26	trial	trial	NOUN
aiua-11120	56	27	registers	register	NOUN
aiua-11120	56	28	such	such	ADJ
aiua-11120	56	29	as	as	ADP
aiua-11120	56	30	www.clinicaltrials.gov	www.clinicaltrials.gov	NOUN
aiua-11120	56	31	,	,	PUNCT
aiua-11120	56	32	www.clinicaltrialsregister.eu	www.clinicaltrialsregister.eu	NOUN
aiua-11120	56	33	,	,	PUNCT
aiua-11120	56	34	etc	etc	X
aiua-11120	56	35	.	.	X
aiua-11120	56	36	)	)	PUNCT
aiua-11120	56	37	.	.	PUNCT
aiua-11120	57	1	selection	selection	NOUN
aiua-11120	57	2	of	of	ADP
aiua-11120	57	3	studies	study	NOUN
aiua-11120	57	4	retrieved	retrieve	VERB
aiua-11120	57	5	papers	paper	NOUN
aiua-11120	57	6	were	be	AUX
aiua-11120	57	7	independently	independently	ADV
aiua-11120	57	8	screened	screen	VERB
aiua-11120	57	9	by	by	ADP
aiua-11120	57	10	two	two	NUM
aiua-11120	57	11	archivio	archivio	NOUN
aiua-11120	57	12	italiano	italiano	X
aiua-11120	57	13	di	di	X
aiua-11120	57	14	urologia	urologia	PROPN
aiua-11120	57	15	e	e	PROPN
aiua-11120	57	16	andrologia	andrologia	PROPN
aiua-11120	57	17	2022	2022	NUM
aiua-11120	57	18	;	;	PUNCT
aiua-11120	57	19	94	94	NUM
aiua-11120	57	20	,	,	PUNCT
aiua-11120	57	21	4	4	NUM
aiua-11120	57	22	r.	r.	NOUN
aiua-11120	57	23	bapir	bapir	NOUN
aiua-11120	57	24	,	,	PUNCT
aiua-11120	57	25	k.	k.	PROPN
aiua-11120	57	26	hassan	hassan	PROPN
aiua-11120	57	27	bhatti	bhatti	PROPN
aiua-11120	57	28	,	,	PUNCT
aiua-11120	57	29	ahmed	ahmed	PROPN
aiua-11120	57	30	eliwa	eliwa	PROPN
aiua-11120	57	31	,	,	PUNCT
aiua-11120	57	32	et	et	PROPN
aiua-11120	57	33	al	al	PROPN
aiua-11120	57	34	.	.	PROPN
aiua-11120	57	35	494	494	NUM
aiua-11120	57	36	authors	author	NOUN
aiua-11120	57	37	by	by	ADP
aiua-11120	57	38	title	title	NOUN
aiua-11120	57	39	and	and	CCONJ
aiua-11120	57	40	abstract	abstract	ADJ
aiua-11120	57	41	to	to	PART
aiua-11120	57	42	exclude	exclude	VERB
aiua-11120	57	43	documents	document	NOUN
aiua-11120	57	44	that	that	PRON
aiua-11120	57	45	did	do	AUX
aiua-11120	57	46	not	not	PART
aiua-11120	57	47	meet	meet	VERB
aiua-11120	57	48	the	the	DET
aiua-11120	57	49	inclusion	inclusion	NOUN
aiua-11120	57	50	criteria	criterion	NOUN
aiua-11120	57	51	.	.	PUNCT
aiua-11120	58	1	duplicate	duplicate	ADJ
aiua-11120	58	2	references	reference	NOUN
aiua-11120	58	3	were	be	AUX
aiua-11120	58	4	deleted	delete	VERB
aiua-11120	58	5	.	.	PUNCT
aiua-11120	59	1	full	full	ADJ
aiua-11120	59	2	texts	text	NOUN
aiua-11120	59	3	of	of	ADP
aiua-11120	59	4	selected	select	VERB
aiua-11120	59	5	papers	paper	NOUN
aiua-11120	59	6	were	be	AUX
aiua-11120	59	7	downloaded	download	VERB
aiua-11120	59	8	to	to	PART
aiua-11120	59	9	confirm	confirm	VERB
aiua-11120	59	10	/	/	SYM
aiua-11120	59	11	reject	reject	VERB
aiua-11120	59	12	inclusion	inclusion	NOUN
aiua-11120	59	13	and	and	CCONJ
aiua-11120	59	14	to	to	PART
aiua-11120	59	15	extract	extract	VERB
aiua-11120	59	16	relevant	relevant	ADJ
aiua-11120	59	17	information	information	NOUN
aiua-11120	59	18	.	.	PUNCT
aiua-11120	60	1	controversies	controversy	NOUN
aiua-11120	60	2	were	be	AUX
aiua-11120	60	3	resolved	resolve	VERB
aiua-11120	60	4	by	by	ADP
aiua-11120	60	5	a	a	DET
aiua-11120	60	6	third	third	ADJ
aiua-11120	60	7	researcher	researcher	NOUN
aiua-11120	60	8	.	.	PUNCT
aiua-11120	61	1	a	a	DET
aiua-11120	61	2	prisma	prisma	NOUN
aiua-11120	61	3	flow	flow	NOUN
aiua-11120	61	4	diagram	diagram	NOUN
aiua-11120	61	5	summarizes	summarize	VERB
aiua-11120	61	6	the	the	DET
aiua-11120	61	7	study	study	NOUN
aiua-11120	61	8	selection	selection	NOUN
aiua-11120	61	9	process	process	NOUN
aiua-11120	61	10	(	(	PUNCT
aiua-11120	61	11	figure	figure	NOUN
aiua-11120	61	12	1	1	NUM
aiua-11120	61	13	)	)	PUNCT
aiua-11120	61	14	.	.	PUNCT
aiua-11120	62	1	data	datum	NOUN
aiua-11120	62	2	extraction	extraction	NOUN
aiua-11120	62	3	(	(	PUNCT
aiua-11120	62	4	supplementary	supplementary	ADJ
aiua-11120	62	5	materials	material	NOUN
aiua-11120	62	6	pico	pico	NOUN
aiua-11120	62	7	tables	table	NOUN
aiua-11120	62	8	)	)	PUNCT
aiua-11120	62	9	data	datum	NOUN
aiua-11120	62	10	extraction	extraction	NOUN
aiua-11120	62	11	was	be	AUX
aiua-11120	62	12	performed	perform	VERB
aiua-11120	62	13	by	by	ADP
aiua-11120	62	14	four	four	NUM
aiua-11120	62	15	authors	author	NOUN
aiua-11120	62	16	using	use	VERB
aiua-11120	62	17	a	a	DET
aiua-11120	62	18	standardized	standardized	ADJ
aiua-11120	62	19	form	form	NOUN
aiua-11120	62	20	.	.	PUNCT
aiua-11120	63	1	the	the	DET
aiua-11120	63	2	following	follow	VERB
aiua-11120	63	3	information	information	NOUN
aiua-11120	63	4	was	be	AUX
aiua-11120	63	5	obtained	obtain	VERB
aiua-11120	63	6	from	from	ADP
aiua-11120	63	7	each	each	DET
aiua-11120	63	8	study	study	NOUN
aiua-11120	63	9	:	:	PUNCT
aiua-11120	63	10	author(s	author(s	NOUN
aiua-11120	63	11	)	)	PUNCT
aiua-11120	63	12	,	,	PUNCT
aiua-11120	63	13	publication	publication	NOUN
aiua-11120	63	14	year	year	NOUN
aiua-11120	63	15	,	,	PUNCT
aiua-11120	63	16	study	study	NOUN
aiua-11120	63	17	design	design	NOUN
aiua-11120	63	18	,	,	PUNCT
aiua-11120	63	19	population	population	NOUN
aiua-11120	63	20	,	,	PUNCT
aiua-11120	63	21	interventions	intervention	NOUN
aiua-11120	63	22	,	,	PUNCT
aiua-11120	63	23	comparisons	comparison	NOUN
aiua-11120	63	24	,	,	PUNCT
aiua-11120	63	25	outcomes	outcome	NOUN
aiua-11120	63	26	/	/	SYM
aiua-11120	63	27	endpoints	endpoint	NOUN
aiua-11120	63	28	.	.	PUNCT
aiua-11120	64	1	in	in	ADP
aiua-11120	64	2	case	case	NOUN
aiua-11120	64	3	of	of	ADP
aiua-11120	64	4	missing	missing	ADJ
aiua-11120	64	5	or	or	CCONJ
aiua-11120	64	6	insufficient	insufficient	ADJ
aiua-11120	64	7	information	information	NOUN
aiua-11120	64	8	,	,	PUNCT
aiua-11120	64	9	we	we	PRON
aiua-11120	64	10	analyzed	analyze	VERB
aiua-11120	64	11	the	the	DET
aiua-11120	64	12	reason	reason	NOUN
aiua-11120	64	13	for	for	ADP
aiua-11120	64	14	incompleteness	incompleteness	NOUN
aiua-11120	64	15	and	and	CCONJ
aiua-11120	64	16	considered	consider	VERB
aiua-11120	64	17	the	the	DET
aiua-11120	64	18	impact	impact	NOUN
aiua-11120	64	19	of	of	ADP
aiua-11120	64	20	missing	miss	VERB
aiua-11120	64	21	data	datum	NOUN
aiua-11120	64	22	on	on	ADP
aiua-11120	64	23	the	the	DET
aiua-11120	64	24	meta	meta	ADJ
aiua-11120	64	25	-	-	PUNCT
aiua-11120	64	26	analysis	analysis	NOUN
aiua-11120	64	27	results	result	NOUN
aiua-11120	64	28	.	.	PUNCT
aiua-11120	65	1	quality	quality	NOUN
aiua-11120	65	2	evaluation	evaluation	NOUN
aiua-11120	65	3	(	(	PUNCT
aiua-11120	65	4	supplementary	supplementary	ADJ
aiua-11120	65	5	materials	material	NOUN
aiua-11120	65	6	rob	rob	PROPN
aiua-11120	65	7	evaluation	evaluation	NOUN
aiua-11120	65	8	)	)	PUNCT
aiua-11120	65	9	two	two	NUM
aiua-11120	65	10	authors	author	NOUN
aiua-11120	65	11	independently	independently	ADV
aiua-11120	65	12	performed	perform	VERB
aiua-11120	65	13	the	the	DET
aiua-11120	65	14	quality	quality	NOUN
aiua-11120	65	15	assessment	assessment	NOUN
aiua-11120	65	16	by	by	ADP
aiua-11120	65	17	identifying	identify	VERB
aiua-11120	65	18	potential	potential	ADJ
aiua-11120	65	19	biases	bias	NOUN
aiua-11120	65	20	using	use	VERB
aiua-11120	65	21	the	the	DET
aiua-11120	65	22	2019	2019	NUM
aiua-11120	65	23	cochrane	cochrane	NOUN
aiua-11120	65	24	risk	risk	NOUN
aiua-11120	65	25	of	of	ADP
aiua-11120	65	26	bias	bias	NOUN
aiua-11120	65	27	tool	tool	NOUN
aiua-11120	65	28	(	(	PUNCT
aiua-11120	65	29	rob	rob	PROPN
aiua-11120	65	30	)	)	PUNCT
aiua-11120	65	31	2	2	NUM
aiua-11120	65	32	(	(	PUNCT
aiua-11120	65	33	17	17	NUM
aiua-11120	65	34	)	)	PUNCT
aiua-11120	65	35	.	.	PUNCT
aiua-11120	66	1	study	study	NOUN
aiua-11120	66	2	quality	quality	NOUN
aiua-11120	66	3	was	be	AUX
aiua-11120	66	4	assessed	assess	VERB
aiua-11120	66	5	against	against	ADP
aiua-11120	66	6	pre	pre	ADJ
aiua-11120	66	7	-	-	ADJ
aiua-11120	66	8	defined	define	VERB
aiua-11120	66	9	criteria	criterion	NOUN
aiua-11120	66	10	in	in	ADP
aiua-11120	66	11	relation	relation	NOUN
aiua-11120	66	12	to	to	ADP
aiua-11120	66	13	randomization	randomization	NOUN
aiua-11120	66	14	process	process	NOUN
aiua-11120	66	15	(	(	PUNCT
aiua-11120	66	16	d1	d1	NOUN
aiua-11120	66	17	)	)	PUNCT
aiua-11120	66	18	,	,	PUNCT
aiua-11120	66	19	deviations	deviation	NOUN
aiua-11120	66	20	from	from	ADP
aiua-11120	66	21	the	the	DET
aiua-11120	66	22	intended	intend	VERB
aiua-11120	66	23	interventions	intervention	NOUN
aiua-11120	66	24	(	(	PUNCT
aiua-11120	66	25	d2	d2	PROPN
aiua-11120	66	26	)	)	PUNCT
aiua-11120	66	27	,	,	PUNCT
aiua-11120	66	28	missing	miss	VERB
aiua-11120	66	29	outcome	outcome	NOUN
aiua-11120	66	30	data	datum	NOUN
aiua-11120	66	31	(	(	PUNCT
aiua-11120	66	32	d3	d3	PROPN
aiua-11120	66	33	)	)	PUNCT
aiua-11120	66	34	,	,	PUNCT
aiua-11120	66	35	measurement	measurement	NOUN
aiua-11120	66	36	of	of	ADP
aiua-11120	66	37	the	the	DET
aiua-11120	66	38	outcome	outcome	NOUN
aiua-11120	66	39	(	(	PUNCT
aiua-11120	66	40	d4	d4	PROPN
aiua-11120	66	41	)	)	PUNCT
aiua-11120	66	42	and	and	CCONJ
aiua-11120	66	43	selection	selection	NOUN
aiua-11120	66	44	of	of	ADP
aiua-11120	66	45	the	the	DET
aiua-11120	66	46	reported	report	VERB
aiua-11120	66	47	result	result	NOUN
aiua-11120	66	48	(	(	PUNCT
aiua-11120	66	49	d5	d5	NOUN
aiua-11120	66	50	)	)	PUNCT
aiua-11120	66	51	.	.	PUNCT
aiua-11120	67	1	disagreements	disagreement	NOUN
aiua-11120	67	2	were	be	AUX
aiua-11120	67	3	resolved	resolve	VERB
aiua-11120	67	4	by	by	ADP
aiua-11120	67	5	discussion	discussion	NOUN
aiua-11120	67	6	.	.	PUNCT
aiua-11120	68	1	the	the	DET
aiua-11120	68	2	presence	presence	NOUN
aiua-11120	68	3	of	of	ADP
aiua-11120	68	4	high	high	ADJ
aiua-11120	68	5	risk	risk	NOUN
aiua-11120	68	6	of	of	ADP
aiua-11120	68	7	bias	bias	NOUN
aiua-11120	68	8	was	be	AUX
aiua-11120	68	9	not	not	PART
aiua-11120	68	10	used	use	VERB
aiua-11120	68	11	as	as	ADP
aiua-11120	68	12	a	a	DET
aiua-11120	68	13	criterion	criterion	NOUN
aiua-11120	68	14	to	to	PART
aiua-11120	68	15	exclude	exclude	VERB
aiua-11120	68	16	studies	study	NOUN
aiua-11120	68	17	from	from	ADP
aiua-11120	68	18	analysis	analysis	NOUN
aiua-11120	68	19	.	.	PUNCT
aiua-11120	69	1	publication	publication	NOUN
aiua-11120	69	2	bias	bias	NOUN
aiua-11120	69	3	was	be	AUX
aiua-11120	69	4	planned	plan	VERB
aiua-11120	69	5	to	to	PART
aiua-11120	69	6	be	be	AUX
aiua-11120	69	7	assessed	assess	VERB
aiua-11120	69	8	by	by	ADP
aiua-11120	69	9	funnel	funnel	NOUN
aiua-11120	69	10	plot	plot	NOUN
aiua-11120	69	11	in	in	ADP
aiua-11120	69	12	the	the	DET
aiua-11120	69	13	presence	presence	NOUN
aiua-11120	69	14	of	of	ADP
aiua-11120	69	15	at	at	ADV
aiua-11120	69	16	least	least	ADV
aiua-11120	69	17	5	5	NUM
aiua-11120	69	18	trials	trial	NOUN
aiua-11120	69	19	in	in	ADP
aiua-11120	69	20	each	each	DET
aiua-11120	69	21	metaanalysis	metaanalysis	NOUN
aiua-11120	69	22	.	.	PUNCT
aiua-11120	70	1	if	if	SCONJ
aiua-11120	70	2	a	a	DET
aiua-11120	70	3	potential	potential	ADJ
aiua-11120	70	4	reporting	reporting	NOUN
aiua-11120	70	5	bias	bias	NOUN
aiua-11120	70	6	was	be	AUX
aiua-11120	70	7	found	find	VERB
aiua-11120	70	8	by	by	ADP
aiua-11120	70	9	visual	visual	ADJ
aiua-11120	70	10	inspection	inspection	NOUN
aiua-11120	70	11	of	of	ADP
aiua-11120	70	12	the	the	DET
aiua-11120	70	13	plots	plot	NOUN
aiua-11120	70	14	,	,	PUNCT
aiua-11120	70	15	the	the	DET
aiua-11120	70	16	berg	berg	PROPN
aiua-11120	70	17	and	and	CCONJ
aiua-11120	70	18	egger	egger	NOUN
aiua-11120	70	19	tests	test	NOUN
aiua-11120	70	20	were	be	AUX
aiua-11120	70	21	used	use	VERB
aiua-11120	70	22	to	to	PART
aiua-11120	70	23	test	test	VERB
aiua-11120	70	24	funnel	funnel	NOUN
aiua-11120	70	25	plots	plot	NOUN
aiua-11120	70	26	symmetry	symmetry	NOUN
aiua-11120	70	27	and	and	CCONJ
aiua-11120	70	28	to	to	PART
aiua-11120	70	29	confirm	confirm	VERB
aiua-11120	70	30	the	the	DET
aiua-11120	70	31	presence	presence	NOUN
aiua-11120	70	32	/	/	SYM
aiua-11120	70	33	absence	absence	NOUN
aiua-11120	70	34	publication	publication	NOUN
aiua-11120	70	35	bias	bias	NOUN
aiua-11120	70	36	.	.	PUNCT
aiua-11120	71	1	a	a	DET
aiua-11120	71	2	summary	summary	NOUN
aiua-11120	71	3	of	of	ADP
aiua-11120	71	4	findings	finding	NOUN
aiua-11120	71	5	table	table	NOUN
aiua-11120	71	6	was	be	AUX
aiua-11120	71	7	generated	generate	VERB
aiua-11120	71	8	,	,	PUNCT
aiua-11120	71	9	and	and	CCONJ
aiua-11120	71	10	the	the	DET
aiua-11120	71	11	quality	quality	NOUN
aiua-11120	71	12	of	of	ADP
aiua-11120	71	13	the	the	DET
aiua-11120	71	14	evidence	evidence	NOUN
aiua-11120	71	15	emerging	emerge	VERB
aiua-11120	71	16	from	from	ADP
aiua-11120	71	17	meta	meta	NOUN
aiua-11120	71	18	-	-	PUNCT
aiua-11120	71	19	analyses	analysis	NOUN
aiua-11120	71	20	including	include	VERB
aiua-11120	71	21	at	at	ADV
aiua-11120	71	22	least	least	ADV
aiua-11120	71	23	3	3	NUM
aiua-11120	71	24	studies	study	NOUN
aiua-11120	71	25	was	be	AUX
aiua-11120	71	26	rated	rate	VERB
aiua-11120	71	27	according	accord	VERB
aiua-11120	71	28	to	to	ADP
aiua-11120	71	29	grade	grade	NOUN
aiua-11120	71	30	criteria	criterion	NOUN
aiua-11120	71	31	.	.	PUNCT
aiua-11120	72	1	statistical	statistical	ADJ
aiua-11120	72	2	analysis	analysis	NOUN
aiua-11120	72	3	statistical	statistical	ADJ
aiua-11120	72	4	analysis	analysis	NOUN
aiua-11120	72	5	was	be	AUX
aiua-11120	72	6	performed	perform	VERB
aiua-11120	72	7	using	use	VERB
aiua-11120	72	8	the	the	DET
aiua-11120	72	9	revman5	revman5	PROPN
aiua-11120	72	10	software	software	NOUN
aiua-11120	72	11	.	.	PUNCT
aiua-11120	73	1	mean	mean	VERB
aiua-11120	73	2	differences	difference	NOUN
aiua-11120	73	3	,	,	PUNCT
aiua-11120	73	4	95	95	NUM
aiua-11120	73	5	%	%	NOUN
aiua-11120	73	6	confidence	confidence	NOUN
aiua-11120	73	7	intervals	interval	NOUN
aiua-11120	73	8	(	(	PUNCT
aiua-11120	73	9	ci	ci	NOUN
aiua-11120	73	10	)	)	PUNCT
aiua-11120	73	11	and	and	CCONJ
aiua-11120	73	12	z	z	NOUN
aiua-11120	73	13	statistics	statistic	NOUN
aiua-11120	73	14	were	be	AUX
aiua-11120	73	15	calculated	calculate	VERB
aiua-11120	73	16	(	(	PUNCT
aiua-11120	73	17	random	random	ADJ
aiua-11120	73	18	-	-	PUNCT
aiua-11120	73	19	effects	effect	NOUN
aiua-11120	73	20	model	model	NOUN
aiua-11120	73	21	,	,	PUNCT
aiua-11120	73	22	inverse	inverse	ADJ
aiua-11120	73	23	variance	variance	NOUN
aiua-11120	73	24	method	method	NOUN
aiua-11120	73	25	)	)	PUNCT
aiua-11120	73	26	.	.	PUNCT
aiua-11120	74	1	study	study	NOUN
aiua-11120	74	2	heterogeneity	heterogeneity	NOUN
aiua-11120	74	3	was	be	AUX
aiua-11120	74	4	assessed	assess	VERB
aiua-11120	74	5	by	by	ADP
aiua-11120	74	6	calculating	calculate	VERB
aiua-11120	74	7	the	the	DET
aiua-11120	74	8	i^2	i^2	PROPN
aiua-11120	74	9	(	(	PUNCT
aiua-11120	74	10	and	and	CCONJ
aiua-11120	74	11	95	95	NUM
aiua-11120	74	12	%	%	NOUN
aiua-11120	74	13	ci	ci	NOUN
aiua-11120	74	14	)	)	PUNCT
aiua-11120	74	15	,	,	PUNCT
aiua-11120	74	16	which	which	PRON
aiua-11120	74	17	was	be	AUX
aiua-11120	74	18	interpreted	interpret	VERB
aiua-11120	74	19	as	as	ADP
aiua-11120	74	20	of	of	ADP
aiua-11120	74	21	lesser	less	ADJ
aiua-11120	74	22	importance	importance	NOUN
aiua-11120	74	23	(	(	PUNCT
aiua-11120	74	24	i^2	i^2	X
aiua-11120	74	25	≤	≤	NUM
aiua-11120	74	26	40	40	NUM
aiua-11120	74	27	%	%	NOUN
aiua-11120	74	28	)	)	PUNCT
aiua-11120	74	29	,	,	PUNCT
aiua-11120	74	30	moderate	moderate	ADJ
aiua-11120	74	31	(	(	PUNCT
aiua-11120	74	32	i^2	i^2	X
aiua-11120	74	33	=	=	PUNCT
aiua-11120	74	34	30%-60	30%-60	NUM
aiua-11120	74	35	%	%	NOUN
aiua-11120	74	36	)	)	PUNCT
aiua-11120	74	37	,	,	PUNCT
aiua-11120	74	38	substantial	substantial	ADJ
aiua-11120	74	39	(	(	PUNCT
aiua-11120	74	40	i^2	i^2	X
aiua-11120	74	41	=	=	PUNCT
aiua-11120	74	42	50%-90	50%-90	NUM
aiua-11120	74	43	%	%	NOUN
aiua-11120	74	44	)	)	PUNCT
aiua-11120	74	45	or	or	CCONJ
aiua-11120	74	46	considerable	considerable	ADJ
aiua-11120	74	47	(	(	PUNCT
aiua-11120	74	48	i^2	i^2	X
aiua-11120	74	49	≥	≥	NUM
aiua-11120	74	50	75	75	NUM
aiua-11120	74	51	%	%	NOUN
aiua-11120	74	52	)	)	PUNCT
aiua-11120	74	53	,	,	PUNCT
aiua-11120	74	54	according	accord	VERB
aiua-11120	74	55	to	to	ADP
aiua-11120	74	56	cochrane	cochrane	NOUN
aiua-11120	74	57	criteria	criterion	NOUN
aiua-11120	74	58	.	.	PUNCT
aiua-11120	75	1	sensitivity	sensitivity	NOUN
aiua-11120	75	2	analysis	analysis	NOUN
aiua-11120	75	3	was	be	AUX
aiua-11120	75	4	planned	plan	VERB
aiua-11120	75	5	in	in	ADP
aiua-11120	75	6	case	case	NOUN
aiua-11120	75	7	substantial	substantial	ADJ
aiua-11120	75	8	or	or	CCONJ
aiua-11120	75	9	considerable	considerable	ADJ
aiua-11120	75	10	heterogeneity	heterogeneity	NOUN
aiua-11120	75	11	of	of	ADP
aiua-11120	75	12	pooled	pool	VERB
aiua-11120	75	13	analyses	analysis	NOUN
aiua-11120	75	14	including	include	VERB
aiua-11120	75	15	at	at	ADV
aiua-11120	75	16	least	least	ADV
aiua-11120	75	17	5	5	NUM
aiua-11120	75	18	studies	study	NOUN
aiua-11120	75	19	.	.	PUNCT
aiua-11120	76	1	results	result	NOUN
aiua-11120	76	2	in	in	ADP
aiua-11120	76	3	total	total	ADJ
aiua-11120	76	4	,	,	PUNCT
aiua-11120	76	5	157	157	NUM
aiua-11120	76	6	records	record	NOUN
aiua-11120	76	7	(	(	PUNCT
aiua-11120	76	8	97	97	NUM
aiua-11120	76	9	from	from	ADP
aiua-11120	76	10	medline	medline	NOUN
aiua-11120	76	11	,	,	PUNCT
aiua-11120	76	12	60	60	NUM
aiua-11120	76	13	from	from	ADP
aiua-11120	76	14	embase	embase	NOUN
aiua-11120	76	15	)	)	PUNCT
aiua-11120	76	16	were	be	AUX
aiua-11120	76	17	retrieved	retrieve	VERB
aiua-11120	76	18	by	by	ADP
aiua-11120	76	19	database	database	NOUN
aiua-11120	76	20	searching	searching	NOUN
aiua-11120	76	21	;	;	PUNCT
aiua-11120	76	22	94	94	NUM
aiua-11120	76	23	papers	paper	NOUN
aiua-11120	76	24	were	be	AUX
aiua-11120	76	25	included	include	VERB
aiua-11120	76	26	after	after	ADP
aiua-11120	76	27	title	title	NOUN
aiua-11120	76	28	and	and	CCONJ
aiua-11120	76	29	abstract	abstract	ADJ
aiua-11120	76	30	screening	screening	NOUN
aiua-11120	76	31	(	(	PUNCT
aiua-11120	76	32	62	62	NUM
aiua-11120	76	33	from	from	ADP
aiua-11120	76	34	medline	medline	NOUN
aiua-11120	76	35	,	,	PUNCT
aiua-11120	76	36	32	32	NUM
aiua-11120	76	37	from	from	ADP
aiua-11120	76	38	embase	embase	NOUN
aiua-11120	76	39	)	)	PUNCT
aiua-11120	76	40	.	.	PUNCT
aiua-11120	77	1	after	after	ADP
aiua-11120	77	2	removal	removal	NOUN
aiua-11120	77	3	of	of	ADP
aiua-11120	77	4	17	17	NUM
aiua-11120	77	5	duplicates	duplicate	NOUN
aiua-11120	77	6	,	,	PUNCT
aiua-11120	77	7	we	we	PRON
aiua-11120	77	8	evaluated	evaluate	VERB
aiua-11120	77	9	77	77	NUM
aiua-11120	77	10	papers	paper	NOUN
aiua-11120	77	11	by	by	ADP
aiua-11120	77	12	full	full	ADJ
aiua-11120	77	13	-	-	PUNCT
aiua-11120	77	14	text	text	NOUN
aiua-11120	77	15	reading	reading	NOUN
aiua-11120	77	16	.	.	PUNCT
aiua-11120	78	1	twelve	twelve	NUM
aiua-11120	78	2	studies	study	NOUN
aiua-11120	78	3	were	be	AUX
aiua-11120	78	4	excluded	exclude	VERB
aiua-11120	78	5	:	:	PUNCT
aiua-11120	78	6	five	five	NUM
aiua-11120	78	7	studies	study	NOUN
aiua-11120	78	8	reported	report	VERB
aiua-11120	78	9	data	datum	NOUN
aiua-11120	78	10	contained	contain	VERB
aiua-11120	78	11	in	in	ADP
aiua-11120	78	12	other	other	ADJ
aiua-11120	78	13	included	include	VERB
aiua-11120	78	14	studies	study	NOUN
aiua-11120	78	15	,	,	PUNCT
aiua-11120	78	16	a	a	DET
aiua-11120	78	17	study	study	NOUN
aiua-11120	78	18	evaluated	evaluate	VERB
aiua-11120	78	19	the	the	DET
aiua-11120	78	20	expression	expression	NOUN
aiua-11120	78	21	of	of	ADP
aiua-11120	78	22	cb1	cb1	PROPN
aiua-11120	78	23	and	and	CCONJ
aiua-11120	78	24	cb2	cb2	PROPN
aiua-11120	78	25	receptors	receptor	NOUN
aiua-11120	78	26	after	after	SCONJ
aiua-11120	78	27	sublingual	sublingual	ADJ
aiua-11120	78	28	administration	administration	PROPN
aiua-11120	78	29	of	of	ADP
aiua-11120	78	30	spray	spray	NOUN
aiua-11120	78	31	cannabidiol	cannabidiol	NOUN
aiua-11120	78	32	,	,	PUNCT
aiua-11120	78	33	an	an	DET
aiua-11120	78	34	article	article	NOUN
aiua-11120	78	35	contained	contain	VERB
aiua-11120	78	36	a	a	DET
aiua-11120	78	37	review	review	NOUN
aiua-11120	78	38	of	of	ADP
aiua-11120	78	39	the	the	DET
aiua-11120	78	40	literature	literature	NOUN
aiua-11120	78	41	,	,	PUNCT
aiua-11120	78	42	two	two	NUM
aiua-11120	78	43	studies	study	NOUN
aiua-11120	78	44	focused	focus	VERB
aiua-11120	78	45	on	on	ADP
aiua-11120	78	46	non	non	ADJ
aiua-11120	78	47	-	-	ADJ
aiua-11120	78	48	neurogenic	neurogenic	ADJ
aiua-11120	78	49	oab	oab	PROPN
aiua-11120	78	50	,	,	PUNCT
aiua-11120	78	51	one	one	NUM
aiua-11120	78	52	study	study	NOUN
aiua-11120	78	53	addressed	address	VERB
aiua-11120	78	54	a	a	DET
aiua-11120	78	55	pediatric	pediatric	ADJ
aiua-11120	78	56	population	population	NOUN
aiua-11120	78	57	,	,	PUNCT
aiua-11120	78	58	two	two	NUM
aiua-11120	78	59	studies	study	NOUN
aiua-11120	78	60	were	be	AUX
aiua-11120	78	61	open	open	ADJ
aiua-11120	78	62	-	-	PUNCT
aiua-11120	78	63	label	label	NOUN
aiua-11120	78	64	.	.	PUNCT
aiua-11120	79	1	sixty	sixty	NUM
aiua-11120	79	2	-	-	PUNCT
aiua-11120	79	3	two	two	NUM
aiua-11120	79	4	studies	study	NOUN
aiua-11120	79	5	were	be	AUX
aiua-11120	79	6	finally	finally	ADV
aiua-11120	79	7	selected	select	VERB
aiua-11120	79	8	(	(	PUNCT
aiua-11120	79	9	figure	figure	NOUN
aiua-11120	79	10	1	1	NUM
aiua-11120	79	11	)	)	PUNCT
aiua-11120	79	12	table	table	NOUN
aiua-11120	79	13	1	1	NUM
aiua-11120	79	14	lists	list	VERB
aiua-11120	79	15	the	the	DET
aiua-11120	79	16	62	62	NUM
aiua-11120	79	17	studies	study	NOUN
aiua-11120	79	18	included	include	VERB
aiua-11120	79	19	in	in	ADP
aiua-11120	79	20	this	this	DET
aiua-11120	79	21	review	review	NOUN
aiua-11120	79	22	,	,	PUNCT
aiua-11120	79	23	according	accord	VERB
aiua-11120	79	24	to	to	ADP
aiua-11120	79	25	underlying	underlie	VERB
aiua-11120	79	26	disease	disease	NOUN
aiua-11120	79	27	and	and	CCONJ
aiua-11120	79	28	type	type	NOUN
aiua-11120	79	29	of	of	ADP
aiua-11120	79	30	treatment	treatment	NOUN
aiua-11120	79	31	.	.	PUNCT
aiua-11120	80	1	quantitative	quantitative	ADJ
aiua-11120	80	2	analysis	analysis	NOUN
aiua-11120	80	3	was	be	AUX
aiua-11120	80	4	limited	limit	VERB
aiua-11120	80	5	to	to	ADP
aiua-11120	80	6	the	the	DET
aiua-11120	80	7	comparisons	comparison	NOUN
aiua-11120	80	8	of	of	ADP
aiua-11120	80	9	mirabegron	mirabegron	PROPN
aiua-11120	80	10	vs.	vs.	ADP
aiua-11120	80	11	placebo	placebo	NOUN
aiua-11120	80	12	,	,	PUNCT
aiua-11120	80	13	anticholinergics	anticholinergic	NOUN
aiua-11120	80	14	vs.	vs.	ADP
aiua-11120	80	15	placebo	placebo	NOUN
aiua-11120	80	16	,	,	PUNCT
aiua-11120	80	17	ttns	ttns	NOUN
aiua-11120	80	18	figure	figure	VERB
aiua-11120	80	19	1	1	NUM
aiua-11120	80	20	.	.	PUNCT
aiua-11120	80	21	flow	flow	NOUN
aiua-11120	80	22	diagram	diagram	NOUN
aiua-11120	80	23	.	.	PUNCT
aiua-11120	81	1	495archivio	495archivio	NOUN
aiua-11120	81	2	italiano	italiano	NOUN
aiua-11120	81	3	di	di	PROPN
aiua-11120	81	4	urologia	urologia	PROPN
aiua-11120	81	5	e	e	PROPN
aiua-11120	81	6	andrologia	andrologia	PROPN
aiua-11120	81	7	2022	2022	NUM
aiua-11120	81	8	;	;	PUNCT
aiua-11120	81	9	94	94	NUM
aiua-11120	81	10	,	,	PUNCT
aiua-11120	81	11	4	4	NUM
aiua-11120	81	12	treatment	treatment	NOUN
aiua-11120	81	13	of	of	ADP
aiua-11120	81	14	overactive	overactive	ADJ
aiua-11120	81	15	neurogenic	neurogenic	ADJ
aiua-11120	81	16	bladder	bladder	NOUN
aiua-11120	81	17	vs.	vs.	ADP
aiua-11120	81	18	sham	sham	NOUN
aiua-11120	81	19	intervention	intervention	NOUN
aiua-11120	81	20	,	,	PUNCT
aiua-11120	81	21	and	and	CCONJ
aiua-11120	81	22	pfmt	pfmt	VERB
aiua-11120	81	23	vs.	vs.	ADP
aiua-11120	81	24	controls	control	NOUN
aiua-11120	81	25	.	.	PUNCT
aiua-11120	82	1	other	other	ADJ
aiua-11120	82	2	outcomes	outcome	NOUN
aiua-11120	82	3	were	be	AUX
aiua-11120	82	4	not	not	PART
aiua-11120	82	5	analyzed	analyze	VERB
aiua-11120	82	6	quantitatively	quantitatively	ADV
aiua-11120	82	7	because	because	SCONJ
aiua-11120	82	8	several	several	ADJ
aiua-11120	82	9	extensive	extensive	ADJ
aiua-11120	82	10	meta	meta	ADJ
aiua-11120	82	11	-	-	PUNCT
aiua-11120	82	12	analyses	analysis	NOUN
aiua-11120	82	13	were	be	AUX
aiua-11120	82	14	previously	previously	ADV
aiua-11120	82	15	published	publish	VERB
aiua-11120	82	16	.	.	PUNCT
aiua-11120	83	1	anticholinergics	anticholinergic	NOUN
aiua-11120	83	2	we	we	PRON
aiua-11120	83	3	found	find	VERB
aiua-11120	83	4	9	9	NUM
aiua-11120	83	5	papers	paper	NOUN
aiua-11120	83	6	evaluating	evaluate	VERB
aiua-11120	83	7	the	the	DET
aiua-11120	83	8	effects	effect	NOUN
aiua-11120	83	9	of	of	ADP
aiua-11120	83	10	anticholinergics	anticholinergic	NOUN
aiua-11120	83	11	(	(	PUNCT
aiua-11120	83	12	18	18	NUM
aiua-11120	83	13	-	-	SYM
aiua-11120	83	14	26	26	NUM
aiua-11120	83	15	)	)	PUNCT
aiua-11120	83	16	.	.	PUNCT
aiua-11120	84	1	three	three	NUM
aiua-11120	84	2	papers	paper	NOUN
aiua-11120	84	3	compared	compare	VERB
aiua-11120	84	4	anticholinergic	anticholinergic	ADJ
aiua-11120	84	5	agents	agent	NOUN
aiua-11120	84	6	with	with	ADP
aiua-11120	84	7	placebo	placebo	NOUN
aiua-11120	84	8	for	for	ADP
aiua-11120	84	9	treatment	treatment	NOUN
aiua-11120	84	10	of	of	ADP
aiua-11120	84	11	overactive	overactive	ADJ
aiua-11120	84	12	bladder	bladder	NOUN
aiua-11120	84	13	in	in	ADP
aiua-11120	84	14	patients	patient	NOUN
aiua-11120	84	15	with	with	ADP
aiua-11120	84	16	parkinson	parkinson	NOUN
aiua-11120	84	17	disease	disease	NOUN
aiua-11120	84	18	(	(	PUNCT
aiua-11120	84	19	n	n	NOUN
aiua-11120	84	20	=	=	SYM
aiua-11120	84	21	2	2	NUM
aiua-11120	84	22	)	)	PUNCT
aiua-11120	84	23	,	,	PUNCT
aiua-11120	84	24	multiple	multiple	ADJ
aiua-11120	84	25	sclerosis	sclerosis	NOUN
aiua-11120	84	26	or	or	CCONJ
aiua-11120	84	27	spinal	spinal	NOUN
aiua-11120	84	28	cord	cord	NOUN
aiua-11120	84	29	injury	injury	NOUN
aiua-11120	84	30	(	(	PUNCT
aiua-11120	84	31	n	n	NOUN
aiua-11120	84	32	=	=	SYM
aiua-11120	84	33	1	1	NUM
aiua-11120	84	34	)	)	PUNCT
aiua-11120	84	35	(	(	PUNCT
aiua-11120	84	36	18	18	NUM
aiua-11120	84	37	-	-	SYM
aiua-11120	84	38	20	20	NUM
aiua-11120	84	39	)	)	PUNCT
aiua-11120	84	40	.	.	PUNCT
aiua-11120	85	1	quantitative	quantitative	ADJ
aiua-11120	85	2	analysis	analysis	NOUN
aiua-11120	85	3	of	of	ADP
aiua-11120	85	4	two	two	NUM
aiua-11120	85	5	studies	study	NOUN
aiua-11120	85	6	(	(	PUNCT
aiua-11120	85	7	18	18	NUM
aiua-11120	85	8	,	,	PUNCT
aiua-11120	85	9	19	19	NUM
aiua-11120	85	10	)	)	PUNCT
aiua-11120	85	11	in	in	ADP
aiua-11120	85	12	patients	patient	NOUN
aiua-11120	85	13	with	with	ADP
aiua-11120	85	14	parkinson	parkinson	NOUN
aiua-11120	85	15	disease	disease	NOUN
aiua-11120	85	16	demonstrated	demonstrate	VERB
aiua-11120	85	17	that	that	SCONJ
aiua-11120	85	18	anticholinergics	anticholinergic	NOUN
aiua-11120	85	19	were	be	AUX
aiua-11120	85	20	more	more	ADV
aiua-11120	85	21	effective	effective	ADJ
aiua-11120	85	22	than	than	ADP
aiua-11120	85	23	placebo	placebo	NOUN
aiua-11120	85	24	in	in	ADP
aiua-11120	85	25	decreasing	decrease	VERB
aiua-11120	85	26	the	the	DET
aiua-11120	85	27	number	number	NOUN
aiua-11120	85	28	of	of	ADP
aiua-11120	85	29	day	day	NOUN
aiua-11120	85	30	voids	voids	NOUN
aiua-11120	85	31	(	(	PUNCT
aiua-11120	85	32	mean	mean	INTJ
aiua-11120	85	33	difference	difference	NOUN
aiua-11120	85	34	[	[	X
aiua-11120	85	35	md	md	X
aiua-11120	85	36	]	]	X
aiua-11120	85	37	,	,	PUNCT
aiua-11120	85	38	-1.16	-1.16	PROPN
aiua-11120	85	39	,	,	PUNCT
aiua-11120	85	40	95	95	NUM
aiua-11120	85	41	%	%	NOUN
aiua-11120	85	42	ci	ci	NOUN
aiua-11120	85	43	1.80	1.80	NUM
aiua-11120	85	44	to	to	ADP
aiua-11120	85	45	0.52	0.52	NUM
aiua-11120	85	46	,	,	PUNCT
aiua-11120	85	47	2	2	NUM
aiua-11120	85	48	trials	trial	NOUN
aiua-11120	85	49	,	,	PUNCT
aiua-11120	85	50	86	86	NUM
aiua-11120	85	51	patients	patient	NOUN
aiua-11120	85	52	,	,	PUNCT
aiua-11120	85	53	z	z	NOUN
aiua-11120	85	54	=	=	NUM
aiua-11120	85	55	3.56	3.56	NUM
aiua-11120	85	56	,	,	PUNCT
aiua-11120	85	57	p	p	X
aiua-11120	85	58	<	<	X
aiua-11120	85	59	0.004	0.004	NUM
aiua-11120	85	60	)	)	PUNCT
aiua-11120	85	61	.	.	PUNCT
aiua-11120	86	1	changes	change	NOUN
aiua-11120	86	2	from	from	ADP
aiua-11120	86	3	baseline	baseline	ADJ
aiua-11120	86	4	number	number	NOUN
aiua-11120	86	5	of	of	ADP
aiua-11120	86	6	incontinence	incontinence	NOUN
aiua-11120	86	7	and	and	CCONJ
aiua-11120	86	8	nocturia	nocturia	PROPN
aiua-11120	86	9	episodes	episode	NOUN
aiua-11120	86	10	were	be	AUX
aiua-11120	86	11	not	not	PART
aiua-11120	86	12	significantly	significantly	ADV
aiua-11120	86	13	different	different	ADJ
aiua-11120	86	14	between	between	ADP
aiua-11120	86	15	anticholinergics	anticholinergic	NOUN
aiua-11120	86	16	and	and	CCONJ
aiua-11120	86	17	placebo	placebo	NOUN
aiua-11120	86	18	(	(	PUNCT
aiua-11120	86	19	md	md	PROPN
aiua-11120	86	20	,	,	PUNCT
aiua-11120	86	21	-0.44	-0.44	NOUN
aiua-11120	86	22	,	,	PUNCT
aiua-11120	86	23	95	95	NUM
aiua-11120	86	24	%	%	NOUN
aiua-11120	86	25	ci	ci	NOUN
aiua-11120	86	26	-1.23	-1.23	NOUN
aiua-11120	86	27	to	to	ADP
aiua-11120	86	28	0.35	0.35	NUM
aiua-11120	86	29	,	,	PUNCT
aiua-11120	86	30	2	2	NUM
aiua-11120	86	31	trials	trial	NOUN
aiua-11120	86	32	,	,	PUNCT
aiua-11120	86	33	86	86	NUM
aiua-11120	86	34	patients	patient	NOUN
aiua-11120	86	35	,	,	PUNCT
aiua-11120	86	36	z	z	NOUN
aiua-11120	86	37	=	=	NUM
aiua-11120	86	38	1.08	1.08	NUM
aiua-11120	86	39	,	,	PUNCT
aiua-11120	86	40	p	p	NOUN
aiua-11120	86	41	=	=	NOUN
aiua-11120	86	42	0.28	0.28	NUM
aiua-11120	86	43	,	,	PUNCT
aiua-11120	86	44	and	and	CCONJ
aiua-11120	86	45	md	md	PROPN
aiua-11120	86	46	,	,	PUNCT
aiua-11120	86	47	-0.36	-0.36	NOUN
aiua-11120	86	48	,	,	PUNCT
aiua-11120	86	49	95	95	NUM
aiua-11120	86	50	%	%	NOUN
aiua-11120	86	51	ci	ci	NOUN
aiua-11120	86	52	-1.17	-1.17	PROPN
aiua-11120	86	53	to	to	ADP
aiua-11120	86	54	0.45	0.45	NUM
aiua-11120	86	55	,	,	PUNCT
aiua-11120	86	56	2	2	NUM
aiua-11120	86	57	trials	trial	NOUN
aiua-11120	86	58	,	,	PUNCT
aiua-11120	86	59	86	86	NUM
aiua-11120	86	60	patients	patient	NOUN
aiua-11120	86	61	,	,	PUNCT
aiua-11120	86	62	z	z	NOUN
aiua-11120	86	63	=	=	NUM
aiua-11120	86	64	0.87	0.87	NUM
aiua-11120	86	65	,	,	PUNCT
aiua-11120	86	66	p	p	X
aiua-11120	86	67	=	=	NOUN
aiua-11120	86	68	0.39	0.39	NUM
aiua-11120	86	69	,	,	PUNCT
aiua-11120	86	70	respectively	respectively	ADV
aiua-11120	86	71	)	)	PUNCT
aiua-11120	86	72	(	(	PUNCT
aiua-11120	86	73	figure	figure	NOUN
aiua-11120	86	74	2	2	NUM
aiua-11120	86	75	)	)	PUNCT
aiua-11120	86	76	.	.	PUNCT
aiua-11120	87	1	adverse	adverse	ADJ
aiua-11120	87	2	events	event	NOUN
aiua-11120	87	3	associated	associate	VERB
aiua-11120	87	4	with	with	ADP
aiua-11120	87	5	anticholinergics	anticholinergic	NOUN
aiua-11120	87	6	as	as	ADP
aiua-11120	87	7	dry	dry	ADJ
aiua-11120	87	8	mouth	mouth	NOUN
aiua-11120	87	9	,	,	PUNCT
aiua-11120	87	10	constipation	constipation	NOUN
aiua-11120	87	11	,	,	PUNCT
aiua-11120	87	12	and	and	CCONJ
aiua-11120	87	13	blurred	blurred	ADJ
aiua-11120	87	14	vision	vision	NOUN
aiua-11120	87	15	are	be	AUX
aiua-11120	87	16	well	well	ADV
aiua-11120	87	17	known	know	VERB
aiua-11120	87	18	and	and	CCONJ
aiua-11120	87	19	may	may	AUX
aiua-11120	87	20	lead	lead	VERB
aiua-11120	87	21	to	to	ADP
aiua-11120	87	22	therapy	therapy	NOUN
aiua-11120	87	23	discontinuation	discontinuation	NOUN
aiua-11120	87	24	.	.	PUNCT
aiua-11120	88	1	in	in	ADP
aiua-11120	88	2	a	a	DET
aiua-11120	88	3	study	study	NOUN
aiua-11120	88	4	comparing	compare	VERB
aiua-11120	88	5	solifenacin	solifenacin	PROPN
aiua-11120	88	6	or	or	CCONJ
aiua-11120	88	7	oxybutynin	oxybutynin	NOUN
aiua-11120	88	8	with	with	ADP
aiua-11120	88	9	placebo	placebo	NOUN
aiua-11120	88	10	the	the	DET
aiua-11120	88	11	most	most	ADV
aiua-11120	88	12	common	common	ADJ
aiua-11120	88	13	treatment	treatment	NOUN
aiua-11120	88	14	emergent	emergent	ADJ
aiua-11120	88	15	side	side	NOUN
aiua-11120	88	16	effects	effect	NOUN
aiua-11120	88	17	were	be	AUX
aiua-11120	88	18	dry	dry	ADJ
aiua-11120	88	19	mouth	mouth	NOUN
aiua-11120	88	20	and	and	CCONJ
aiua-11120	88	21	urinary	urinary	ADJ
aiua-11120	88	22	tract	tract	NOUN
aiua-11120	88	23	infections	infection	NOUN
aiua-11120	88	24	although	although	SCONJ
aiua-11120	88	25	most	most	ADJ
aiua-11120	88	26	events	event	NOUN
aiua-11120	88	27	were	be	AUX
aiua-11120	88	28	considered	consider	VERB
aiua-11120	88	29	mild	mild	ADJ
aiua-11120	88	30	in	in	ADP
aiua-11120	88	31	severity	severity	NOUN
aiua-11120	88	32	(	(	PUNCT
aiua-11120	88	33	20	20	NUM
aiua-11120	88	34	)	)	PUNCT
aiua-11120	88	35	.	.	PUNCT
aiua-11120	89	1	dry	dry	ADJ
aiua-11120	89	2	mouth	mouth	NOUN
aiua-11120	89	3	was	be	AUX
aiua-11120	89	4	observed	observe	VERB
aiua-11120	89	5	more	more	ADV
aiua-11120	89	6	frequently	frequently	ADV
aiua-11120	89	7	in	in	ADP
aiua-11120	89	8	patients	patient	NOUN
aiua-11120	89	9	taking	take	VERB
aiua-11120	89	10	oxybutyinin	oxybutyinin	NOUN
aiua-11120	89	11	(	(	PUNCT
aiua-11120	89	12	17	17	NUM
aiua-11120	89	13	%	%	NOUN
aiua-11120	89	14	)	)	PUNCT
aiua-11120	89	15	then	then	ADV
aiua-11120	89	16	in	in	ADP
aiua-11120	89	17	those	those	PRON
aiua-11120	89	18	receiving	receive	VERB
aiua-11120	89	19	solifenacin	solifenacin	NOUN
aiua-11120	89	20	(	(	PUNCT
aiua-11120	89	21	4.2	4.2	NUM
aiua-11120	89	22	-	-	SYM
aiua-11120	89	23	7.8	7.8	NUM
aiua-11120	89	24	%	%	NOUN
aiua-11120	89	25	)	)	PUNCT
aiua-11120	89	26	or	or	CCONJ
aiua-11120	89	27	placebo	placebo	NOUN
aiua-11120	89	28	(	(	PUNCT
aiua-11120	89	29	2.3	2.3	NUM
aiua-11120	89	30	%	%	NOUN
aiua-11120	89	31	)	)	PUNCT
aiua-11120	89	32	.	.	PUNCT
aiua-11120	90	1	changes	change	NOUN
aiua-11120	90	2	from	from	ADP
aiua-11120	90	3	baseline	baseline	NOUN
aiua-11120	90	4	in	in	ADP
aiua-11120	90	5	vas	vas	X
aiua-11120	90	6	dry	dry	ADJ
aiua-11120	90	7	mouth	mouth	NOUN
aiua-11120	90	8	score	score	NOUN
aiua-11120	90	9	were	be	AUX
aiua-11120	90	10	significantly	significantly	ADV
aiua-11120	90	11	higher	high	ADJ
aiua-11120	90	12	in	in	ADP
aiua-11120	90	13	the	the	DET
aiua-11120	90	14	oxybutynin	oxybutynin	PROPN
aiua-11120	90	15	group	group	NOUN
aiua-11120	90	16	than	than	ADP
aiua-11120	90	17	in	in	ADP
aiua-11120	90	18	placebo	placebo	NOUN
aiua-11120	90	19	whereas	whereas	SCONJ
aiua-11120	90	20	there	there	PRON
aiua-11120	90	21	was	be	VERB
aiua-11120	90	22	no	no	DET
aiua-11120	90	23	difference	difference	NOUN
aiua-11120	90	24	of	of	ADP
aiua-11120	90	25	vas	vas	X
aiua-11120	90	26	dry	dry	ADJ
aiua-11120	90	27	mouth	mouth	NOUN
aiua-11120	90	28	score	score	NOUN
aiua-11120	90	29	between	between	ADP
aiua-11120	90	30	solifenacin	solifenacin	PROPN
aiua-11120	90	31	group	group	NOUN
aiua-11120	90	32	and	and	CCONJ
aiua-11120	90	33	placebo	placebo	NOUN
aiua-11120	90	34	.	.	PUNCT
aiua-11120	91	1	in	in	ADP
aiua-11120	91	2	another	another	DET
aiua-11120	91	3	study	study	NOUN
aiua-11120	91	4	,	,	PUNCT
aiua-11120	91	5	solifenacin	solifenacin	PROPN
aiua-11120	91	6	was	be	AUX
aiua-11120	91	7	well	well	ADV
aiua-11120	91	8	tolerated	tolerate	VERB
aiua-11120	91	9	but	but	CCONJ
aiua-11120	91	10	a	a	DET
aiua-11120	91	11	case	case	NOUN
aiua-11120	91	12	of	of	ADP
aiua-11120	91	13	urinary	urinary	ADJ
aiua-11120	91	14	retention	retention	NOUN
aiua-11120	91	15	was	be	AUX
aiua-11120	91	16	observed	observe	VERB
aiua-11120	91	17	in	in	ADP
aiua-11120	91	18	the	the	DET
aiua-11120	91	19	treatment	treatment	NOUN
aiua-11120	91	20	group	group	NOUN
aiua-11120	91	21	(	(	PUNCT
aiua-11120	91	22	11	11	NUM
aiua-11120	91	23	%	%	NOUN
aiua-11120	91	24	)	)	PUNCT
aiua-11120	91	25	.	.	PUNCT
aiua-11120	92	1	xerostomia	xerostomia	PROPN
aiua-11120	92	2	and	and	CCONJ
aiua-11120	92	3	constipation	constipation	NOUN
aiua-11120	92	4	were	be	AUX
aiua-11120	92	5	also	also	ADV
aiua-11120	92	6	observed	observe	VERB
aiua-11120	92	7	(	(	PUNCT
aiua-11120	92	8	18	18	NUM
aiua-11120	92	9	)	)	PUNCT
aiua-11120	92	10	.	.	PUNCT
aiua-11120	93	1	during	during	ADP
aiua-11120	93	2	the	the	DET
aiua-11120	93	3	treatment	treatment	NOUN
aiua-11120	93	4	with	with	ADP
aiua-11120	93	5	fesoterodine	fesoterodine	NOUN
aiua-11120	93	6	4	4	NUM
aiua-11120	93	7	mg	mg	NOUN
aiua-11120	93	8	there	there	PRON
aiua-11120	93	9	was	be	VERB
aiua-11120	93	10	no	no	DET
aiua-11120	93	11	serious	serious	ADJ
aiua-11120	93	12	adverse	adverse	ADJ
aiua-11120	93	13	event	event	NOUN
aiua-11120	93	14	and	and	CCONJ
aiua-11120	93	15	no	no	DET
aiua-11120	93	16	urinary	urinary	ADJ
aiua-11120	93	17	retention	retention	NOUN
aiua-11120	93	18	episode	episode	NOUN
aiua-11120	93	19	in	in	ADP
aiua-11120	93	20	both	both	PRON
aiua-11120	93	21	fesoterodine	fesoterodine	NOUN
aiua-11120	93	22	and	and	CCONJ
aiua-11120	93	23	placebo	placebo	NOUN
aiua-11120	93	24	groups	group	NOUN
aiua-11120	93	25	.	.	PUNCT
aiua-11120	94	1	xerostomia	xerostomia	NOUN
aiua-11120	94	2	(	(	PUNCT
aiua-11120	94	3	3	3	NUM
aiua-11120	94	4	%	%	NOUN
aiua-11120	94	5	)	)	PUNCT
aiua-11120	94	6	and	and	CCONJ
aiua-11120	94	7	constipation	constipation	NOUN
aiua-11120	94	8	(	(	PUNCT
aiua-11120	94	9	3	3	NUM
aiua-11120	94	10	%	%	NOUN
aiua-11120	94	11	)	)	PUNCT
aiua-11120	94	12	were	be	AUX
aiua-11120	94	13	observed	observe	VERB
aiua-11120	94	14	in	in	ADP
aiua-11120	94	15	the	the	DET
aiua-11120	94	16	treatment	treatment	NOUN
aiua-11120	94	17	group	group	NOUN
aiua-11120	94	18	(	(	PUNCT
aiua-11120	94	19	19	19	NUM
aiua-11120	94	20	)	)	PUNCT
aiua-11120	94	21	.	.	PUNCT
aiua-11120	95	1	one	one	NUM
aiua-11120	95	2	study	study	NOUN
aiua-11120	95	3	demonstrated	demonstrate	VERB
aiua-11120	95	4	that	that	SCONJ
aiua-11120	95	5	short	short	ADJ
aiua-11120	95	6	-	-	PUNCT
aiua-11120	95	7	term	term	NOUN
aiua-11120	95	8	treatment	treatment	NOUN
aiua-11120	95	9	using	use	VERB
aiua-11120	95	10	oral	oral	ADJ
aiua-11120	95	11	extended	extend	VERB
aiua-11120	95	12	-	-	PUNCT
aiua-11120	95	13	release	release	NOUN
aiua-11120	95	14	oxybutynin	oxybutynin	ADJ
aiua-11120	95	15	5	5	NUM
aiua-11120	95	16	mg	mg	ADP
aiua-11120	95	17	once	once	ADV
aiua-11120	95	18	daily	daily	ADV
aiua-11120	95	19	was	be	AUX
aiua-11120	95	20	safe	safe	ADJ
aiua-11120	95	21	and	and	CCONJ
aiua-11120	95	22	well	well	ADV
aiua-11120	95	23	tolerated	tolerate	VERB
aiua-11120	95	24	compared	compare	VERB
aiua-11120	95	25	to	to	ADP
aiua-11120	95	26	placebo	placebo	NOUN
aiua-11120	95	27	(	(	PUNCT
aiua-11120	95	28	with	with	ADP
aiua-11120	95	29	no	no	DET
aiua-11120	95	30	onset	onset	NOUN
aiua-11120	95	31	of	of	ADP
aiua-11120	95	32	delirium	delirium	NOUN
aiua-11120	95	33	)	)	PUNCT
aiua-11120	95	34	in	in	ADP
aiua-11120	95	35	older	old	ADJ
aiua-11120	95	36	female	female	ADJ
aiua-11120	95	37	nursing	nursing	NOUN
aiua-11120	95	38	home	home	NOUN
aiua-11120	95	39	participants	participant	NOUN
aiua-11120	95	40	with	with	ADP
aiua-11120	95	41	mild	mild	ADJ
aiua-11120	95	42	to	to	ADP
aiua-11120	95	43	severe	severe	ADJ
aiua-11120	95	44	dementia	dementia	NOUN
aiua-11120	95	45	(	(	PUNCT
aiua-11120	95	46	21	21	NUM
aiua-11120	95	47	)	)	PUNCT
aiua-11120	95	48	.	.	PUNCT
aiua-11120	96	1	four	four	NUM
aiua-11120	96	2	studies	study	NOUN
aiua-11120	96	3	compared	compare	VERB
aiua-11120	96	4	the	the	DET
aiua-11120	96	5	outcome	outcome	NOUN
aiua-11120	96	6	of	of	ADP
aiua-11120	96	7	the	the	DET
aiua-11120	96	8	treatment	treatment	NOUN
aiua-11120	96	9	with	with	ADP
aiua-11120	96	10	anticholinergic	anticholinergic	ADJ
aiua-11120	96	11	agents	agent	NOUN
aiua-11120	96	12	administered	administer	VERB
aiua-11120	96	13	at	at	ADP
aiua-11120	96	14	different	different	ADJ
aiua-11120	96	15	dose	dose	NOUN
aiua-11120	96	16	,	,	PUNCT
aiua-11120	96	17	or	or	CCONJ
aiua-11120	96	18	as	as	ADP
aiua-11120	96	19	different	different	ADJ
aiua-11120	96	20	formulations	formulation	NOUN
aiua-11120	96	21	,	,	PUNCT
aiua-11120	96	22	or	or	CCONJ
aiua-11120	96	23	via	via	ADP
aiua-11120	96	24	different	different	ADJ
aiua-11120	96	25	routes	route	NOUN
aiua-11120	96	26	(	(	PUNCT
aiua-11120	96	27	22	22	NUM
aiua-11120	96	28	-	-	SYM
aiua-11120	96	29	25	25	NUM
aiua-11120	96	30	)	)	PUNCT
aiua-11120	96	31	.	.	PUNCT
aiua-11120	97	1	oral	oral	ADJ
aiua-11120	97	2	trospium	trospium	NOUN
aiua-11120	97	3	chloride	chloride	NOUN
aiua-11120	97	4	at	at	ADP
aiua-11120	97	5	standard	standard	ADJ
aiua-11120	97	6	dosage	dosage	NOUN
aiua-11120	97	7	was	be	AUX
aiua-11120	97	8	compared	compare	VERB
aiua-11120	97	9	with	with	ADP
aiua-11120	97	10	oral	oral	ADJ
aiua-11120	97	11	trospium	trospium	NOUN
aiua-11120	97	12	chloride	chloride	NOUN
aiua-11120	97	13	administered	administer	VERB
aiua-11120	97	14	at	at	ADP
aiua-11120	97	15	adjustable	adjustable	ADJ
aiua-11120	97	16	doses	dose	NOUN
aiua-11120	97	17	.	.	PUNCT
aiua-11120	98	1	a	a	DET
aiua-11120	98	2	therapeutic	therapeutic	ADJ
aiua-11120	98	3	response	response	NOUN
aiua-11120	98	4	was	be	AUX
aiua-11120	98	5	achieved	achieve	VERB
aiua-11120	98	6	in	in	ADP
aiua-11120	98	7	58	58	NUM
aiua-11120	98	8	%	%	NOUN
aiua-11120	98	9	of	of	ADP
aiua-11120	98	10	patients	patient	NOUN
aiua-11120	98	11	in	in	ADP
aiua-11120	98	12	the	the	DET
aiua-11120	98	13	adjustable	adjustable	ADJ
aiua-11120	98	14	dose	dose	NOUN
aiua-11120	98	15	group	group	NOUN
aiua-11120	98	16	and	and	CCONJ
aiua-11120	98	17	in	in	ADP
aiua-11120	98	18	72	72	NUM
aiua-11120	98	19	%	%	NOUN
aiua-11120	98	20	of	of	ADP
aiua-11120	98	21	those	those	PRON
aiua-11120	98	22	in	in	ADP
aiua-11120	98	23	the	the	DET
aiua-11120	98	24	standard	standard	ADJ
aiua-11120	98	25	dose	dose	NOUN
aiua-11120	98	26	group	group	NOUN
aiua-11120	98	27	(	(	PUNCT
aiua-11120	98	28	p	p	X
aiua-11120	98	29	=	=	NOUN
aiua-11120	98	30	0.23	0.23	NUM
aiua-11120	98	31	)	)	PUNCT
aiua-11120	98	32	.	.	PUNCT
aiua-11120	99	1	rates	rate	NOUN
aiua-11120	99	2	of	of	ADP
aiua-11120	99	3	side	side	NOUN
aiua-11120	99	4	effects	effect	NOUN
aiua-11120	99	5	were	be	AUX
aiua-11120	99	6	similar	similar	ADJ
aiua-11120	99	7	between	between	ADP
aiua-11120	99	8	groups	group	NOUN
aiua-11120	99	9	(	(	PUNCT
aiua-11120	99	10	35	35	NUM
aiua-11120	99	11	%	%	NOUN
aiua-11120	99	12	vs	vs	ADP
aiua-11120	99	13	37	37	NUM
aiua-11120	99	14	%	%	NOUN
aiua-11120	99	15	)	)	PUNCT
aiua-11120	99	16	(	(	PUNCT
aiua-11120	99	17	22	22	NUM
aiua-11120	99	18	)	)	PUNCT
aiua-11120	99	19	.	.	PUNCT
aiua-11120	100	1	oral	oral	ADJ
aiua-11120	100	2	treatment	treatment	NOUN
aiua-11120	100	3	with	with	ADP
aiua-11120	100	4	oxybutynin	oxybutynin	ADJ
aiua-11120	100	5	immediate	immediate	ADJ
aiua-11120	100	6	release	release	NOUN
aiua-11120	100	7	was	be	AUX
aiua-11120	100	8	compared	compare	VERB
aiua-11120	100	9	to	to	ADP
aiua-11120	100	10	intravesical	intravesical	ADJ
aiua-11120	100	11	oxybutynin	oxybutynin	NOUN
aiua-11120	100	12	or	or	CCONJ
aiua-11120	100	13	atropine	atropine	NOUN
aiua-11120	100	14	.	.	PUNCT
aiua-11120	101	1	the	the	DET
aiua-11120	101	2	increase	increase	NOUN
aiua-11120	101	3	in	in	ADP
aiua-11120	101	4	maximum	maximum	ADJ
aiua-11120	101	5	bladder	bladder	NOUN
aiua-11120	101	6	capacity	capacity	NOUN
aiua-11120	101	7	was	be	AUX
aiua-11120	101	8	higher	high	ADJ
aiua-11120	101	9	with	with	ADP
aiua-11120	101	10	intravesical	intravesical	ADJ
aiua-11120	101	11	application	application	NOUN
aiua-11120	101	12	,	,	PUNCT
aiua-11120	101	13	also	also	ADV
aiua-11120	101	14	causing	cause	VERB
aiua-11120	101	15	less	less	ADV
aiua-11120	101	16	frequent	frequent	ADJ
aiua-11120	101	17	and	and	CCONJ
aiua-11120	101	18	less	less	ADV
aiua-11120	101	19	severe	severe	ADJ
aiua-11120	101	20	side	side	NOUN
aiua-11120	101	21	effects	effect	NOUN
aiua-11120	101	22	(	(	PUNCT
aiua-11120	101	23	23	23	NUM
aiua-11120	101	24	,	,	PUNCT
aiua-11120	101	25	24	24	NUM
aiua-11120	101	26	)	)	PUNCT
aiua-11120	101	27	.	.	PUNCT
aiua-11120	102	1	propiverine	propiverine	VERB
aiua-11120	102	2	extended	extend	VERB
aiua-11120	102	3	-	-	PUNCT
aiua-11120	102	4	release	release	NOUN
aiua-11120	102	5	(	(	PUNCT
aiua-11120	102	6	er	er	INTJ
aiua-11120	102	7	)	)	PUNCT
aiua-11120	102	8	was	be	AUX
aiua-11120	102	9	compared	compare	VERB
aiua-11120	102	10	with	with	ADP
aiua-11120	102	11	table	table	NOUN
aiua-11120	102	12	1	1	NUM
aiua-11120	102	13	.	.	PUNCT
aiua-11120	103	1	studies	study	NOUN
aiua-11120	103	2	retrieved	retrieve	VERB
aiua-11120	103	3	divided	divide	VERB
aiua-11120	103	4	by	by	ADP
aiua-11120	103	5	treatment	treatment	NOUN
aiua-11120	103	6	.	.	PUNCT
aiua-11120	104	1	treatment	treatment	NOUN
aiua-11120	104	2	design	design	NOUN
aiua-11120	104	3	n	n	CCONJ
aiua-11120	104	4	°	°	NUM
aiua-11120	104	5	of	of	ADP
aiua-11120	104	6	studies	study	NOUN
aiua-11120	104	7	disease	disease	NOUN
aiua-11120	104	8	mirabegron	mirabegron	PROPN
aiua-11120	104	9	compared	compare	VERB
aiua-11120	104	10	to	to	ADP
aiua-11120	104	11	placebo	placebo	NOUN
aiua-11120	104	12	5	5	NUM
aiua-11120	104	13	pd	pd	NOUN
aiua-11120	104	14	(	(	PUNCT
aiua-11120	104	15	3	3	NUM
aiua-11120	104	16	)	)	PUNCT
aiua-11120	104	17	,	,	PUNCT
aiua-11120	104	18	ms	ms	PROPN
aiua-11120	104	19	or	or	CCONJ
aiua-11120	104	20	sci	sci	PROPN
aiua-11120	104	21	(	(	PUNCT
aiua-11120	104	22	2	2	NUM
aiua-11120	104	23	)	)	PUNCT
aiua-11120	104	24	anticholinergics	anticholinergic	NOUN
aiua-11120	104	25	compared	compare	VERB
aiua-11120	104	26	to	to	ADP
aiua-11120	104	27	placebo	placebo	NOUN
aiua-11120	104	28	3	3	NUM
aiua-11120	104	29	pd	pd	PROPN
aiua-11120	104	30	(	(	PUNCT
aiua-11120	104	31	2	2	NUM
aiua-11120	104	32	)	)	PUNCT
aiua-11120	104	33	,	,	PUNCT
aiua-11120	104	34	ms	ms	PROPN
aiua-11120	104	35	or	or	CCONJ
aiua-11120	104	36	sci	sci	PROPN
aiua-11120	104	37	(	(	PUNCT
aiua-11120	104	38	1	1	NUM
aiua-11120	104	39	)	)	PUNCT
aiua-11120	104	40	compared	compare	VERB
aiua-11120	104	41	to	to	ADP
aiua-11120	104	42	placebo	placebo	NOUN
aiua-11120	104	43	to	to	PART
aiua-11120	104	44	evaluate	evaluate	VERB
aiua-11120	104	45	the	the	DET
aiua-11120	104	46	cognitive	cognitive	ADJ
aiua-11120	104	47	effects	effect	NOUN
aiua-11120	104	48	of	of	ADP
aiua-11120	104	49	oxybutynin	oxybutynin	ADJ
aiua-11120	104	50	1	1	NUM
aiua-11120	104	51	old	old	ADJ
aiua-11120	104	52	people	people	NOUN
aiua-11120	104	53	with	with	ADP
aiua-11120	104	54	cognitive	cognitive	ADJ
aiua-11120	104	55	impairment	impairment	ADJ
aiua-11120	104	56	oral	oral	ADJ
aiua-11120	104	57	trospium	trospium	NOUN
aiua-11120	104	58	,	,	PUNCT
aiua-11120	104	59	standard	standard	ADJ
aiua-11120	104	60	vs.	vs.	X
aiua-11120	104	61	adjustable	adjustable	ADJ
aiua-11120	104	62	dose	dose	VERB
aiua-11120	104	63	1	1	NUM
aiua-11120	104	64	neurogenic	neurogenic	ADJ
aiua-11120	104	65	detrusor	detrusor	NOUN
aiua-11120	104	66	overactivity	overactivity	NOUN
aiua-11120	104	67	oral	oral	PROPN
aiua-11120	104	68	oxybutynin	oxybutynin	PROPN
aiua-11120	104	69	ir	ir	PROPN
aiua-11120	104	70	vs.	vs.	ADP
aiua-11120	104	71	intravesical	intravesical	ADJ
aiua-11120	104	72	oxybutynin	oxybutynin	PROPN
aiua-11120	104	73	or	or	CCONJ
aiua-11120	104	74	atropin	atropin	PROPN
aiua-11120	104	75	2	2	NUM
aiua-11120	105	1	neurogenic	neurogenic	ADJ
aiua-11120	105	2	detrusor	detrusor	NOUN
aiua-11120	105	3	overactivity	overactivity	NOUN
aiua-11120	105	4	propiverine	propiverine	PROPN
aiua-11120	105	5	ir	ir	PROPN
aiua-11120	105	6	vs.	vs.	ADP
aiua-11120	105	7	er	er	INTJ
aiua-11120	105	8	1	1	NUM
aiua-11120	105	9	neurogenic	neurogenic	ADJ
aiua-11120	105	10	detrusor	detrusor	NOUN
aiua-11120	105	11	overactivity	overactivity	NOUN
aiua-11120	105	12	propiverine	propiverine	NOUN
aiua-11120	105	13	vs.	vs.	ADP
aiua-11120	105	14	oxybutynin	oxybutynin	PROPN
aiua-11120	105	15	1	1	NUM
aiua-11120	105	16	neurogenic	neurogenic	ADJ
aiua-11120	105	17	detrusor	detrusor	NOUN
aiua-11120	105	18	overactivity	overactivity	NOUN
aiua-11120	105	19	comparison	comparison	NOUN
aiua-11120	105	20	of	of	ADP
aiua-11120	105	21	drugs	drug	NOUN
aiua-11120	105	22	mirabegron	mirabegron	PROPN
aiua-11120	105	23	vs.	vs.	ADP
aiua-11120	105	24	darifenacin	darifenacin	PROPN
aiua-11120	105	25	1	1	NUM
aiua-11120	105	26	poststroke	poststroke	VERB
aiua-11120	105	27	oxybutyinin+trospium	oxybutyinin+trospium	PROPN
aiua-11120	105	28	vs.	vs.	ADP
aiua-11120	105	29	oxybutynin+solifenacin	oxybutynin+solifenacin	PROPN
aiua-11120	105	30	1	1	NUM
aiua-11120	105	31	neurogenic	neurogenic	ADJ
aiua-11120	105	32	detrusor	detrusor	NOUN
aiua-11120	105	33	overactivity	overactivity	NOUN
aiua-11120	105	34	milnacipran	milnacipran	PROPN
aiua-11120	105	35	vs.	vs.	ADP
aiua-11120	105	36	paroxetine	paroxetine	PROPN
aiua-11120	105	37	1	1	NUM
aiua-11120	105	38	neurogenic	neurogenic	ADJ
aiua-11120	105	39	detrusor	detrusor	NOUN
aiua-11120	105	40	overactivity	overactivity	NOUN
aiua-11120	105	41	cannabinoids	cannabinoid	NOUN
aiua-11120	105	42	compared	compare	VERB
aiua-11120	105	43	to	to	ADP
aiua-11120	105	44	placebo	placebo	NOUN
aiua-11120	105	45	2	2	NUM
aiua-11120	105	46	ms	ms	PROPN
aiua-11120	105	47	intravesical	intravesical	ADJ
aiua-11120	105	48	instillations	instillation	NOUN
aiua-11120	105	49	capsaicin	capsaicin	PROPN
aiua-11120	105	50	compared	compare	VERB
aiua-11120	105	51	to	to	ADP
aiua-11120	105	52	saline	saline	VERB
aiua-11120	105	53	2	2	NUM
aiua-11120	105	54	spinal	spinal	NOUN
aiua-11120	105	55	cord	cord	NOUN
aiua-11120	105	56	lesions	lesion	NOUN
aiua-11120	105	57	neurogenic	neurogenic	ADJ
aiua-11120	105	58	detrusor	detrusor	NOUN
aiua-11120	105	59	overactivity	overactivity	NOUN
aiua-11120	105	60	nociceptin	nociceptin	ADV
aiua-11120	105	61	/	/	SYM
aiua-11120	105	62	orphanin	orphanin	NOUN
aiua-11120	105	63	fq	fq	PROPN
aiua-11120	105	64	1	1	NUM
aiua-11120	105	65	neurogenic	neurogenic	ADJ
aiua-11120	105	66	detrusor	detrusor	NOUN
aiua-11120	105	67	overactivity	overactivity	NOUN
aiua-11120	105	68	botulinum	botulinum	ADJ
aiua-11120	105	69	toxin	toxin	NOUN
aiua-11120	105	70	compared	compare	VERB
aiua-11120	105	71	to	to	ADP
aiua-11120	105	72	placebo	placebo	NOUN
aiua-11120	105	73	13	13	NUM
aiua-11120	105	74	neurogenic	neurogenic	ADJ
aiua-11120	105	75	detrusor	detrusor	NOUN
aiua-11120	105	76	overactivity	overactivity	NOUN
aiua-11120	105	77	trigone	trigone	NOUN
aiua-11120	105	78	excluding	exclude	VERB
aiua-11120	105	79	vs.	vs.	X
aiua-11120	105	80	trigone	trigone	NOUN
aiua-11120	105	81	including	include	VERB
aiua-11120	105	82	2	2	NUM
aiua-11120	105	83	comparison	comparison	NOUN
aiua-11120	105	84	of	of	ADP
aiua-11120	105	85	different	different	ADJ
aiua-11120	105	86	doses	dose	NOUN
aiua-11120	105	87	1	1	NUM
aiua-11120	105	88	transcutaneous	transcutaneous	ADJ
aiua-11120	105	89	tibial	tibial	ADJ
aiua-11120	105	90	nerve	nerve	NOUN
aiua-11120	105	91	stimulation	stimulation	NOUN
aiua-11120	105	92	(	(	PUNCT
aiua-11120	105	93	ttns	ttns	NOUN
aiua-11120	105	94	)	)	PUNCT
aiua-11120	105	95	compared	compare	VERB
aiua-11120	105	96	to	to	ADP
aiua-11120	105	97	sham	sham	PROPN
aiua-11120	105	98	3	3	NUM
aiua-11120	105	99	compared	compare	VERB
aiua-11120	105	100	to	to	ADP
aiua-11120	105	101	pelvic	pelvic	ADJ
aiua-11120	105	102	floor	floor	NOUN
aiua-11120	105	103	muscle	muscle	NOUN
aiua-11120	105	104	training	train	VERB
aiua-11120	105	105	1	1	NUM
aiua-11120	105	106	compared	compare	VERB
aiua-11120	105	107	to	to	ADP
aiua-11120	105	108	oxybutynin	oxybutynin	PROPN
aiua-11120	105	109	2	2	NUM
aiua-11120	105	110	acupuncture	acupuncture	NOUN
aiua-11120	105	111	2	2	NUM
aiua-11120	105	112	pd	pd	NOUN
aiua-11120	105	113	,	,	PUNCT
aiua-11120	105	114	poststroke	poststroke	VERB
aiua-11120	105	115	transcutaneous	transcutaneous	ADJ
aiua-11120	105	116	electrical	electrical	ADJ
aiua-11120	105	117	nerve	nerve	NOUN
aiua-11120	105	118	stimulation	stimulation	NOUN
aiua-11120	105	119	(	(	PUNCT
aiua-11120	105	120	tens	ten	NOUN
aiua-11120	105	121	)	)	PUNCT
aiua-11120	105	122	compared	compare	VERB
aiua-11120	105	123	to	to	ADP
aiua-11120	105	124	sham	sham	PROPN
aiua-11120	105	125	3	3	NUM
aiua-11120	105	126	poststroke	poststroke	NOUN
aiua-11120	105	127	(	(	PUNCT
aiua-11120	105	128	3	3	NUM
aiua-11120	105	129	)	)	PUNCT
aiua-11120	105	130	compared	compare	VERB
aiua-11120	105	131	to	to	ADP
aiua-11120	105	132	oxybutynin	oxybutynin	PROPN
aiua-11120	105	133	1	1	NUM
aiua-11120	105	134	pelvic	pelvic	ADJ
aiua-11120	105	135	floor	floor	NOUN
aiua-11120	105	136	muscle	muscle	NOUN
aiua-11120	105	137	training	training	NOUN
aiua-11120	105	138	(	(	PUNCT
aiua-11120	105	139	pfmt	pfmt	NOUN
aiua-11120	105	140	)	)	PUNCT
aiua-11120	105	141	compared	compare	VERB
aiua-11120	105	142	to	to	ADP
aiua-11120	105	143	controls	control	NOUN
aiua-11120	105	144	6	6	NUM
aiua-11120	105	145	pd	pd	NOUN
aiua-11120	105	146	(	(	PUNCT
aiua-11120	105	147	2	2	NUM
aiua-11120	105	148	)	)	PUNCT
aiua-11120	105	149	,	,	PUNCT
aiua-11120	105	150	ms	ms	NOUN
aiua-11120	105	151	(	(	PUNCT
aiua-11120	105	152	2	2	NUM
aiua-11120	105	153	)	)	PUNCT
aiua-11120	105	154	,	,	PUNCT
aiua-11120	105	155	poststroke	poststroke	X
aiua-11120	105	156	(	(	PUNCT
aiua-11120	105	157	2	2	X
aiua-11120	105	158	)	)	PUNCT
aiua-11120	105	159	pfmt+electrostimulation	pfmt+electrostimulation	NOUN
aiua-11120	105	160	vs.	vs.	ADP
aiua-11120	105	161	pfmt	pfmt	NOUN
aiua-11120	105	162	3	3	NUM
aiua-11120	105	163	ms	ms	NOUN
aiua-11120	105	164	(	(	PUNCT
aiua-11120	105	165	3	3	NUM
aiua-11120	105	166	)	)	PUNCT
aiua-11120	105	167	compared	compare	VERB
aiua-11120	105	168	to	to	ADP
aiua-11120	105	169	intravaginal	intravaginal	ADJ
aiua-11120	105	170	neuromuscular	neuromuscular	ADJ
aiua-11120	105	171	electrical	electrical	ADJ
aiua-11120	105	172	stimulation	stimulation	NOUN
aiua-11120	105	173	or	or	CCONJ
aiua-11120	105	174	to	to	PART
aiua-11120	105	175	ttns	ttns	VERB
aiua-11120	105	176	1	1	NUM
aiua-11120	105	177	others	other	NOUN
aiua-11120	105	178	deep	deep	ADJ
aiua-11120	105	179	brain	brain	NOUN
aiua-11120	105	180	stimulation/	stimulation/	NUM
aiua-11120	105	181	intradetrusor	intradetrusor	NOUN
aiua-11120	105	182	adipose	adipose	ADP
aiua-11120	105	183	stem	stem	NOUN
aiua-11120	105	184	cells	cell	NOUN
aiua-11120	105	185	(	(	PUNCT
aiua-11120	105	186	adsc	adsc	ADJ
aiua-11120	105	187	)	)	PUNCT
aiua-11120	105	188	injections	injection	NOUN
aiua-11120	105	189	2	2	NUM
aiua-11120	105	190	pd	pd	NOUN
aiua-11120	105	191	archivio	archivio	NOUN
aiua-11120	105	192	italiano	italiano	X
aiua-11120	105	193	di	di	X
aiua-11120	105	194	urologia	urologia	PROPN
aiua-11120	105	195	e	e	PROPN
aiua-11120	105	196	andrologia	andrologia	PROPN
aiua-11120	105	197	2022	2022	NUM
aiua-11120	105	198	;	;	PUNCT
aiua-11120	105	199	94	94	NUM
aiua-11120	105	200	,	,	PUNCT
aiua-11120	105	201	4	4	NUM
aiua-11120	105	202	r.	r.	NOUN
aiua-11120	105	203	bapir	bapir	NOUN
aiua-11120	105	204	,	,	PUNCT
aiua-11120	105	205	k.	k.	PROPN
aiua-11120	105	206	hassan	hassan	PROPN
aiua-11120	105	207	bhatti	bhatti	PROPN
aiua-11120	105	208	,	,	PUNCT
aiua-11120	105	209	ahmed	ahmed	PROPN
aiua-11120	105	210	eliwa	eliwa	PROPN
aiua-11120	105	211	,	,	PUNCT
aiua-11120	105	212	et	et	PROPN
aiua-11120	105	213	al	al	PROPN
aiua-11120	105	214	.	.	PROPN
aiua-11120	105	215	496	496	NUM
aiua-11120	105	216	propiverine	propiverine	ADJ
aiua-11120	105	217	immediate	immediate	ADJ
aiua-11120	105	218	-	-	PUNCT
aiua-11120	105	219	release	release	NOUN
aiua-11120	105	220	(	(	PUNCT
aiua-11120	105	221	ir	ir	NOUN
aiua-11120	105	222	)	)	PUNCT
aiua-11120	105	223	.	.	PUNCT
aiua-11120	106	1	the	the	DET
aiua-11120	106	2	latter	latter	ADJ
aiua-11120	106	3	showed	show	VERB
aiua-11120	106	4	slightly	slightly	ADV
aiua-11120	106	5	better	well	ADJ
aiua-11120	106	6	tolerability	tolerability	NOUN
aiua-11120	106	7	compared	compare	VERB
aiua-11120	106	8	to	to	PART
aiua-11120	106	9	propiverine	propiverine	VERB
aiua-11120	106	10	er	er	INTJ
aiua-11120	106	11	(	(	PUNCT
aiua-11120	106	12	25	25	NUM
aiua-11120	106	13	)	)	PUNCT
aiua-11120	106	14	.	.	PUNCT
aiua-11120	107	1	the	the	DET
aiua-11120	107	2	effects	effect	NOUN
aiua-11120	107	3	of	of	ADP
aiua-11120	107	4	propiverine	propiverine	NOUN
aiua-11120	107	5	and	and	CCONJ
aiua-11120	107	6	oxybutynin	oxybutynin	PROPN
aiua-11120	107	7	were	be	AUX
aiua-11120	107	8	compared	compare	VERB
aiua-11120	107	9	in	in	ADP
aiua-11120	107	10	a	a	DET
aiua-11120	107	11	study	study	NOUN
aiua-11120	107	12	by	by	ADP
aiua-11120	107	13	stöhrer	stöhrer	PROPN
aiua-11120	107	14	et	et	PROPN
aiua-11120	107	15	al	al	PROPN
aiua-11120	107	16	.	.	PUNCT
aiua-11120	108	1	both	both	DET
aiua-11120	108	2	treatments	treatment	NOUN
aiua-11120	108	3	increased	increase	VERB
aiua-11120	108	4	maximum	maximum	ADJ
aiua-11120	108	5	cystometric	cystometric	ADJ
aiua-11120	108	6	capacity	capacity	NOUN
aiua-11120	108	7	and	and	CCONJ
aiua-11120	108	8	lowered	lower	VERB
aiua-11120	108	9	maximum	maximum	ADJ
aiua-11120	108	10	detrusor	detrusor	NOUN
aiua-11120	108	11	pressure	pressure	NOUN
aiua-11120	108	12	during	during	ADP
aiua-11120	108	13	the	the	DET
aiua-11120	108	14	filling	filling	NOUN
aiua-11120	108	15	phase	phase	NOUN
aiua-11120	108	16	with	with	ADP
aiua-11120	108	17	no	no	DET
aiua-11120	108	18	significant	significant	ADJ
aiua-11120	108	19	differences	difference	NOUN
aiua-11120	108	20	between	between	ADP
aiua-11120	108	21	treatment	treatment	NOUN
aiua-11120	108	22	groups	group	NOUN
aiua-11120	108	23	.	.	PUNCT
aiua-11120	109	1	adverse	adverse	ADJ
aiua-11120	109	2	events	event	NOUN
aiua-11120	109	3	were	be	AUX
aiua-11120	109	4	reported	report	VERB
aiua-11120	109	5	less	less	ADV
aiua-11120	109	6	frequently	frequently	ADV
aiua-11120	109	7	in	in	ADP
aiua-11120	109	8	the	the	DET
aiua-11120	109	9	propiverine	propiverine	ADJ
aiua-11120	109	10	arm	arm	NOUN
aiua-11120	109	11	compared	compare	VERB
aiua-11120	109	12	to	to	ADP
aiua-11120	109	13	the	the	DET
aiua-11120	109	14	oxybutynin	oxybutynin	PROPN
aiua-11120	109	15	group	group	NOUN
aiua-11120	109	16	(	(	PUNCT
aiua-11120	109	17	63.0	63.0	NUM
aiua-11120	109	18	%	%	NOUN
aiua-11120	109	19	versus	versus	ADP
aiua-11120	109	20	77.8	77.8	NUM
aiua-11120	109	21	%	%	NOUN
aiua-11120	109	22	)	)	PUNCT
aiua-11120	109	23	(	(	PUNCT
aiua-11120	109	24	26	26	NUM
aiua-11120	109	25	)	)	PUNCT
aiua-11120	109	26	.	.	PUNCT
aiua-11120	110	1	mirabegron	mirabegron	PROPN
aiua-11120	110	2	we	we	PRON
aiua-11120	110	3	retrieved	retrieve	VERB
aiua-11120	110	4	five	five	NUM
aiua-11120	110	5	rcts	rct	NOUN
aiua-11120	110	6	comparing	compare	VERB
aiua-11120	110	7	mirabegron	mirabegron	NOUN
aiua-11120	110	8	vs.	vs.	ADP
aiua-11120	110	9	placebo	placebo	NOUN
aiua-11120	110	10	in	in	ADP
aiua-11120	110	11	patients	patient	NOUN
aiua-11120	110	12	with	with	ADP
aiua-11120	110	13	oab	oab	PROPN
aiua-11120	110	14	and	and	CCONJ
aiua-11120	110	15	parkinson	parkinson	NOUN
aiua-11120	110	16	disease	disease	NOUN
aiua-11120	110	17	(	(	PUNCT
aiua-11120	110	18	n	n	NOUN
aiua-11120	110	19	=	=	SYM
aiua-11120	110	20	3	3	NUM
aiua-11120	110	21	)	)	PUNCT
aiua-11120	110	22	(	(	PUNCT
aiua-11120	110	23	27	27	NUM
aiua-11120	110	24	-	-	SYM
aiua-11120	110	25	29	29	NUM
aiua-11120	110	26	)	)	PUNCT
aiua-11120	110	27	or	or	CCONJ
aiua-11120	110	28	spinal	spinal	ADJ
aiua-11120	110	29	cord	cord	NOUN
aiua-11120	110	30	injury	injury	NOUN
aiua-11120	110	31	/	/	SYM
aiua-11120	110	32	multiple	multiple	ADJ
aiua-11120	110	33	sclerosis	sclerosis	NOUN
aiua-11120	110	34	(	(	PUNCT
aiua-11120	110	35	n	n	NOUN
aiua-11120	110	36	=	=	SYM
aiua-11120	110	37	2	2	NUM
aiua-11120	110	38	)	)	PUNCT
aiua-11120	110	39	(	(	PUNCT
aiua-11120	110	40	30	30	NUM
aiua-11120	110	41	,	,	PUNCT
aiua-11120	110	42	31	31	NUM
aiua-11120	110	43	)	)	PUNCT
aiua-11120	110	44	.	.	PUNCT
aiua-11120	111	1	three	three	NUM
aiua-11120	111	2	studies	study	NOUN
aiua-11120	111	3	evaluated	evaluate	VERB
aiua-11120	111	4	the	the	DET
aiua-11120	111	5	clinical	clinical	ADJ
aiua-11120	111	6	results	result	NOUN
aiua-11120	111	7	of	of	ADP
aiua-11120	111	8	mirabegron	mirabegron	ADJ
aiua-11120	111	9	treatment	treatment	NOUN
aiua-11120	111	10	in	in	ADP
aiua-11120	111	11	patients	patient	NOUN
aiua-11120	111	12	with	with	ADP
aiua-11120	111	13	parkinson	parkinson	NOUN
aiua-11120	111	14	disease	disease	NOUN
aiua-11120	111	15	.	.	PUNCT
aiua-11120	112	1	changes	change	NOUN
aiua-11120	112	2	from	from	ADP
aiua-11120	112	3	baseline	baseline	ADJ
aiua-11120	112	4	values	value	NOUN
aiua-11120	112	5	of	of	ADP
aiua-11120	112	6	the	the	DET
aiua-11120	112	7	oab	oab	PROPN
aiua-11120	112	8	-	-	PROPN
aiua-11120	112	9	ss	ss	NOUN
aiua-11120	112	10	score	score	NOUN
aiua-11120	112	11	,	,	PUNCT
aiua-11120	112	12	day	day	NOUN
aiua-11120	112	13	void	void	ADJ
aiua-11120	112	14	rates	rate	NOUN
aiua-11120	112	15	or	or	CCONJ
aiua-11120	112	16	of	of	ADP
aiua-11120	112	17	incontinence	incontinence	NOUN
aiua-11120	112	18	and	and	CCONJ
aiua-11120	112	19	urgency	urgency	NOUN
aiua-11120	112	20	episodes	episode	NOUN
aiua-11120	112	21	were	be	AUX
aiua-11120	112	22	not	not	PART
aiua-11120	112	23	significantly	significantly	ADV
aiua-11120	112	24	different	different	ADJ
aiua-11120	112	25	between	between	ADP
aiua-11120	112	26	mirabegron	mirabegron	PROPN
aiua-11120	112	27	and	and	CCONJ
aiua-11120	112	28	placebo	placebo	NOUN
aiua-11120	112	29	(	(	PUNCT
aiua-11120	112	30	md	md	PROPN
aiua-11120	112	31	,	,	PUNCT
aiua-11120	112	32	-2.01	-2.01	NUM
aiua-11120	112	33	,	,	PUNCT
aiua-11120	112	34	95	95	NUM
aiua-11120	112	35	%	%	NOUN
aiua-11120	112	36	ci	ci	NOUN
aiua-11120	112	37	-4.24	-4.24	NOUN
aiua-11120	112	38	to	to	ADP
aiua-11120	112	39	0.21	0.21	NUM
aiua-11120	112	40	,	,	PUNCT
aiua-11120	112	41	2	2	NUM
aiua-11120	112	42	trials	trial	NOUN
aiua-11120	112	43	,	,	PUNCT
aiua-11120	112	44	212	212	NUM
aiua-11120	112	45	patients	patient	NOUN
aiua-11120	112	46	,	,	PUNCT
aiua-11120	112	47	z	z	NOUN
aiua-11120	112	48	=	=	SYM
aiua-11120	112	49	1.78	1.78	NUM
aiua-11120	112	50	,	,	PUNCT
aiua-11120	112	51	p	p	X
aiua-11120	112	52	=	=	NOUN
aiua-11120	112	53	0.08	0.08	NUM
aiua-11120	112	54	;	;	PUNCT
aiua-11120	112	55	md	md	PROPN
aiua-11120	112	56	,	,	PUNCT
aiua-11120	112	57	-0.80	-0.80	NOUN
aiua-11120	112	58	,	,	PUNCT
aiua-11120	112	59	95	95	NUM
aiua-11120	112	60	%	%	NOUN
aiua-11120	112	61	ci	ci	NOUN
aiua-11120	112	62	,	,	PUNCT
aiua-11120	112	63	-3.04	-3.04	NOUN
aiua-11120	112	64	to	to	ADP
aiua-11120	112	65	1.43,2	1.43,2	NUM
aiua-11120	112	66	trials	trial	NOUN
aiua-11120	112	67	,	,	PUNCT
aiua-11120	112	68	227	227	NUM
aiua-11120	112	69	patients	patient	NOUN
aiua-11120	112	70	,	,	PUNCT
aiua-11120	112	71	z	z	NOUN
aiua-11120	112	72	=	=	SYM
aiua-11120	112	73	0.71	0.71	NUM
aiua-11120	112	74	,	,	PUNCT
aiua-11120	112	75	p	p	X
aiua-11120	112	76	=	=	NOUN
aiua-11120	112	77	0.48	0.48	NUM
aiua-11120	112	78	;	;	PUNCT
aiua-11120	112	79	md	md	PROPN
aiua-11120	112	80	,	,	PUNCT
aiua-11120	112	81	-0.11	-0.11	X
aiua-11120	112	82	,	,	PUNCT
aiua-11120	112	83	95	95	NUM
aiua-11120	112	84	%	%	NOUN
aiua-11120	112	85	ci	ci	NOUN
aiua-11120	112	86	-3.12	-3.12	NUM
aiua-11120	112	87	to	to	ADP
aiua-11120	112	88	2.91	2.91	NUM
aiua-11120	112	89	,	,	PUNCT
aiua-11120	112	90	2	2	NUM
aiua-11120	112	91	trials,195	trials,195	NOUN
aiua-11120	112	92	patients	patient	NOUN
aiua-11120	112	93	,	,	PUNCT
aiua-11120	112	94	z	z	NOUN
aiua-11120	112	95	=	=	NOUN
aiua-11120	112	96	0.07	0.07	NUM
aiua-11120	112	97	,	,	PUNCT
aiua-11120	112	98	p	p	X
aiua-11120	112	99	=	=	PROPN
aiua-11120	112	100	0.94	0.94	NUM
aiua-11120	112	101	;	;	PUNCT
aiua-11120	112	102	md	md	PROPN
aiua-11120	112	103	,	,	PUNCT
aiua-11120	112	104	-0.56	-0.56	NUM
aiua-11120	112	105	,	,	PUNCT
aiua-11120	112	106	95	95	NUM
aiua-11120	112	107	%	%	NOUN
aiua-11120	112	108	ci	ci	NOUN
aiua-11120	112	109	-1.88	-1.88	NUM
aiua-11120	112	110	to	to	ADP
aiua-11120	112	111	0.75	0.75	NUM
aiua-11120	112	112	,	,	PUNCT
aiua-11120	112	113	3	3	NUM
aiua-11120	112	114	trials	trial	NOUN
aiua-11120	112	115	,	,	PUNCT
aiua-11120	112	116	227	227	NUM
aiua-11120	112	117	patients	patient	NOUN
aiua-11120	112	118	,	,	PUNCT
aiua-11120	112	119	z	z	NOUN
aiua-11120	112	120	=	=	NUM
aiua-11120	112	121	0.84	0.84	NUM
aiua-11120	112	122	,	,	PUNCT
aiua-11120	112	123	p	p	X
aiua-11120	112	124	=	=	NOUN
aiua-11120	112	125	0.40	0.40	NUM
aiua-11120	112	126	;	;	PUNCT
aiua-11120	112	127	respectively	respectively	ADV
aiua-11120	112	128	)	)	PUNCT
aiua-11120	112	129	(	(	PUNCT
aiua-11120	112	130	figure	figure	NOUN
aiua-11120	112	131	3	3	NUM
aiua-11120	112	132	,	,	PUNCT
aiua-11120	112	133	panels	panel	VERB
aiua-11120	112	134	a	a	DET
aiua-11120	112	135	,	,	PUNCT
aiua-11120	112	136	b	b	NOUN
aiua-11120	112	137	,	,	PUNCT
aiua-11120	112	138	c	c	NOUN
aiua-11120	112	139	and	and	CCONJ
aiua-11120	112	140	d	d	NOUN
aiua-11120	112	141	)	)	PUNCT
aiua-11120	112	142	.	.	PUNCT
aiua-11120	113	1	two	two	NUM
aiua-11120	113	2	studies	study	NOUN
aiua-11120	113	3	evaluated	evaluate	VERB
aiua-11120	113	4	changes	change	NOUN
aiua-11120	113	5	of	of	ADP
aiua-11120	113	6	urodynamic	urodynamic	ADJ
aiua-11120	113	7	values	value	NOUN
aiua-11120	113	8	in	in	ADP
aiua-11120	113	9	patients	patient	NOUN
aiua-11120	113	10	with	with	ADP
aiua-11120	113	11	spinal	spinal	ADJ
aiua-11120	113	12	cord	cord	NOUN
aiua-11120	113	13	injury	injury	NOUN
aiua-11120	113	14	/	/	SYM
aiua-11120	113	15	multiple	multiple	ADJ
aiua-11120	113	16	sclerosis	sclerosis	NOUN
aiua-11120	113	17	treated	treat	VERB
aiua-11120	113	18	with	with	ADP
aiua-11120	113	19	mirabegron	mirabegron	PROPN
aiua-11120	113	20	.	.	PUNCT
aiua-11120	114	1	mirabegron	mirabegron	PROPN
aiua-11120	114	2	was	be	AUX
aiua-11120	114	3	more	more	ADV
aiua-11120	114	4	effective	effective	ADJ
aiua-11120	114	5	than	than	ADP
aiua-11120	114	6	placebo	placebo	NOUN
aiua-11120	114	7	in	in	ADP
aiua-11120	114	8	increasing	increase	VERB
aiua-11120	114	9	cystometric	cystometric	ADJ
aiua-11120	114	10	capacity	capacity	NOUN
aiua-11120	114	11	(	(	PUNCT
aiua-11120	114	12	md	md	PROPN
aiua-11120	114	13	,	,	PUNCT
aiua-11120	114	14	89.89	89.89	NUM
aiua-11120	114	15	ml	ml	NOUN
aiua-11120	114	16	,	,	PUNCT
aiua-11120	114	17	95	95	NUM
aiua-11120	114	18	%	%	NOUN
aiua-11120	114	19	ci	ci	NOUN
aiua-11120	114	20	29.76	29.76	NUM
aiua-11120	114	21	to	to	ADP
aiua-11120	114	22	150.01	150.01	NUM
aiua-11120	114	23	,	,	PUNCT
aiua-11120	114	24	2	2	NUM
aiua-11120	114	25	trials	trial	NOUN
aiua-11120	114	26	,	,	PUNCT
aiua-11120	114	27	98	98	NUM
aiua-11120	114	28	patients	patient	NOUN
aiua-11120	114	29	,	,	PUNCT
aiua-11120	114	30	z	z	NOUN
aiua-11120	114	31	=	=	NUM
aiua-11120	114	32	2.93	2.93	NUM
aiua-11120	114	33	,	,	PUNCT
aiua-11120	114	34	p	p	X
aiua-11120	114	35	<	<	X
aiua-11120	114	36	0.003	0.003	NUM
aiua-11120	114	37	)	)	PUNCT
aiua-11120	114	38	.	.	PUNCT
aiua-11120	115	1	changes	change	NOUN
aiua-11120	115	2	from	from	ADP
aiua-11120	115	3	baseline	baseline	ADJ
aiua-11120	115	4	values	value	NOUN
aiua-11120	115	5	of	of	ADP
aiua-11120	115	6	peak	peak	NOUN
aiua-11120	115	7	pressure	pressure	NOUN
aiua-11120	115	8	and	and	CCONJ
aiua-11120	115	9	volume	volume	NOUN
aiua-11120	115	10	at	at	ADP
aiua-11120	115	11	first	first	ADJ
aiua-11120	115	12	contraction	contraction	NOUN
aiua-11120	115	13	were	be	AUX
aiua-11120	115	14	not	not	PART
aiua-11120	115	15	significantly	significantly	ADV
aiua-11120	115	16	different	different	ADJ
aiua-11120	115	17	between	between	ADP
aiua-11120	115	18	mirabegron	mirabegron	PROPN
aiua-11120	115	19	and	and	CCONJ
aiua-11120	115	20	placebo	placebo	NOUN
aiua-11120	115	21	(	(	PUNCT
aiua-11120	115	22	md	md	PROPN
aiua-11120	115	23	,	,	PUNCT
aiua-11120	115	24	13.34	13.34	NUM
aiua-11120	115	25	cm2	cm2	NOUN
aiua-11120	115	26	,	,	PUNCT
aiua-11120	115	27	95	95	NUM
aiua-11120	115	28	%	%	NOUN
aiua-11120	115	29	ci	ci	NOUN
aiua-11120	115	30	-55.70	-55.70	X
aiua-11120	115	31	to	to	ADP
aiua-11120	115	32	29.01	29.01	NUM
aiua-11120	115	33	,	,	PUNCT
aiua-11120	115	34	2	2	NUM
aiua-11120	115	35	trials	trial	NOUN
aiua-11120	115	36	,	,	PUNCT
aiua-11120	115	37	97	97	NUM
aiua-11120	115	38	patients	patient	NOUN
aiua-11120	115	39	,	,	PUNCT
aiua-11120	115	40	z	z	NOUN
aiua-11120	115	41	=	=	NOUN
aiua-11120	115	42	0.62	0.62	NUM
aiua-11120	115	43	,	,	PUNCT
aiua-11120	115	44	p	p	NOUN
aiua-11120	115	45	=	=	NOUN
aiua-11120	115	46	0.54	0.54	NUM
aiua-11120	115	47	and	and	CCONJ
aiua-11120	115	48	md	md	PROPN
aiua-11120	115	49	,	,	PUNCT
aiua-11120	115	50	22.92	22.92	NUM
aiua-11120	115	51	ml	ml	NOUN
aiua-11120	115	52	,	,	PUNCT
aiua-11120	115	53	95	95	NUM
aiua-11120	115	54	%	%	NOUN
aiua-11120	115	55	ci	ci	NOUN
aiua-11120	115	56	20.78	20.78	NUM
aiua-11120	115	57	to	to	ADP
aiua-11120	115	58	66.63,2	66.63,2	NUM
aiua-11120	115	59	trials	trial	NOUN
aiua-11120	115	60	,	,	PUNCT
aiua-11120	115	61	98	98	NUM
aiua-11120	115	62	patients	patient	NOUN
aiua-11120	115	63	,	,	PUNCT
aiua-11120	115	64	z	z	NOUN
aiua-11120	115	65	=	=	NUM
aiua-11120	115	66	1.03	1.03	NUM
aiua-11120	115	67	,	,	PUNCT
aiua-11120	115	68	p	p	X
aiua-11120	115	69	=	=	NOUN
aiua-11120	115	70	0.30	0.30	NUM
aiua-11120	115	71	,	,	PUNCT
aiua-11120	115	72	respectively	respectively	ADV
aiua-11120	115	73	)	)	PUNCT
aiua-11120	115	74	(	(	PUNCT
aiua-11120	115	75	figure	figure	VERB
aiua-11120	115	76	4	4	NUM
aiua-11120	115	77	a	a	PRON
aiua-11120	115	78	,	,	PUNCT
aiua-11120	115	79	b	b	NOUN
aiua-11120	115	80	and	and	CCONJ
aiua-11120	115	81	c	c	NOUN
aiua-11120	115	82	)	)	PUNCT
aiua-11120	115	83	.	.	PUNCT
aiua-11120	116	1	in	in	ADP
aiua-11120	116	2	general	general	ADJ
aiua-11120	116	3	,	,	PUNCT
aiua-11120	116	4	the	the	DET
aiua-11120	116	5	rate	rate	NOUN
aiua-11120	116	6	of	of	ADP
aiua-11120	116	7	treatment	treatment	NOUN
aiua-11120	116	8	emergent	emergent	ADJ
aiua-11120	116	9	adverse	adverse	ADJ
aiua-11120	116	10	events	event	NOUN
aiua-11120	116	11	was	be	AUX
aiua-11120	116	12	similar	similar	ADJ
aiua-11120	116	13	in	in	ADP
aiua-11120	116	14	the	the	DET
aiua-11120	116	15	mirabegron	mirabegron	ADJ
aiua-11120	116	16	and	and	CCONJ
aiua-11120	116	17	placebo	placebo	NOUN
aiua-11120	116	18	groups	group	NOUN
aiua-11120	116	19	and	and	CCONJ
aiua-11120	116	20	the	the	DET
aiua-11120	116	21	degree	degree	NOUN
aiua-11120	116	22	of	of	ADP
aiua-11120	116	23	adverse	adverse	ADJ
aiua-11120	116	24	events	event	NOUN
aiua-11120	116	25	was	be	AUX
aiua-11120	116	26	mild	mild	ADJ
aiua-11120	116	27	or	or	CCONJ
aiua-11120	116	28	moderate	moderate	ADJ
aiua-11120	116	29	in	in	ADP
aiua-11120	116	30	most	most	ADJ
aiua-11120	116	31	cases	case	NOUN
aiua-11120	116	32	.	.	PUNCT
aiua-11120	117	1	a	a	DET
aiua-11120	117	2	major	major	ADJ
aiua-11120	117	3	safety	safety	NOUN
aiua-11120	117	4	concern	concern	NOUN
aiua-11120	117	5	with	with	ADP
aiua-11120	117	6	mirabegron	mirabegron	PROPN
aiua-11120	117	7	is	be	AUX
aiua-11120	117	8	cardiovascular	cardiovascular	ADJ
aiua-11120	117	9	safety	safety	NOUN
aiua-11120	117	10	because	because	SCONJ
aiua-11120	117	11	of	of	ADP
aiua-11120	117	12	beta	beta	NOUN
aiua-11120	117	13	-	-	PUNCT
aiua-11120	117	14	adrenergic	adrenergic	ADJ
aiua-11120	117	15	stimulation	stimulation	NOUN
aiua-11120	117	16	.	.	PUNCT
aiua-11120	118	1	in	in	ADP
aiua-11120	118	2	three	three	NUM
aiua-11120	118	3	studies	study	NOUN
aiua-11120	118	4	changes	change	NOUN
aiua-11120	118	5	in	in	ADP
aiua-11120	118	6	cardiovascular	cardiovascular	ADJ
aiua-11120	118	7	parameters	parameter	NOUN
aiua-11120	118	8	were	be	AUX
aiua-11120	118	9	actively	actively	ADV
aiua-11120	118	10	assessed	assess	VERB
aiua-11120	118	11	demonstrating	demonstrate	VERB
aiua-11120	118	12	no	no	DET
aiua-11120	118	13	significant	significant	ADJ
aiua-11120	118	14	changes	change	NOUN
aiua-11120	118	15	of	of	ADP
aiua-11120	118	16	mean	mean	ADJ
aiua-11120	118	17	systolic	systolic	ADJ
aiua-11120	118	18	and	and	CCONJ
aiua-11120	118	19	diastolic	diastolic	ADJ
aiua-11120	118	20	blood	blood	NOUN
aiua-11120	118	21	pressure	pressure	NOUN
aiua-11120	118	22	,	,	PUNCT
aiua-11120	118	23	pulse	pulse	NOUN
aiua-11120	118	24	rate	rate	NOUN
aiua-11120	118	25	,	,	PUNCT
aiua-11120	118	26	and	and	CCONJ
aiua-11120	118	27	qtc	qtc	PROPN
aiua-11120	118	28	interval	interval	NOUN
aiua-11120	118	29	during	during	ADP
aiua-11120	118	30	mirabegron	mirabegron	PROPN
aiua-11120	118	31	treatment	treatment	NOUN
aiua-11120	118	32	(	(	PUNCT
aiua-11120	118	33	28	28	NUM
aiua-11120	118	34	,	,	PUNCT
aiua-11120	118	35	30	30	NUM
aiua-11120	118	36	,	,	PUNCT
aiua-11120	118	37	31	31	NUM
aiua-11120	118	38	)	)	PUNCT
aiua-11120	118	39	.	.	PUNCT
aiua-11120	119	1	the	the	DET
aiua-11120	119	2	risk	risk	NOUN
aiua-11120	119	3	of	of	ADP
aiua-11120	119	4	urinary	urinary	ADJ
aiua-11120	119	5	retention	retention	NOUN
aiua-11120	119	6	is	be	AUX
aiua-11120	119	7	another	another	DET
aiua-11120	119	8	concern	concern	NOUN
aiua-11120	119	9	associated	associate	VERB
aiua-11120	119	10	to	to	ADP
aiua-11120	119	11	mirabegron	mirabegron	PROPN
aiua-11120	119	12	treatment	treatment	NOUN
aiua-11120	119	13	.	.	PUNCT
aiua-11120	120	1	data	datum	NOUN
aiua-11120	120	2	from	from	ADP
aiua-11120	120	3	two	two	NUM
aiua-11120	120	4	studies	study	NOUN
aiua-11120	120	5	(	(	PUNCT
aiua-11120	120	6	27	27	NUM
aiua-11120	120	7	,	,	PUNCT
aiua-11120	120	8	31	31	NUM
aiua-11120	120	9	)	)	PUNCT
aiua-11120	120	10	showed	show	VERB
aiua-11120	120	11	no	no	DET
aiua-11120	120	12	significant	significant	ADJ
aiua-11120	120	13	change	change	NOUN
aiua-11120	120	14	of	of	ADP
aiua-11120	120	15	mean	mean	ADJ
aiua-11120	120	16	post	post	ADJ
aiua-11120	120	17	-	-	ADJ
aiua-11120	120	18	voiding	voiding	ADJ
aiua-11120	120	19	residual	residual	ADJ
aiua-11120	120	20	volume	volume	NOUN
aiua-11120	120	21	or	or	CCONJ
aiua-11120	120	22	proportion	proportion	NOUN
aiua-11120	120	23	with	with	ADP
aiua-11120	120	24	pvr	pvr	PROPN
aiua-11120	120	25	>	>	X
aiua-11120	120	26	100	100	NUM
aiua-11120	120	27	ml	ml	NOUN
aiua-11120	120	28	,	,	PUNCT
aiua-11120	120	29	figure	figure	NOUN
aiua-11120	120	30	2	2	NUM
aiua-11120	120	31	.	.	PUNCT
aiua-11120	120	32	a	a	DET
aiua-11120	120	33	,	,	PUNCT
aiua-11120	120	34	changes	change	NOUN
aiua-11120	120	35	from	from	ADP
aiua-11120	120	36	baseline	baseline	ADJ
aiua-11120	120	37	number	number	NOUN
aiua-11120	120	38	of	of	ADP
aiua-11120	120	39	incontinence	incontinence	NOUN
aiua-11120	120	40	in	in	ADP
aiua-11120	120	41	patients	patient	NOUN
aiua-11120	120	42	with	with	ADP
aiua-11120	120	43	parkinson	parkinson	NOUN
aiua-11120	120	44	disease	disease	NOUN
aiua-11120	120	45	treated	treat	VERB
aiua-11120	120	46	with	with	ADP
aiua-11120	120	47	anticholinergics	anticholinergic	NOUN
aiua-11120	120	48	vs.	vs.	ADP
aiua-11120	120	49	placebo	placebo	NOUN
aiua-11120	120	50	;	;	PUNCT
aiua-11120	120	51	b	b	X
aiua-11120	120	52	,	,	PUNCT
aiua-11120	120	53	changes	change	NOUN
aiua-11120	120	54	from	from	ADP
aiua-11120	120	55	baseline	baseline	ADJ
aiua-11120	120	56	number	number	NOUN
aiua-11120	120	57	of	of	ADP
aiua-11120	120	58	night	night	NOUN
aiua-11120	120	59	voids	voids	NOUN
aiua-11120	120	60	in	in	ADP
aiua-11120	120	61	patients	patient	NOUN
aiua-11120	120	62	with	with	ADP
aiua-11120	120	63	parkinson	parkinson	NOUN
aiua-11120	120	64	disease	disease	NOUN
aiua-11120	120	65	treated	treat	VERB
aiua-11120	120	66	with	with	ADP
aiua-11120	120	67	anticholinergics	anticholinergic	NOUN
aiua-11120	120	68	vs.	vs.	ADP
aiua-11120	120	69	placebo	placebo	NOUN
aiua-11120	120	70	;	;	PUNCT
aiua-11120	120	71	c	c	X
aiua-11120	120	72	,	,	PUNCT
aiua-11120	120	73	changes	change	NOUN
aiua-11120	120	74	from	from	ADP
aiua-11120	120	75	baseline	baseline	ADJ
aiua-11120	120	76	number	number	NOUN
aiua-11120	120	77	of	of	ADP
aiua-11120	120	78	day	day	NOUN
aiua-11120	120	79	voids	voids	NOUN
aiua-11120	120	80	in	in	ADP
aiua-11120	120	81	patients	patient	NOUN
aiua-11120	120	82	with	with	ADP
aiua-11120	120	83	parkinson	parkinson	NOUN
aiua-11120	120	84	disease	disease	NOUN
aiua-11120	120	85	treated	treat	VERB
aiua-11120	120	86	with	with	ADP
aiua-11120	120	87	anticholinergics	anticholinergic	NOUN
aiua-11120	120	88	vs.	vs.	ADP
aiua-11120	120	89	placebo	placebo	NOUN
aiua-11120	120	90	.	.	PUNCT
aiua-11120	121	1	diamonds	diamond	NOUN
aiua-11120	121	2	on	on	ADP
aiua-11120	121	3	the	the	DET
aiua-11120	121	4	left	left	ADJ
aiua-11120	121	5	side	side	NOUN
aiua-11120	121	6	of	of	ADP
aiua-11120	121	7	the	the	DET
aiua-11120	121	8	no	no	DET
aiua-11120	121	9	-	-	PUNCT
aiua-11120	121	10	effect	effect	NOUN
aiua-11120	121	11	line	line	NOUN
aiua-11120	121	12	indicate	indicate	VERB
aiua-11120	121	13	decreased	decrease	VERB
aiua-11120	121	14	numbers	number	NOUN
aiua-11120	121	15	of	of	ADP
aiua-11120	121	16	episodes	episode	NOUN
aiua-11120	121	17	in	in	ADP
aiua-11120	121	18	patients	patient	NOUN
aiua-11120	121	19	treated	treat	VERB
aiua-11120	121	20	with	with	ADP
aiua-11120	121	21	active	active	ADJ
aiua-11120	121	22	drugs	drug	NOUN
aiua-11120	121	23	(	(	PUNCT
aiua-11120	121	24	anticholinergics	anticholinergic	NOUN
aiua-11120	121	25	)	)	PUNCT
aiua-11120	121	26	compared	compare	VERB
aiua-11120	121	27	to	to	ADP
aiua-11120	121	28	placebo	placebo	NOUN
aiua-11120	121	29	.	.	PUNCT
aiua-11120	122	1	mean	mean	VERB
aiua-11120	122	2	differences	difference	NOUN
aiua-11120	122	3	with	with	ADP
aiua-11120	122	4	95	95	NUM
aiua-11120	122	5	%	%	NOUN
aiua-11120	122	6	confidence	confidence	NOUN
aiua-11120	122	7	intervals	interval	NOUN
aiua-11120	122	8	and	and	CCONJ
aiua-11120	122	9	heterogeneity	heterogeneity	NOUN
aiua-11120	122	10	statistics	statistic	NOUN
aiua-11120	122	11	(	(	PUNCT
aiua-11120	122	12	i^2	i^2	PROPN
aiua-11120	122	13	)	)	PUNCT
aiua-11120	122	14	are	be	AUX
aiua-11120	122	15	shown	show	VERB
aiua-11120	122	16	.	.	PUNCT
aiua-11120	123	1	a.	a.	NOUN
aiua-11120	123	2	day	day	PROPN
aiua-11120	123	3	voids	voids	PROPN
aiua-11120	123	4	b.	b.	PROPN
aiua-11120	123	5	incontinence	incontinence	PROPN
aiua-11120	123	6	c.	c.	PROPN
aiua-11120	123	7	nocturia	nocturia	PROPN
aiua-11120	123	8	497archivio	497archivio	PROPN
aiua-11120	123	9	italiano	italiano	NOUN
aiua-11120	123	10	di	di	X
aiua-11120	123	11	urologia	urologia	PROPN
aiua-11120	123	12	e	e	PROPN
aiua-11120	123	13	andrologia	andrologia	PROPN
aiua-11120	123	14	2022	2022	NUM
aiua-11120	123	15	;	;	PUNCT
aiua-11120	123	16	94	94	NUM
aiua-11120	123	17	,	,	PUNCT
aiua-11120	123	18	4	4	NUM
aiua-11120	123	19	treatment	treatment	NOUN
aiua-11120	123	20	of	of	ADP
aiua-11120	123	21	overactive	overactive	ADJ
aiua-11120	123	22	neurogenic	neurogenic	ADJ
aiua-11120	123	23	bladder	bladder	NOUN
aiua-11120	123	24	whereas	whereas	SCONJ
aiua-11120	123	25	in	in	ADP
aiua-11120	123	26	a	a	DET
aiua-11120	123	27	study	study	NOUN
aiua-11120	123	28	a	a	DET
aiua-11120	123	29	case	case	NOUN
aiua-11120	123	30	with	with	ADP
aiua-11120	123	31	pvr	pvr	PROPN
aiua-11120	123	32	>	>	X
aiua-11120	123	33	100	100	NUM
aiua-11120	123	34	was	be	AUX
aiua-11120	123	35	described	describe	VERB
aiua-11120	123	36	in	in	ADP
aiua-11120	123	37	mirabegron	mirabegron	PROPN
aiua-11120	123	38	group	group	NOUN
aiua-11120	123	39	but	but	CCONJ
aiua-11120	123	40	not	not	PART
aiua-11120	123	41	in	in	ADP
aiua-11120	123	42	placebo	placebo	NOUN
aiua-11120	123	43	(	(	PUNCT
aiua-11120	123	44	28	28	NUM
aiua-11120	123	45	)	)	PUNCT
aiua-11120	123	46	.	.	PUNCT
aiua-11120	124	1	comparison	comparison	NOUN
aiua-11120	124	2	between	between	ADP
aiua-11120	124	3	various	various	ADJ
aiua-11120	124	4	drugs	drug	NOUN
aiua-11120	124	5	three	three	NUM
aiua-11120	124	6	studies	study	NOUN
aiua-11120	124	7	compared	compare	VERB
aiua-11120	124	8	the	the	DET
aiua-11120	124	9	efficacy	efficacy	NOUN
aiua-11120	124	10	and	and	CCONJ
aiua-11120	124	11	safety	safety	NOUN
aiua-11120	124	12	of	of	ADP
aiua-11120	124	13	different	different	ADJ
aiua-11120	124	14	drugs	drug	NOUN
aiua-11120	124	15	used	use	VERB
aiua-11120	124	16	for	for	ADP
aiua-11120	124	17	treatment	treatment	NOUN
aiua-11120	124	18	of	of	ADP
aiua-11120	124	19	neurogenic	neurogenic	ADJ
aiua-11120	124	20	oab	oab	PROPN
aiua-11120	124	21	.	.	PUNCT
aiua-11120	125	1	in	in	ADP
aiua-11120	125	2	patients	patient	NOUN
aiua-11120	125	3	who	who	PRON
aiua-11120	125	4	had	have	VERB
aiua-11120	125	5	ischemic	ischemic	ADJ
aiua-11120	125	6	stroke	stroke	NOUN
aiua-11120	125	7	,	,	PUNCT
aiua-11120	125	8	mirabegron	mirabegron	PROPN
aiua-11120	125	9	and	and	CCONJ
aiua-11120	125	10	darifenacin	darifenacin	PROPN
aiua-11120	125	11	showed	show	VERB
aiua-11120	125	12	similar	similar	ADJ
aiua-11120	125	13	improvement	improvement	NOUN
aiua-11120	125	14	of	of	ADP
aiua-11120	125	15	bladder	bladder	NOUN
aiua-11120	125	16	diary	diary	NOUN
aiua-11120	125	17	parameter	parameter	NOUN
aiua-11120	125	18	without	without	ADP
aiua-11120	125	19	deterioration	deterioration	NOUN
aiua-11120	125	20	of	of	ADP
aiua-11120	125	21	cognitive	cognitive	ADJ
aiua-11120	125	22	function	function	NOUN
aiua-11120	125	23	(	(	PUNCT
aiua-11120	125	24	32	32	NUM
aiua-11120	125	25	)	)	PUNCT
aiua-11120	125	26	.	.	PUNCT
aiua-11120	126	1	both	both	DET
aiua-11120	126	2	combination	combination	NOUN
aiua-11120	126	3	of	of	ADP
aiua-11120	126	4	trospium	trospium	ADJ
aiua-11120	126	5	chloride	chloride	NOUN
aiua-11120	126	6	with	with	ADP
aiua-11120	126	7	oxybutynin	oxybutynin	PROPN
aiua-11120	126	8	,	,	PUNCT
aiua-11120	126	9	and	and	CCONJ
aiua-11120	126	10	solifenacin	solifenacin	NOUN
aiua-11120	126	11	with	with	ADP
aiua-11120	126	12	oxybutynin	oxybutynin	PROPN
aiua-11120	126	13	improved	improve	VERB
aiua-11120	126	14	subjective	subjective	ADJ
aiua-11120	126	15	and	and	CCONJ
aiua-11120	126	16	urodynamic	urodynamic	ADJ
aiua-11120	126	17	urinary	urinary	ADJ
aiua-11120	126	18	parameters	parameter	NOUN
aiua-11120	126	19	,	,	PUNCT
aiua-11120	126	20	though	though	SCONJ
aiua-11120	126	21	side	side	ADJ
aiua-11120	126	22	effects	effect	NOUN
aiua-11120	126	23	were	be	AUX
aiua-11120	126	24	higher	high	ADJ
aiua-11120	126	25	in	in	ADP
aiua-11120	126	26	patients	patient	NOUN
aiua-11120	126	27	taking	take	VERB
aiua-11120	126	28	oxybutyinin	oxybutyinin	PROPN
aiua-11120	126	29	plus	plus	CCONJ
aiua-11120	126	30	solifenacin	solifenacin	PROPN
aiua-11120	126	31	(	(	PUNCT
aiua-11120	126	32	33	33	NUM
aiua-11120	126	33	)	)	PUNCT
aiua-11120	126	34	.	.	PUNCT
aiua-11120	127	1	a	a	DET
aiua-11120	127	2	study	study	NOUN
aiua-11120	127	3	proposed	propose	VERB
aiua-11120	127	4	the	the	DET
aiua-11120	127	5	use	use	NOUN
aiua-11120	127	6	of	of	ADP
aiua-11120	127	7	serotonin	serotonin	NOUN
aiua-11120	127	8	and	and	CCONJ
aiua-11120	127	9	noradrenaline	noradrenaline	ADJ
aiua-11120	127	10	reuptake	reuptake	NOUN
aiua-11120	127	11	inhibitors	inhibitor	NOUN
aiua-11120	127	12	(	(	PUNCT
aiua-11120	127	13	snris	snris	PROPN
aiua-11120	127	14	)	)	PUNCT
aiua-11120	127	15	as	as	ADP
aiua-11120	127	16	an	an	DET
aiua-11120	127	17	alternative	alternative	NOUN
aiua-11120	127	18	to	to	ADP
aiua-11120	127	19	anticholinergic	anticholinergic	ADJ
aiua-11120	127	20	treatment	treatment	NOUN
aiua-11120	127	21	in	in	ADP
aiua-11120	127	22	order	order	NOUN
aiua-11120	127	23	to	to	PART
aiua-11120	127	24	minimize	minimize	VERB
aiua-11120	127	25	antimuscarinic	antimuscarinic	ADJ
aiua-11120	127	26	or	or	CCONJ
aiua-11120	127	27	cardio	cardio	NOUN
aiua-11120	127	28	-	-	PUNCT
aiua-11120	127	29	suppressive	suppressive	ADJ
aiua-11120	127	30	effects	effect	NOUN
aiua-11120	127	31	.	.	PUNCT
aiua-11120	128	1	snris	snris	PROPN
aiua-11120	128	2	are	be	AUX
aiua-11120	128	3	currently	currently	ADV
aiua-11120	128	4	used	use	VERB
aiua-11120	128	5	for	for	ADP
aiua-11120	128	6	treatment	treatment	NOUN
aiua-11120	128	7	of	of	ADP
aiua-11120	128	8	depression	depression	NOUN
aiua-11120	128	9	,	,	PUNCT
aiua-11120	128	10	though	though	SCONJ
aiua-11120	128	11	the	the	DET
aiua-11120	128	12	snri	snri	NOUN
aiua-11120	128	13	duloxetine	duloxetine	NOUN
aiua-11120	128	14	has	have	AUX
aiua-11120	128	15	been	be	AUX
aiua-11120	128	16	used	use	VERB
aiua-11120	128	17	to	to	PART
aiua-11120	128	18	treat	treat	VERB
aiua-11120	128	19	stress	stress	ADJ
aiua-11120	128	20	urinary	urinary	ADJ
aiua-11120	128	21	incontinence	incontinence	NOUN
aiua-11120	128	22	thanks	thank	NOUN
aiua-11120	128	23	to	to	ADP
aiua-11120	128	24	its	its	PRON
aiua-11120	128	25	activity	activity	NOUN
aiua-11120	128	26	on	on	ADP
aiua-11120	128	27	the	the	DET
aiua-11120	128	28	urinary	urinary	ADJ
aiua-11120	128	29	sphincter	sphincter	NOUN
aiua-11120	128	30	,	,	PUNCT
aiua-11120	128	31	presumably	presumably	ADV
aiua-11120	128	32	via	via	ADP
aiua-11120	128	33	serotoninergic	serotoninergic	ADJ
aiua-11120	128	34	and	and	CCONJ
aiua-11120	128	35	adrenergic	adrenergic	ADJ
aiua-11120	128	36	receptors	receptor	NOUN
aiua-11120	128	37	of	of	ADP
aiua-11120	128	38	the	the	DET
aiua-11120	128	39	sacral	sacral	ADJ
aiua-11120	128	40	onuf	onuf	PROPN
aiua-11120	128	41	’s	’s	PART
aiua-11120	128	42	nucleus	nucleus	NOUN
aiua-11120	128	43	.	.	PUNCT
aiua-11120	129	1	snris	snris	PROPN
aiua-11120	129	2	lack	lack	VERB
aiua-11120	129	3	anticholinergic	anticholinergic	ADJ
aiua-11120	129	4	properties	property	NOUN
aiua-11120	129	5	,	,	PUNCT
aiua-11120	129	6	unlike	unlike	ADP
aiua-11120	129	7	conventional	conventional	ADJ
aiua-11120	129	8	figure	figure	NOUN
aiua-11120	129	9	3	3	NUM
aiua-11120	129	10	.	.	PUNCT
aiua-11120	130	1	a	a	DET
aiua-11120	130	2	,	,	PUNCT
aiua-11120	130	3	changes	change	NOUN
aiua-11120	130	4	from	from	ADP
aiua-11120	130	5	baseline	baseline	ADJ
aiua-11120	130	6	values	value	NOUN
aiua-11120	130	7	of	of	ADP
aiua-11120	130	8	oab	oab	PROPN
aiua-11120	130	9	-	-	PROPN
aiua-11120	130	10	ss	ss	PROPN
aiua-11120	130	11	scores	score	NOUN
aiua-11120	130	12	after	after	ADP
aiua-11120	130	13	mirabegron	mirabegron	PROPN
aiua-11120	130	14	vs.	vs.	ADP
aiua-11120	130	15	placebo	placebo	NOUN
aiua-11120	130	16	in	in	ADP
aiua-11120	130	17	patients	patient	NOUN
aiua-11120	130	18	with	with	ADP
aiua-11120	130	19	parkinson	parkinson	NOUN
aiua-11120	130	20	disease	disease	NOUN
aiua-11120	130	21	;	;	PUNCT
aiua-11120	130	22	b	b	X
aiua-11120	130	23	,	,	PUNCT
aiua-11120	130	24	changes	change	NOUN
aiua-11120	130	25	from	from	ADP
aiua-11120	130	26	baseline	baseline	ADJ
aiua-11120	130	27	number	number	NOUN
aiua-11120	130	28	of	of	ADP
aiua-11120	130	29	day	day	NOUN
aiua-11120	130	30	voids	voids	NOUN
aiua-11120	130	31	after	after	ADP
aiua-11120	130	32	mirabegron	mirabegron	PROPN
aiua-11120	130	33	vs.	vs.	ADP
aiua-11120	130	34	placebo	placebo	NOUN
aiua-11120	130	35	in	in	ADP
aiua-11120	130	36	patients	patient	NOUN
aiua-11120	130	37	with	with	ADP
aiua-11120	130	38	parkinson	parkinson	NOUN
aiua-11120	130	39	disease	disease	NOUN
aiua-11120	130	40	;	;	PUNCT
aiua-11120	130	41	c	c	X
aiua-11120	130	42	,	,	PUNCT
aiua-11120	130	43	changes	change	NOUN
aiua-11120	130	44	from	from	ADP
aiua-11120	130	45	baseline	baseline	ADJ
aiua-11120	130	46	number	number	NOUN
aiua-11120	130	47	of	of	ADP
aiua-11120	130	48	urgency	urgency	NOUN
aiua-11120	130	49	episodes	episode	NOUN
aiua-11120	130	50	after	after	ADP
aiua-11120	130	51	mirabegron	mirabegron	PROPN
aiua-11120	130	52	vs.	vs.	ADP
aiua-11120	130	53	placebo	placebo	NOUN
aiua-11120	130	54	in	in	ADP
aiua-11120	130	55	patients	patient	NOUN
aiua-11120	130	56	with	with	ADP
aiua-11120	130	57	parkinson	parkinson	NOUN
aiua-11120	130	58	disease	disease	NOUN
aiua-11120	130	59	;	;	PUNCT
aiua-11120	130	60	d	d	X
aiua-11120	130	61	,	,	PUNCT
aiua-11120	130	62	changes	change	NOUN
aiua-11120	130	63	from	from	ADP
aiua-11120	130	64	baseline	baseline	ADJ
aiua-11120	130	65	number	number	NOUN
aiua-11120	130	66	of	of	ADP
aiua-11120	130	67	incontinence	incontinence	NOUN
aiua-11120	130	68	episodes	episode	NOUN
aiua-11120	130	69	after	after	ADP
aiua-11120	130	70	mirabegron	mirabegron	PROPN
aiua-11120	130	71	vs.	vs.	ADP
aiua-11120	130	72	placebo	placebo	NOUN
aiua-11120	130	73	in	in	ADP
aiua-11120	130	74	patients	patient	NOUN
aiua-11120	130	75	with	with	ADP
aiua-11120	130	76	parkinson	parkinson	NOUN
aiua-11120	130	77	disease	disease	NOUN
aiua-11120	130	78	.	.	PUNCT
aiua-11120	131	1	diamonds	diamond	NOUN
aiua-11120	131	2	on	on	ADP
aiua-11120	131	3	the	the	DET
aiua-11120	131	4	left	left	ADJ
aiua-11120	131	5	side	side	NOUN
aiua-11120	131	6	of	of	ADP
aiua-11120	131	7	the	the	DET
aiua-11120	131	8	no	no	DET
aiua-11120	131	9	-	-	PUNCT
aiua-11120	131	10	effect	effect	NOUN
aiua-11120	131	11	line	line	NOUN
aiua-11120	131	12	indicate	indicate	VERB
aiua-11120	131	13	decreased	decrease	VERB
aiua-11120	131	14	numbers	number	NOUN
aiua-11120	131	15	of	of	ADP
aiua-11120	131	16	episodes	episode	NOUN
aiua-11120	131	17	or	or	CCONJ
aiua-11120	131	18	symptom	symptom	NOUN
aiua-11120	131	19	scores	score	NOUN
aiua-11120	131	20	in	in	ADP
aiua-11120	131	21	patients	patient	NOUN
aiua-11120	131	22	treated	treat	VERB
aiua-11120	131	23	with	with	ADP
aiua-11120	131	24	mirabegron	mirabegron	PROPN
aiua-11120	131	25	compared	compare	VERB
aiua-11120	131	26	to	to	ADP
aiua-11120	131	27	placebo	placebo	NOUN
aiua-11120	131	28	.	.	PUNCT
aiua-11120	132	1	mean	mean	VERB
aiua-11120	132	2	differences	difference	NOUN
aiua-11120	132	3	with	with	ADP
aiua-11120	132	4	95	95	NUM
aiua-11120	132	5	%	%	NOUN
aiua-11120	132	6	confidence	confidence	NOUN
aiua-11120	132	7	intervals	interval	NOUN
aiua-11120	132	8	and	and	CCONJ
aiua-11120	132	9	heterogeneity	heterogeneity	NOUN
aiua-11120	132	10	statistics	statistic	NOUN
aiua-11120	132	11	(	(	PUNCT
aiua-11120	132	12	i^2	i^2	PROPN
aiua-11120	132	13	)	)	PUNCT
aiua-11120	132	14	are	be	AUX
aiua-11120	132	15	shown	show	VERB
aiua-11120	132	16	.	.	PUNCT
aiua-11120	133	1	c.	c.	PROPN
aiua-11120	133	2	urgency	urgency	PROPN
aiua-11120	133	3	b.	b.	PROPN
aiua-11120	133	4	day	day	PROPN
aiua-11120	133	5	voids	voids	NOUN
aiua-11120	133	6	a.	a.	NOUN
aiua-11120	133	7	oab	oab	PROPN
aiua-11120	133	8	-	-	PROPN
aiua-11120	133	9	ss	ss	PROPN
aiua-11120	133	10	d.	d.	PROPN
aiua-11120	133	11	incontinence	incontinence	PROPN
aiua-11120	133	12	archivio	archivio	PROPN
aiua-11120	133	13	italiano	italiano	X
aiua-11120	133	14	di	di	X
aiua-11120	133	15	urologia	urologia	PROPN
aiua-11120	133	16	e	e	PROPN
aiua-11120	133	17	andrologia	andrologia	PROPN
aiua-11120	133	18	2022	2022	NUM
aiua-11120	133	19	;	;	PUNCT
aiua-11120	133	20	94	94	NUM
aiua-11120	133	21	,	,	PUNCT
aiua-11120	133	22	4	4	NUM
aiua-11120	133	23	r.	r.	NOUN
aiua-11120	133	24	bapir	bapir	NOUN
aiua-11120	133	25	,	,	PUNCT
aiua-11120	133	26	k.	k.	PROPN
aiua-11120	133	27	hassan	hassan	PROPN
aiua-11120	133	28	bhatti	bhatti	PROPN
aiua-11120	133	29	,	,	PUNCT
aiua-11120	133	30	ahmed	ahmed	PROPN
aiua-11120	133	31	eliwa	eliwa	PROPN
aiua-11120	133	32	,	,	PUNCT
aiua-11120	133	33	et	et	PROPN
aiua-11120	133	34	al	al	PROPN
aiua-11120	133	35	.	.	PROPN
aiua-11120	134	1	498	498	NUM
aiua-11120	134	2	antidepressants	antidepressant	NOUN
aiua-11120	134	3	,	,	PUNCT
aiua-11120	134	4	and	and	CCONJ
aiua-11120	134	5	stimulation	stimulation	NOUN
aiua-11120	134	6	of	of	ADP
aiua-11120	134	7	serotoninergic	serotoninergic	ADJ
aiua-11120	134	8	receptors	receptor	NOUN
aiua-11120	134	9	seems	seem	VERB
aiua-11120	134	10	to	to	PART
aiua-11120	134	11	suppress	suppress	VERB
aiua-11120	134	12	bladder	bladder	NOUN
aiua-11120	134	13	contractility	contractility	NOUN
aiua-11120	134	14	.	.	PUNCT
aiua-11120	135	1	for	for	ADP
aiua-11120	135	2	this	this	DET
aiua-11120	135	3	reason	reason	NOUN
aiua-11120	135	4	,	,	PUNCT
aiua-11120	135	5	snris	snris	PROPN
aiua-11120	135	6	could	could	AUX
aiua-11120	135	7	have	have	VERB
aiua-11120	135	8	a	a	DET
aiua-11120	135	9	role	role	NOUN
aiua-11120	135	10	in	in	ADP
aiua-11120	135	11	the	the	DET
aiua-11120	135	12	treatment	treatment	NOUN
aiua-11120	135	13	of	of	ADP
aiua-11120	135	14	neurogenic	neurogenic	ADJ
aiua-11120	135	15	oab	oab	PROPN
aiua-11120	135	16	.	.	PUNCT
aiua-11120	136	1	a	a	DET
aiua-11120	136	2	study	study	NOUN
aiua-11120	136	3	compared	compare	VERB
aiua-11120	136	4	the	the	DET
aiua-11120	136	5	effect	effect	NOUN
aiua-11120	136	6	of	of	ADP
aiua-11120	136	7	the	the	DET
aiua-11120	136	8	snri	snri	NOUN
aiua-11120	136	9	milnacipran	milnacipran	NOUN
aiua-11120	136	10	on	on	ADP
aiua-11120	136	11	oab	oab	PROPN
aiua-11120	136	12	symptoms	symptom	NOUN
aiua-11120	136	13	compared	compare	VERB
aiua-11120	136	14	to	to	ADP
aiua-11120	136	15	paroxetine	paroxetine	NOUN
aiua-11120	136	16	,	,	PUNCT
aiua-11120	136	17	a	a	DET
aiua-11120	136	18	selective	selective	ADJ
aiua-11120	136	19	serotonin	serotonin	NOUN
aiua-11120	136	20	reuptake	reuptake	NOUN
aiua-11120	136	21	inhibitor	inhibitor	NOUN
aiua-11120	136	22	(	(	PUNCT
aiua-11120	136	23	ssri	ssri	ADJ
aiua-11120	136	24	)	)	PUNCT
aiua-11120	136	25	lacking	lack	VERB
aiua-11120	136	26	adrenergic	adrenergic	ADJ
aiua-11120	136	27	effect	effect	NOUN
aiua-11120	136	28	.	.	PUNCT
aiua-11120	137	1	milnacipran	milnacipran	VERB
aiua-11120	137	2	,	,	PUNCT
aiua-11120	137	3	but	but	CCONJ
aiua-11120	137	4	not	not	PART
aiua-11120	137	5	paroxetine	paroxetine	NOUN
aiua-11120	137	6	,	,	PUNCT
aiua-11120	137	7	improved	improve	VERB
aiua-11120	137	8	the	the	DET
aiua-11120	137	9	quality	quality	NOUN
aiua-11120	137	10	of	of	ADP
aiua-11120	137	11	life	life	NOUN
aiua-11120	137	12	of	of	ADP
aiua-11120	137	13	patients	patient	NOUN
aiua-11120	137	14	by	by	ADP
aiua-11120	137	15	reducing	reduce	VERB
aiua-11120	137	16	daytime	daytime	ADJ
aiua-11120	137	17	urinary	urinary	ADJ
aiua-11120	137	18	frequency	frequency	NOUN
aiua-11120	137	19	and	and	CCONJ
aiua-11120	137	20	by	by	ADP
aiua-11120	137	21	increasing	increase	VERB
aiua-11120	137	22	the	the	DET
aiua-11120	137	23	bladder	bladder	NOUN
aiua-11120	137	24	capacity	capacity	NOUN
aiua-11120	137	25	(	(	PUNCT
aiua-11120	137	26	34	34	NUM
aiua-11120	137	27	)	)	PUNCT
aiua-11120	137	28	.	.	PUNCT
aiua-11120	138	1	cannabinoids	cannabinoid	NOUN
aiua-11120	138	2	two	two	NUM
aiua-11120	138	3	studies	study	NOUN
aiua-11120	138	4	reported	report	VERB
aiua-11120	138	5	the	the	DET
aiua-11120	138	6	effect	effect	NOUN
aiua-11120	138	7	of	of	ADP
aiua-11120	138	8	cannabis	cannabis	NOUN
aiua-11120	138	9	-	-	PUNCT
aiua-11120	138	10	containing	contain	VERB
aiua-11120	138	11	medicines	medicine	NOUN
aiua-11120	138	12	in	in	ADP
aiua-11120	138	13	patients	patient	NOUN
aiua-11120	138	14	with	with	ADP
aiua-11120	138	15	overactive	overactive	ADJ
aiua-11120	138	16	bladder	bladder	NOUN
aiua-11120	138	17	and	and	CCONJ
aiua-11120	138	18	multiple	multiple	ADJ
aiua-11120	138	19	sclerosis	sclerosis	NOUN
aiua-11120	138	20	(	(	PUNCT
aiua-11120	138	21	35	35	NUM
aiua-11120	138	22	,	,	PUNCT
aiua-11120	138	23	36	36	NUM
aiua-11120	138	24	)	)	PUNCT
aiua-11120	138	25	.	.	PUNCT
aiua-11120	139	1	cannabinoids	cannabinoid	NOUN
aiua-11120	139	2	(	(	PUNCT
aiua-11120	139	3	cannabis	cannabis	NOUN
aiua-11120	139	4	extract	extract	NOUN
aiua-11120	139	5	,	,	PUNCT
aiua-11120	139	6	δ9	δ9	NOUN
aiua-11120	139	7	-	-	PUNCT
aiua-11120	139	8	tetrahydrocannabinol	tetrahydrocannabinol	NOUN
aiua-11120	139	9	or	or	CCONJ
aiua-11120	139	10	thc	thc	NOUN
aiua-11120	139	11	,	,	PUNCT
aiua-11120	139	12	nabiximols	nabiximol	NOUN
aiua-11120	139	13	or	or	CCONJ
aiua-11120	139	14	sativex	sativex	ADJ
aiua-11120	139	15	)	)	PUNCT
aiua-11120	139	16	were	be	AUX
aiua-11120	139	17	used	use	VERB
aiua-11120	139	18	to	to	PART
aiua-11120	139	19	treat	treat	VERB
aiua-11120	139	20	oab	oab	PROPN
aiua-11120	139	21	in	in	ADP
aiua-11120	139	22	patients	patient	NOUN
aiua-11120	139	23	with	with	ADP
aiua-11120	139	24	ms	ms	PROPN
aiua-11120	139	25	.	.	PROPN
aiua-11120	139	26	cannabis	cannabis	PROPN
aiua-11120	139	27	extract	extract	NOUN
aiua-11120	139	28	and	and	CCONJ
aiua-11120	139	29	thc	thc	PROPN
aiua-11120	139	30	reduced	reduce	VERB
aiua-11120	139	31	incontinence	incontinence	NOUN
aiua-11120	139	32	episode	episode	NOUN
aiua-11120	139	33	rates	rate	NOUN
aiua-11120	139	34	by	by	ADP
aiua-11120	139	35	38	38	NUM
aiua-11120	139	36	%	%	NOUN
aiua-11120	139	37	and	and	CCONJ
aiua-11120	139	38	33	33	NUM
aiua-11120	139	39	%	%	NOUN
aiua-11120	139	40	,	,	PUNCT
aiua-11120	139	41	respectively	respectively	ADV
aiua-11120	139	42	.	.	PUNCT
aiua-11120	140	1	sativex	sativex	PROPN
aiua-11120	140	2	,	,	PUNCT
aiua-11120	140	3	an	an	DET
aiua-11120	140	4	endocannabinoid	endocannabinoid	NOUN
aiua-11120	140	5	system	system	NOUN
aiua-11120	140	6	modulator	modulator	NOUN
aiua-11120	140	7	,	,	PUNCT
aiua-11120	140	8	significantly	significantly	ADV
aiua-11120	140	9	reduced	reduce	VERB
aiua-11120	140	10	nocturia	nocturia	PROPN
aiua-11120	140	11	episodes	episode	NOUN
aiua-11120	140	12	and	and	CCONJ
aiua-11120	140	13	daytime	daytime	ADJ
aiua-11120	140	14	voids	void	NOUN
aiua-11120	140	15	.	.	PUNCT
aiua-11120	141	1	dizziness	dizziness	NOUN
aiua-11120	141	2	(	(	PUNCT
aiua-11120	141	3	16	16	NUM
aiua-11120	141	4	%	%	NOUN
aiua-11120	141	5	)	)	PUNCT
aiua-11120	141	6	,	,	PUNCT
aiua-11120	141	7	disorientation	disorientation	NOUN
aiua-11120	141	8	(	(	PUNCT
aiua-11120	141	9	6	6	NUM
aiua-11120	141	10	%	%	NOUN
aiua-11120	141	11	)	)	PUNCT
aiua-11120	141	12	and	and	CCONJ
aiua-11120	141	13	dissociation	dissociation	NOUN
aiua-11120	141	14	(	(	PUNCT
aiua-11120	141	15	6	6	NUM
aiua-11120	141	16	%	%	NOUN
aiua-11120	141	17	)	)	PUNCT
aiua-11120	141	18	were	be	AUX
aiua-11120	141	19	observed	observe	VERB
aiua-11120	141	20	during	during	ADP
aiua-11120	141	21	treatment	treatment	NOUN
aiua-11120	141	22	.	.	PUNCT
aiua-11120	142	1	intravesical	intravesical	ADJ
aiua-11120	142	2	instillations	instillation	NOUN
aiua-11120	142	3	in	in	ADP
aiua-11120	142	4	two	two	NUM
aiua-11120	142	5	studies	study	NOUN
aiua-11120	142	6	,	,	PUNCT
aiua-11120	142	7	a	a	DET
aiua-11120	142	8	single	single	ADJ
aiua-11120	142	9	intravesical	intravesical	ADJ
aiua-11120	142	10	instillation	instillation	NOUN
aiua-11120	142	11	of	of	ADP
aiua-11120	142	12	capsaicin	capsaicin	PROPN
aiua-11120	142	13	significantly	significantly	ADV
aiua-11120	142	14	decreased	decrease	VERB
aiua-11120	142	15	voiding	void	VERB
aiua-11120	142	16	frequency	frequency	NOUN
aiua-11120	142	17	and	and	CCONJ
aiua-11120	142	18	incontinence	incontinence	NOUN
aiua-11120	142	19	episodes	episode	NOUN
aiua-11120	142	20	,	,	PUNCT
aiua-11120	142	21	increased	increase	VERB
aiua-11120	142	22	the	the	DET
aiua-11120	142	23	maximum	maximum	ADJ
aiua-11120	142	24	cystometric	cystometric	ADJ
aiua-11120	142	25	capacity	capacity	NOUN
aiua-11120	142	26	and	and	CCONJ
aiua-11120	142	27	decreased	decrease	VERB
aiua-11120	142	28	the	the	DET
aiua-11120	142	29	maximum	maximum	ADJ
aiua-11120	142	30	detrusor	detrusor	NOUN
aiua-11120	142	31	pressure	pressure	NOUN
aiua-11120	142	32	(	(	PUNCT
aiua-11120	142	33	37	37	NUM
aiua-11120	142	34	,	,	PUNCT
aiua-11120	142	35	38	38	NUM
aiua-11120	142	36	)	)	PUNCT
aiua-11120	142	37	.	.	PUNCT
aiua-11120	143	1	capsaicin	capsaicin	NOUN
aiua-11120	143	2	diluted	dilute	VERB
aiua-11120	143	3	in	in	ADP
aiua-11120	143	4	ethanol	ethanol	NOUN
aiua-11120	143	5	solvent	solvent	NOUN
aiua-11120	143	6	caused	cause	VERB
aiua-11120	143	7	significant	significant	ADJ
aiua-11120	143	8	side	side	NOUN
aiua-11120	143	9	effects	effect	NOUN
aiua-11120	143	10	in	in	ADP
aiua-11120	143	11	70	70	NUM
aiua-11120	143	12	%	%	NOUN
aiua-11120	143	13	of	of	ADP
aiua-11120	143	14	cases	case	NOUN
aiua-11120	143	15	,	,	PUNCT
aiua-11120	143	16	whereas	whereas	SCONJ
aiua-11120	143	17	side	side	ADJ
aiua-11120	143	18	effects	effect	NOUN
aiua-11120	143	19	were	be	AUX
aiua-11120	143	20	limited	limit	VERB
aiua-11120	143	21	using	use	VERB
aiua-11120	143	22	a	a	DET
aiua-11120	143	23	glucidic	glucidic	ADJ
aiua-11120	143	24	solvent	solvent	NOUN
aiua-11120	143	25	.	.	PUNCT
aiua-11120	144	1	the	the	DET
aiua-11120	144	2	therapeutic	therapeutic	ADJ
aiua-11120	144	3	effect	effect	NOUN
aiua-11120	144	4	of	of	ADP
aiua-11120	144	5	capsaicin	capsaicin	PROPN
aiua-11120	144	6	is	be	AUX
aiua-11120	144	7	time	time	NOUN
aiua-11120	144	8	-	-	PUNCT
aiua-11120	144	9	limited	limited	ADJ
aiua-11120	144	10	with	with	ADP
aiua-11120	144	11	no	no	DET
aiua-11120	144	12	significant	significant	ADJ
aiua-11120	144	13	efficacy	efficacy	NOUN
aiua-11120	144	14	observed	observe	VERB
aiua-11120	144	15	after	after	ADP
aiua-11120	144	16	three	three	NUM
aiua-11120	144	17	months	month	NOUN
aiua-11120	144	18	.	.	PUNCT
aiua-11120	145	1	intravesical	intravesical	ADJ
aiua-11120	145	2	instillations	instillation	NOUN
aiua-11120	145	3	of	of	ADP
aiua-11120	145	4	nociceptin	nociceptin	ADV
aiua-11120	145	5	/	/	SYM
aiua-11120	145	6	orphanin	orphanin	PROPN
aiua-11120	145	7	fq	fq	PROPN
aiua-11120	145	8	also	also	ADV
aiua-11120	145	9	decreased	decrease	VERB
aiua-11120	145	10	urine	urine	NOUN
aiua-11120	145	11	leakages	leakage	NOUN
aiua-11120	145	12	and	and	CCONJ
aiua-11120	145	13	increased	increase	VERB
aiua-11120	145	14	the	the	DET
aiua-11120	145	15	voiding	void	VERB
aiua-11120	145	16	bladder	bladder	NOUN
aiua-11120	145	17	capacity	capacity	NOUN
aiua-11120	145	18	without	without	ADP
aiua-11120	145	19	significant	significant	ADJ
aiua-11120	145	20	side	side	NOUN
aiua-11120	145	21	effects	effect	NOUN
aiua-11120	145	22	(	(	PUNCT
aiua-11120	145	23	39	39	NUM
aiua-11120	145	24	)	)	PUNCT
aiua-11120	145	25	.	.	PUNCT
aiua-11120	146	1	botulinum	botulinum	ADJ
aiua-11120	146	2	toxin	toxin	NOUN
aiua-11120	146	3	thirteen	thirteen	NUM
aiua-11120	146	4	studies	study	NOUN
aiua-11120	146	5	evaluated	evaluate	VERB
aiua-11120	146	6	the	the	DET
aiua-11120	146	7	effect	effect	NOUN
aiua-11120	146	8	of	of	ADP
aiua-11120	146	9	botulinum	botulinum	ADJ
aiua-11120	146	10	toxin	toxin	NOUN
aiua-11120	146	11	intra	intra	ADJ
aiua-11120	146	12	-	-	ADJ
aiua-11120	146	13	detrusor	detrusor	ADJ
aiua-11120	146	14	injection	injection	NOUN
aiua-11120	146	15	compared	compare	VERB
aiua-11120	146	16	to	to	AUX
aiua-11120	146	17	saline	saline	VERB
aiua-11120	146	18	injection	injection	NOUN
aiua-11120	146	19	in	in	ADP
aiua-11120	146	20	patients	patient	NOUN
aiua-11120	146	21	with	with	ADP
aiua-11120	146	22	neurogenic	neurogenic	ADJ
aiua-11120	146	23	detrusor	detrusor	NOUN
aiua-11120	146	24	overactivity	overactivity	NOUN
aiua-11120	146	25	associated	associate	VERB
aiua-11120	146	26	with	with	ADP
aiua-11120	146	27	spinal	spinal	ADJ
aiua-11120	146	28	injury	injury	NOUN
aiua-11120	146	29	or	or	CCONJ
aiua-11120	146	30	multiple	multiple	ADJ
aiua-11120	146	31	sclerosis	sclerosis	NOUN
aiua-11120	146	32	(	(	PUNCT
aiua-11120	146	33	40	40	NUM
aiua-11120	146	34	-	-	SYM
aiua-11120	146	35	52	52	NUM
aiua-11120	146	36	)	)	PUNCT
aiua-11120	146	37	.	.	PUNCT
aiua-11120	147	1	intravesical	intravesical	ADJ
aiua-11120	147	2	botulinum	botulinum	ADJ
aiua-11120	147	3	toxin	toxin	NOUN
aiua-11120	147	4	treatment	treatment	NOUN
aiua-11120	147	5	proved	prove	VERB
aiua-11120	147	6	to	to	PART
aiua-11120	147	7	be	be	AUX
aiua-11120	147	8	effective	effective	ADJ
aiua-11120	147	9	and	and	CCONJ
aiua-11120	147	10	safe	safe	ADJ
aiua-11120	147	11	for	for	ADP
aiua-11120	147	12	the	the	DET
aiua-11120	147	13	treatment	treatment	NOUN
aiua-11120	147	14	of	of	ADP
aiua-11120	147	15	neurogenic	neurogenic	ADJ
aiua-11120	147	16	detrusor	detrusor	NOUN
aiua-11120	147	17	overactivity	overactivity	NOUN
aiua-11120	147	18	.	.	PUNCT
aiua-11120	148	1	transient	transient	ADJ
aiua-11120	148	2	adverse	adverse	ADJ
aiua-11120	148	3	events	event	NOUN
aiua-11120	148	4	were	be	AUX
aiua-11120	148	5	urinary	urinary	ADJ
aiua-11120	148	6	retention	retention	NOUN
aiua-11120	148	7	,	,	PUNCT
aiua-11120	148	8	figure	figure	VERB
aiua-11120	148	9	4	4	NUM
aiua-11120	148	10	.	.	PUNCT
aiua-11120	149	1	a	a	DET
aiua-11120	149	2	,	,	PUNCT
aiua-11120	149	3	changes	change	NOUN
aiua-11120	149	4	of	of	ADP
aiua-11120	149	5	cystometric	cystometric	ADJ
aiua-11120	149	6	capacity	capacity	NOUN
aiua-11120	149	7	values	value	NOUN
aiua-11120	149	8	in	in	ADP
aiua-11120	149	9	patients	patient	NOUN
aiua-11120	149	10	with	with	ADP
aiua-11120	149	11	spinal	spinal	ADJ
aiua-11120	149	12	cord	cord	NOUN
aiua-11120	149	13	injury	injury	NOUN
aiua-11120	149	14	/	/	SYM
aiua-11120	149	15	multiple	multiple	ADJ
aiua-11120	149	16	sclerosis	sclerosis	NOUN
aiua-11120	149	17	treated	treat	VERB
aiua-11120	149	18	with	with	ADP
aiua-11120	149	19	mirabegron	mirabegron	PROPN
aiua-11120	149	20	vs.	vs.	X
aiua-11120	149	21	placebo	placebo	NOUN
aiua-11120	149	22	;	;	PUNCT
aiua-11120	149	23	b	b	X
aiua-11120	149	24	,	,	PUNCT
aiua-11120	149	25	changes	change	NOUN
aiua-11120	149	26	of	of	ADP
aiua-11120	149	27	peak	peak	NOUN
aiua-11120	149	28	pressure	pressure	NOUN
aiua-11120	149	29	values	value	NOUN
aiua-11120	149	30	in	in	ADP
aiua-11120	149	31	patients	patient	NOUN
aiua-11120	149	32	with	with	ADP
aiua-11120	149	33	spinal	spinal	ADJ
aiua-11120	149	34	cord	cord	NOUN
aiua-11120	149	35	injury	injury	NOUN
aiua-11120	149	36	/	/	SYM
aiua-11120	149	37	multiple	multiple	ADJ
aiua-11120	149	38	sclerosis	sclerosis	NOUN
aiua-11120	149	39	treated	treat	VERB
aiua-11120	149	40	with	with	ADP
aiua-11120	149	41	mirabegron	mirabegron	PROPN
aiua-11120	149	42	vs.	vs.	X
aiua-11120	149	43	placebo	placebo	NOUN
aiua-11120	149	44	;	;	PUNCT
aiua-11120	149	45	c	c	X
aiua-11120	149	46	,	,	PUNCT
aiua-11120	149	47	changes	change	NOUN
aiua-11120	149	48	of	of	ADP
aiua-11120	149	49	volume	volume	NOUN
aiua-11120	149	50	at	at	ADP
aiua-11120	149	51	1st	1st	ADJ
aiua-11120	149	52	contraction	contraction	NOUN
aiua-11120	149	53	values	value	NOUN
aiua-11120	149	54	in	in	ADP
aiua-11120	149	55	patients	patient	NOUN
aiua-11120	149	56	with	with	ADP
aiua-11120	149	57	spinal	spinal	ADJ
aiua-11120	149	58	cord	cord	NOUN
aiua-11120	149	59	injury	injury	NOUN
aiua-11120	149	60	/	/	SYM
aiua-11120	149	61	multiple	multiple	ADJ
aiua-11120	149	62	sclerosis	sclerosis	NOUN
aiua-11120	149	63	treated	treat	VERB
aiua-11120	149	64	with	with	ADP
aiua-11120	149	65	mirabegron	mirabegron	PROPN
aiua-11120	149	66	vs.	vs.	X
aiua-11120	149	67	placebo	placebo	NOUN
aiua-11120	149	68	.	.	PUNCT
aiua-11120	150	1	diamonds	diamond	NOUN
aiua-11120	150	2	on	on	ADP
aiua-11120	150	3	the	the	DET
aiua-11120	150	4	right	right	ADJ
aiua-11120	150	5	side	side	NOUN
aiua-11120	150	6	of	of	ADP
aiua-11120	150	7	the	the	DET
aiua-11120	150	8	no	no	DET
aiua-11120	150	9	-	-	PUNCT
aiua-11120	150	10	effect	effect	NOUN
aiua-11120	150	11	line	line	NOUN
aiua-11120	150	12	indicate	indicate	VERB
aiua-11120	150	13	increased	increase	VERB
aiua-11120	150	14	cystometric	cystometric	ADJ
aiua-11120	150	15	capacity	capacity	NOUN
aiua-11120	150	16	(	(	PUNCT
aiua-11120	150	17	a	a	X
aiua-11120	150	18	)	)	PUNCT
aiua-11120	150	19	and	and	CCONJ
aiua-11120	150	20	volume	volume	NOUN
aiua-11120	150	21	at	at	ADP
aiua-11120	150	22	first	first	ADJ
aiua-11120	150	23	contraction	contraction	NOUN
aiua-11120	150	24	(	(	PUNCT
aiua-11120	150	25	c	c	NOUN
aiua-11120	150	26	)	)	PUNCT
aiua-11120	150	27	in	in	ADP
aiua-11120	150	28	patients	patient	NOUN
aiua-11120	150	29	treated	treat	VERB
aiua-11120	150	30	with	with	ADP
aiua-11120	150	31	mirabegron	mirabegron	PROPN
aiua-11120	150	32	compared	compare	VERB
aiua-11120	150	33	to	to	ADP
aiua-11120	150	34	placebo	placebo	NOUN
aiua-11120	150	35	.	.	PUNCT
aiua-11120	151	1	diamonds	diamond	NOUN
aiua-11120	151	2	on	on	ADP
aiua-11120	151	3	the	the	DET
aiua-11120	151	4	right	right	ADJ
aiua-11120	151	5	side	side	NOUN
aiua-11120	151	6	of	of	ADP
aiua-11120	151	7	the	the	DET
aiua-11120	151	8	no	no	DET
aiua-11120	151	9	-	-	PUNCT
aiua-11120	151	10	effect	effect	NOUN
aiua-11120	151	11	line	line	NOUN
aiua-11120	151	12	indicate	indicate	VERB
aiua-11120	151	13	decreased	decrease	VERB
aiua-11120	151	14	peak	peak	NOUN
aiua-11120	151	15	pressure	pressure	NOUN
aiua-11120	151	16	in	in	ADP
aiua-11120	151	17	patients	patient	NOUN
aiua-11120	151	18	treated	treat	VERB
aiua-11120	151	19	with	with	ADP
aiua-11120	151	20	mirabegron	mirabegron	PROPN
aiua-11120	151	21	compared	compare	VERB
aiua-11120	151	22	with	with	ADP
aiua-11120	151	23	placebo	placebo	NOUN
aiua-11120	151	24	.	.	PUNCT
aiua-11120	152	1	mean	mean	VERB
aiua-11120	152	2	differences	difference	NOUN
aiua-11120	152	3	with	with	ADP
aiua-11120	152	4	95	95	NUM
aiua-11120	152	5	%	%	NOUN
aiua-11120	152	6	confidence	confidence	NOUN
aiua-11120	152	7	intervals	interval	NOUN
aiua-11120	152	8	and	and	CCONJ
aiua-11120	152	9	heterogeneity	heterogeneity	NOUN
aiua-11120	152	10	statistics	statistic	NOUN
aiua-11120	152	11	(	(	PUNCT
aiua-11120	152	12	i^2	i^2	PROPN
aiua-11120	152	13	)	)	PUNCT
aiua-11120	152	14	are	be	AUX
aiua-11120	152	15	shown	show	VERB
aiua-11120	152	16	.	.	PUNCT
aiua-11120	153	1	cystometric	cystometric	ADJ
aiua-11120	153	2	capacity	capacity	NOUN
aiua-11120	153	3	peak	peak	NOUN
aiua-11120	153	4	pressure	pressure	NOUN
aiua-11120	153	5	volume	volume	NOUN
aiua-11120	153	6	at	at	ADP
aiua-11120	153	7	first	first	ADJ
aiua-11120	153	8	contraction	contraction	NOUN
aiua-11120	153	9	499archivio	499archivio	PROPN
aiua-11120	153	10	italiano	italiano	NOUN
aiua-11120	153	11	di	di	X
aiua-11120	153	12	urologia	urologia	PROPN
aiua-11120	153	13	e	e	PROPN
aiua-11120	153	14	andrologia	andrologia	PROPN
aiua-11120	153	15	2022	2022	NUM
aiua-11120	153	16	;	;	PUNCT
aiua-11120	153	17	94	94	NUM
aiua-11120	153	18	,	,	PUNCT
aiua-11120	153	19	4	4	NUM
aiua-11120	153	20	treatment	treatment	NOUN
aiua-11120	153	21	of	of	ADP
aiua-11120	153	22	overactive	overactive	ADJ
aiua-11120	153	23	neurogenic	neurogenic	ADJ
aiua-11120	153	24	bladder	bladder	NOUN
aiua-11120	153	25	hematuria	hematuria	NOUN
aiua-11120	153	26	,	,	PUNCT
aiua-11120	153	27	muscle	muscle	NOUN
aiua-11120	153	28	weakness	weakness	NOUN
aiua-11120	153	29	,	,	PUNCT
aiua-11120	153	30	and	and	CCONJ
aiua-11120	153	31	urinary	urinary	ADJ
aiua-11120	153	32	tract	tract	NOUN
aiua-11120	153	33	infection	infection	NOUN
aiua-11120	153	34	.	.	PUNCT
aiua-11120	154	1	two	two	NUM
aiua-11120	154	2	studies	study	NOUN
aiua-11120	154	3	compared	compare	VERB
aiua-11120	154	4	the	the	DET
aiua-11120	154	5	effect	effect	NOUN
aiua-11120	154	6	of	of	ADP
aiua-11120	154	7	injections	injection	NOUN
aiua-11120	154	8	in	in	ADP
aiua-11120	154	9	the	the	DET
aiua-11120	154	10	detrusor	detrusor	NOUN
aiua-11120	154	11	excluding	exclude	VERB
aiua-11120	154	12	the	the	DET
aiua-11120	154	13	trigone	trigone	NOUN
aiua-11120	154	14	with	with	ADP
aiua-11120	154	15	injections	injection	NOUN
aiua-11120	154	16	including	include	VERB
aiua-11120	154	17	the	the	DET
aiua-11120	154	18	trigone	trigone	NOUN
aiua-11120	154	19	(	(	PUNCT
aiua-11120	154	20	53	53	NUM
aiua-11120	154	21	,	,	PUNCT
aiua-11120	154	22	54	54	NUM
aiua-11120	154	23	)	)	PUNCT
aiua-11120	154	24	.	.	PUNCT
aiua-11120	155	1	a	a	DET
aiua-11120	155	2	study	study	NOUN
aiua-11120	155	3	compared	compare	VERB
aiua-11120	155	4	the	the	DET
aiua-11120	155	5	effect	effect	NOUN
aiua-11120	155	6	of	of	ADP
aiua-11120	155	7	the	the	DET
aiua-11120	155	8	administration	administration	NOUN
aiua-11120	155	9	of	of	ADP
aiua-11120	155	10	two	two	NUM
aiua-11120	155	11	different	different	ADJ
aiua-11120	155	12	doses	dose	NOUN
aiua-11120	155	13	of	of	ADP
aiua-11120	155	14	botulinum	botulinum	ADJ
aiua-11120	155	15	toxin	toxin	NOUN
aiua-11120	155	16	type	type	NOUN
aiua-11120	155	17	a	a	DET
aiua-11120	155	18	(	(	PUNCT
aiua-11120	155	19	55	55	NUM
aiua-11120	155	20	)	)	PUNCT
aiua-11120	155	21	.	.	PUNCT
aiua-11120	156	1	most	most	ADJ
aiua-11120	156	2	of	of	ADP
aiua-11120	156	3	these	these	DET
aiua-11120	156	4	studies	study	NOUN
aiua-11120	156	5	were	be	AUX
aiua-11120	156	6	included	include	VERB
aiua-11120	156	7	in	in	ADP
aiua-11120	156	8	recently	recently	ADV
aiua-11120	156	9	published	publish	VERB
aiua-11120	156	10	meta	meta	NOUN
aiua-11120	156	11	-	-	PUNCT
aiua-11120	156	12	analyses	analysis	NOUN
aiua-11120	156	13	.	.	PUNCT
aiua-11120	157	1	our	our	PRON
aiua-11120	157	2	search	search	NOUN
aiua-11120	157	3	added	add	VERB
aiua-11120	157	4	to	to	ADP
aiua-11120	157	5	published	publish	VERB
aiua-11120	157	6	systematic	systematic	ADJ
aiua-11120	157	7	reviews	review	NOUN
aiua-11120	157	8	three	three	NUM
aiua-11120	157	9	studies	study	NOUN
aiua-11120	157	10	which	which	PRON
aiua-11120	157	11	were	be	AUX
aiua-11120	157	12	published	publish	VERB
aiua-11120	157	13	after	after	ADP
aiua-11120	157	14	2017	2017	NUM
aiua-11120	157	15	.	.	PUNCT
aiua-11120	158	1	kennelly	kennelly	PROPN
aiua-11120	158	2	et	et	PROPN
aiua-11120	158	3	al	al	PROPN
aiua-11120	158	4	.	.	PROPN
aiua-11120	158	5	reported	report	VERB
aiua-11120	158	6	pooled	pool	VERB
aiua-11120	158	7	data	datum	NOUN
aiua-11120	158	8	from	from	ADP
aiua-11120	158	9	two	two	NUM
aiua-11120	158	10	phase	phase	NOUN
aiua-11120	158	11	3	3	NUM
aiua-11120	158	12	studies	study	NOUN
aiua-11120	158	13	assessing	assess	VERB
aiua-11120	158	14	the	the	DET
aiua-11120	158	15	safety	safety	NOUN
aiua-11120	158	16	and	and	CCONJ
aiua-11120	158	17	efficacy	efficacy	NOUN
aiua-11120	158	18	of	of	ADP
aiua-11120	158	19	abobotulinumtoxina	abobotulinumtoxina	PROPN
aiua-11120	158	20	(	(	PUNCT
aiua-11120	158	21	abobonta	abobonta	PROPN
aiua-11120	158	22	)	)	PUNCT
aiua-11120	158	23	in	in	ADP
aiua-11120	158	24	patients	patient	NOUN
aiua-11120	158	25	with	with	ADP
aiua-11120	158	26	neurogenic	neurogenic	ADJ
aiua-11120	158	27	detrusor	detrusor	NOUN
aiua-11120	158	28	overactivity	overactivity	NOUN
aiua-11120	158	29	who	who	PRON
aiua-11120	158	30	were	be	AUX
aiua-11120	158	31	routinely	routinely	ADV
aiua-11120	158	32	performing	perform	VERB
aiua-11120	158	33	clean	clean	ADJ
aiua-11120	158	34	intermittent	intermittent	ADJ
aiua-11120	158	35	catheterization	catheterization	NOUN
aiua-11120	158	36	.	.	PUNCT
aiua-11120	159	1	treatment	treatment	NOUN
aiua-11120	159	2	with	with	ADP
aiua-11120	159	3	abobont	abobont	NOUN
aiua-11120	159	4	-	-	PUNCT
aiua-11120	159	5	a	a	PRON
aiua-11120	159	6	significantly	significantly	ADV
aiua-11120	159	7	reduced	reduce	VERB
aiua-11120	159	8	incontinence	incontinence	NOUN
aiua-11120	159	9	episodes	episode	NOUN
aiua-11120	159	10	per	per	ADP
aiua-11120	159	11	week	week	NOUN
aiua-11120	159	12	in	in	ADP
aiua-11120	159	13	comparison	comparison	NOUN
aiua-11120	159	14	to	to	ADP
aiua-11120	159	15	placebo	placebo	NOUN
aiua-11120	159	16	(	(	PUNCT
aiua-11120	159	17	p	p	X
aiua-11120	159	18	<	<	X
aiua-11120	159	19	0.001	0.001	NUM
aiua-11120	159	20	)	)	PUNCT
aiua-11120	159	21	and	and	CCONJ
aiua-11120	159	22	significantly	significantly	ADV
aiua-11120	159	23	increased	increase	VERB
aiua-11120	159	24	the	the	DET
aiua-11120	159	25	volume	volume	NOUN
aiua-11120	159	26	per	per	ADP
aiua-11120	159	27	void	void	NOUN
aiua-11120	159	28	denys	denys	PROPN
aiua-11120	159	29	et	et	PROPN
aiua-11120	159	30	al	al	PROPN
aiua-11120	159	31	.	.	PROPN
aiua-11120	159	32	compared	compare	VERB
aiua-11120	159	33	the	the	DET
aiua-11120	159	34	administration	administration	NOUN
aiua-11120	159	35	of	of	ADP
aiua-11120	159	36	abobotulinumtoxina	abobotulinumtoxina	PROPN
aiua-11120	159	37	by	by	ADP
aiua-11120	159	38	15	15	NUM
aiua-11120	159	39	intra	intra	ADJ
aiua-11120	159	40	-	-	ADJ
aiua-11120	159	41	detrusor	detrusor	NOUN
aiua-11120	159	42	injections	injection	NOUN
aiua-11120	159	43	in	in	ADP
aiua-11120	159	44	comparison	comparison	NOUN
aiua-11120	159	45	to	to	ADP
aiua-11120	159	46	30	30	NUM
aiua-11120	159	47	injections	injection	NOUN
aiua-11120	159	48	(	(	PUNCT
aiua-11120	159	49	43	43	NUM
aiua-11120	159	50	)	)	PUNCT
aiua-11120	159	51	.	.	PUNCT
aiua-11120	160	1	both	both	DET
aiua-11120	160	2	15	15	NUM
aiua-11120	160	3	and	and	CCONJ
aiua-11120	160	4	30	30	NUM
aiua-11120	160	5	injections	injection	NOUN
aiua-11120	160	6	administration	administration	NOUN
aiua-11120	160	7	modes	mode	NOUN
aiua-11120	160	8	decreased	decrease	VERB
aiua-11120	160	9	the	the	DET
aiua-11120	160	10	daily	daily	ADJ
aiua-11120	160	11	number	number	NOUN
aiua-11120	160	12	of	of	ADP
aiua-11120	160	13	incontinence	incontinence	NOUN
aiua-11120	160	14	episodes	episode	NOUN
aiua-11120	160	15	and	and	CCONJ
aiua-11120	160	16	improved	improve	VERB
aiua-11120	160	17	urodynamic	urodynamic	ADJ
aiua-11120	160	18	parameters	parameter	NOUN
aiua-11120	160	19	in	in	ADP
aiua-11120	160	20	patients	patient	NOUN
aiua-11120	160	21	with	with	ADP
aiua-11120	160	22	ndo	ndo	PROPN
aiua-11120	160	23	.	.	PUNCT
aiua-11120	160	24	honda	honda	PROPN
aiua-11120	160	25	et	et	PROPN
aiua-11120	160	26	al	al	PROPN
aiua-11120	160	27	.	.	PROPN
aiua-11120	160	28	described	describe	VERB
aiua-11120	160	29	the	the	DET
aiua-11120	160	30	results	result	NOUN
aiua-11120	160	31	of	of	ADP
aiua-11120	160	32	the	the	DET
aiua-11120	160	33	administration	administration	NOUN
aiua-11120	160	34	of	of	ADP
aiua-11120	160	35	onabotulinumtoxina	onabotulinumtoxina	PROPN
aiua-11120	160	36	in	in	ADP
aiua-11120	160	37	japanese	japanese	ADJ
aiua-11120	160	38	patients	patient	NOUN
aiua-11120	160	39	with	with	ADP
aiua-11120	160	40	neurogenic	neurogenic	ADJ
aiua-11120	160	41	detrusor	detrusor	NOUN
aiua-11120	160	42	overactivity	overactivity	NOUN
aiua-11120	160	43	,	,	PUNCT
aiua-11120	160	44	demonstrating	demonstrate	VERB
aiua-11120	160	45	reduction	reduction	NOUN
aiua-11120	160	46	of	of	ADP
aiua-11120	160	47	urinary	urinary	ADJ
aiua-11120	160	48	incontinence	incontinence	NOUN
aiua-11120	160	49	episodes	episode	NOUN
aiua-11120	160	50	and	and	CCONJ
aiua-11120	160	51	improvement	improvement	NOUN
aiua-11120	160	52	of	of	ADP
aiua-11120	160	53	urodynamic	urodynamic	ADJ
aiua-11120	160	54	parameters	parameter	NOUN
aiua-11120	160	55	(	(	PUNCT
aiua-11120	160	56	47	47	NUM
aiua-11120	160	57	)	)	PUNCT
aiua-11120	160	58	.	.	PUNCT
aiua-11120	161	1	transcutaneous	transcutaneous	ADJ
aiua-11120	161	2	tibial	tibial	ADJ
aiua-11120	161	3	nerve	nerve	NOUN
aiua-11120	161	4	stimulation	stimulation	NOUN
aiua-11120	161	5	(	(	PUNCT
aiua-11120	161	6	ttns	ttns	NOUN
aiua-11120	161	7	)	)	PUNCT
aiua-11120	161	8	six	six	NUM
aiua-11120	161	9	studies	study	NOUN
aiua-11120	161	10	reported	report	VERB
aiua-11120	161	11	the	the	DET
aiua-11120	161	12	results	result	NOUN
aiua-11120	161	13	of	of	ADP
aiua-11120	161	14	ttns	ttns	NOUN
aiua-11120	161	15	in	in	ADP
aiua-11120	161	16	neurogenic	neurogenic	ADJ
aiua-11120	161	17	oab	oab	PROPN
aiua-11120	161	18	.	.	PROPN
aiua-11120	162	1	three	three	NUM
aiua-11120	162	2	studies	study	NOUN
aiua-11120	162	3	compared	compare	VERB
aiua-11120	162	4	active	active	ADJ
aiua-11120	162	5	treatment	treatment	NOUN
aiua-11120	162	6	with	with	ADP
aiua-11120	162	7	sham	sham	ADJ
aiua-11120	162	8	treatment	treatment	NOUN
aiua-11120	162	9	(	(	PUNCT
aiua-11120	162	10	56	56	NUM
aiua-11120	162	11	-	-	SYM
aiua-11120	162	12	58	58	NUM
aiua-11120	162	13	)	)	PUNCT
aiua-11120	162	14	and	and	CCONJ
aiua-11120	162	15	3	3	NUM
aiua-11120	162	16	compared	compare	VERB
aiua-11120	162	17	ttns	ttns	NOUN
aiua-11120	162	18	with	with	ADP
aiua-11120	162	19	other	other	ADJ
aiua-11120	162	20	treatments	treatment	NOUN
aiua-11120	162	21	such	such	ADJ
aiua-11120	162	22	as	as	ADP
aiua-11120	162	23	pelvic	pelvic	ADJ
aiua-11120	162	24	floor	floor	NOUN
aiua-11120	162	25	muscle	muscle	NOUN
aiua-11120	162	26	training	training	NOUN
aiua-11120	162	27	(	(	PUNCT
aiua-11120	162	28	59	59	NUM
aiua-11120	162	29	)	)	PUNCT
aiua-11120	162	30	or	or	CCONJ
aiua-11120	162	31	oral	oral	ADJ
aiua-11120	162	32	anticholinergics	anticholinergic	NOUN
aiua-11120	162	33	(	(	PUNCT
aiua-11120	162	34	n	n	NOUN
aiua-11120	162	35	=	=	SYM
aiua-11120	162	36	2	2	NUM
aiua-11120	162	37	)	)	PUNCT
aiua-11120	162	38	(	(	PUNCT
aiua-11120	162	39	60	60	NUM
aiua-11120	162	40	,	,	PUNCT
aiua-11120	162	41	61	61	NUM
aiua-11120	162	42	)	)	PUNCT
aiua-11120	162	43	.	.	PUNCT
aiua-11120	163	1	ttns	ttns	PROPN
aiua-11120	163	2	reduced	reduce	VERB
aiua-11120	163	3	urinary	urinary	ADJ
aiua-11120	163	4	frequency	frequency	NOUN
aiua-11120	163	5	,	,	PUNCT
aiua-11120	163	6	urgency	urgency	NOUN
aiua-11120	163	7	,	,	PUNCT
aiua-11120	163	8	and	and	CCONJ
aiua-11120	163	9	incontinence	incontinence	NOUN
aiua-11120	163	10	episodes	episode	NOUN
aiua-11120	163	11	in	in	ADP
aiua-11120	163	12	comparison	comparison	NOUN
aiua-11120	163	13	to	to	ADP
aiua-11120	163	14	placebo	placebo	NOUN
aiua-11120	163	15	.	.	PUNCT
aiua-11120	164	1	quantitative	quantitative	ADJ
aiua-11120	164	2	analysis	analysis	NOUN
aiua-11120	164	3	of	of	ADP
aiua-11120	164	4	two	two	NUM
aiua-11120	164	5	studies	study	NOUN
aiua-11120	164	6	comparing	compare	VERB
aiua-11120	164	7	ttns	ttns	NOUN
aiua-11120	164	8	with	with	ADP
aiua-11120	164	9	sham	sham	ADJ
aiua-11120	164	10	treatment	treatment	NOUN
aiua-11120	164	11	in	in	ADP
aiua-11120	164	12	patients	patient	NOUN
aiua-11120	164	13	with	with	ADP
aiua-11120	164	14	parkinson	parkinson	NOUN
aiua-11120	164	15	disease	disease	NOUN
aiua-11120	164	16	shows	show	VERB
aiua-11120	164	17	that	that	SCONJ
aiua-11120	164	18	ttns	ttns	NOUN
aiua-11120	164	19	was	be	AUX
aiua-11120	164	20	more	more	ADV
aiua-11120	164	21	effective	effective	ADJ
aiua-11120	164	22	than	than	ADP
aiua-11120	164	23	sham	sham	ADJ
aiua-11120	164	24	in	in	ADP
aiua-11120	164	25	decreasing	decrease	VERB
aiua-11120	164	26	the	the	DET
aiua-11120	164	27	number	number	NOUN
aiua-11120	164	28	of	of	ADP
aiua-11120	164	29	nocturia	nocturia	PROPN
aiua-11120	164	30	episodes	episode	NOUN
aiua-11120	164	31	(	(	PUNCT
aiua-11120	164	32	md	md	PROPN
aiua-11120	164	33	,	,	PUNCT
aiua-11120	164	34	-1.40	-1.40	NOUN
aiua-11120	164	35	,	,	PUNCT
aiua-11120	164	36	95	95	NUM
aiua-11120	164	37	%	%	NOUN
aiua-11120	164	38	ci	ci	NOUN
aiua-11120	164	39	-2.39	-2.39	NOUN
aiua-11120	164	40	to	to	ADP
aiua-11120	164	41	-0.42	-0.42	NUM
aiua-11120	164	42	,	,	PUNCT
aiua-11120	164	43	2	2	NUM
aiua-11120	164	44	trials	trial	NOUN
aiua-11120	164	45	,	,	PUNCT
aiua-11120	164	46	53	53	NUM
aiua-11120	164	47	patients	patient	NOUN
aiua-11120	164	48	,	,	PUNCT
aiua-11120	164	49	z	z	NOUN
aiua-11120	164	50	=	=	NUM
aiua-11120	164	51	2.79	2.79	NUM
aiua-11120	164	52	,	,	PUNCT
aiua-11120	164	53	p	p	X
aiua-11120	164	54	<	<	X
aiua-11120	164	55	0.005	0.005	NUM
aiua-11120	164	56	)	)	PUNCT
aiua-11120	164	57	.	.	PUNCT
aiua-11120	165	1	changes	change	NOUN
aiua-11120	165	2	from	from	ADP
aiua-11120	165	3	baseline	baseline	NOUN
aiua-11120	165	4	of	of	ADP
aiua-11120	165	5	oab	oab	PROPN
aiua-11120	165	6	scores	score	NOUN
aiua-11120	165	7	were	be	AUX
aiua-11120	165	8	not	not	PART
aiua-11120	165	9	significantly	significantly	ADV
aiua-11120	165	10	different	different	ADJ
aiua-11120	165	11	between	between	ADP
aiua-11120	165	12	ttns	ttns	NOUN
aiua-11120	165	13	and	and	CCONJ
aiua-11120	165	14	sham	sham	NOUN
aiua-11120	165	15	(	(	PUNCT
aiua-11120	165	16	md	md	PROPN
aiua-11120	165	17	2.87	2.87	NUM
aiua-11120	165	18	,	,	PUNCT
aiua-11120	165	19	95	95	NUM
aiua-11120	165	20	%	%	NOUN
aiua-11120	165	21	ci	ci	NOUN
aiua-11120	165	22	-17.25	-17.25	PROPN
aiua-11120	165	23	to	to	ADP
aiua-11120	165	24	11.51	11.51	NUM
aiua-11120	165	25	,	,	PUNCT
aiua-11120	165	26	2	2	NUM
aiua-11120	165	27	trials	trial	NOUN
aiua-11120	165	28	,	,	PUNCT
aiua-11120	165	29	53	53	NUM
aiua-11120	165	30	patients	patient	NOUN
aiua-11120	165	31	,	,	PUNCT
aiua-11120	165	32	z	z	NOUN
aiua-11120	165	33	=	=	SYM
aiua-11120	165	34	0.39	0.39	NUM
aiua-11120	165	35	,	,	PUNCT
aiua-11120	165	36	p	p	X
aiua-11120	165	37	=	=	NOUN
aiua-11120	165	38	0.70	0.70	NUM
aiua-11120	165	39	)	)	PUNCT
aiua-11120	165	40	(	(	PUNCT
aiua-11120	165	41	figure	figure	NOUN
aiua-11120	165	42	5a	5a	NUM
aiua-11120	165	43	,	,	PUNCT
aiua-11120	165	44	b	b	NOUN
aiua-11120	165	45	)	)	PUNCT
aiua-11120	165	46	.	.	PUNCT
aiua-11120	166	1	in	in	ADP
aiua-11120	166	2	a	a	DET
aiua-11120	166	3	study	study	NOUN
aiua-11120	166	4	including	include	VERB
aiua-11120	166	5	patients	patient	NOUN
aiua-11120	166	6	with	with	ADP
aiua-11120	166	7	multiple	multiple	ADJ
aiua-11120	166	8	sclerosis	sclerosis	NOUN
aiua-11120	166	9	,	,	PUNCT
aiua-11120	166	10	quality	quality	NOUN
aiua-11120	166	11	of	of	ADP
aiua-11120	166	12	life	life	NOUN
aiua-11120	166	13	scores	score	NOUN
aiua-11120	166	14	(	(	PUNCT
aiua-11120	166	15	sf	sf	NOUN
aiua-11120	166	16	-	-	PUNCT
aiua-11120	166	17	qualiveen	qualiveen	NOUN
aiua-11120	166	18	)	)	PUNCT
aiua-11120	166	19	,	,	PUNCT
aiua-11120	166	20	overactive	overactive	ADJ
aiua-11120	166	21	bladder	bladder	NOUN
aiua-11120	166	22	symptom	symptom	NOUN
aiua-11120	166	23	scores	score	NOUN
aiua-11120	166	24	(	(	PUNCT
aiua-11120	166	25	usp	usp	NOUN
aiua-11120	166	26	)	)	PUNCT
aiua-11120	166	27	and	and	CCONJ
aiua-11120	166	28	rates	rate	NOUN
aiua-11120	166	29	of	of	ADP
aiua-11120	166	30	urgency	urgency	NOUN
aiua-11120	166	31	episodes	episode	NOUN
aiua-11120	166	32	were	be	AUX
aiua-11120	166	33	improved	improve	VERB
aiua-11120	166	34	after	after	ADP
aiua-11120	166	35	both	both	PRON
aiua-11120	166	36	pfmt	pfmt	NOUN
aiua-11120	166	37	and	and	CCONJ
aiua-11120	166	38	ttns	ttns	NOUN
aiua-11120	166	39	but	but	CCONJ
aiua-11120	166	40	no	no	DET
aiua-11120	166	41	differences	difference	NOUN
aiua-11120	166	42	between	between	ADP
aiua-11120	166	43	the	the	DET
aiua-11120	166	44	two	two	NUM
aiua-11120	166	45	groups	group	NOUN
aiua-11120	166	46	were	be	AUX
aiua-11120	166	47	observed	observe	VERB
aiua-11120	166	48	(	(	PUNCT
aiua-11120	166	49	59	59	NUM
aiua-11120	166	50	)	)	PUNCT
aiua-11120	166	51	.	.	PUNCT
aiua-11120	167	1	ttns	ttns	PROPN
aiua-11120	167	2	was	be	AUX
aiua-11120	167	3	compared	compare	VERB
aiua-11120	167	4	to	to	ADP
aiua-11120	167	5	oxybutynin	oxybutynin	PROPN
aiua-11120	167	6	(	(	PUNCT
aiua-11120	167	7	5	5	NUM
aiua-11120	167	8	mg	mg	NOUN
aiua-11120	167	9	bid	bid	NOUN
aiua-11120	167	10	)	)	PUNCT
aiua-11120	167	11	in	in	ADP
aiua-11120	167	12	patients	patient	NOUN
aiua-11120	167	13	with	with	ADP
aiua-11120	167	14	oab	oab	PROPN
aiua-11120	167	15	and	and	CCONJ
aiua-11120	167	16	multiple	multiple	ADJ
aiua-11120	167	17	sclerosis	sclerosis	NOUN
aiua-11120	167	18	.	.	PUNCT
aiua-11120	168	1	ttns	ttns	PROPN
aiua-11120	168	2	showed	show	VERB
aiua-11120	168	3	a	a	DET
aiua-11120	168	4	less	less	ADV
aiua-11120	168	5	significant	significant	ADJ
aiua-11120	168	6	reduction	reduction	NOUN
aiua-11120	168	7	of	of	ADP
aiua-11120	168	8	oab	oab	PROPN
aiua-11120	168	9	-	-	PUNCT
aiua-11120	168	10	s	s	X
aiua-11120	168	11	(	(	PUNCT
aiua-11120	168	12	overactive	overactive	ADJ
aiua-11120	168	13	bladder	bladder	NOUN
aiua-11120	168	14	symptoms	symptom	NOUN
aiua-11120	168	15	)	)	PUNCT
aiua-11120	168	16	and	and	CCONJ
aiua-11120	168	17	oab	oab	PROPN
aiua-11120	168	18	-	-	PROPN
aiua-11120	168	19	q	q	X
aiua-11120	168	20	(	(	PUNCT
aiua-11120	168	21	overactive	overactive	ADJ
aiua-11120	168	22	bladder	bladder	NOUN
aiua-11120	168	23	quality	quality	NOUN
aiua-11120	168	24	of	of	ADP
aiua-11120	168	25	life	life	NOUN
aiua-11120	168	26	)	)	PUNCT
aiua-11120	168	27	scores	score	NOUN
aiua-11120	168	28	in	in	ADP
aiua-11120	168	29	comparison	comparison	NOUN
aiua-11120	168	30	to	to	ADP
aiua-11120	168	31	oxybutynin	oxybutynin	PROPN
aiua-11120	168	32	,	,	PUNCT
aiua-11120	168	33	though	though	SCONJ
aiua-11120	168	34	the	the	DET
aiua-11120	168	35	latter	latter	ADJ
aiua-11120	168	36	was	be	AUX
aiua-11120	168	37	associated	associate	VERB
aiua-11120	168	38	with	with	ADP
aiua-11120	168	39	a	a	DET
aiua-11120	168	40	higher	high	ADJ
aiua-11120	168	41	rate	rate	NOUN
aiua-11120	168	42	of	of	ADP
aiua-11120	168	43	side	side	NOUN
aiua-11120	168	44	effects	effect	NOUN
aiua-11120	168	45	(	(	PUNCT
aiua-11120	168	46	35	35	NUM
aiua-11120	168	47	%	%	NOUN
aiua-11120	168	48	)	)	PUNCT
aiua-11120	168	49	(	(	PUNCT
aiua-11120	168	50	60	60	NUM
aiua-11120	168	51	)	)	PUNCT
aiua-11120	168	52	.	.	PUNCT
aiua-11120	169	1	in	in	ADP
aiua-11120	169	2	another	another	DET
aiua-11120	169	3	study	study	NOUN
aiua-11120	169	4	including	include	VERB
aiua-11120	169	5	women	woman	NOUN
aiua-11120	169	6	with	with	ADP
aiua-11120	169	7	neurogenic	neurogenic	ADJ
aiua-11120	169	8	bladder	bladder	NOUN
aiua-11120	169	9	,	,	PUNCT
aiua-11120	169	10	the	the	DET
aiua-11120	169	11	association	association	NOUN
aiua-11120	169	12	of	of	ADP
aiua-11120	169	13	ttns	ttns	PROPN
aiua-11120	169	14	with	with	ADP
aiua-11120	169	15	tolterodine	tolterodine	NOUN
aiua-11120	169	16	4	4	NUM
aiua-11120	169	17	mg	mg	NOUN
aiua-11120	169	18	improved	improve	VERB
aiua-11120	169	19	urgency	urgency	NOUN
aiua-11120	169	20	symptoms	symptom	NOUN
aiua-11120	169	21	(	(	PUNCT
aiua-11120	169	22	61	61	NUM
aiua-11120	169	23	)	)	PUNCT
aiua-11120	169	24	.	.	PUNCT
aiua-11120	170	1	acupuncture	acupuncture	VERB
aiua-11120	170	2	the	the	DET
aiua-11120	170	3	effect	effect	NOUN
aiua-11120	170	4	of	of	ADP
aiua-11120	170	5	acupuncture	acupuncture	NOUN
aiua-11120	170	6	and	and	CCONJ
aiua-11120	170	7	electroacupuncture	electroacupuncture	NOUN
aiua-11120	170	8	was	be	AUX
aiua-11120	170	9	reported	report	VERB
aiua-11120	170	10	in	in	ADP
aiua-11120	170	11	2	2	NUM
aiua-11120	170	12	studies	study	NOUN
aiua-11120	170	13	in	in	ADP
aiua-11120	170	14	patients	patient	NOUN
aiua-11120	170	15	with	with	ADP
aiua-11120	170	16	parkinson	parkinson	NOUN
aiua-11120	170	17	’s	’s	PART
aiua-11120	170	18	disease	disease	NOUN
aiua-11120	170	19	and	and	CCONJ
aiua-11120	170	20	post	post	ADJ
aiua-11120	170	21	-	-	ADJ
aiua-11120	170	22	stroke	stroke	ADJ
aiua-11120	170	23	oab	oab	PROPN
aiua-11120	170	24	.	.	PROPN
aiua-11120	171	1	in	in	ADP
aiua-11120	171	2	pd	pd	PROPN
aiua-11120	171	3	patients	patient	NOUN
aiua-11120	171	4	,	,	PUNCT
aiua-11120	171	5	acupuncture	acupuncture	NOUN
aiua-11120	171	6	associated	associate	VERB
aiua-11120	171	7	with	with	ADP
aiua-11120	171	8	a	a	DET
aiua-11120	171	9	low	low	ADJ
aiua-11120	171	10	dose	dose	NOUN
aiua-11120	171	11	of	of	ADP
aiua-11120	171	12	tolterodine	tolterodine	NOUN
aiua-11120	171	13	(	(	PUNCT
aiua-11120	171	14	1	1	NUM
aiua-11120	171	15	mg	mg	NOUN
aiua-11120	171	16	bid	bid	NOUN
aiua-11120	171	17	)	)	PUNCT
aiua-11120	171	18	improved	improve	VERB
aiua-11120	171	19	daily	daily	ADJ
aiua-11120	171	20	rates	rate	NOUN
aiua-11120	171	21	of	of	ADP
aiua-11120	171	22	frequency	frequency	NOUN
aiua-11120	171	23	and	and	CCONJ
aiua-11120	171	24	incontinence	incontinence	NOUN
aiua-11120	171	25	as	as	ADV
aiua-11120	171	26	well	well	ADV
aiua-11120	171	27	as	as	ADP
aiua-11120	171	28	mean	mean	ADJ
aiua-11120	171	29	urine	urine	NOUN
aiua-11120	171	30	volumes	volume	NOUN
aiua-11120	171	31	more	more	ADV
aiua-11120	171	32	than	than	ADP
aiua-11120	171	33	full	full	ADJ
aiua-11120	171	34	-	-	PUNCT
aiua-11120	171	35	dose	dose	NOUN
aiua-11120	171	36	tolterodine	tolterodine	NOUN
aiua-11120	171	37	(	(	PUNCT
aiua-11120	171	38	2	2	NUM
aiua-11120	171	39	mg	mg	NOUN
aiua-11120	171	40	bid	bid	NOUN
aiua-11120	171	41	)	)	PUNCT
aiua-11120	171	42	(	(	PUNCT
aiua-11120	171	43	62	62	NUM
aiua-11120	171	44	)	)	PUNCT
aiua-11120	171	45	.	.	PUNCT
aiua-11120	172	1	in	in	ADP
aiua-11120	172	2	post	post	ADJ
aiua-11120	172	3	-	-	ADJ
aiua-11120	172	4	stroke	stroke	ADJ
aiua-11120	172	5	patients	patient	NOUN
aiua-11120	172	6	,	,	PUNCT
aiua-11120	172	7	electroacupuncture	electroacupuncture	ADJ
aiua-11120	172	8	treatment	treatment	NOUN
aiua-11120	172	9	improved	improve	VERB
aiua-11120	172	10	the	the	DET
aiua-11120	172	11	perceived	perceive	VERB
aiua-11120	172	12	severity	severity	NOUN
aiua-11120	172	13	of	of	ADP
aiua-11120	172	14	oab	oab	PROPN
aiua-11120	172	15	symptoms	symptom	NOUN
aiua-11120	172	16	in	in	ADP
aiua-11120	172	17	comfigure	comfigure	NOUN
aiua-11120	172	18	5	5	NUM
aiua-11120	172	19	.	.	PUNCT
aiua-11120	173	1	a	a	DET
aiua-11120	173	2	,	,	PUNCT
aiua-11120	173	3	changes	change	NOUN
aiua-11120	173	4	from	from	ADP
aiua-11120	173	5	baseline	baseline	NOUN
aiua-11120	173	6	of	of	ADP
aiua-11120	173	7	oab	oab	PROPN
aiua-11120	173	8	scores	score	NOUN
aiua-11120	173	9	in	in	ADP
aiua-11120	173	10	patients	patient	NOUN
aiua-11120	173	11	with	with	ADP
aiua-11120	173	12	parkinson	parkinson	NOUN
aiua-11120	173	13	disease	disease	NOUN
aiua-11120	173	14	treated	treat	VERB
aiua-11120	173	15	with	with	ADP
aiua-11120	173	16	ttns	ttn	NOUN
aiua-11120	173	17	vs	vs	ADP
aiua-11120	173	18	sham	sham	ADJ
aiua-11120	173	19	treatment	treatment	NOUN
aiua-11120	173	20	;	;	PUNCT
aiua-11120	173	21	b	b	X
aiua-11120	173	22	,	,	PUNCT
aiua-11120	173	23	changes	change	NOUN
aiua-11120	173	24	from	from	ADP
aiua-11120	173	25	baseline	baseline	NOUN
aiua-11120	173	26	of	of	ADP
aiua-11120	173	27	the	the	DET
aiua-11120	173	28	number	number	NOUN
aiua-11120	173	29	of	of	ADP
aiua-11120	173	30	night	night	NOUN
aiua-11120	173	31	voids	voids	NOUN
aiua-11120	173	32	in	in	ADP
aiua-11120	173	33	patients	patient	NOUN
aiua-11120	173	34	with	with	ADP
aiua-11120	173	35	parkinson	parkinson	NOUN
aiua-11120	173	36	disease	disease	NOUN
aiua-11120	173	37	treated	treat	VERB
aiua-11120	173	38	with	with	ADP
aiua-11120	173	39	ttns	ttn	NOUN
aiua-11120	173	40	vs	vs	ADP
aiua-11120	173	41	sham	sham	ADJ
aiua-11120	173	42	treatment	treatment	NOUN
aiua-11120	173	43	.	.	PUNCT
aiua-11120	174	1	diamonds	diamond	NOUN
aiua-11120	174	2	on	on	ADP
aiua-11120	174	3	the	the	DET
aiua-11120	174	4	left	left	ADJ
aiua-11120	174	5	side	side	NOUN
aiua-11120	174	6	of	of	ADP
aiua-11120	174	7	the	the	DET
aiua-11120	174	8	no	no	DET
aiua-11120	174	9	-	-	PUNCT
aiua-11120	174	10	effect	effect	NOUN
aiua-11120	174	11	line	line	NOUN
aiua-11120	174	12	indicate	indicate	VERB
aiua-11120	174	13	decreased	decrease	VERB
aiua-11120	174	14	numbers	number	NOUN
aiua-11120	174	15	of	of	ADP
aiua-11120	174	16	episodes	episode	NOUN
aiua-11120	174	17	or	or	CCONJ
aiua-11120	174	18	symptom	symptom	NOUN
aiua-11120	174	19	scores	score	NOUN
aiua-11120	174	20	in	in	ADP
aiua-11120	174	21	patients	patient	NOUN
aiua-11120	174	22	treated	treat	VERB
aiua-11120	174	23	with	with	ADP
aiua-11120	174	24	ttns	ttn	NOUN
aiua-11120	174	25	compared	compare	VERB
aiua-11120	174	26	to	to	ADP
aiua-11120	174	27	sham	sham	ADJ
aiua-11120	174	28	treatment	treatment	NOUN
aiua-11120	174	29	.	.	PUNCT
aiua-11120	175	1	mean	mean	VERB
aiua-11120	175	2	differences	difference	NOUN
aiua-11120	175	3	with	with	ADP
aiua-11120	175	4	95	95	NUM
aiua-11120	175	5	%	%	NOUN
aiua-11120	175	6	confidence	confidence	NOUN
aiua-11120	175	7	intervals	interval	NOUN
aiua-11120	175	8	and	and	CCONJ
aiua-11120	175	9	heterogeneity	heterogeneity	NOUN
aiua-11120	175	10	statistics	statistic	NOUN
aiua-11120	175	11	(	(	PUNCT
aiua-11120	175	12	i^2	i^2	PROPN
aiua-11120	175	13	)	)	PUNCT
aiua-11120	175	14	are	be	AUX
aiua-11120	175	15	shown	show	VERB
aiua-11120	175	16	.	.	PUNCT
aiua-11120	176	1	a.	a.	NOUN
aiua-11120	176	2	oab	oab	PROPN
aiua-11120	176	3	-	-	PROPN
aiua-11120	176	4	ss	ss	PROPN
aiua-11120	176	5	b.	b.	PROPN
aiua-11120	176	6	nocturia	nocturia	PROPN
aiua-11120	176	7	archivio	archivio	PROPN
aiua-11120	176	8	italiano	italiano	X
aiua-11120	176	9	di	di	X
aiua-11120	176	10	urologia	urologia	PROPN
aiua-11120	176	11	e	e	PROPN
aiua-11120	176	12	andrologia	andrologia	PROPN
aiua-11120	176	13	2022	2022	NUM
aiua-11120	176	14	;	;	PUNCT
aiua-11120	176	15	94	94	NUM
aiua-11120	176	16	,	,	PUNCT
aiua-11120	176	17	4	4	NUM
aiua-11120	176	18	r.	r.	NOUN
aiua-11120	176	19	bapir	bapir	NOUN
aiua-11120	176	20	,	,	PUNCT
aiua-11120	176	21	k.	k.	PROPN
aiua-11120	176	22	hassan	hassan	PROPN
aiua-11120	176	23	bhatti	bhatti	PROPN
aiua-11120	176	24	,	,	PUNCT
aiua-11120	176	25	ahmed	ahmed	PROPN
aiua-11120	176	26	eliwa	eliwa	PROPN
aiua-11120	176	27	,	,	PUNCT
aiua-11120	176	28	et	et	PROPN
aiua-11120	176	29	al	al	PROPN
aiua-11120	176	30	.	.	PROPN
aiua-11120	177	1	500	500	NUM
aiua-11120	177	2	parison	parison	NOUN
aiua-11120	177	3	with	with	ADP
aiua-11120	177	4	standard	standard	ADJ
aiua-11120	177	5	care	care	NOUN
aiua-11120	177	6	,	,	PUNCT
aiua-11120	177	7	though	though	SCONJ
aiua-11120	177	8	no	no	DET
aiua-11120	177	9	significant	significant	ADJ
aiua-11120	177	10	differences	difference	NOUN
aiua-11120	177	11	were	be	AUX
aiua-11120	177	12	observed	observe	VERB
aiua-11120	177	13	in	in	ADP
aiua-11120	177	14	bladder	bladder	NOUN
aiua-11120	177	15	diary	diary	NOUN
aiua-11120	177	16	parameters	parameter	NOUN
aiua-11120	177	17	and	and	CCONJ
aiua-11120	177	18	quality	quality	NOUN
aiua-11120	177	19	of	of	ADP
aiua-11120	177	20	life	life	NOUN
aiua-11120	177	21	scores	score	NOUN
aiua-11120	177	22	(	(	PUNCT
aiua-11120	177	23	ssqol	ssqol	PROPN
aiua-11120	177	24	)	)	PUNCT
aiua-11120	177	25	.	.	PUNCT
aiua-11120	178	1	both	both	DET
aiua-11120	178	2	acupuncture	acupuncture	NOUN
aiua-11120	178	3	and	and	CCONJ
aiua-11120	178	4	electroacupuncture	electroacupuncture	NOUN
aiua-11120	178	5	were	be	AUX
aiua-11120	178	6	well	well	ADV
aiua-11120	178	7	tolerated	tolerate	VERB
aiua-11120	178	8	(	(	PUNCT
aiua-11120	178	9	63	63	NUM
aiua-11120	178	10	)	)	PUNCT
aiua-11120	178	11	.	.	PUNCT
aiua-11120	179	1	transcutaneous	transcutaneous	ADJ
aiua-11120	179	2	electrical	electrical	ADJ
aiua-11120	179	3	nerve	nerve	NOUN
aiua-11120	179	4	stimulation	stimulation	NOUN
aiua-11120	179	5	(	(	PUNCT
aiua-11120	179	6	tens	ten	NOUN
aiua-11120	179	7	)	)	PUNCT
aiua-11120	179	8	transcutaneous	transcutaneous	ADJ
aiua-11120	179	9	electrical	electrical	ADJ
aiua-11120	179	10	nerve	nerve	NOUN
aiua-11120	179	11	stimulation	stimulation	NOUN
aiua-11120	179	12	has	have	AUX
aiua-11120	179	13	been	be	AUX
aiua-11120	179	14	used	use	VERB
aiua-11120	179	15	to	to	PART
aiua-11120	179	16	treat	treat	VERB
aiua-11120	179	17	post	post	ADJ
aiua-11120	179	18	-	-	ADJ
aiua-11120	179	19	stroke	stroke	ADJ
aiua-11120	179	20	neurogenic	neurogenic	ADJ
aiua-11120	179	21	overactive	overactive	ADJ
aiua-11120	179	22	bladder	bladder	NOUN
aiua-11120	179	23	.	.	PUNCT
aiua-11120	180	1	positive	positive	ADJ
aiua-11120	180	2	pads	pad	NOUN
aiua-11120	180	3	were	be	AUX
aiua-11120	180	4	usually	usually	ADV
aiua-11120	180	5	placed	place	VERB
aiua-11120	180	6	in	in	ADP
aiua-11120	180	7	the	the	DET
aiua-11120	180	8	region	region	NOUN
aiua-11120	180	9	of	of	ADP
aiua-11120	180	10	the	the	DET
aiua-11120	180	11	second	second	ADJ
aiua-11120	180	12	sacral	sacral	ADJ
aiua-11120	180	13	level	level	NOUN
aiua-11120	180	14	of	of	ADP
aiua-11120	180	15	the	the	DET
aiua-11120	180	16	vertebral	vertebral	ADJ
aiua-11120	180	17	column	column	NOUN
aiua-11120	180	18	and	and	CCONJ
aiua-11120	180	19	negative	negative	ADJ
aiua-11120	180	20	pads	pad	NOUN
aiua-11120	180	21	were	be	AUX
aiua-11120	180	22	placed	place	VERB
aiua-11120	180	23	at	at	ADP
aiua-11120	180	24	the	the	DET
aiua-11120	180	25	level	level	NOUN
aiua-11120	180	26	of	of	ADP
aiua-11120	180	27	the	the	DET
aiua-11120	180	28	middle	middle	ADJ
aiua-11120	180	29	and	and	CCONJ
aiua-11120	180	30	lower	low	ADJ
aiua-11120	180	31	third	third	ADJ
aiua-11120	180	32	of	of	ADP
aiua-11120	180	33	the	the	DET
aiua-11120	180	34	junction	junction	NOUN
aiua-11120	180	35	between	between	ADP
aiua-11120	180	36	the	the	DET
aiua-11120	180	37	posterior	posterior	ADJ
aiua-11120	180	38	superior	superior	ADJ
aiua-11120	180	39	iliac	iliac	NOUN
aiua-11120	180	40	spine	spine	NOUN
aiua-11120	180	41	and	and	CCONJ
aiua-11120	180	42	the	the	DET
aiua-11120	180	43	ischial	ischial	ADJ
aiua-11120	180	44	node	node	NOUN
aiua-11120	180	45	.	.	PUNCT
aiua-11120	181	1	treatments	treatment	NOUN
aiua-11120	181	2	were	be	AUX
aiua-11120	181	3	administered	administer	VERB
aiua-11120	181	4	30	30	NUM
aiua-11120	181	5	minutes	minute	NOUN
aiua-11120	181	6	once	once	ADV
aiua-11120	181	7	a	a	DET
aiua-11120	181	8	day	day	NOUN
aiua-11120	181	9	for	for	ADP
aiua-11120	181	10	60	60	NUM
aiua-11120	181	11	-	-	SYM
aiua-11120	181	12	90	90	NUM
aiua-11120	181	13	days	day	NOUN
aiua-11120	181	14	,	,	PUNCT
aiua-11120	181	15	in	in	ADP
aiua-11120	181	16	the	the	DET
aiua-11120	181	17	form	form	NOUN
aiua-11120	181	18	of	of	ADP
aiua-11120	181	19	unidirectional	unidirectional	ADJ
aiua-11120	181	20	square	square	ADJ
aiua-11120	181	21	waves	wave	NOUN
aiua-11120	181	22	with	with	ADP
aiua-11120	181	23	different	different	ADJ
aiua-11120	181	24	combinations	combination	NOUN
aiua-11120	181	25	of	of	ADP
aiua-11120	181	26	pulse	pulse	NOUN
aiua-11120	181	27	duration	duration	NOUN
aiua-11120	181	28	and	and	CCONJ
aiua-11120	181	29	frequency	frequency	NOUN
aiua-11120	181	30	.	.	PUNCT
aiua-11120	182	1	in	in	ADP
aiua-11120	182	2	three	three	NUM
aiua-11120	182	3	studies	study	NOUN
aiua-11120	182	4	,	,	PUNCT
aiua-11120	182	5	tens	ten	NOUN
aiua-11120	182	6	was	be	AUX
aiua-11120	182	7	compared	compare	VERB
aiua-11120	182	8	to	to	ADP
aiua-11120	182	9	sham	sham	ADJ
aiua-11120	182	10	treatment	treatment	NOUN
aiua-11120	182	11	for	for	ADP
aiua-11120	182	12	treatment	treatment	NOUN
aiua-11120	182	13	of	of	ADP
aiua-11120	182	14	post	post	ADJ
aiua-11120	182	15	-	-	ADJ
aiua-11120	182	16	ischemic	ischemic	ADJ
aiua-11120	182	17	stroke	stroke	NOUN
aiua-11120	182	18	urinary	urinary	ADJ
aiua-11120	182	19	incontinence	incontinence	NOUN
aiua-11120	182	20	,	,	PUNCT
aiua-11120	182	21	whereas	whereas	SCONJ
aiua-11120	182	22	one	one	NUM
aiua-11120	182	23	study	study	NOUN
aiua-11120	182	24	compared	compare	VERB
aiua-11120	182	25	tens	ten	NOUN
aiua-11120	182	26	to	to	ADP
aiua-11120	182	27	anticholinergic	anticholinergic	ADJ
aiua-11120	182	28	drugs	drug	NOUN
aiua-11120	182	29	(	(	PUNCT
aiua-11120	182	30	64	64	NUM
aiua-11120	182	31	-	-	SYM
aiua-11120	182	32	67	67	NUM
aiua-11120	182	33	)	)	PUNCT
aiua-11120	182	34	.	.	PUNCT
aiua-11120	183	1	tens	ten	NOUN
aiua-11120	183	2	improved	improve	VERB
aiua-11120	183	3	symptom	symptom	NOUN
aiua-11120	183	4	scores	score	NOUN
aiua-11120	183	5	,	,	PUNCT
aiua-11120	183	6	voiding	void	VERB
aiua-11120	183	7	diary	diary	ADJ
aiua-11120	183	8	parameters	parameter	NOUN
aiua-11120	183	9	(	(	PUNCT
aiua-11120	183	10	daily	daily	ADJ
aiua-11120	183	11	micturition	micturition	NOUN
aiua-11120	183	12	,	,	PUNCT
aiua-11120	183	13	nocturia	nocturia	PROPN
aiua-11120	183	14	,	,	PUNCT
aiua-11120	183	15	urgent	urgent	ADJ
aiua-11120	183	16	urination	urination	NOUN
aiua-11120	183	17	,	,	PUNCT
aiua-11120	183	18	and	and	CCONJ
aiua-11120	183	19	urge	urge	VERB
aiua-11120	183	20	ui	ui	PROPN
aiua-11120	183	21	)	)	PUNCT
aiua-11120	183	22	,	,	PUNCT
aiua-11120	183	23	and	and	CCONJ
aiua-11120	183	24	urodynamic	urodynamic	ADJ
aiua-11120	183	25	findings	finding	NOUN
aiua-11120	183	26	(	(	PUNCT
aiua-11120	183	27	maximum	maximum	ADJ
aiua-11120	183	28	cystometry	cystometry	NOUN
aiua-11120	183	29	volume	volume	NOUN
aiua-11120	183	30	,	,	PUNCT
aiua-11120	183	31	flow	flow	NOUN
aiua-11120	183	32	rate	rate	NOUN
aiua-11120	183	33	,	,	PUNCT
aiua-11120	183	34	pressure	pressure	NOUN
aiua-11120	183	35	of	of	ADP
aiua-11120	183	36	detrusor	detrusor	NOUN
aiua-11120	183	37	in	in	ADP
aiua-11120	183	38	the	the	DET
aiua-11120	183	39	end	end	NOUN
aiua-11120	183	40	of	of	ADP
aiua-11120	183	41	the	the	DET
aiua-11120	183	42	filling	filling	NOUN
aiua-11120	183	43	phase	phase	NOUN
aiua-11120	183	44	)	)	PUNCT
aiua-11120	183	45	.	.	PUNCT
aiua-11120	184	1	in	in	ADP
aiua-11120	184	2	the	the	DET
aiua-11120	184	3	study	study	NOUN
aiua-11120	184	4	comparing	compare	VERB
aiua-11120	184	5	tens	ten	NOUN
aiua-11120	184	6	with	with	ADP
aiua-11120	184	7	anticholinergics	anticholinergic	NOUN
aiua-11120	184	8	,	,	PUNCT
aiua-11120	184	9	the	the	DET
aiua-11120	184	10	former	former	ADJ
aiua-11120	184	11	was	be	AUX
aiua-11120	184	12	superior	superior	ADJ
aiua-11120	184	13	than	than	ADP
aiua-11120	184	14	the	the	DET
aiua-11120	184	15	latter	latter	ADJ
aiua-11120	184	16	.	.	PUNCT
aiua-11120	185	1	pelvic	pelvic	ADJ
aiua-11120	185	2	floor	floor	NOUN
aiua-11120	185	3	muscle	muscle	NOUN
aiua-11120	185	4	training	train	VERB
aiua-11120	185	5	six	six	NUM
aiua-11120	185	6	studies	study	NOUN
aiua-11120	185	7	evaluated	evaluate	VERB
aiua-11120	185	8	the	the	DET
aiua-11120	185	9	outcome	outcome	NOUN
aiua-11120	185	10	of	of	ADP
aiua-11120	185	11	behavioral	behavioral	ADJ
aiua-11120	185	12	therapy	therapy	NOUN
aiua-11120	185	13	,	,	PUNCT
aiua-11120	185	14	including	include	VERB
aiua-11120	185	15	pelvic	pelvic	ADJ
aiua-11120	185	16	floor	floor	NOUN
aiua-11120	185	17	muscle	muscle	NOUN
aiua-11120	185	18	training	training	NOUN
aiua-11120	185	19	(	(	PUNCT
aiua-11120	185	20	pfmt	pfmt	NOUN
aiua-11120	185	21	)	)	PUNCT
aiua-11120	185	22	in	in	ADP
aiua-11120	185	23	comparison	comparison	NOUN
aiua-11120	185	24	with	with	ADP
aiua-11120	185	25	controls	control	NOUN
aiua-11120	185	26	(	(	PUNCT
aiua-11120	185	27	2	2	NUM
aiua-11120	185	28	in	in	ADP
aiua-11120	185	29	parkinson	parkinson	NOUN
aiua-11120	185	30	disease	disease	NOUN
aiua-11120	185	31	,	,	PUNCT
aiua-11120	185	32	2	2	NUM
aiua-11120	185	33	in	in	ADP
aiua-11120	185	34	incontinence	incontinence	NOUN
aiua-11120	185	35	post	post	NOUN
aiua-11120	185	36	-	-	NOUN
aiua-11120	185	37	stroke	stroke	ADJ
aiua-11120	185	38	,	,	PUNCT
aiua-11120	185	39	2	2	NUM
aiua-11120	185	40	in	in	ADP
aiua-11120	185	41	multiple	multiple	ADJ
aiua-11120	185	42	sclerosis	sclerosis	NOUN
aiua-11120	185	43	)	)	PUNCT
aiua-11120	185	44	(	(	PUNCT
aiua-11120	185	45	68	68	NUM
aiua-11120	185	46	-	-	SYM
aiua-11120	185	47	73	73	NUM
aiua-11120	185	48	)	)	PUNCT
aiua-11120	185	49	.	.	PUNCT
aiua-11120	186	1	the	the	DET
aiua-11120	186	2	quantitative	quantitative	ADJ
aiua-11120	186	3	analysis	analysis	NOUN
aiua-11120	186	4	of	of	ADP
aiua-11120	186	5	the	the	DET
aiua-11120	186	6	results	result	NOUN
aiua-11120	186	7	of	of	ADP
aiua-11120	186	8	two	two	NUM
aiua-11120	186	9	studies	study	NOUN
aiua-11120	186	10	in	in	ADP
aiua-11120	186	11	patients	patient	NOUN
aiua-11120	186	12	with	with	ADP
aiua-11120	186	13	parkinson	parkinson	NOUN
aiua-11120	186	14	disease	disease	NOUN
aiua-11120	186	15	comparing	compare	VERB
aiua-11120	186	16	pelvic	pelvic	ADJ
aiua-11120	186	17	floor	floor	NOUN
aiua-11120	186	18	muscle	muscle	NOUN
aiua-11120	186	19	training	training	NOUN
aiua-11120	186	20	with	with	ADP
aiua-11120	186	21	conservative	conservative	ADJ
aiua-11120	186	22	advice	advice	NOUN
aiua-11120	186	23	,	,	PUNCT
aiua-11120	186	24	demonstrated	demonstrate	VERB
aiua-11120	186	25	that	that	SCONJ
aiua-11120	186	26	pfmt	pfmt	NOUN
aiua-11120	186	27	was	be	AUX
aiua-11120	186	28	more	more	ADV
aiua-11120	186	29	effective	effective	ADJ
aiua-11120	186	30	than	than	ADP
aiua-11120	186	31	the	the	DET
aiua-11120	186	32	latter	latter	ADJ
aiua-11120	186	33	in	in	ADP
aiua-11120	186	34	decreasing	decrease	VERB
aiua-11120	186	35	the	the	DET
aiua-11120	186	36	values	value	NOUN
aiua-11120	186	37	of	of	ADP
aiua-11120	186	38	the	the	DET
aiua-11120	186	39	iciq	iciq	NOUN
aiua-11120	186	40	score	score	NOUN
aiua-11120	186	41	(	(	PUNCT
aiua-11120	186	42	md	md	PROPN
aiua-11120	186	43	-1.12	-1.12	NOUN
aiua-11120	186	44	,	,	PUNCT
aiua-11120	186	45	95	95	NUM
aiua-11120	186	46	%	%	NOUN
aiua-11120	186	47	ci	ci	NOUN
aiua-11120	186	48	-2.13	-2.13	PRON
aiua-11120	186	49	to	to	ADP
aiua-11120	186	50	-0.11	-0.11	NUM
aiua-11120	186	51	,	,	PUNCT
aiua-11120	186	52	2	2	NUM
aiua-11120	186	53	trials	trial	NOUN
aiua-11120	186	54	,	,	PUNCT
aiua-11120	186	55	91	91	NUM
aiua-11120	186	56	patients	patient	NOUN
aiua-11120	186	57	,	,	PUNCT
aiua-11120	186	58	z	z	NOUN
aiua-11120	186	59	=	=	SYM
aiua-11120	186	60	2.17	2.17	NUM
aiua-11120	186	61	,	,	PUNCT
aiua-11120	186	62	p	p	X
aiua-11120	186	63	=	=	NOUN
aiua-11120	186	64	0.03	0.03	NUM
aiua-11120	186	65	)	)	PUNCT
aiua-11120	186	66	.	.	PUNCT
aiua-11120	187	1	the	the	DET
aiua-11120	187	2	number	number	NOUN
aiua-11120	187	3	of	of	ADP
aiua-11120	187	4	incontinence	incontinence	NOUN
aiua-11120	187	5	episodes	episode	NOUN
aiua-11120	187	6	from	from	ADP
aiua-11120	187	7	baseline	baseline	NOUN
aiua-11120	187	8	was	be	AUX
aiua-11120	187	9	not	not	PART
aiua-11120	187	10	significantly	significantly	ADV
aiua-11120	187	11	different	different	ADJ
aiua-11120	187	12	between	between	ADP
aiua-11120	187	13	pfmt	pfmt	NOUN
aiua-11120	187	14	and	and	CCONJ
aiua-11120	187	15	controls	control	NOUN
aiua-11120	187	16	(	(	PUNCT
aiua-11120	187	17	md	md	PROPN
aiua-11120	187	18	,	,	PUNCT
aiua-11120	187	19	0.41	0.41	NUM
aiua-11120	187	20	,	,	PUNCT
aiua-11120	187	21	95	95	NUM
aiua-11120	187	22	%	%	NOUN
aiua-11120	187	23	ci	ci	NOUN
aiua-11120	187	24	-2.84	-2.84	NOUN
aiua-11120	187	25	to	to	ADP
aiua-11120	187	26	2.03	2.03	NUM
aiua-11120	187	27	,	,	PUNCT
aiua-11120	187	28	2	2	NUM
aiua-11120	187	29	trials	trial	NOUN
aiua-11120	187	30	,	,	PUNCT
aiua-11120	187	31	91	91	NUM
aiua-11120	187	32	patients	patient	NOUN
aiua-11120	187	33	,	,	PUNCT
aiua-11120	187	34	z	z	NOUN
aiua-11120	187	35	=	=	NOUN
aiua-11120	187	36	0.33	0.33	NUM
aiua-11120	187	37	,	,	PUNCT
aiua-11120	187	38	p	p	X
aiua-11120	187	39	=	=	NOUN
aiua-11120	187	40	0.74	0.74	NUM
aiua-11120	187	41	)	)	PUNCT
aiua-11120	187	42	(	(	PUNCT
aiua-11120	187	43	figure	figure	NOUN
aiua-11120	187	44	6	6	NUM
aiua-11120	187	45	)	)	PUNCT
aiua-11120	187	46	.	.	PUNCT
aiua-11120	188	1	other	other	ADJ
aiua-11120	188	2	studies	study	NOUN
aiua-11120	188	3	compared	compare	VERB
aiua-11120	188	4	pfmt	pfmt	NOUN
aiua-11120	188	5	plus	plus	CCONJ
aiua-11120	188	6	vaginal	vaginal	ADJ
aiua-11120	188	7	electrostimulation	electrostimulation	NOUN
aiua-11120	188	8	to	to	ADP
aiua-11120	188	9	home	home	NOUN
aiua-11120	188	10	pfmt	pfmt	NOUN
aiua-11120	188	11	in	in	ADP
aiua-11120	188	12	patients	patient	NOUN
aiua-11120	188	13	with	with	ADP
aiua-11120	188	14	multiple	multiple	ADJ
aiua-11120	188	15	sclerosis	sclerosis	NOUN
aiua-11120	188	16	(	(	PUNCT
aiua-11120	188	17	74	74	NUM
aiua-11120	188	18	-	-	SYM
aiua-11120	188	19	77	77	NUM
aiua-11120	188	20	)	)	PUNCT
aiua-11120	188	21	.	.	PUNCT
aiua-11120	189	1	in	in	ADP
aiua-11120	189	2	patients	patient	NOUN
aiua-11120	189	3	with	with	ADP
aiua-11120	189	4	multiple	multiple	ADJ
aiua-11120	189	5	sclerosis	sclerosis	NOUN
aiua-11120	189	6	and	and	CCONJ
aiua-11120	189	7	luts	luts	PROPN
aiua-11120	189	8	,	,	PUNCT
aiua-11120	189	9	the	the	DET
aiua-11120	189	10	association	association	NOUN
aiua-11120	189	11	of	of	ADP
aiua-11120	189	12	pfmt	pfmt	NOUN
aiua-11120	189	13	(	(	PUNCT
aiua-11120	189	14	with	with	ADP
aiua-11120	189	15	emg	emg	NOUN
aiua-11120	189	16	feedback	feedback	NOUN
aiua-11120	189	17	)	)	PUNCT
aiua-11120	189	18	and	and	CCONJ
aiua-11120	189	19	intravaginal	intravaginal	ADJ
aiua-11120	189	20	nmes	nme	NOUN
aiua-11120	189	21	significantly	significantly	ADV
aiua-11120	189	22	improved	improve	VERB
aiua-11120	189	23	pelvic	pelvic	ADJ
aiua-11120	189	24	floor	floor	NOUN
aiua-11120	189	25	muscle	muscle	NOUN
aiua-11120	189	26	assessment	assessment	NOUN
aiua-11120	189	27	findings	finding	NOUN
aiua-11120	189	28	and	and	CCONJ
aiua-11120	189	29	oab	oab	PROPN
aiua-11120	189	30	-	-	PUNCT
aiua-11120	189	31	v8	v8	PROPN
aiua-11120	189	32	scores	score	NOUN
aiua-11120	189	33	more	more	ADV
aiua-11120	189	34	than	than	ADP
aiua-11120	189	35	pfmt	pfmt	NOUN
aiua-11120	189	36	alone	alone	ADV
aiua-11120	189	37	and	and	CCONJ
aiua-11120	189	38	the	the	DET
aiua-11120	189	39	association	association	NOUN
aiua-11120	189	40	of	of	ADP
aiua-11120	189	41	pfmt	pfmt	NOUN
aiua-11120	189	42	with	with	ADP
aiua-11120	189	43	ttns	ttns	NOUN
aiua-11120	189	44	.	.	PUNCT
aiua-11120	190	1	three	three	NUM
aiua-11120	190	2	studies	study	NOUN
aiua-11120	190	3	from	from	ADP
aiua-11120	190	4	the	the	DET
aiua-11120	190	5	same	same	ADJ
aiua-11120	190	6	group	group	NOUN
aiua-11120	190	7	compared	compare	VERB
aiua-11120	190	8	outcomes	outcome	NOUN
aiua-11120	190	9	of	of	ADP
aiua-11120	190	10	pfmt	pfmt	NOUN
aiua-11120	190	11	alone	alone	ADV
aiua-11120	190	12	with	with	ADP
aiua-11120	190	13	pfmt	pfmt	NOUN
aiua-11120	190	14	with	with	ADP
aiua-11120	190	15	vaginal	vaginal	ADJ
aiua-11120	190	16	electrostimulation	electrostimulation	NOUN
aiua-11120	190	17	in	in	ADP
aiua-11120	190	18	women	woman	NOUN
aiua-11120	190	19	with	with	ADP
aiua-11120	190	20	luts	luts	PROPN
aiua-11120	190	21	in	in	ADP
aiua-11120	190	22	multiple	multiple	ADJ
aiua-11120	190	23	sclerosis	sclerosis	NOUN
aiua-11120	190	24	.	.	PUNCT
aiua-11120	191	1	oab	oab	PROPN
aiua-11120	191	2	-	-	PUNCT
aiua-11120	191	3	v8	v8	PROPN
aiua-11120	191	4	scores	score	NOUN
aiua-11120	191	5	,	,	PUNCT
aiua-11120	191	6	quality	quality	NOUN
aiua-11120	191	7	of	of	ADP
aiua-11120	191	8	life	life	NOUN
aiua-11120	191	9	and	and	CCONJ
aiua-11120	191	10	perineal	perineal	ADJ
aiua-11120	191	11	musculature	musculature	NOUN
aiua-11120	191	12	contraction	contraction	NOUN
aiua-11120	191	13	were	be	AUX
aiua-11120	191	14	improved	improve	VERB
aiua-11120	191	15	after	after	ADP
aiua-11120	191	16	both	both	DET
aiua-11120	191	17	treatments	treatment	NOUN
aiua-11120	191	18	,	,	PUNCT
aiua-11120	191	19	although	although	SCONJ
aiua-11120	191	20	a	a	DET
aiua-11120	191	21	greater	great	ADJ
aiua-11120	191	22	increase	increase	NOUN
aiua-11120	191	23	was	be	AUX
aiua-11120	191	24	obtained	obtain	VERB
aiua-11120	191	25	with	with	ADP
aiua-11120	191	26	the	the	DET
aiua-11120	191	27	addition	addition	NOUN
aiua-11120	191	28	of	of	ADP
aiua-11120	191	29	electrostimulation	electrostimulation	NOUN
aiua-11120	191	30	.	.	PUNCT
aiua-11120	192	1	other	other	ADJ
aiua-11120	192	2	studies	study	NOUN
aiua-11120	192	3	deep	deep	ADJ
aiua-11120	192	4	brain	brain	NOUN
aiua-11120	192	5	stimulation	stimulation	NOUN
aiua-11120	192	6	(	(	PUNCT
aiua-11120	192	7	dbs	dbs	PROPN
aiua-11120	192	8	)	)	PUNCT
aiua-11120	192	9	,	,	PUNCT
aiua-11120	192	10	a	a	DET
aiua-11120	192	11	surgical	surgical	ADJ
aiua-11120	192	12	treatment	treatment	NOUN
aiua-11120	192	13	for	for	ADP
aiua-11120	192	14	motor	motor	NOUN
aiua-11120	192	15	symptoms	symptom	NOUN
aiua-11120	192	16	in	in	ADP
aiua-11120	192	17	advanced	advanced	ADJ
aiua-11120	192	18	pd	pd	PROPN
aiua-11120	192	19	,	,	PUNCT
aiua-11120	192	20	showed	show	VERB
aiua-11120	192	21	improvement	improvement	NOUN
aiua-11120	192	22	of	of	ADP
aiua-11120	192	23	luts	luts	PROPN
aiua-11120	192	24	in	in	ADP
aiua-11120	192	25	pd	pd	PROPN
aiua-11120	192	26	patients	patient	NOUN
aiua-11120	192	27	(	(	PUNCT
aiua-11120	192	28	78	78	NUM
aiua-11120	192	29	)	)	PUNCT
aiua-11120	192	30	.	.	PUNCT
aiua-11120	193	1	intra	intra	ADJ
aiua-11120	193	2	-	-	ADJ
aiua-11120	193	3	detrusor	detrusor	ADJ
aiua-11120	193	4	injections	injection	NOUN
aiua-11120	193	5	of	of	ADP
aiua-11120	193	6	adipose	adipose	ADJ
aiua-11120	193	7	stem	stem	NOUN
aiua-11120	193	8	cells	cell	NOUN
aiua-11120	193	9	(	(	PUNCT
aiua-11120	193	10	adsc	adsc	ADV
aiua-11120	193	11	)	)	PUNCT
aiua-11120	193	12	were	be	AUX
aiua-11120	193	13	also	also	ADV
aiua-11120	193	14	used	use	VERB
aiua-11120	193	15	to	to	PART
aiua-11120	193	16	treat	treat	VERB
aiua-11120	193	17	pd	pd	ADV
aiua-11120	193	18	-	-	PUNCT
aiua-11120	193	19	related	relate	VERB
aiua-11120	193	20	oab	oab	PROPN
aiua-11120	193	21	symptoms	symptom	NOUN
aiua-11120	193	22	.	.	PUNCT
aiua-11120	194	1	a	a	DET
aiua-11120	194	2	single	single	ADJ
aiua-11120	194	3	adsc	adsc	ADJ
aiua-11120	194	4	injection	injection	NOUN
aiua-11120	194	5	significantly	significantly	ADV
aiua-11120	194	6	improved	improve	VERB
aiua-11120	194	7	symptom	symptom	NOUN
aiua-11120	194	8	scores	score	NOUN
aiua-11120	194	9	and	and	CCONJ
aiua-11120	194	10	voiding	void	VERB
aiua-11120	194	11	diary	diary	ADJ
aiua-11120	194	12	parameters	parameter	NOUN
aiua-11120	194	13	(	(	PUNCT
aiua-11120	194	14	79	79	NUM
aiua-11120	194	15	)	)	PUNCT
aiua-11120	194	16	.	.	PUNCT
aiua-11120	195	1	figure	figure	VERB
aiua-11120	195	2	6	6	NUM
aiua-11120	195	3	.	.	PUNCT
aiua-11120	196	1	a	a	DET
aiua-11120	196	2	,	,	PUNCT
aiua-11120	196	3	changes	change	NOUN
aiua-11120	196	4	from	from	ADP
aiua-11120	196	5	baseline	baseline	NOUN
aiua-11120	196	6	of	of	ADP
aiua-11120	196	7	iciq	iciq	NOUN
aiua-11120	196	8	-	-	PUNCT
aiua-11120	196	9	oab	oab	PROPN
aiua-11120	196	10	scores	score	NOUN
aiua-11120	196	11	in	in	ADP
aiua-11120	196	12	patients	patient	NOUN
aiua-11120	196	13	with	with	ADP
aiua-11120	196	14	parkinson	parkinson	NOUN
aiua-11120	196	15	disease	disease	NOUN
aiua-11120	196	16	treated	treat	VERB
aiua-11120	196	17	with	with	ADP
aiua-11120	196	18	pelvic	pelvic	ADJ
aiua-11120	196	19	floor	floor	NOUN
aiua-11120	196	20	muscle	muscle	NOUN
aiua-11120	196	21	training	training	NOUN
aiua-11120	196	22	vs.	vs.	ADP
aiua-11120	196	23	conservative	conservative	ADJ
aiua-11120	196	24	advice	advice	NOUN
aiua-11120	196	25	;	;	PUNCT
aiua-11120	196	26	b	b	X
aiua-11120	196	27	,	,	PUNCT
aiua-11120	196	28	changes	change	NOUN
aiua-11120	196	29	from	from	ADP
aiua-11120	196	30	baseline	baseline	NOUN
aiua-11120	196	31	of	of	ADP
aiua-11120	196	32	the	the	DET
aiua-11120	196	33	incontinence	incontinence	NOUN
aiua-11120	196	34	episodes	episode	NOUN
aiua-11120	196	35	in	in	ADP
aiua-11120	196	36	patients	patient	NOUN
aiua-11120	196	37	with	with	ADP
aiua-11120	196	38	parkinson	parkinson	NOUN
aiua-11120	196	39	disease	disease	NOUN
aiua-11120	196	40	subjected	subject	VERB
aiua-11120	196	41	to	to	ADP
aiua-11120	196	42	the	the	DET
aiua-11120	196	43	same	same	ADJ
aiua-11120	196	44	treatments	treatment	NOUN
aiua-11120	196	45	.	.	PUNCT
aiua-11120	197	1	diamonds	diamond	NOUN
aiua-11120	197	2	on	on	ADP
aiua-11120	197	3	the	the	DET
aiua-11120	197	4	left	left	ADJ
aiua-11120	197	5	side	side	NOUN
aiua-11120	197	6	of	of	ADP
aiua-11120	197	7	the	the	DET
aiua-11120	197	8	no	no	DET
aiua-11120	197	9	-	-	PUNCT
aiua-11120	197	10	effect	effect	NOUN
aiua-11120	197	11	line	line	NOUN
aiua-11120	197	12	indicate	indicate	VERB
aiua-11120	197	13	decreased	decrease	VERB
aiua-11120	197	14	numbers	number	NOUN
aiua-11120	197	15	of	of	ADP
aiua-11120	197	16	episodes	episode	NOUN
aiua-11120	197	17	or	or	CCONJ
aiua-11120	197	18	symptom	symptom	NOUN
aiua-11120	197	19	scores	score	NOUN
aiua-11120	197	20	in	in	ADP
aiua-11120	197	21	patients	patient	NOUN
aiua-11120	197	22	treated	treat	VERB
aiua-11120	197	23	with	with	ADP
aiua-11120	197	24	pfmt	pfmt	NOUN
aiua-11120	197	25	compared	compare	VERB
aiua-11120	197	26	to	to	ADP
aiua-11120	197	27	advice	advice	NOUN
aiua-11120	197	28	.	.	PUNCT
aiua-11120	198	1	mean	mean	VERB
aiua-11120	198	2	differences	difference	NOUN
aiua-11120	198	3	with	with	ADP
aiua-11120	198	4	95	95	NUM
aiua-11120	198	5	%	%	NOUN
aiua-11120	198	6	confidence	confidence	NOUN
aiua-11120	198	7	intervals	interval	NOUN
aiua-11120	198	8	and	and	CCONJ
aiua-11120	198	9	heterogeneity	heterogeneity	NOUN
aiua-11120	198	10	statistics	statistic	NOUN
aiua-11120	198	11	(	(	PUNCT
aiua-11120	198	12	i^2	i^2	PROPN
aiua-11120	198	13	)	)	PUNCT
aiua-11120	198	14	are	be	AUX
aiua-11120	198	15	shown	show	VERB
aiua-11120	198	16	.	.	PUNCT
aiua-11120	199	1	b.	b.	PROPN
aiua-11120	199	2	incontinence	incontinence	PROPN
aiua-11120	199	3	a.	a.	PROPN
aiua-11120	199	4	iciq	iciq	PROPN
aiua-11120	199	5	score	score	NOUN
aiua-11120	199	6	501archivio	501archivio	PROPN
aiua-11120	199	7	italiano	italiano	NOUN
aiua-11120	199	8	di	di	NOUN
aiua-11120	199	9	urologia	urologia	PROPN
aiua-11120	199	10	e	e	PROPN
aiua-11120	199	11	andrologia	andrologia	PROPN
aiua-11120	199	12	2022	2022	NUM
aiua-11120	199	13	;	;	PUNCT
aiua-11120	199	14	94	94	NUM
aiua-11120	199	15	,	,	PUNCT
aiua-11120	199	16	4	4	NUM
aiua-11120	199	17	treatment	treatment	NOUN
aiua-11120	199	18	of	of	ADP
aiua-11120	199	19	overactive	overactive	ADJ
aiua-11120	199	20	neurogenic	neurogenic	ADJ
aiua-11120	199	21	bladder	bladder	NOUN
aiua-11120	199	22	discussion	discussion	NOUN
aiua-11120	199	23	anticholinergics	anticholinergic	NOUN
aiua-11120	199	24	anticholinergics	anticholinergic	NOUN
aiua-11120	199	25	are	be	AUX
aiua-11120	199	26	the	the	DET
aiua-11120	199	27	first	first	ADJ
aiua-11120	199	28	-	-	PUNCT
aiua-11120	199	29	line	line	NOUN
aiua-11120	199	30	choice	choice	NOUN
aiua-11120	199	31	for	for	ADP
aiua-11120	199	32	the	the	DET
aiua-11120	199	33	pharmacologic	pharmacologic	ADJ
aiua-11120	199	34	treatment	treatment	NOUN
aiua-11120	199	35	of	of	ADP
aiua-11120	199	36	oab	oab	PROPN
aiua-11120	199	37	.	.	PUNCT
aiua-11120	200	1	they	they	PRON
aiua-11120	200	2	are	be	AUX
aiua-11120	200	3	used	use	VERB
aiua-11120	200	4	to	to	PART
aiua-11120	200	5	stabilize	stabilize	VERB
aiua-11120	200	6	the	the	DET
aiua-11120	200	7	detrusor	detrusor	NOUN
aiua-11120	200	8	muscle	muscle	NOUN
aiua-11120	200	9	and	and	CCONJ
aiua-11120	200	10	improve	improve	VERB
aiua-11120	200	11	bladder	bladder	NOUN
aiua-11120	200	12	compliance	compliance	NOUN
aiua-11120	200	13	because	because	SCONJ
aiua-11120	200	14	detrusor	detrusor	NOUN
aiua-11120	200	15	smooth	smooth	ADJ
aiua-11120	200	16	contraction	contraction	NOUN
aiua-11120	200	17	is	be	AUX
aiua-11120	200	18	initiated	initiate	VERB
aiua-11120	200	19	via	via	ADP
aiua-11120	200	20	release	release	NOUN
aiua-11120	200	21	of	of	ADP
aiua-11120	200	22	acetylcholine	acetylcholine	NOUN
aiua-11120	200	23	.	.	PUNCT
aiua-11120	201	1	the	the	DET
aiua-11120	201	2	major	major	ADJ
aiua-11120	201	3	disadvantage	disadvantage	NOUN
aiua-11120	201	4	of	of	ADP
aiua-11120	201	5	oral	oral	ADJ
aiua-11120	201	6	anticholinergics	anticholinergic	NOUN
aiua-11120	201	7	are	be	AUX
aiua-11120	201	8	the	the	DET
aiua-11120	201	9	side	side	NOUN
aiua-11120	201	10	effects	effect	NOUN
aiua-11120	201	11	that	that	PRON
aiua-11120	201	12	result	result	VERB
aiua-11120	201	13	in	in	ADP
aiua-11120	201	14	treatment	treatment	NOUN
aiua-11120	201	15	discontinuation	discontinuation	NOUN
aiua-11120	201	16	in	in	ADP
aiua-11120	201	17	up	up	ADP
aiua-11120	201	18	to	to	PART
aiua-11120	201	19	70	70	NUM
aiua-11120	201	20	%	%	NOUN
aiua-11120	201	21	of	of	ADP
aiua-11120	201	22	patients	patient	NOUN
aiua-11120	201	23	,	,	PUNCT
aiua-11120	201	24	depending	depend	VERB
aiua-11120	201	25	on	on	ADP
aiua-11120	201	26	the	the	DET
aiua-11120	201	27	duration	duration	NOUN
aiua-11120	201	28	of	of	ADP
aiua-11120	201	29	treatment	treatment	NOUN
aiua-11120	201	30	.	.	PUNCT
aiua-11120	202	1	furthermore	furthermore	ADV
aiua-11120	202	2	,	,	PUNCT
aiua-11120	202	3	a	a	DET
aiua-11120	202	4	potential	potential	ADJ
aiua-11120	202	5	risk	risk	NOUN
aiua-11120	202	6	of	of	ADP
aiua-11120	202	7	cognitive	cognitive	ADJ
aiua-11120	202	8	decline	decline	NOUN
aiua-11120	202	9	and	and	CCONJ
aiua-11120	202	10	worsening	worsen	VERB
aiua-11120	202	11	of	of	ADP
aiua-11120	202	12	gait	gait	NOUN
aiua-11120	202	13	in	in	ADP
aiua-11120	202	14	patients	patient	NOUN
aiua-11120	202	15	with	with	ADP
aiua-11120	202	16	pd	pd	PROPN
aiua-11120	202	17	has	have	AUX
aiua-11120	202	18	been	be	AUX
aiua-11120	202	19	recently	recently	ADV
aiua-11120	202	20	suggested	suggest	VERB
aiua-11120	202	21	.	.	PUNCT
aiua-11120	203	1	in	in	ADP
aiua-11120	203	2	2009	2009	NUM
aiua-11120	203	3	,	,	PUNCT
aiua-11120	203	4	a	a	DET
aiua-11120	203	5	cochrane	cochrane	NOUN
aiua-11120	203	6	systematic	systematic	ADJ
aiua-11120	203	7	review	review	NOUN
aiua-11120	203	8	assessed	assess	VERB
aiua-11120	203	9	the	the	DET
aiua-11120	203	10	efficacy	efficacy	NOUN
aiua-11120	203	11	and	and	CCONJ
aiua-11120	203	12	tolerability	tolerability	NOUN
aiua-11120	203	13	of	of	ADP
aiua-11120	203	14	anticholinergic	anticholinergic	ADJ
aiua-11120	203	15	agents	agent	NOUN
aiua-11120	203	16	in	in	ADP
aiua-11120	203	17	patients	patient	NOUN
aiua-11120	203	18	with	with	ADP
aiua-11120	203	19	overactive	overactive	ADJ
aiua-11120	203	20	bladder	bladder	NOUN
aiua-11120	203	21	associated	associate	VERB
aiua-11120	203	22	to	to	ADP
aiua-11120	203	23	multiple	multiple	ADJ
aiua-11120	203	24	sclerosis	sclerosis	NOUN
aiua-11120	203	25	(	(	PUNCT
aiua-11120	203	26	ms	ms	PROPN
aiua-11120	203	27	)	)	PUNCT
aiua-11120	203	28	(	(	PUNCT
aiua-11120	203	29	3	3	NUM
aiua-11120	203	30	)	)	PUNCT
aiua-11120	203	31	.	.	PUNCT
aiua-11120	204	1	only	only	ADV
aiua-11120	204	2	three	three	NUM
aiua-11120	204	3	rcts	rct	NOUN
aiua-11120	204	4	were	be	AUX
aiua-11120	204	5	considered	consider	VERB
aiua-11120	204	6	suitable	suitable	ADJ
aiua-11120	204	7	for	for	ADP
aiua-11120	204	8	analysis	analysis	NOUN
aiua-11120	204	9	.	.	PUNCT
aiua-11120	205	1	an	an	DET
aiua-11120	205	2	older	old	ADJ
aiua-11120	205	3	randomized	randomized	ADJ
aiua-11120	205	4	cross	cross	ADJ
aiua-11120	205	5	-	-	ADJ
aiua-11120	205	6	over	over	ADP
aiua-11120	205	7	study	study	NOUN
aiua-11120	205	8	compared	compare	VERB
aiua-11120	205	9	methantheline	methantheline	PROPN
aiua-11120	205	10	bromide	bromide	NOUN
aiua-11120	205	11	,	,	PUNCT
aiua-11120	205	12	flavoxate	flavoxate	ADJ
aiua-11120	205	13	chloride	chloride	NOUN
aiua-11120	205	14	and	and	CCONJ
aiua-11120	205	15	meladrazine	meladrazine	ADJ
aiua-11120	205	16	tartrate	tartrate	NOUN
aiua-11120	205	17	(	(	PUNCT
aiua-11120	205	18	hebjorn	hebjorn	ADJ
aiua-11120	205	19	1977	1977	NUM
aiua-11120	205	20	)	)	PUNCT
aiua-11120	205	21	(	(	PUNCT
aiua-11120	205	22	81	81	NUM
aiua-11120	205	23	)	)	PUNCT
aiua-11120	205	24	.	.	PUNCT
aiua-11120	206	1	a	a	DET
aiua-11120	206	2	more	more	ADV
aiua-11120	206	3	recent	recent	ADJ
aiua-11120	206	4	study	study	NOUN
aiua-11120	206	5	found	find	VERB
aiua-11120	206	6	reduced	reduced	ADJ
aiua-11120	206	7	symptoms	symptom	NOUN
aiua-11120	206	8	after	after	ADP
aiua-11120	206	9	oxybutynin	oxybutynin	PROPN
aiua-11120	206	10	compared	compare	VERB
aiua-11120	206	11	to	to	ADP
aiua-11120	206	12	propantheline	propantheline	NOUN
aiua-11120	206	13	(	(	PUNCT
aiua-11120	206	14	gajewski	gajewski	PROPN
aiua-11120	206	15	1986	1986	NUM
aiua-11120	206	16	)	)	PUNCT
aiua-11120	206	17	(	(	PUNCT
aiua-11120	206	18	82	82	NUM
aiua-11120	206	19	)	)	PUNCT
aiua-11120	206	20	.	.	PUNCT
aiua-11120	207	1	finally	finally	ADV
aiua-11120	207	2	,	,	PUNCT
aiua-11120	207	3	a	a	DET
aiua-11120	207	4	study	study	NOUN
aiua-11120	207	5	found	find	VERB
aiua-11120	207	6	no	no	DET
aiua-11120	207	7	significant	significant	ADJ
aiua-11120	207	8	difference	difference	NOUN
aiua-11120	207	9	in	in	ADP
aiua-11120	207	10	term	term	NOUN
aiua-11120	207	11	of	of	ADP
aiua-11120	207	12	efficacy	efficacy	NOUN
aiua-11120	207	13	between	between	ADP
aiua-11120	207	14	oral	oral	ADJ
aiua-11120	207	15	oxybutynin	oxybutynin	ADJ
aiua-11120	207	16	and	and	CCONJ
aiua-11120	207	17	intravesical	intravesical	ADJ
aiua-11120	207	18	atropine	atropine	NOUN
aiua-11120	207	19	,	,	PUNCT
aiua-11120	207	20	although	although	SCONJ
aiua-11120	207	21	side	side	ADJ
aiua-11120	207	22	effects	effect	NOUN
aiua-11120	207	23	and	and	CCONJ
aiua-11120	207	24	quality	quality	NOUN
aiua-11120	207	25	of	of	ADP
aiua-11120	207	26	life	life	NOUN
aiua-11120	207	27	were	be	AUX
aiua-11120	207	28	in	in	ADP
aiua-11120	207	29	favor	favor	NOUN
aiua-11120	207	30	of	of	ADP
aiua-11120	207	31	the	the	DET
aiua-11120	207	32	latter	latter	ADJ
aiua-11120	207	33	(	(	PUNCT
aiua-11120	207	34	fader	fader	NOUN
aiua-11120	207	35	2007	2007	NUM
aiua-11120	207	36	)	)	PUNCT
aiua-11120	207	37	(	(	PUNCT
aiua-11120	207	38	83	83	NUM
aiua-11120	207	39	)	)	PUNCT
aiua-11120	207	40	.	.	PUNCT
aiua-11120	208	1	the	the	DET
aiua-11120	208	2	authors	author	NOUN
aiua-11120	208	3	concluded	conclude	VERB
aiua-11120	208	4	that	that	SCONJ
aiua-11120	208	5	evidence	evidence	NOUN
aiua-11120	208	6	was	be	AUX
aiua-11120	208	7	insufficient	insufficient	ADJ
aiua-11120	208	8	to	to	PART
aiua-11120	208	9	demonstrate	demonstrate	VERB
aiua-11120	208	10	any	any	DET
aiua-11120	208	11	benefit	benefit	NOUN
aiua-11120	208	12	from	from	ADP
aiua-11120	208	13	the	the	DET
aiua-11120	208	14	administration	administration	NOUN
aiua-11120	208	15	of	of	ADP
aiua-11120	208	16	anticholinergics	anticholinergic	NOUN
aiua-11120	208	17	for	for	ADP
aiua-11120	208	18	urinary	urinary	ADJ
aiua-11120	208	19	symptoms	symptom	NOUN
aiua-11120	208	20	in	in	ADP
aiua-11120	208	21	multiple	multiple	ADJ
aiua-11120	208	22	sclerosis	sclerosis	NOUN
aiua-11120	208	23	.	.	PUNCT
aiua-11120	209	1	in	in	ADP
aiua-11120	209	2	addition	addition	NOUN
aiua-11120	209	3	,	,	PUNCT
aiua-11120	209	4	high	high	ADJ
aiua-11120	209	5	rates	rate	NOUN
aiua-11120	209	6	of	of	ADP
aiua-11120	209	7	adverse	adverse	ADJ
aiua-11120	209	8	effects	effect	NOUN
aiua-11120	209	9	were	be	AUX
aiua-11120	209	10	reported	report	VERB
aiua-11120	209	11	,	,	PUNCT
aiua-11120	209	12	with	with	ADP
aiua-11120	209	13	20	20	NUM
aiua-11120	209	14	%	%	NOUN
aiua-11120	209	15	of	of	ADP
aiua-11120	209	16	patients	patient	NOUN
aiua-11120	209	17	who	who	PRON
aiua-11120	209	18	had	have	VERB
aiua-11120	209	19	to	to	PART
aiua-11120	209	20	withdraw	withdraw	VERB
aiua-11120	209	21	from	from	ADP
aiua-11120	209	22	oral	oral	ADJ
aiua-11120	209	23	treatment	treatment	NOUN
aiua-11120	209	24	.	.	PUNCT
aiua-11120	210	1	in	in	ADP
aiua-11120	210	2	a	a	DET
aiua-11120	210	3	systematic	systematic	ADJ
aiua-11120	210	4	review	review	NOUN
aiua-11120	210	5	by	by	ADP
aiua-11120	210	6	madhuvrata	madhuvrata	NOUN
aiua-11120	210	7	et	et	PROPN
aiua-11120	210	8	al	al	PROPN
aiua-11120	210	9	.	.	PROPN
aiua-11120	211	1	(	(	PUNCT
aiua-11120	211	2	2	2	NUM
aiua-11120	211	3	)	)	PUNCT
aiua-11120	211	4	,	,	PUNCT
aiua-11120	211	5	eight	eight	NUM
aiua-11120	211	6	rcts	rct	NOUN
aiua-11120	211	7	comparing	compare	VERB
aiua-11120	211	8	anticholinergic	anticholinergic	ADJ
aiua-11120	211	9	drugs	drug	NOUN
aiua-11120	211	10	with	with	ADP
aiua-11120	211	11	placebo	placebo	NOUN
aiua-11120	211	12	in	in	ADP
aiua-11120	211	13	adult	adult	NOUN
aiua-11120	211	14	neurogenic	neurogenic	ADJ
aiua-11120	211	15	oab	oab	PROPN
aiua-11120	211	16	were	be	AUX
aiua-11120	211	17	included	include	VERB
aiua-11120	211	18	.	.	PUNCT
aiua-11120	212	1	the	the	DET
aiua-11120	212	2	metanalysis	metanalysis	NOUN
aiua-11120	212	3	of	of	ADP
aiua-11120	212	4	three	three	NUM
aiua-11120	212	5	studies	study	NOUN
aiua-11120	212	6	showed	show	VERB
aiua-11120	212	7	higher	high	ADJ
aiua-11120	212	8	maximum	maximum	ADJ
aiua-11120	212	9	cystometric	cystometric	ADJ
aiua-11120	212	10	capacity	capacity	NOUN
aiua-11120	212	11	,	,	PUNCT
aiua-11120	212	12	higher	high	ADJ
aiua-11120	212	13	volume	volume	NOUN
aiua-11120	212	14	at	at	ADP
aiua-11120	212	15	first	first	ADJ
aiua-11120	212	16	contraction	contraction	NOUN
aiua-11120	212	17	,	,	PUNCT
aiua-11120	212	18	and	and	CCONJ
aiua-11120	212	19	lower	low	ADJ
aiua-11120	212	20	maximum	maximum	ADJ
aiua-11120	212	21	detrusor	detrusor	NOUN
aiua-11120	212	22	pressure	pressure	NOUN
aiua-11120	212	23	after	after	ADP
aiua-11120	212	24	anticholinergics	anticholinergic	NOUN
aiua-11120	212	25	compared	compare	VERB
aiua-11120	212	26	to	to	ADP
aiua-11120	212	27	placebo	placebo	NOUN
aiua-11120	212	28	.	.	PUNCT
aiua-11120	213	1	on	on	ADP
aiua-11120	213	2	the	the	DET
aiua-11120	213	3	contrary	contrary	NOUN
aiua-11120	213	4	,	,	PUNCT
aiua-11120	213	5	no	no	DET
aiua-11120	213	6	significant	significant	ADJ
aiua-11120	213	7	changes	change	NOUN
aiua-11120	213	8	in	in	ADP
aiua-11120	213	9	frequency	frequency	NOUN
aiua-11120	213	10	of	of	ADP
aiua-11120	213	11	micturition	micturition	NOUN
aiua-11120	213	12	or	or	CCONJ
aiua-11120	213	13	incontinence	incontinence	NOUN
aiua-11120	213	14	episodes	episode	NOUN
aiua-11120	213	15	per	per	ADP
aiua-11120	213	16	24	24	NUM
aiua-11120	213	17	hours	hour	NOUN
aiua-11120	213	18	were	be	AUX
aiua-11120	213	19	observed	observe	VERB
aiua-11120	213	20	.	.	PUNCT
aiua-11120	214	1	the	the	DET
aiua-11120	214	2	present	present	ADJ
aiua-11120	214	3	review	review	NOUN
aiua-11120	214	4	included	include	VERB
aiua-11120	214	5	three	three	NUM
aiua-11120	214	6	rcts	rct	NOUN
aiua-11120	214	7	(	(	PUNCT
aiua-11120	214	8	18	18	NUM
aiua-11120	214	9	-	-	SYM
aiua-11120	214	10	20	20	NUM
aiua-11120	214	11	)	)	PUNCT
aiua-11120	214	12	comparing	compare	VERB
aiua-11120	214	13	anticholinergics	anticholinergic	NOUN
aiua-11120	214	14	with	with	ADP
aiua-11120	214	15	placebo	placebo	NOUN
aiua-11120	214	16	,	,	PUNCT
aiua-11120	214	17	which	which	PRON
aiua-11120	214	18	were	be	AUX
aiua-11120	214	19	published	publish	VERB
aiua-11120	214	20	after	after	ADP
aiua-11120	214	21	the	the	DET
aiua-11120	214	22	review	review	NOUN
aiua-11120	214	23	of	of	ADP
aiua-11120	214	24	madhuvrata	madhuvrata	NOUN
aiua-11120	214	25	et	et	PROPN
aiua-11120	214	26	al	al	PROPN
aiua-11120	214	27	.	.	PROPN
aiua-11120	215	1	in	in	ADP
aiua-11120	215	2	patients	patient	NOUN
aiua-11120	215	3	with	with	ADP
aiua-11120	215	4	parkinson	parkinson	NOUN
aiua-11120	215	5	disease	disease	NOUN
aiua-11120	215	6	,	,	PUNCT
aiua-11120	215	7	anticholinergics	anticholinergic	NOUN
aiua-11120	215	8	were	be	AUX
aiua-11120	215	9	more	more	ADV
aiua-11120	215	10	effective	effective	ADJ
aiua-11120	215	11	than	than	ADP
aiua-11120	215	12	placebo	placebo	NOUN
aiua-11120	215	13	in	in	ADP
aiua-11120	215	14	decreasing	decrease	VERB
aiua-11120	215	15	the	the	DET
aiua-11120	215	16	number	number	NOUN
aiua-11120	215	17	of	of	ADP
aiua-11120	215	18	day	day	NOUN
aiua-11120	215	19	voids	voids	NOUN
aiua-11120	215	20	,	,	PUNCT
aiua-11120	215	21	though	though	SCONJ
aiua-11120	215	22	the	the	DET
aiua-11120	215	23	number	number	NOUN
aiua-11120	215	24	of	of	ADP
aiua-11120	215	25	incontinence	incontinence	NOUN
aiua-11120	215	26	episodes	episode	NOUN
aiua-11120	215	27	and	and	CCONJ
aiua-11120	215	28	nocturia	nocturia	PROPN
aiua-11120	215	29	were	be	AUX
aiua-11120	215	30	not	not	PART
aiua-11120	215	31	significantly	significantly	ADV
aiua-11120	215	32	decreased	decrease	VERB
aiua-11120	215	33	.	.	PUNCT
aiua-11120	216	1	the	the	DET
aiua-11120	216	2	most	most	ADV
aiua-11120	216	3	frequent	frequent	ADJ
aiua-11120	216	4	side	side	NOUN
aiua-11120	216	5	effect	effect	NOUN
aiua-11120	216	6	was	be	AUX
aiua-11120	216	7	dry	dry	ADJ
aiua-11120	216	8	mouth	mouth	NOUN
aiua-11120	216	9	which	which	PRON
aiua-11120	216	10	was	be	AUX
aiua-11120	216	11	observed	observe	VERB
aiua-11120	216	12	in	in	ADP
aiua-11120	216	13	17	17	NUM
aiua-11120	216	14	%	%	NOUN
aiua-11120	216	15	of	of	ADP
aiua-11120	216	16	the	the	DET
aiua-11120	216	17	patients	patient	NOUN
aiua-11120	216	18	taking	take	VERB
aiua-11120	216	19	oxybutynin	oxybutynin	PROPN
aiua-11120	216	20	.	.	PUNCT
aiua-11120	217	1	similarly	similarly	ADV
aiua-11120	217	2	,	,	PUNCT
aiua-11120	217	3	the	the	DET
aiua-11120	217	4	meta	meta	NOUN
aiua-11120	217	5	-	-	PUNCT
aiua-11120	217	6	analysis	analysis	NOUN
aiua-11120	217	7	of	of	ADP
aiua-11120	217	8	madhuvrata	madhuvrata	NOUN
aiua-11120	217	9	et	et	PROPN
aiua-11120	217	10	al	al	PROPN
aiua-11120	217	11	.	.	PROPN
aiua-11120	218	1	(	(	PUNCT
aiua-11120	218	2	2	2	X
aiua-11120	218	3	)	)	PUNCT
aiua-11120	218	4	showed	show	VERB
aiua-11120	218	5	statistically	statistically	ADV
aiua-11120	218	6	significantly	significantly	ADV
aiua-11120	218	7	higher	high	ADJ
aiua-11120	218	8	dry	dry	ADJ
aiua-11120	218	9	mouth	mouth	NOUN
aiua-11120	218	10	with	with	ADP
aiua-11120	218	11	anticholinergic	anticholinergic	ADJ
aiua-11120	218	12	drugs	drug	NOUN
aiua-11120	218	13	compared	compare	VERB
aiua-11120	218	14	with	with	ADP
aiua-11120	218	15	placebo	placebo	NOUN
aiua-11120	218	16	(	(	PUNCT
aiua-11120	218	17	32	32	NUM
aiua-11120	218	18	vs	vs	ADP
aiua-11120	218	19	7	7	NUM
aiua-11120	218	20	%	%	NOUN
aiua-11120	218	21	)	)	PUNCT
aiua-11120	218	22	,	,	PUNCT
aiua-11120	218	23	but	but	CCONJ
aiua-11120	218	24	did	do	AUX
aiua-11120	218	25	not	not	PART
aiua-11120	218	26	report	report	VERB
aiua-11120	218	27	any	any	DET
aiua-11120	218	28	statistically	statistically	ADV
aiua-11120	218	29	significant	significant	ADJ
aiua-11120	218	30	difference	difference	NOUN
aiua-11120	218	31	in	in	ADP
aiua-11120	218	32	any	any	DET
aiua-11120	218	33	other	other	ADJ
aiua-11120	218	34	adverse	adverse	ADJ
aiua-11120	218	35	event	event	NOUN
aiua-11120	218	36	,	,	PUNCT
aiua-11120	218	37	nor	nor	CCONJ
aiua-11120	218	38	in	in	ADP
aiua-11120	218	39	withdrawal	withdrawal	NOUN
aiua-11120	218	40	rates	rate	NOUN
aiua-11120	218	41	due	due	ADJ
aiua-11120	218	42	to	to	ADP
aiua-11120	218	43	adverse	adverse	ADJ
aiua-11120	218	44	events	event	NOUN
aiua-11120	218	45	(	(	PUNCT
aiua-11120	218	46	8	8	NUM
aiua-11120	218	47	vs	vs	ADP
aiua-11120	218	48	2	2	NUM
aiua-11120	218	49	%	%	NOUN
aiua-11120	218	50	)	)	PUNCT
aiua-11120	218	51	.	.	PUNCT
aiua-11120	219	1	there	there	PRON
aiua-11120	219	2	were	be	VERB
aiua-11120	219	3	no	no	DET
aiua-11120	219	4	statistically	statistically	ADV
aiua-11120	219	5	significant	significant	ADJ
aiua-11120	219	6	differences	difference	NOUN
aiua-11120	219	7	in	in	ADP
aiua-11120	219	8	any	any	PRON
aiua-11120	219	9	of	of	ADP
aiua-11120	219	10	the	the	DET
aiua-11120	219	11	outcomes	outcome	NOUN
aiua-11120	219	12	between	between	ADP
aiua-11120	219	13	oxybutynin	oxybutynin	PROPN
aiua-11120	219	14	and	and	CCONJ
aiua-11120	219	15	other	other	ADJ
aiua-11120	219	16	anticholinergics	anticholinergic	NOUN
aiua-11120	219	17	nor	nor	CCONJ
aiua-11120	219	18	among	among	ADP
aiua-11120	219	19	different	different	ADJ
aiua-11120	219	20	doses	dose	NOUN
aiua-11120	219	21	and	and	CCONJ
aiua-11120	219	22	preparations	preparation	NOUN
aiua-11120	219	23	of	of	ADP
aiua-11120	219	24	anticholinergic	anticholinergic	ADJ
aiua-11120	219	25	drugs	drug	NOUN
aiua-11120	219	26	.	.	PUNCT
aiua-11120	220	1	a	a	DET
aiua-11120	220	2	meta	meta	ADJ
aiua-11120	220	3	-	-	PUNCT
aiua-11120	220	4	analysis	analysis	NOUN
aiua-11120	220	5	of	of	ADP
aiua-11120	220	6	rcts	rct	NOUN
aiua-11120	220	7	on	on	ADP
aiua-11120	220	8	the	the	DET
aiua-11120	220	9	efficacy	efficacy	NOUN
aiua-11120	220	10	and	and	CCONJ
aiua-11120	220	11	safety	safety	NOUN
aiua-11120	220	12	of	of	ADP
aiua-11120	220	13	anticholinergic	anticholinergic	ADJ
aiua-11120	220	14	drugs	drug	NOUN
aiua-11120	220	15	for	for	ADP
aiua-11120	220	16	non	non	ADJ
aiua-11120	220	17	-	-	ADJ
aiua-11120	220	18	neurogenic	neurogenic	ADJ
aiua-11120	220	19	overactive	overactive	ADJ
aiua-11120	220	20	bladder	bladder	NOUN
aiua-11120	220	21	(	(	PUNCT
aiua-11120	220	22	83	83	NUM
aiua-11120	220	23	)	)	PUNCT
aiua-11120	220	24	concluded	conclude	VERB
aiua-11120	220	25	that	that	SCONJ
aiua-11120	220	26	extended	extend	VERB
aiua-11120	220	27	-	-	PUNCT
aiua-11120	220	28	release	release	NOUN
aiua-11120	220	29	formulations	formulation	NOUN
aiua-11120	220	30	showed	show	VERB
aiua-11120	220	31	some	some	DET
aiua-11120	220	32	advantages	advantage	NOUN
aiua-11120	220	33	when	when	SCONJ
aiua-11120	220	34	compared	compare	VERB
aiua-11120	220	35	to	to	ADP
aiua-11120	220	36	immediate	immediate	ADJ
aiua-11120	220	37	release	release	NOUN
aiua-11120	220	38	ones	one	NOUN
aiua-11120	220	39	,	,	PUNCT
aiua-11120	220	40	both	both	CCONJ
aiua-11120	220	41	in	in	ADP
aiua-11120	220	42	terms	term	NOUN
aiua-11120	220	43	of	of	ADP
aiua-11120	220	44	efficacy	efficacy	NOUN
aiua-11120	220	45	and	and	CCONJ
aiua-11120	220	46	safety	safety	NOUN
aiua-11120	220	47	.	.	PUNCT
aiua-11120	221	1	no	no	DET
aiua-11120	221	2	significant	significant	ADJ
aiua-11120	221	3	advantage	advantage	NOUN
aiua-11120	221	4	was	be	AUX
aiua-11120	221	5	observed	observe	VERB
aiua-11120	221	6	after	after	ADP
aiua-11120	221	7	transdermal	transdermal	ADJ
aiua-11120	221	8	delivery	delivery	NOUN
aiua-11120	221	9	compared	compare	VERB
aiua-11120	221	10	to	to	ADP
aiua-11120	221	11	oral	oral	ADJ
aiua-11120	221	12	intake	intake	NOUN
aiua-11120	221	13	.	.	PUNCT
aiua-11120	222	1	in	in	ADP
aiua-11120	222	2	general	general	ADJ
aiua-11120	222	3	,	,	PUNCT
aiua-11120	222	4	dose	dose	ADJ
aiua-11120	222	5	escalation	escalation	NOUN
aiua-11120	222	6	obtained	obtain	VERB
aiua-11120	222	7	some	some	DET
aiua-11120	222	8	improvements	improvement	NOUN
aiua-11120	222	9	in	in	ADP
aiua-11120	222	10	term	term	NOUN
aiua-11120	222	11	of	of	ADP
aiua-11120	222	12	efficacy	efficacy	NOUN
aiua-11120	222	13	,	,	PUNCT
aiua-11120	222	14	although	although	SCONJ
aiua-11120	222	15	it	it	PRON
aiua-11120	222	16	was	be	AUX
aiua-11120	222	17	associated	associate	VERB
aiua-11120	222	18	with	with	ADP
aiua-11120	222	19	a	a	DET
aiua-11120	222	20	significant	significant	ADJ
aiua-11120	222	21	increase	increase	NOUN
aiua-11120	222	22	in	in	ADP
aiua-11120	222	23	the	the	DET
aiua-11120	222	24	rate	rate	NOUN
aiua-11120	222	25	of	of	ADP
aiua-11120	222	26	adverse	adverse	ADJ
aiua-11120	222	27	events	event	NOUN
aiua-11120	222	28	.	.	PUNCT
aiua-11120	223	1	tolterodine	tolterodine	PROPN
aiua-11120	223	2	ir	ir	PROPN
aiua-11120	223	3	was	be	AUX
aiua-11120	223	4	associated	associate	VERB
aiua-11120	223	5	with	with	ADP
aiua-11120	223	6	less	less	ADJ
aiua-11120	223	7	adverse	adverse	ADJ
aiua-11120	223	8	events	event	NOUN
aiua-11120	223	9	than	than	ADP
aiua-11120	223	10	oxybutynin	oxybutynin	PROPN
aiua-11120	223	11	ir	ir	PROPN
aiua-11120	223	12	.	.	PUNCT
aiua-11120	224	1	in	in	ADP
aiua-11120	224	2	our	our	PRON
aiua-11120	224	3	review	review	NOUN
aiua-11120	224	4	,	,	PUNCT
aiua-11120	224	5	we	we	PRON
aiua-11120	224	6	included	include	VERB
aiua-11120	224	7	three	three	NUM
aiua-11120	224	8	studies	study	NOUN
aiua-11120	224	9	comparing	compare	VERB
aiua-11120	224	10	the	the	DET
aiua-11120	224	11	effect	effect	NOUN
aiua-11120	224	12	of	of	ADP
aiua-11120	224	13	the	the	DET
aiua-11120	224	14	treatment	treatment	NOUN
aiua-11120	224	15	with	with	ADP
aiua-11120	224	16	anticholinergic	anticholinergic	ADJ
aiua-11120	224	17	agents	agent	NOUN
aiua-11120	224	18	administered	administer	VERB
aiua-11120	224	19	at	at	ADP
aiua-11120	224	20	different	different	ADJ
aiua-11120	224	21	doses	dose	NOUN
aiua-11120	224	22	or	or	CCONJ
aiua-11120	224	23	with	with	ADP
aiua-11120	224	24	different	different	ADJ
aiua-11120	224	25	formulation	formulation	NOUN
aiua-11120	224	26	.	.	PUNCT
aiua-11120	225	1	oral	oral	ADJ
aiua-11120	225	2	trospium	trospium	NOUN
aiua-11120	225	3	chloride	chloride	NOUN
aiua-11120	225	4	at	at	ADP
aiua-11120	225	5	standard	standard	ADJ
aiua-11120	225	6	doses	dose	NOUN
aiua-11120	225	7	and	and	CCONJ
aiua-11120	225	8	at	at	ADP
aiua-11120	225	9	adjustable	adjustable	ADJ
aiua-11120	225	10	doses	dose	NOUN
aiua-11120	225	11	showed	show	VERB
aiua-11120	225	12	similar	similar	ADJ
aiua-11120	225	13	therapeutic	therapeutic	ADJ
aiua-11120	225	14	responses	response	NOUN
aiua-11120	225	15	and	and	CCONJ
aiua-11120	225	16	similar	similar	ADJ
aiua-11120	225	17	rates	rate	NOUN
aiua-11120	225	18	of	of	ADP
aiua-11120	225	19	side	side	NOUN
aiua-11120	225	20	effects	effect	NOUN
aiua-11120	225	21	(	(	PUNCT
aiua-11120	225	22	22	22	NUM
aiua-11120	225	23	)	)	PUNCT
aiua-11120	225	24	.	.	PUNCT
aiua-11120	226	1	similarly	similarly	ADV
aiua-11120	226	2	,	,	PUNCT
aiua-11120	226	3	when	when	SCONJ
aiua-11120	226	4	compared	compare	VERB
aiua-11120	226	5	to	to	PART
aiua-11120	226	6	propiverine	propiverine	VERB
aiua-11120	226	7	ir	ir	PROPN
aiua-11120	226	8	,	,	PUNCT
aiua-11120	226	9	propiverine	propiverine	ADJ
aiua-11120	226	10	er	er	INTJ
aiua-11120	226	11	showed	show	VERB
aiua-11120	226	12	a	a	DET
aiua-11120	226	13	slightly	slightly	ADV
aiua-11120	226	14	better	well	ADJ
aiua-11120	226	15	tolerability	tolerability	NOUN
aiua-11120	226	16	(	(	PUNCT
aiua-11120	226	17	25	25	NUM
aiua-11120	226	18	)	)	PUNCT
aiua-11120	226	19	.	.	PUNCT
aiua-11120	227	1	a	a	DET
aiua-11120	227	2	comparison	comparison	NOUN
aiua-11120	227	3	of	of	ADP
aiua-11120	227	4	propiverine	propiverine	NOUN
aiua-11120	227	5	vs.	vs.	X
aiua-11120	227	6	oxybutynin	oxybutynin	PROPN
aiua-11120	227	7	showed	show	VERB
aiua-11120	227	8	no	no	DET
aiua-11120	227	9	significant	significant	ADJ
aiua-11120	227	10	differences	difference	NOUN
aiua-11120	227	11	in	in	ADP
aiua-11120	227	12	the	the	DET
aiua-11120	227	13	increase	increase	NOUN
aiua-11120	227	14	of	of	ADP
aiua-11120	227	15	maximum	maximum	ADJ
aiua-11120	227	16	cystometric	cystometric	ADJ
aiua-11120	227	17	capacity	capacity	NOUN
aiua-11120	227	18	and	and	CCONJ
aiua-11120	227	19	decrease	decrease	NOUN
aiua-11120	227	20	of	of	ADP
aiua-11120	227	21	maximum	maximum	ADJ
aiua-11120	227	22	detrusor	detrusor	NOUN
aiua-11120	227	23	pressure	pressure	NOUN
aiua-11120	227	24	during	during	ADP
aiua-11120	227	25	the	the	DET
aiua-11120	227	26	filling	filling	NOUN
aiua-11120	227	27	phase	phase	NOUN
aiua-11120	227	28	.	.	PUNCT
aiua-11120	228	1	adverse	adverse	ADJ
aiua-11120	228	2	events	event	NOUN
aiua-11120	228	3	were	be	AUX
aiua-11120	228	4	reported	report	VERB
aiua-11120	228	5	less	less	ADV
aiua-11120	228	6	frequently	frequently	ADV
aiua-11120	228	7	in	in	ADP
aiua-11120	228	8	the	the	DET
aiua-11120	228	9	propiverine	propiverine	ADJ
aiua-11120	228	10	arm	arm	NOUN
aiua-11120	228	11	compared	compare	VERB
aiua-11120	228	12	to	to	ADP
aiua-11120	228	13	the	the	DET
aiua-11120	228	14	oxybutynin	oxybutynin	PROPN
aiua-11120	228	15	group	group	NOUN
aiua-11120	228	16	(	(	PUNCT
aiua-11120	228	17	63.0	63.0	NUM
aiua-11120	228	18	%	%	NOUN
aiua-11120	228	19	versus	versus	ADP
aiua-11120	228	20	77.8	77.8	NUM
aiua-11120	228	21	%	%	NOUN
aiua-11120	228	22	)	)	PUNCT
aiua-11120	228	23	(	(	PUNCT
aiua-11120	228	24	26	26	NUM
aiua-11120	228	25	)	)	PUNCT
aiua-11120	228	26	.	.	PUNCT
aiua-11120	229	1	shen	shen	PROPN
aiua-11120	229	2	et	et	PROPN
aiua-11120	229	3	al	al	PROPN
aiua-11120	229	4	.	.	PROPN
aiua-11120	230	1	(	(	PUNCT
aiua-11120	230	2	4	4	X
aiua-11120	230	3	)	)	PUNCT
aiua-11120	230	4	recently	recently	ADV
aiua-11120	230	5	reviewed	review	VERB
aiua-11120	230	6	randomized	randomized	ADJ
aiua-11120	230	7	and	and	CCONJ
aiua-11120	230	8	non	non	ADJ
aiua-11120	230	9	-	-	ADJ
aiua-11120	230	10	randomized	randomized	ADJ
aiua-11120	230	11	studies	study	NOUN
aiua-11120	230	12	evaluating	evaluate	VERB
aiua-11120	230	13	effectiveness	effectiveness	NOUN
aiua-11120	230	14	and	and	CCONJ
aiua-11120	230	15	safety	safety	NOUN
aiua-11120	230	16	of	of	ADP
aiua-11120	230	17	intravesical	intravesical	ADJ
aiua-11120	230	18	oxybutynin	oxybutynin	PROPN
aiua-11120	230	19	therapy	therapy	NOUN
aiua-11120	230	20	for	for	ADP
aiua-11120	230	21	patients	patient	NOUN
aiua-11120	230	22	with	with	ADP
aiua-11120	230	23	neurogenic	neurogenic	ADJ
aiua-11120	230	24	detrusor	detrusor	NOUN
aiua-11120	230	25	overactivity	overactivity	NOUN
aiua-11120	230	26	compared	compare	VERB
aiua-11120	230	27	to	to	ADP
aiua-11120	230	28	oral	oral	ADJ
aiua-11120	230	29	oxybutynin	oxybutynin	PROPN
aiua-11120	230	30	.	.	PUNCT
aiua-11120	231	1	in	in	ADP
aiua-11120	231	2	studies	study	NOUN
aiua-11120	231	3	in	in	ADP
aiua-11120	231	4	adults	adult	NOUN
aiua-11120	231	5	,	,	PUNCT
aiua-11120	231	6	maximum	maximum	ADJ
aiua-11120	231	7	bladder	bladder	NOUN
aiua-11120	231	8	capacity	capacity	NOUN
aiua-11120	231	9	increased	increase	VERB
aiua-11120	231	10	and	and	CCONJ
aiua-11120	231	11	detrusor	detrusor	NOUN
aiua-11120	231	12	pressure	pressure	NOUN
aiua-11120	231	13	at	at	ADP
aiua-11120	231	14	maximum	maximum	ADJ
aiua-11120	231	15	bladder	bladder	NOUN
aiua-11120	231	16	decreased	decrease	VERB
aiua-11120	231	17	more	more	ADV
aiua-11120	231	18	after	after	ADP
aiua-11120	231	19	intravesical	intravesical	ADJ
aiua-11120	231	20	oxybutynin	oxybutynin	NOUN
aiua-11120	231	21	than	than	ADP
aiua-11120	231	22	after	after	ADP
aiua-11120	231	23	oral	oral	ADJ
aiua-11120	231	24	treatment	treatment	NOUN
aiua-11120	231	25	.	.	PUNCT
aiua-11120	232	1	after	after	ADP
aiua-11120	232	2	treatment	treatment	NOUN
aiua-11120	232	3	,	,	PUNCT
aiua-11120	232	4	76.9	76.9	NUM
aiua-11120	232	5	%	%	NOUN
aiua-11120	232	6	of	of	ADP
aiua-11120	232	7	adult	adult	NOUN
aiua-11120	232	8	patients	patient	NOUN
aiua-11120	232	9	were	be	AUX
aiua-11120	232	10	considered	consider	VERB
aiua-11120	232	11	“	"	PUNCT
aiua-11120	232	12	dry	dry	ADJ
aiua-11120	232	13	or	or	CCONJ
aiua-11120	232	14	improved	improve	VERB
aiua-11120	232	15	”	"	PUNCT
aiua-11120	232	16	.	.	PUNCT
aiua-11120	233	1	side	side	NOUN
aiua-11120	233	2	effects	effect	NOUN
aiua-11120	233	3	were	be	AUX
aiua-11120	233	4	reported	report	VERB
aiua-11120	233	5	in	in	ADP
aiua-11120	233	6	13.5	13.5	NUM
aiua-11120	233	7	%	%	NOUN
aiua-11120	233	8	of	of	ADP
aiua-11120	233	9	cases	case	NOUN
aiua-11120	233	10	and	and	CCONJ
aiua-11120	233	11	6.6	6.6	NUM
aiua-11120	233	12	%	%	NOUN
aiua-11120	233	13	of	of	ADP
aiua-11120	233	14	patients	patient	NOUN
aiua-11120	233	15	withdraw	withdraw	VERB
aiua-11120	233	16	for	for	ADP
aiua-11120	233	17	side	side	NOUN
aiua-11120	233	18	effects	effect	NOUN
aiua-11120	233	19	.	.	PUNCT
aiua-11120	234	1	our	our	PRON
aiua-11120	234	2	review	review	NOUN
aiua-11120	234	3	did	do	AUX
aiua-11120	234	4	not	not	PART
aiua-11120	234	5	add	add	VERB
aiua-11120	234	6	any	any	DET
aiua-11120	234	7	new	new	ADJ
aiua-11120	234	8	study	study	NOUN
aiua-11120	234	9	on	on	ADP
aiua-11120	234	10	intravesical	intravesical	ADJ
aiua-11120	234	11	anticholinergic	anticholinergic	ADJ
aiua-11120	234	12	administration	administration	NOUN
aiua-11120	234	13	to	to	AUX
aiua-11120	234	14	shen	shen	PROPN
aiua-11120	234	15	’s	’s	PART
aiua-11120	234	16	meta	meta	ADJ
aiua-11120	234	17	-	-	PUNCT
aiua-11120	234	18	analysis	analysis	NOUN
aiua-11120	234	19	.	.	PUNCT
aiua-11120	235	1	combined	combined	ADJ
aiua-11120	235	2	administration	administration	NOUN
aiua-11120	235	3	of	of	ADP
aiua-11120	235	4	two	two	NUM
aiua-11120	235	5	different	different	ADJ
aiua-11120	235	6	anticholinergic	anticholinergic	ADJ
aiua-11120	235	7	drugs	drug	NOUN
aiua-11120	235	8	instead	instead	ADV
aiua-11120	235	9	of	of	ADP
aiua-11120	235	10	standard	standard	NOUN
aiua-11120	235	11	of	of	ADP
aiua-11120	235	12	care	care	NOUN
aiua-11120	235	13	(	(	PUNCT
aiua-11120	235	14	a	a	DET
aiua-11120	235	15	single	single	ADJ
aiua-11120	235	16	antimuscarinic	antimuscarinic	ADJ
aiua-11120	235	17	drug	drug	NOUN
aiua-11120	235	18	administered	administer	VERB
aiua-11120	235	19	at	at	ADP
aiua-11120	235	20	maximum	maximum	NOUN
aiua-11120	235	21	of	of	ADP
aiua-11120	235	22	recommended	recommend	VERB
aiua-11120	235	23	dosage	dosage	NOUN
aiua-11120	235	24	)	)	PUNCT
aiua-11120	235	25	was	be	AUX
aiua-11120	235	26	proposed	propose	VERB
aiua-11120	235	27	to	to	PART
aiua-11120	235	28	improve	improve	VERB
aiua-11120	235	29	efficacy	efficacy	NOUN
aiua-11120	235	30	without	without	ADP
aiua-11120	235	31	affecting	affect	VERB
aiua-11120	235	32	tolerability	tolerability	NOUN
aiua-11120	235	33	.	.	PUNCT
aiua-11120	236	1	combined	combined	ADJ
aiua-11120	236	2	administration	administration	NOUN
aiua-11120	236	3	of	of	ADP
aiua-11120	236	4	trospium	trospium	PROPN
aiua-11120	236	5	chloride	chloride	NOUN
aiua-11120	236	6	with	with	ADP
aiua-11120	236	7	oxybutynin	oxybutynin	PROPN
aiua-11120	236	8	and	and	CCONJ
aiua-11120	236	9	solifenacin	solifenacin	NOUN
aiua-11120	236	10	with	with	ADP
aiua-11120	236	11	oxybutynin	oxybutynin	PROPN
aiua-11120	236	12	(	(	PUNCT
aiua-11120	236	13	33	33	NUM
aiua-11120	236	14	)	)	PUNCT
aiua-11120	236	15	improved	improve	VERB
aiua-11120	236	16	subjective	subjective	ADJ
aiua-11120	236	17	and	and	CCONJ
aiua-11120	236	18	urodynamic	urodynamic	ADJ
aiua-11120	236	19	urinary	urinary	ADJ
aiua-11120	236	20	parameters	parameter	NOUN
aiua-11120	236	21	,	,	PUNCT
aiua-11120	236	22	although	although	SCONJ
aiua-11120	236	23	side	side	ADJ
aiua-11120	236	24	effects	effect	NOUN
aiua-11120	236	25	were	be	AUX
aiua-11120	236	26	higher	high	ADJ
aiua-11120	236	27	in	in	ADP
aiua-11120	236	28	patients	patient	NOUN
aiua-11120	236	29	taking	take	VERB
aiua-11120	236	30	oxybutyinin	oxybutyinin	PROPN
aiua-11120	236	31	plus	plus	CCONJ
aiua-11120	236	32	solifenacin	solifenacin	PROPN
aiua-11120	236	33	.	.	PUNCT
aiua-11120	237	1	mirabegron	mirabegron	PROPN
aiua-11120	237	2	mirabegron	mirabegron	PROPN
aiua-11120	237	3	is	be	AUX
aiua-11120	237	4	a	a	DET
aiua-11120	237	5	beta-3	beta-3	NUM
aiua-11120	237	6	adrenoceptor	adrenoceptor	NOUN
aiua-11120	237	7	agonist	agonist	NOUN
aiua-11120	237	8	that	that	PRON
aiua-11120	237	9	mediates	mediate	VERB
aiua-11120	237	10	bladder	bladder	NOUN
aiua-11120	237	11	relaxation	relaxation	NOUN
aiua-11120	237	12	and	and	CCONJ
aiua-11120	237	13	facilitates	facilitate	VERB
aiua-11120	237	14	the	the	DET
aiua-11120	237	15	filling	filling	NOUN
aiua-11120	237	16	phase	phase	NOUN
aiua-11120	237	17	by	by	ADP
aiua-11120	237	18	stimulating	stimulate	VERB
aiua-11120	237	19	beta-3	beta-3	NUM
aiua-11120	237	20	adrenoceptors	adrenoceptor	NOUN
aiua-11120	237	21	.	.	PUNCT
aiua-11120	238	1	mirabegron	mirabegron	PROPN
aiua-11120	238	2	is	be	AUX
aiua-11120	238	3	commonly	commonly	ADV
aiua-11120	238	4	used	use	VERB
aiua-11120	238	5	for	for	ADP
aiua-11120	238	6	idiopathic	idiopathic	ADJ
aiua-11120	238	7	oab	oab	PROPN
aiua-11120	238	8	treatment	treatment	NOUN
aiua-11120	238	9	because	because	SCONJ
aiua-11120	238	10	of	of	ADP
aiua-11120	238	11	its	its	PRON
aiua-11120	238	12	efficacy	efficacy	NOUN
aiua-11120	238	13	,	,	PUNCT
aiua-11120	238	14	comparable	comparable	ADJ
aiua-11120	238	15	to	to	ADP
aiua-11120	238	16	that	that	PRON
aiua-11120	238	17	of	of	ADP
aiua-11120	238	18	anticholinergic	anticholinergic	ADJ
aiua-11120	238	19	drugs	drug	NOUN
aiua-11120	238	20	,	,	PUNCT
aiua-11120	238	21	but	but	CCONJ
aiua-11120	238	22	with	with	ADP
aiua-11120	238	23	a	a	DET
aiua-11120	238	24	better	well	ADJ
aiua-11120	238	25	tolerability	tolerability	NOUN
aiua-11120	238	26	profile	profile	NOUN
aiua-11120	238	27	(	(	PUNCT
aiua-11120	238	28	84	84	NUM
aiua-11120	238	29	,	,	PUNCT
aiua-11120	238	30	85	85	NUM
aiua-11120	238	31	)	)	PUNCT
aiua-11120	238	32	.	.	PUNCT
aiua-11120	239	1	however	however	ADV
aiua-11120	239	2	,	,	PUNCT
aiua-11120	239	3	mirabegron	mirabegron	PROPN
aiua-11120	239	4	may	may	AUX
aiua-11120	239	5	affect	affect	VERB
aiua-11120	239	6	the	the	DET
aiua-11120	239	7	cardiovascular	cardiovascular	ADJ
aiua-11120	239	8	system	system	NOUN
aiua-11120	239	9	causing	cause	VERB
aiua-11120	239	10	hypertension	hypertension	NOUN
aiua-11120	239	11	,	,	PUNCT
aiua-11120	239	12	increased	increase	VERB
aiua-11120	239	13	heart	heart	NOUN
aiua-11120	239	14	rate	rate	NOUN
aiua-11120	239	15	,	,	PUNCT
aiua-11120	239	16	arrhythmias	arrhythmia	NOUN
aiua-11120	239	17	,	,	PUNCT
aiua-11120	239	18	and	and	CCONJ
aiua-11120	239	19	headache	headache	NOUN
aiua-11120	239	20	(	(	PUNCT
aiua-11120	239	21	86	86	NUM
aiua-11120	239	22	)	)	PUNCT
aiua-11120	239	23	.	.	PUNCT
aiua-11120	240	1	patients	patient	NOUN
aiua-11120	240	2	with	with	ADP
aiua-11120	240	3	neurogenic	neurogenic	ADJ
aiua-11120	240	4	oab	oab	PROPN
aiua-11120	240	5	could	could	AUX
aiua-11120	240	6	be	be	AUX
aiua-11120	240	7	more	more	ADV
aiua-11120	240	8	exposed	expose	VERB
aiua-11120	240	9	to	to	ADP
aiua-11120	240	10	such	such	ADJ
aiua-11120	240	11	side	side	NOUN
aiua-11120	240	12	effects	effect	NOUN
aiua-11120	240	13	because	because	SCONJ
aiua-11120	240	14	of	of	ADP
aiua-11120	240	15	potential	potential	ADJ
aiua-11120	240	16	disturbances	disturbance	NOUN
aiua-11120	240	17	of	of	ADP
aiua-11120	240	18	the	the	DET
aiua-11120	240	19	vegetative	vegetative	ADJ
aiua-11120	240	20	nervous	nervous	ADJ
aiua-11120	240	21	system	system	NOUN
aiua-11120	240	22	.	.	PUNCT
aiua-11120	241	1	in	in	ADP
aiua-11120	241	2	particular	particular	ADJ
aiua-11120	241	3	,	,	PUNCT
aiua-11120	241	4	this	this	PRON
aiua-11120	241	5	could	could	AUX
aiua-11120	241	6	be	be	AUX
aiua-11120	241	7	the	the	DET
aiua-11120	241	8	case	case	NOUN
aiua-11120	241	9	in	in	ADP
aiua-11120	241	10	patients	patient	NOUN
aiua-11120	241	11	with	with	ADP
aiua-11120	241	12	sci	sci	PROPN
aiua-11120	241	13	above	above	ADP
aiua-11120	241	14	the	the	DET
aiua-11120	241	15	t6	t6	PROPN
aiua-11120	241	16	level	level	NOUN
aiua-11120	241	17	that	that	PRON
aiua-11120	241	18	is	be	AUX
aiua-11120	241	19	above	above	ADP
aiua-11120	241	20	the	the	DET
aiua-11120	241	21	outflow	outflow	NOUN
aiua-11120	241	22	of	of	ADP
aiua-11120	241	23	splanchnic	splanchnic	ADJ
aiua-11120	241	24	sympathetic	sympathetic	ADJ
aiua-11120	241	25	fibres	fibre	NOUN
aiua-11120	241	26	.	.	PUNCT
aiua-11120	242	1	our	our	PRON
aiua-11120	242	2	meta	meta	ADJ
aiua-11120	242	3	-	-	PUNCT
aiua-11120	242	4	analysis	analysis	NOUN
aiua-11120	242	5	partially	partially	ADV
aiua-11120	242	6	supported	support	VERB
aiua-11120	242	7	the	the	DET
aiua-11120	242	8	efficacy	efficacy	NOUN
aiua-11120	242	9	of	of	ADP
aiua-11120	242	10	mirabegron	mirabegron	PROPN
aiua-11120	242	11	in	in	ADP
aiua-11120	242	12	patients	patient	NOUN
aiua-11120	242	13	with	with	ADP
aiua-11120	242	14	neurogenic	neurogenic	ADJ
aiua-11120	242	15	overactive	overactive	ADJ
aiua-11120	242	16	bladder	bladder	NOUN
aiua-11120	242	17	.	.	PUNCT
aiua-11120	243	1	the	the	DET
aiua-11120	243	2	cystometric	cystometric	ADJ
aiua-11120	243	3	capacity	capacity	NOUN
aiua-11120	243	4	was	be	AUX
aiua-11120	243	5	increased	increase	VERB
aiua-11120	243	6	after	after	ADP
aiua-11120	243	7	archivio	archivio	NOUN
aiua-11120	243	8	italiano	italiano	X
aiua-11120	243	9	di	di	X
aiua-11120	243	10	urologia	urologia	PROPN
aiua-11120	243	11	e	e	PROPN
aiua-11120	243	12	andrologia	andrologia	PROPN
aiua-11120	243	13	2022	2022	NUM
aiua-11120	243	14	;	;	PUNCT
aiua-11120	243	15	94	94	NUM
aiua-11120	243	16	,	,	PUNCT
aiua-11120	243	17	4	4	NUM
aiua-11120	243	18	r.	r.	NOUN
aiua-11120	243	19	bapir	bapir	NOUN
aiua-11120	243	20	,	,	PUNCT
aiua-11120	243	21	k.	k.	PROPN
aiua-11120	243	22	hassan	hassan	PROPN
aiua-11120	243	23	bhatti	bhatti	PROPN
aiua-11120	243	24	,	,	PUNCT
aiua-11120	243	25	ahmed	ahmed	PROPN
aiua-11120	243	26	eliwa	eliwa	PROPN
aiua-11120	243	27	,	,	PUNCT
aiua-11120	243	28	et	et	PROPN
aiua-11120	243	29	al	al	PROPN
aiua-11120	243	30	.	.	PROPN
aiua-11120	244	1	502	502	NUM
aiua-11120	244	2	mirabegron	mirabegron	NOUN
aiua-11120	244	3	in	in	ADP
aiua-11120	244	4	patients	patient	NOUN
aiua-11120	244	5	with	with	ADP
aiua-11120	244	6	ms	ms	PROPN
aiua-11120	244	7	,	,	PUNCT
aiua-11120	244	8	although	although	SCONJ
aiua-11120	244	9	peak	peak	NOUN
aiua-11120	244	10	pressures	pressure	NOUN
aiua-11120	244	11	and	and	CCONJ
aiua-11120	244	12	volume	volume	NOUN
aiua-11120	244	13	at	at	ADP
aiua-11120	244	14	1st	1st	ADJ
aiua-11120	244	15	contraction	contraction	NOUN
aiua-11120	244	16	were	be	AUX
aiua-11120	244	17	not	not	PART
aiua-11120	244	18	significantly	significantly	ADV
aiua-11120	244	19	increased	increase	VERB
aiua-11120	244	20	.	.	PUNCT
aiua-11120	245	1	symptom	symptom	NOUN
aiua-11120	245	2	scores	score	NOUN
aiua-11120	245	3	and	and	CCONJ
aiua-11120	245	4	bladder	bladder	NOUN
aiua-11120	245	5	diary	diary	NOUN
aiua-11120	245	6	parameters	parameter	NOUN
aiua-11120	245	7	were	be	AUX
aiua-11120	245	8	not	not	PART
aiua-11120	245	9	significantly	significantly	ADV
aiua-11120	245	10	changed	change	VERB
aiua-11120	245	11	in	in	ADP
aiua-11120	245	12	patients	patient	NOUN
aiua-11120	245	13	with	with	ADP
aiua-11120	245	14	pd	pd	PROPN
aiua-11120	245	15	.	.	PUNCT
aiua-11120	246	1	cardiovascular	cardiovascular	ADJ
aiua-11120	246	2	parameters	parameter	NOUN
aiua-11120	246	3	were	be	AUX
aiua-11120	246	4	not	not	PART
aiua-11120	246	5	significantly	significantly	ADV
aiua-11120	246	6	affected	affect	VERB
aiua-11120	246	7	by	by	ADP
aiua-11120	246	8	mirabegron	mirabegron	PROPN
aiua-11120	246	9	treatment	treatment	NOUN
aiua-11120	246	10	although	although	SCONJ
aiua-11120	246	11	patients	patient	NOUN
aiua-11120	246	12	at	at	ADP
aiua-11120	246	13	risk	risk	NOUN
aiua-11120	246	14	for	for	ADP
aiua-11120	246	15	cardiovascular	cardiovascular	ADJ
aiua-11120	246	16	disease	disease	NOUN
aiua-11120	246	17	were	be	AUX
aiua-11120	246	18	excluded	exclude	VERB
aiua-11120	246	19	from	from	ADP
aiua-11120	246	20	most	most	ADJ
aiua-11120	246	21	trials	trial	NOUN
aiua-11120	246	22	.	.	PUNCT
aiua-11120	247	1	mirabegron	mirabegron	PROPN
aiua-11120	247	2	was	be	AUX
aiua-11120	247	3	compared	compare	VERB
aiua-11120	247	4	to	to	ADP
aiua-11120	247	5	darifenacin	darifenacin	PROPN
aiua-11120	247	6	in	in	ADP
aiua-11120	247	7	the	the	DET
aiua-11120	247	8	treatment	treatment	NOUN
aiua-11120	247	9	of	of	ADP
aiua-11120	247	10	oab	oab	PROPN
aiua-11120	247	11	in	in	ADP
aiua-11120	247	12	patients	patient	NOUN
aiua-11120	247	13	with	with	ADP
aiua-11120	247	14	a	a	DET
aiua-11120	247	15	history	history	NOUN
aiua-11120	247	16	of	of	ADP
aiua-11120	247	17	cerebrovascular	cerebrovascular	ADJ
aiua-11120	247	18	accident	accident	NOUN
aiua-11120	247	19	(	(	PUNCT
aiua-11120	247	20	32	32	NUM
aiua-11120	247	21	)	)	PUNCT
aiua-11120	247	22	.	.	PUNCT
aiua-11120	248	1	no	no	DET
aiua-11120	248	2	differences	difference	NOUN
aiua-11120	248	3	in	in	ADP
aiua-11120	248	4	bladder	bladder	NOUN
aiua-11120	248	5	diary	diary	NOUN
aiua-11120	248	6	parameters	parameter	NOUN
aiua-11120	248	7	were	be	AUX
aiua-11120	248	8	observed	observe	VERB
aiua-11120	248	9	between	between	ADP
aiua-11120	248	10	groups	group	NOUN
aiua-11120	248	11	.	.	PUNCT
aiua-11120	249	1	no	no	DET
aiua-11120	249	2	patients	patient	NOUN
aiua-11120	249	3	developed	develop	VERB
aiua-11120	249	4	intolerable	intolerable	ADJ
aiua-11120	249	5	severe	severe	ADJ
aiua-11120	249	6	adverse	adverse	ADJ
aiua-11120	249	7	effects	effect	NOUN
aiua-11120	249	8	and	and	CCONJ
aiua-11120	249	9	no	no	DET
aiua-11120	249	10	deterioration	deterioration	NOUN
aiua-11120	249	11	in	in	ADP
aiua-11120	249	12	the	the	DET
aiua-11120	249	13	cognitive	cognitive	ADJ
aiua-11120	249	14	function	function	NOUN
aiua-11120	249	15	assessed	assess	VERB
aiua-11120	249	16	using	use	VERB
aiua-11120	249	17	moca	moca	PROPN
aiua-11120	249	18	-	-	PUNCT
aiua-11120	249	19	b	b	PROPN
aiua-11120	249	20	scores	score	NOUN
aiua-11120	249	21	was	be	AUX
aiua-11120	249	22	observed	observe	VERB
aiua-11120	249	23	in	in	ADP
aiua-11120	249	24	either	either	DET
aiua-11120	249	25	arm	arm	NOUN
aiua-11120	249	26	.	.	PUNCT
aiua-11120	250	1	cannabis	cannabis	NOUN
aiua-11120	250	2	-	-	PUNCT
aiua-11120	250	3	containing	contain	VERB
aiua-11120	250	4	medicines	medicine	NOUN
aiua-11120	250	5	cannabis	cannabis	NOUN
aiua-11120	250	6	-	-	PUNCT
aiua-11120	250	7	containing	contain	VERB
aiua-11120	250	8	medicines	medicine	NOUN
aiua-11120	250	9	were	be	AUX
aiua-11120	250	10	used	use	VERB
aiua-11120	250	11	in	in	ADP
aiua-11120	250	12	the	the	DET
aiua-11120	250	13	treatment	treatment	NOUN
aiua-11120	250	14	of	of	ADP
aiua-11120	250	15	oab	oab	PROPN
aiua-11120	250	16	in	in	ADP
aiua-11120	250	17	patients	patient	NOUN
aiua-11120	250	18	with	with	ADP
aiua-11120	250	19	multiple	multiple	ADJ
aiua-11120	250	20	sclerosis	sclerosis	NOUN
aiua-11120	250	21	.	.	PUNCT
aiua-11120	251	1	the	the	DET
aiua-11120	251	2	potential	potential	ADJ
aiua-11120	251	3	mechanism	mechanism	NOUN
aiua-11120	251	4	of	of	ADP
aiua-11120	251	5	action	action	NOUN
aiua-11120	251	6	of	of	ADP
aiua-11120	251	7	those	those	DET
aiua-11120	251	8	medicines	medicine	NOUN
aiua-11120	251	9	is	be	AUX
aiua-11120	251	10	not	not	PART
aiua-11120	251	11	fully	fully	ADV
aiua-11120	251	12	elucidated	elucidated	ADJ
aiua-11120	251	13	,	,	PUNCT
aiua-11120	251	14	although	although	SCONJ
aiua-11120	251	15	it	it	PRON
aiua-11120	251	16	could	could	AUX
aiua-11120	251	17	be	be	AUX
aiua-11120	251	18	mediated	mediate	VERB
aiua-11120	251	19	by	by	ADP
aiua-11120	251	20	cb1	cb1	NOUN
aiua-11120	251	21	receptors	receptor	NOUN
aiua-11120	251	22	or	or	CCONJ
aiua-11120	251	23	by	by	ADP
aiua-11120	251	24	transient	transient	ADJ
aiua-11120	251	25	receptor	receptor	NOUN
aiua-11120	251	26	potential	potential	ADJ
aiua-11120	251	27	vanilloid	vanilloid	NOUN
aiua-11120	251	28	1	1	NUM
aiua-11120	251	29	(	(	PUNCT
aiua-11120	251	30	trpv1	trpv1	NOUN
aiua-11120	251	31	)	)	PUNCT
aiua-11120	251	32	receptor	receptor	NOUN
aiua-11120	251	33	in	in	ADP
aiua-11120	251	34	the	the	DET
aiua-11120	251	35	bladder	bladder	NOUN
aiua-11120	251	36	.	.	PUNCT
aiua-11120	252	1	in	in	ADP
aiua-11120	252	2	our	our	PRON
aiua-11120	252	3	review	review	NOUN
aiua-11120	252	4	,	,	PUNCT
aiua-11120	252	5	two	two	NUM
aiua-11120	252	6	rcts	rct	NOUN
aiua-11120	252	7	were	be	AUX
aiua-11120	252	8	included	include	VERB
aiua-11120	252	9	,	,	PUNCT
aiua-11120	252	10	showing	show	VERB
aiua-11120	252	11	that	that	DET
aiua-11120	252	12	treatment	treatment	NOUN
aiua-11120	252	13	with	with	ADP
aiua-11120	252	14	thc	thc	NOUN
aiua-11120	252	15	or	or	CCONJ
aiua-11120	252	16	cannabidiol	cannabidiol	PROPN
aiua-11120	252	17	(	(	PUNCT
aiua-11120	252	18	cbd	cbd	NOUN
aiua-11120	252	19	)	)	PUNCT
aiua-11120	252	20	reduced	reduce	VERB
aiua-11120	252	21	episodes	episode	NOUN
aiua-11120	252	22	of	of	ADP
aiua-11120	252	23	incontinence	incontinence	NOUN
aiua-11120	252	24	,	,	PUNCT
aiua-11120	252	25	daytime	daytime	NOUN
aiua-11120	252	26	voids	void	NOUN
aiua-11120	252	27	and	and	CCONJ
aiua-11120	252	28	nocturia	nocturia	PROPN
aiua-11120	252	29	.	.	PUNCT
aiua-11120	253	1	other	other	ADJ
aiua-11120	253	2	oral	oral	ADJ
aiua-11120	253	3	treatments	treatment	NOUN
aiua-11120	253	4	a	a	DET
aiua-11120	253	5	possible	possible	ADJ
aiua-11120	253	6	alternative	alternative	NOUN
aiua-11120	253	7	to	to	ADP
aiua-11120	253	8	anticholinergics	anticholinergic	NOUN
aiua-11120	253	9	is	be	AUX
aiua-11120	253	10	milnacipran	milnacipran	VERB
aiua-11120	253	11	,	,	PUNCT
aiua-11120	253	12	a	a	DET
aiua-11120	253	13	serotonin	serotonin	NOUN
aiua-11120	253	14	and	and	CCONJ
aiua-11120	253	15	noradrenaline	noradrenaline	ADJ
aiua-11120	253	16	reuptake	reuptake	NOUN
aiua-11120	253	17	inhibitor	inhibitor	NOUN
aiua-11120	253	18	(	(	PUNCT
aiua-11120	253	19	snri	snri	NOUN
aiua-11120	253	20	)	)	PUNCT
aiua-11120	253	21	which	which	PRON
aiua-11120	253	22	can	can	AUX
aiua-11120	253	23	suppress	suppress	VERB
aiua-11120	253	24	bladder	bladder	NOUN
aiua-11120	253	25	contractility	contractility	NOUN
aiua-11120	253	26	by	by	ADP
aiua-11120	253	27	stimulating	stimulate	VERB
aiua-11120	253	28	serotoninergic	serotoninergic	ADJ
aiua-11120	253	29	receptors	receptor	NOUN
aiua-11120	253	30	.	.	PUNCT
aiua-11120	254	1	in	in	ADP
aiua-11120	254	2	a	a	DET
aiua-11120	254	3	single	single	ADJ
aiua-11120	254	4	study	study	NOUN
aiua-11120	254	5	,	,	PUNCT
aiua-11120	254	6	this	this	DET
aiua-11120	254	7	drug	drug	NOUN
aiua-11120	254	8	was	be	AUX
aiua-11120	254	9	able	able	ADJ
aiua-11120	254	10	to	to	PART
aiua-11120	254	11	reduce	reduce	VERB
aiua-11120	254	12	daytime	daytime	ADJ
aiua-11120	254	13	urinary	urinary	ADJ
aiua-11120	254	14	frequency	frequency	NOUN
aiua-11120	254	15	and	and	CCONJ
aiua-11120	254	16	to	to	PART
aiua-11120	254	17	increase	increase	VERB
aiua-11120	254	18	bladder	bladder	NOUN
aiua-11120	254	19	capacity	capacity	NOUN
aiua-11120	254	20	(	(	PUNCT
aiua-11120	254	21	34	34	NUM
aiua-11120	254	22	)	)	PUNCT
aiua-11120	254	23	.	.	PUNCT
aiua-11120	255	1	intravesical	intravesical	ADJ
aiua-11120	255	2	instillations	instillation	NOUN
aiua-11120	255	3	prevention	prevention	NOUN
aiua-11120	255	4	of	of	ADP
aiua-11120	255	5	micturition	micturition	NOUN
aiua-11120	255	6	reflex	reflex	NOUN
aiua-11120	255	7	to	to	PART
aiua-11120	255	8	trigger	trigger	NOUN
aiua-11120	255	9	bladder	bladder	NOUN
aiua-11120	255	10	overactivity	overactivity	NOUN
aiua-11120	255	11	represents	represent	VERB
aiua-11120	255	12	a	a	DET
aiua-11120	255	13	possible	possible	ADJ
aiua-11120	255	14	alternative	alternative	NOUN
aiua-11120	255	15	to	to	ADP
aiua-11120	255	16	drugs	drug	NOUN
aiua-11120	255	17	blocking	block	VERB
aiua-11120	255	18	smooth	smooth	ADJ
aiua-11120	255	19	muscle	muscle	NOUN
aiua-11120	255	20	contraction	contraction	NOUN
aiua-11120	255	21	like	like	ADP
aiua-11120	255	22	anticholinergics	anticholinergic	NOUN
aiua-11120	255	23	.	.	PUNCT
aiua-11120	256	1	drugs	drug	NOUN
aiua-11120	256	2	like	like	ADP
aiua-11120	256	3	capsaicin	capsaicin	NOUN
aiua-11120	256	4	,	,	PUNCT
aiua-11120	256	5	rtx	rtx	PROPN
aiua-11120	256	6	,	,	PUNCT
aiua-11120	256	7	and	and	CCONJ
aiua-11120	256	8	nociception	nociception	NOUN
aiua-11120	256	9	/	/	SYM
aiua-11120	256	10	orphanin	orphanin	PROPN
aiua-11120	256	11	fq	fq	PROPN
aiua-11120	256	12	have	have	VERB
aiua-11120	256	13	an	an	DET
aiua-11120	256	14	effect	effect	NOUN
aiua-11120	256	15	on	on	ADP
aiua-11120	256	16	the	the	DET
aiua-11120	256	17	unmyelinated	unmyelinated	ADJ
aiua-11120	256	18	c	c	NOUN
aiua-11120	256	19	-	-	PUNCT
aiua-11120	256	20	fiber	fiber	NOUN
aiua-11120	256	21	afferent	afferent	ADJ
aiua-11120	256	22	limb	limb	NOUN
aiua-11120	256	23	of	of	ADP
aiua-11120	256	24	the	the	DET
aiua-11120	256	25	micturition	micturition	NOUN
aiua-11120	256	26	reflex	reflex	NOUN
aiua-11120	256	27	.	.	PUNCT
aiua-11120	257	1	instillations	instillation	NOUN
aiua-11120	257	2	of	of	ADP
aiua-11120	257	3	both	both	DET
aiua-11120	257	4	capsaicin	capsaicin	NOUN
aiua-11120	257	5	and	and	CCONJ
aiua-11120	257	6	nociceptin	nociceptin	PROPN
aiua-11120	257	7	/	/	SYM
aiua-11120	257	8	orphanin	orphanin	PROPN
aiua-11120	257	9	fq	fq	PROPN
aiua-11120	257	10	were	be	AUX
aiua-11120	257	11	able	able	ADJ
aiua-11120	257	12	to	to	PART
aiua-11120	257	13	decrease	decrease	VERB
aiua-11120	257	14	incontinence	incontinence	NOUN
aiua-11120	257	15	rates	rate	NOUN
aiua-11120	257	16	and	and	CCONJ
aiua-11120	257	17	to	to	PART
aiua-11120	257	18	improve	improve	VERB
aiua-11120	257	19	urodynamic	urodynamic	ADJ
aiua-11120	257	20	parameters	parameter	NOUN
aiua-11120	257	21	in	in	ADP
aiua-11120	257	22	patients	patient	NOUN
aiua-11120	257	23	with	with	ADP
aiua-11120	257	24	neurogenic	neurogenic	ADJ
aiua-11120	257	25	oba	oba	NOUN
aiua-11120	257	26	(	(	PUNCT
aiua-11120	257	27	37	37	NUM
aiua-11120	257	28	-	-	SYM
aiua-11120	257	29	39	39	NUM
aiua-11120	257	30	)	)	PUNCT
aiua-11120	257	31	.	.	PUNCT
aiua-11120	258	1	botolinum	botolinum	ADJ
aiua-11120	258	2	toxin	toxin	NOUN
aiua-11120	258	3	injections	injection	NOUN
aiua-11120	258	4	botulinum	botulinum	ADJ
aiua-11120	258	5	toxin	toxin	NOUN
aiua-11120	258	6	has	have	AUX
aiua-11120	258	7	been	be	AUX
aiua-11120	258	8	used	use	VERB
aiua-11120	258	9	for	for	ADP
aiua-11120	258	10	many	many	ADJ
aiua-11120	258	11	years	year	NOUN
aiua-11120	258	12	in	in	ADP
aiua-11120	258	13	the	the	DET
aiua-11120	258	14	treatment	treatment	NOUN
aiua-11120	258	15	of	of	ADP
aiua-11120	258	16	severe	severe	ADJ
aiua-11120	258	17	neurogenic	neurogenic	ADJ
aiua-11120	258	18	overactive	overactive	ADJ
aiua-11120	258	19	bladder	bladder	NOUN
aiua-11120	258	20	refractory	refractory	NOUN
aiua-11120	258	21	to	to	ADP
aiua-11120	258	22	standard	standard	ADJ
aiua-11120	258	23	treatment	treatment	NOUN
aiua-11120	258	24	.	.	PUNCT
aiua-11120	259	1	in	in	ADP
aiua-11120	259	2	2007	2007	NUM
aiua-11120	259	3	,	,	PUNCT
aiua-11120	259	4	duthie	duthie	PROPN
aiua-11120	259	5	et	et	PROPN
aiua-11120	259	6	al	al	PROPN
aiua-11120	259	7	.	.	PROPN
aiua-11120	259	8	published	publish	VERB
aiua-11120	259	9	a	a	DET
aiua-11120	259	10	systematic	systematic	ADJ
aiua-11120	259	11	review	review	NOUN
aiua-11120	259	12	on	on	ADP
aiua-11120	259	13	the	the	DET
aiua-11120	259	14	treatment	treatment	NOUN
aiua-11120	259	15	of	of	ADP
aiua-11120	259	16	overactive	overactive	ADJ
aiua-11120	259	17	bladder	bladder	NOUN
aiua-11120	259	18	syndrome	syndrome	NOUN
aiua-11120	259	19	with	with	ADP
aiua-11120	259	20	botulinum	botulinum	ADJ
aiua-11120	259	21	toxin	toxin	NOUN
aiua-11120	259	22	injections	injection	NOUN
aiua-11120	259	23	.	.	PUNCT
aiua-11120	260	1	the	the	DET
aiua-11120	260	2	review	review	NOUN
aiua-11120	260	3	,	,	PUNCT
aiua-11120	260	4	which	which	PRON
aiua-11120	260	5	was	be	AUX
aiua-11120	260	6	updated	update	VERB
aiua-11120	260	7	in	in	ADP
aiua-11120	260	8	2011	2011	NUM
aiua-11120	260	9	(	(	PUNCT
aiua-11120	260	10	9	9	NUM
aiua-11120	260	11	)	)	PUNCT
aiua-11120	260	12	,	,	PUNCT
aiua-11120	260	13	included	include	VERB
aiua-11120	260	14	patients	patient	NOUN
aiua-11120	260	15	affected	affect	VERB
aiua-11120	260	16	by	by	ADP
aiua-11120	260	17	either	either	CCONJ
aiua-11120	260	18	neurogenic	neurogenic	ADJ
aiua-11120	260	19	oab	oab	PROPN
aiua-11120	260	20	or	or	CCONJ
aiua-11120	260	21	idiopathic	idiopathic	ADJ
aiua-11120	260	22	oab	oab	PROPN
aiua-11120	260	23	.	.	PUNCT
aiua-11120	261	1	botulinum	botulinum	ADJ
aiua-11120	261	2	toxin	toxin	NOUN
aiua-11120	261	3	injection	injection	NOUN
aiua-11120	261	4	was	be	AUX
aiua-11120	261	5	superior	superior	ADJ
aiua-11120	261	6	to	to	AUX
aiua-11120	261	7	placebo	placebo	NOUN
aiua-11120	261	8	in	in	ADP
aiua-11120	261	9	all	all	DET
aiua-11120	261	10	studies	study	NOUN
aiua-11120	261	11	included	include	VERB
aiua-11120	261	12	in	in	ADP
aiua-11120	261	13	the	the	DET
aiua-11120	261	14	analysis	analysis	NOUN
aiua-11120	261	15	,	,	PUNCT
aiua-11120	261	16	with	with	ADP
aiua-11120	261	17	an	an	DET
aiua-11120	261	18	effect	effect	NOUN
aiua-11120	261	19	lasting	last	VERB
aiua-11120	261	20	for	for	ADP
aiua-11120	261	21	several	several	ADJ
aiua-11120	261	22	months	month	NOUN
aiua-11120	261	23	depending	depend	VERB
aiua-11120	261	24	on	on	ADP
aiua-11120	261	25	the	the	DET
aiua-11120	261	26	dose	dose	NOUN
aiua-11120	261	27	and	and	CCONJ
aiua-11120	261	28	the	the	DET
aiua-11120	261	29	type	type	NOUN
aiua-11120	261	30	of	of	ADP
aiua-11120	261	31	toxin	toxin	NOUN
aiua-11120	261	32	used	use	VERB
aiua-11120	261	33	.	.	PUNCT
aiua-11120	262	1	other	other	ADJ
aiua-11120	262	2	systematic	systematic	ADJ
aiua-11120	262	3	reviews	review	NOUN
aiua-11120	262	4	with	with	ADP
aiua-11120	262	5	meta	meta	ADJ
aiua-11120	262	6	-	-	PUNCT
aiua-11120	262	7	analysis	analysis	NOUN
aiua-11120	262	8	were	be	AUX
aiua-11120	262	9	subsequently	subsequently	ADV
aiua-11120	262	10	published	publish	VERB
aiua-11120	262	11	to	to	PART
aiua-11120	262	12	confirm	confirm	VERB
aiua-11120	262	13	the	the	DET
aiua-11120	262	14	efficacy	efficacy	NOUN
aiua-11120	262	15	and	and	CCONJ
aiua-11120	262	16	safety	safety	NOUN
aiua-11120	262	17	of	of	ADP
aiua-11120	262	18	this	this	DET
aiua-11120	262	19	treatment	treatment	NOUN
aiua-11120	262	20	.	.	PUNCT
aiua-11120	263	1	zhang	zhang	PROPN
aiua-11120	263	2	et	et	PROPN
aiua-11120	263	3	al	al	PROPN
aiua-11120	263	4	.	.	PROPN
aiua-11120	264	1	(	(	PUNCT
aiua-11120	264	2	10	10	NUM
aiua-11120	264	3	)	)	PUNCT
aiua-11120	264	4	retrieved	retrieve	VERB
aiua-11120	264	5	eight	eight	NUM
aiua-11120	264	6	rcts	rct	NOUN
aiua-11120	264	7	focusing	focus	VERB
aiua-11120	264	8	on	on	ADP
aiua-11120	264	9	efficacy	efficacy	NOUN
aiua-11120	264	10	and	and	CCONJ
aiua-11120	264	11	safety	safety	NOUN
aiua-11120	264	12	of	of	ADP
aiua-11120	264	13	onabotulinumtoxina	onabotulinumtoxina	PROPN
aiua-11120	264	14	in	in	ADP
aiua-11120	264	15	patients	patient	NOUN
aiua-11120	264	16	with	with	ADP
aiua-11120	264	17	neurogenic	neurogenic	ADJ
aiua-11120	264	18	detrusor	detrusor	NOUN
aiua-11120	264	19	overactivity	overactivity	NOUN
aiua-11120	264	20	(	(	PUNCT
aiua-11120	264	21	ndo	ndo	PROPN
aiua-11120	264	22	)	)	PUNCT
aiua-11120	264	23	,	,	PUNCT
aiua-11120	264	24	published	publish	VERB
aiua-11120	264	25	up	up	ADP
aiua-11120	264	26	to	to	ADP
aiua-11120	264	27	september	september	PROPN
aiua-11120	264	28	2012	2012	NUM
aiua-11120	264	29	.	.	PUNCT
aiua-11120	265	1	infiltrations	infiltration	NOUN
aiua-11120	265	2	with	with	ADP
aiua-11120	265	3	onabotulinumtoxina	onabotulinumtoxina	PROPN
aiua-11120	265	4	improved	improve	VERB
aiua-11120	265	5	maximum	maximum	ADJ
aiua-11120	265	6	cystometric	cystometric	ADJ
aiua-11120	265	7	capacity	capacity	NOUN
aiua-11120	265	8	and	and	CCONJ
aiua-11120	265	9	decreased	decrease	VERB
aiua-11120	265	10	maximum	maximum	ADJ
aiua-11120	265	11	detrusor	detrusor	NOUN
aiua-11120	265	12	pressure	pressure	NOUN
aiua-11120	265	13	compared	compare	VERB
aiua-11120	265	14	to	to	ADP
aiua-11120	265	15	placebo	placebo	NOUN
aiua-11120	265	16	.	.	PUNCT
aiua-11120	266	1	the	the	DET
aiua-11120	266	2	treatment	treatment	NOUN
aiua-11120	266	3	was	be	AUX
aiua-11120	266	4	more	more	ADV
aiua-11120	266	5	frequently	frequently	ADV
aiua-11120	266	6	associated	associate	VERB
aiua-11120	266	7	with	with	ADP
aiua-11120	266	8	utis	utis	NOUN
aiua-11120	266	9	than	than	ADP
aiua-11120	266	10	placebo	placebo	NOUN
aiua-11120	266	11	.	.	PUNCT
aiua-11120	267	1	no	no	DET
aiua-11120	267	2	dose	dose	NOUN
aiua-11120	267	3	-	-	PUNCT
aiua-11120	267	4	related	relate	VERB
aiua-11120	267	5	differences	difference	NOUN
aiua-11120	267	6	of	of	ADP
aiua-11120	267	7	efficacy	efficacy	NOUN
aiua-11120	267	8	and	and	CCONJ
aiua-11120	267	9	side	side	NOUN
aiua-11120	267	10	effects	effect	NOUN
aiua-11120	267	11	were	be	AUX
aiua-11120	267	12	observed	observe	VERB
aiua-11120	267	13	when	when	SCONJ
aiua-11120	267	14	regimens	regimen	NOUN
aiua-11120	267	15	based	base	VERB
aiua-11120	267	16	on	on	ADP
aiua-11120	267	17	300	300	NUM
aiua-11120	267	18	u	u	NOUN
aiua-11120	267	19	or	or	CCONJ
aiua-11120	267	20	200	200	NUM
aiua-11120	267	21	u	u	NOUN
aiua-11120	267	22	doses	dose	NOUN
aiua-11120	267	23	were	be	AUX
aiua-11120	267	24	compared	compare	VERB
aiua-11120	267	25	.	.	PUNCT
aiua-11120	268	1	similarly	similarly	ADV
aiua-11120	268	2	,	,	PUNCT
aiua-11120	268	3	zhou	zhou	PROPN
aiua-11120	268	4	et	et	PROPN
aiua-11120	268	5	al	al	PROPN
aiua-11120	268	6	.	.	PROPN
aiua-11120	269	1	(	(	PUNCT
aiua-11120	269	2	11	11	NUM
aiua-11120	269	3	)	)	PUNCT
aiua-11120	269	4	searched	search	VERB
aiua-11120	269	5	databases	database	NOUN
aiua-11120	269	6	(	(	PUNCT
aiua-11120	269	7	up	up	ADP
aiua-11120	269	8	to	to	ADP
aiua-11120	269	9	november	november	PROPN
aiua-11120	269	10	2013	2013	NUM
aiua-11120	269	11	)	)	PUNCT
aiua-11120	269	12	to	to	PART
aiua-11120	269	13	identify	identify	VERB
aiua-11120	269	14	rcts	rct	NOUN
aiua-11120	269	15	focusing	focus	VERB
aiua-11120	269	16	on	on	ADP
aiua-11120	269	17	the	the	DET
aiua-11120	269	18	effect	effect	NOUN
aiua-11120	269	19	of	of	ADP
aiua-11120	269	20	onabotulinumtoxina	onabotulinumtoxina	NOUN
aiua-11120	269	21	for	for	ADP
aiua-11120	269	22	treatment	treatment	NOUN
aiua-11120	269	23	of	of	ADP
aiua-11120	269	24	ndo	ndo	NOUN
aiua-11120	269	25	.	.	PUNCT
aiua-11120	270	1	the	the	DET
aiua-11120	270	2	authors	author	NOUN
aiua-11120	270	3	included	include	VERB
aiua-11120	270	4	four	four	NUM
aiua-11120	270	5	studies	study	NOUN
aiua-11120	270	6	in	in	ADP
aiua-11120	270	7	their	their	PRON
aiua-11120	270	8	analysis	analysis	NOUN
aiua-11120	270	9	,	,	PUNCT
aiua-11120	270	10	which	which	PRON
aiua-11120	270	11	confirmed	confirm	VERB
aiua-11120	270	12	a	a	DET
aiua-11120	270	13	dose	dose	NOUN
aiua-11120	270	14	-	-	PUNCT
aiua-11120	270	15	independent	independent	ADJ
aiua-11120	270	16	reduction	reduction	NOUN
aiua-11120	270	17	of	of	ADP
aiua-11120	270	18	the	the	DET
aiua-11120	270	19	number	number	NOUN
aiua-11120	270	20	of	of	ADP
aiua-11120	270	21	urinary	urinary	ADJ
aiua-11120	270	22	incontinence	incontinence	NOUN
aiua-11120	270	23	episodes	episode	NOUN
aiua-11120	270	24	per	per	ADP
aiua-11120	270	25	week	week	NOUN
aiua-11120	270	26	,	,	PUNCT
aiua-11120	270	27	the	the	DET
aiua-11120	270	28	increase	increase	NOUN
aiua-11120	270	29	of	of	ADP
aiua-11120	270	30	maximum	maximum	ADJ
aiua-11120	270	31	cystometric	cystometric	ADJ
aiua-11120	270	32	capacity	capacity	NOUN
aiua-11120	270	33	,	,	PUNCT
aiua-11120	270	34	and	and	CCONJ
aiua-11120	270	35	the	the	DET
aiua-11120	270	36	reduction	reduction	NOUN
aiua-11120	270	37	of	of	ADP
aiua-11120	270	38	maximum	maximum	ADJ
aiua-11120	270	39	detrusor	detrusor	NOUN
aiua-11120	270	40	pressure	pressure	NOUN
aiua-11120	270	41	compared	compare	VERB
aiua-11120	270	42	to	to	ADP
aiua-11120	270	43	placebo	placebo	NOUN
aiua-11120	270	44	.	.	PUNCT
aiua-11120	271	1	onabotulinumtoxina	onabotulinumtoxina	PROPN
aiua-11120	271	2	was	be	AUX
aiua-11120	271	3	more	more	ADV
aiua-11120	271	4	often	often	ADV
aiua-11120	271	5	associated	associate	VERB
aiua-11120	271	6	with	with	ADP
aiua-11120	271	7	the	the	DET
aiua-11120	271	8	onset	onset	NOUN
aiua-11120	271	9	of	of	ADP
aiua-11120	271	10	utis	utis	NOUN
aiua-11120	271	11	,	,	PUNCT
aiua-11120	271	12	hematuria	hematuria	NOUN
aiua-11120	271	13	and	and	CCONJ
aiua-11120	271	14	urinary	urinary	ADJ
aiua-11120	271	15	retention	retention	NOUN
aiua-11120	271	16	.	.	PUNCT
aiua-11120	272	1	mehta	mehta	PROPN
aiua-11120	272	2	et	et	PROPN
aiua-11120	272	3	al	al	PROPN
aiua-11120	272	4	.	.	PROPN
aiua-11120	273	1	(	(	PUNCT
aiua-11120	273	2	12	12	NUM
aiua-11120	273	3	)	)	PUNCT
aiua-11120	273	4	retrieved	retrieve	VERB
aiua-11120	273	5	14	14	NUM
aiua-11120	273	6	studies	study	NOUN
aiua-11120	273	7	from	from	ADP
aiua-11120	273	8	1980	1980	NUM
aiua-11120	273	9	to	to	ADP
aiua-11120	273	10	june	june	PROPN
aiua-11120	273	11	2012	2012	NUM
aiua-11120	273	12	,	,	PUNCT
aiua-11120	273	13	demonstrating	demonstrate	VERB
aiua-11120	273	14	improvements	improvement	NOUN
aiua-11120	273	15	of	of	ADP
aiua-11120	273	16	postvoid	postvoid	ADJ
aiua-11120	273	17	residual	residual	ADJ
aiua-11120	273	18	urine	urine	NOUN
aiua-11120	273	19	volume	volume	NOUN
aiua-11120	273	20	,	,	PUNCT
aiua-11120	273	21	reflex	reflex	ADJ
aiua-11120	273	22	detrusor	detrusor	NOUN
aiua-11120	273	23	volume	volume	NOUN
aiua-11120	273	24	,	,	PUNCT
aiua-11120	273	25	bladder	bladder	NOUN
aiua-11120	273	26	capacity	capacity	NOUN
aiua-11120	273	27	,	,	PUNCT
aiua-11120	273	28	bladder	bladder	NOUN
aiua-11120	273	29	compliance	compliance	NOUN
aiua-11120	273	30	,	,	PUNCT
aiua-11120	273	31	and	and	CCONJ
aiua-11120	273	32	catheterization	catheterization	NOUN
aiua-11120	273	33	frequency	frequency	NOUN
aiua-11120	273	34	(	(	PUNCT
aiua-11120	273	35	p	p	X
aiua-11120	273	36	<	<	X
aiua-11120	273	37	0.01	0.01	NUM
aiua-11120	273	38	)	)	PUNCT
aiua-11120	273	39	after	after	ADP
aiua-11120	273	40	administration	administration	NOUN
aiua-11120	273	41	of	of	ADP
aiua-11120	273	42	botulinum	botulinum	ADJ
aiua-11120	273	43	toxin	toxin	NOUN
aiua-11120	273	44	type	type	NOUN
aiua-11120	273	45	a	a	DET
aiua-11120	273	46	(	(	PUNCT
aiua-11120	273	47	btx	btx	NOUN
aiua-11120	273	48	-	-	PUNCT
aiua-11120	273	49	a	a	NOUN
aiua-11120	273	50	)	)	PUNCT
aiua-11120	273	51	.	.	PUNCT
aiua-11120	274	1	wu	wu	PROPN
aiua-11120	274	2	et	et	PROPN
aiua-11120	274	3	al	al	PROPN
aiua-11120	274	4	.	.	PROPN
aiua-11120	275	1	(	(	PUNCT
aiua-11120	275	2	13	13	NUM
aiua-11120	275	3	)	)	PUNCT
aiua-11120	275	4	searched	search	VERB
aiua-11120	275	5	the	the	DET
aiua-11120	275	6	literature	literature	NOUN
aiua-11120	275	7	up	up	ADP
aiua-11120	275	8	to	to	ADP
aiua-11120	275	9	may	may	PROPN
aiua-11120	275	10	2017	2017	NUM
aiua-11120	275	11	and	and	CCONJ
aiua-11120	275	12	included	include	VERB
aiua-11120	275	13	five	five	NUM
aiua-11120	275	14	rcts	rct	NOUN
aiua-11120	275	15	in	in	ADP
aiua-11120	275	16	their	their	PRON
aiua-11120	275	17	analysis	analysis	NOUN
aiua-11120	275	18	.	.	PUNCT
aiua-11120	276	1	btx	btx	VERB
aiua-11120	276	2	-	-	PUNCT
aiua-11120	276	3	a	a	DET
aiua-11120	276	4	intra	intra	ADJ
aiua-11120	276	5	-	-	ADJ
aiua-11120	276	6	detrusorial	detrusorial	ADJ
aiua-11120	276	7	infiltrations	infiltration	NOUN
aiua-11120	276	8	reduced	reduce	VERB
aiua-11120	276	9	the	the	DET
aiua-11120	276	10	number	number	NOUN
aiua-11120	276	11	of	of	ADP
aiua-11120	276	12	urinary	urinary	ADJ
aiua-11120	276	13	incontinence	incontinence	NOUN
aiua-11120	276	14	episodes	episode	NOUN
aiua-11120	276	15	per	per	ADP
aiua-11120	276	16	day	day	NOUN
aiua-11120	276	17	and	and	CCONJ
aiua-11120	276	18	per	per	ADP
aiua-11120	276	19	week	week	NOUN
aiua-11120	276	20	compared	compare	VERB
aiua-11120	276	21	to	to	ADP
aiua-11120	276	22	placebo	placebo	NOUN
aiua-11120	276	23	and	and	CCONJ
aiua-11120	276	24	increased	increase	VERB
aiua-11120	276	25	maximum	maximum	ADJ
aiua-11120	276	26	cystometric	cystometric	ADJ
aiua-11120	276	27	capacity	capacity	NOUN
aiua-11120	276	28	and	and	CCONJ
aiua-11120	276	29	decreased	decrease	VERB
aiua-11120	276	30	maximum	maximum	ADJ
aiua-11120	276	31	detrusor	detrusor	NOUN
aiua-11120	276	32	pressure	pressure	NOUN
aiua-11120	276	33	at	at	ADP
aiua-11120	276	34	week	week	NOUN
aiua-11120	276	35	6	6	NUM
aiua-11120	276	36	.	.	PUNCT
aiua-11120	277	1	btx	btx	VERB
aiua-11120	277	2	-	-	PUNCT
aiua-11120	277	3	a	a	DET
aiua-11120	277	4	administration	administration	NOUN
aiua-11120	277	5	was	be	AUX
aiua-11120	277	6	more	more	ADV
aiua-11120	277	7	frequently	frequently	ADV
aiua-11120	277	8	associated	associate	VERB
aiua-11120	277	9	with	with	ADP
aiua-11120	277	10	urinary	urinary	ADJ
aiua-11120	277	11	tract	tract	NOUN
aiua-11120	277	12	infections	infection	NOUN
aiua-11120	277	13	.	.	PUNCT
aiua-11120	278	1	ni	ni	PROPN
aiua-11120	278	2	et	et	PROPN
aiua-11120	278	3	al	al	PROPN
aiua-11120	278	4	.	.	PROPN
aiua-11120	279	1	(	(	PUNCT
aiua-11120	279	2	14	14	NUM
aiua-11120	279	3	)	)	PUNCT
aiua-11120	279	4	searched	search	VERB
aiua-11120	279	5	the	the	DET
aiua-11120	279	6	literature	literature	NOUN
aiua-11120	279	7	up	up	ADP
aiua-11120	279	8	to	to	ADP
aiua-11120	279	9	june	june	PROPN
aiua-11120	279	10	2016	2016	NUM
aiua-11120	279	11	for	for	ADP
aiua-11120	279	12	papers	paper	NOUN
aiua-11120	279	13	reporting	report	VERB
aiua-11120	279	14	the	the	DET
aiua-11120	279	15	outcomes	outcome	NOUN
aiua-11120	279	16	of	of	ADP
aiua-11120	279	17	studies	study	NOUN
aiua-11120	279	18	focusing	focus	VERB
aiua-11120	279	19	on	on	ADP
aiua-11120	279	20	repeated	repeat	VERB
aiua-11120	279	21	btx	btx	VERB
aiua-11120	279	22	-	-	PUNCT
aiua-11120	279	23	a	a	DET
aiua-11120	279	24	injections	injection	NOUN
aiua-11120	279	25	in	in	ADP
aiua-11120	279	26	adult	adult	NOUN
aiua-11120	279	27	patients	patient	NOUN
aiua-11120	279	28	with	with	ADP
aiua-11120	279	29	ndo	ndo	PROPN
aiua-11120	279	30	.	.	PUNCT
aiua-11120	280	1	they	they	PRON
aiua-11120	280	2	included	include	VERB
aiua-11120	280	3	18	18	NUM
aiua-11120	280	4	retrospective	retrospective	ADJ
aiua-11120	280	5	or	or	CCONJ
aiua-11120	280	6	prospective	prospective	ADJ
aiua-11120	280	7	cohort	cohort	NOUN
aiua-11120	280	8	studies	study	NOUN
aiua-11120	280	9	,	,	PUNCT
aiua-11120	280	10	but	but	CCONJ
aiua-11120	280	11	no	no	DET
aiua-11120	280	12	rct	rct	PROPN
aiua-11120	280	13	.	.	PUNCT
aiua-11120	281	1	the	the	DET
aiua-11120	281	2	meta	meta	ADJ
aiua-11120	281	3	-	-	PUNCT
aiua-11120	281	4	analysis	analysis	NOUN
aiua-11120	281	5	demonstrated	demonstrate	VERB
aiua-11120	281	6	that	that	SCONJ
aiua-11120	281	7	repeated	repeat	VERB
aiua-11120	281	8	btx	btx	NOUN
aiua-11120	281	9	-	-	PUNCT
aiua-11120	281	10	a	a	DET
aiua-11120	281	11	injections	injection	NOUN
aiua-11120	281	12	allowed	allow	VERB
aiua-11120	281	13	sustained	sustain	VERB
aiua-11120	281	14	improvements	improvement	NOUN
aiua-11120	281	15	in	in	ADP
aiua-11120	281	16	patients	patient	NOUN
aiua-11120	281	17	with	with	ADP
aiua-11120	281	18	ndo	ndo	PROPN
aiua-11120	281	19	,	,	PUNCT
aiua-11120	281	20	with	with	ADP
aiua-11120	281	21	a	a	DET
aiua-11120	281	22	stable	stable	ADJ
aiua-11120	281	23	and	and	CCONJ
aiua-11120	281	24	low	low	ADJ
aiua-11120	281	25	rate	rate	NOUN
aiua-11120	281	26	of	of	ADP
aiua-11120	281	27	adverse	adverse	ADJ
aiua-11120	281	28	events	event	NOUN
aiua-11120	281	29	.	.	PUNCT
aiua-11120	282	1	jo	jo	PROPN
aiua-11120	282	2	et	et	PROPN
aiua-11120	282	3	al	al	PROPN
aiua-11120	282	4	.	.	PROPN
aiua-11120	283	1	(	(	PUNCT
aiua-11120	283	2	15	15	NUM
aiua-11120	283	3	)	)	PUNCT
aiua-11120	283	4	searched	search	VERB
aiua-11120	283	5	for	for	ADP
aiua-11120	283	6	rcts	rct	NOUN
aiua-11120	283	7	assessing	assess	VERB
aiua-11120	283	8	the	the	DET
aiua-11120	283	9	efficacy	efficacy	NOUN
aiua-11120	283	10	and	and	CCONJ
aiua-11120	283	11	safety	safety	NOUN
aiua-11120	283	12	of	of	ADP
aiua-11120	283	13	onabotulinumtoxina	onabotulinumtoxina	PROPN
aiua-11120	283	14	,	,	PUNCT
aiua-11120	283	15	administered	administer	VERB
aiua-11120	283	16	in	in	ADP
aiua-11120	283	17	different	different	ADJ
aiua-11120	283	18	injection	injection	NOUN
aiua-11120	283	19	sites	site	NOUN
aiua-11120	283	20	,	,	PUNCT
aiua-11120	283	21	for	for	ADP
aiua-11120	283	22	treatment	treatment	NOUN
aiua-11120	283	23	of	of	ADP
aiua-11120	283	24	oab	oab	PROPN
aiua-11120	283	25	.	.	PUNCT
aiua-11120	284	1	the	the	DET
aiua-11120	284	2	authors	author	NOUN
aiua-11120	284	3	included	include	VERB
aiua-11120	284	4	studies	study	NOUN
aiua-11120	284	5	performed	perform	VERB
aiua-11120	284	6	in	in	ADP
aiua-11120	284	7	adults	adult	NOUN
aiua-11120	284	8	treated	treat	VERB
aiua-11120	284	9	for	for	ADP
aiua-11120	284	10	both	both	DET
aiua-11120	284	11	neurogenic	neurogenic	ADJ
aiua-11120	284	12	detrusor	detrusor	NOUN
aiua-11120	284	13	overactive	overactive	ADJ
aiua-11120	284	14	bladder	bladder	NOUN
aiua-11120	284	15	and	and	CCONJ
aiua-11120	284	16	idiopathic	idiopathic	ADJ
aiua-11120	284	17	oab	oab	PROPN
aiua-11120	284	18	.	.	PUNCT
aiua-11120	284	19	trigone	trigone	NOUN
aiua-11120	284	20	-	-	PUNCT
aiua-11120	284	21	including	include	VERB
aiua-11120	284	22	injections	injection	NOUN
aiua-11120	284	23	demonstrated	demonstrate	VERB
aiua-11120	284	24	more	more	ADV
aiua-11120	284	25	significant	significant	ADJ
aiua-11120	284	26	improvement	improvement	NOUN
aiua-11120	284	27	in	in	ADP
aiua-11120	284	28	symptom	symptom	NOUN
aiua-11120	284	29	score	score	NOUN
aiua-11120	284	30	,	,	PUNCT
aiua-11120	284	31	higher	high	ADJ
aiua-11120	284	32	complete	complete	ADJ
aiua-11120	284	33	dryness	dryness	NOUN
aiua-11120	284	34	rates	rate	NOUN
aiua-11120	284	35	,	,	PUNCT
aiua-11120	284	36	and	and	CCONJ
aiua-11120	284	37	lower	low	ADJ
aiua-11120	284	38	rates	rate	NOUN
aiua-11120	284	39	of	of	ADP
aiua-11120	284	40	incontinence	incontinence	NOUN
aiua-11120	284	41	episodes	episode	NOUN
aiua-11120	284	42	compared	compare	VERB
aiua-11120	284	43	to	to	ADP
aiua-11120	284	44	trigone	trigone	NOUN
aiua-11120	284	45	-	-	PUNCT
aiua-11120	284	46	sparing	spare	VERB
aiua-11120	284	47	injections	injection	NOUN
aiua-11120	284	48	.	.	PUNCT
aiua-11120	285	1	moreover	moreover	ADV
aiua-11120	285	2	,	,	PUNCT
aiua-11120	285	3	lower	low	ADJ
aiua-11120	285	4	detrusor	detrusor	NOUN
aiua-11120	285	5	pressure	pressure	NOUN
aiua-11120	285	6	and	and	CCONJ
aiua-11120	285	7	higher	high	ADJ
aiua-11120	285	8	volume	volume	NOUN
aiua-11120	285	9	at	at	ADP
aiua-11120	285	10	first	first	ADJ
aiua-11120	285	11	desire	desire	NOUN
aiua-11120	285	12	to	to	PART
aiua-11120	285	13	void	void	VERB
aiua-11120	285	14	were	be	AUX
aiua-11120	285	15	observed	observe	VERB
aiua-11120	285	16	with	with	ADP
aiua-11120	285	17	trigoneincluding	trigoneinclude	VERB
aiua-11120	285	18	injection	injection	NOUN
aiua-11120	285	19	.	.	PUNCT
aiua-11120	286	1	we	we	PRON
aiua-11120	286	2	added	add	VERB
aiua-11120	286	3	three	three	NUM
aiua-11120	286	4	recently	recently	ADV
aiua-11120	286	5	published	publish	VERB
aiua-11120	286	6	studies	study	NOUN
aiua-11120	286	7	assessing	assess	VERB
aiua-11120	286	8	the	the	DET
aiua-11120	286	9	effect	effect	NOUN
aiua-11120	286	10	of	of	ADP
aiua-11120	286	11	abobotulinumtoxina	abobotulinumtoxina	PROPN
aiua-11120	286	12	in	in	ADP
aiua-11120	286	13	patients	patient	NOUN
aiua-11120	286	14	with	with	ADP
aiua-11120	286	15	ndo	ndo	PROPN
aiua-11120	286	16	on	on	ADP
aiua-11120	286	17	clean	clean	ADJ
aiua-11120	286	18	intermittent	intermittent	ADJ
aiua-11120	286	19	catheterization	catheterization	NOUN
aiua-11120	286	20	(	(	PUNCT
aiua-11120	286	21	49	49	NUM
aiua-11120	286	22	)	)	PUNCT
aiua-11120	286	23	,	,	PUNCT
aiua-11120	286	24	comparing	compare	VERB
aiua-11120	286	25	the	the	DET
aiua-11120	286	26	performance	performance	NOUN
aiua-11120	286	27	of	of	ADP
aiua-11120	286	28	abobotulinumtoxina	abobotulinumtoxina	PROPN
aiua-11120	286	29	by	by	ADP
aiua-11120	286	30	15	15	NUM
aiua-11120	286	31	intra	intra	ADJ
aiua-11120	286	32	-	-	ADJ
aiua-11120	286	33	detrusor	detrusor	NOUN
aiua-11120	286	34	injections	injection	NOUN
aiua-11120	286	35	with	with	ADP
aiua-11120	286	36	a	a	DET
aiua-11120	286	37	30	30	NUM
aiua-11120	286	38	-	-	PUNCT
aiua-11120	286	39	injection	injection	NOUN
aiua-11120	286	40	regimen	regiman	NOUN
aiua-11120	286	41	(	(	PUNCT
aiua-11120	286	42	43	43	NUM
aiua-11120	286	43	)	)	PUNCT
aiua-11120	286	44	,	,	PUNCT
aiua-11120	286	45	and	and	CCONJ
aiua-11120	286	46	describing	describe	VERB
aiua-11120	286	47	the	the	DET
aiua-11120	286	48	results	result	NOUN
aiua-11120	286	49	of	of	ADP
aiua-11120	286	50	the	the	DET
aiua-11120	286	51	administration	administration	NOUN
aiua-11120	286	52	of	of	ADP
aiua-11120	286	53	onabotulinumtoxina	onabotulinumtoxina	PROPN
aiua-11120	286	54	in	in	ADP
aiua-11120	286	55	japanese	japanese	ADJ
aiua-11120	286	56	patients	patient	NOUN
aiua-11120	286	57	(	(	PUNCT
aiua-11120	286	58	47	47	NUM
aiua-11120	286	59	)	)	PUNCT
aiua-11120	286	60	.	.	PUNCT
aiua-11120	287	1	abobotulinumtoxina	abobotulinumtoxina	PROPN
aiua-11120	287	2	showed	show	VERB
aiua-11120	287	3	its	its	PRON
aiua-11120	287	4	efficacy	efficacy	NOUN
aiua-11120	287	5	in	in	ADP
aiua-11120	287	6	treating	treat	VERB
aiua-11120	287	7	patients	patient	NOUN
aiua-11120	287	8	with	with	ADP
aiua-11120	287	9	ndo	ndo	PROPN
aiua-11120	287	10	compared	compare	VERB
aiua-11120	287	11	to	to	ADP
aiua-11120	287	12	placebo	placebo	NOUN
aiua-11120	287	13	even	even	ADV
aiua-11120	287	14	when	when	SCONJ
aiua-11120	287	15	the	the	DET
aiua-11120	287	16	number	number	NOUN
aiua-11120	287	17	of	of	ADP
aiua-11120	287	18	injections	injection	NOUN
aiua-11120	287	19	was	be	AUX
aiua-11120	287	20	reduced	reduce	VERB
aiua-11120	287	21	and	and	CCONJ
aiua-11120	287	22	the	the	DET
aiua-11120	287	23	efficacy	efficacy	NOUN
aiua-11120	287	24	of	of	ADP
aiua-11120	287	25	onabotulinumtoxina	onabotulinumtoxina	PROPN
aiua-11120	287	26	was	be	AUX
aiua-11120	287	27	confirmed	confirm	VERB
aiua-11120	287	28	in	in	ADP
aiua-11120	287	29	an	an	DET
aiua-11120	287	30	asian	asian	ADJ
aiua-11120	287	31	population	population	NOUN
aiua-11120	287	32	.	.	PUNCT
aiua-11120	288	1	503archivio	503archivio	PROPN
aiua-11120	288	2	italiano	italiano	NOUN
aiua-11120	288	3	di	di	X
aiua-11120	288	4	urologia	urologia	PROPN
aiua-11120	288	5	e	e	PROPN
aiua-11120	288	6	andrologia	andrologia	PROPN
aiua-11120	288	7	2022	2022	NUM
aiua-11120	288	8	;	;	PUNCT
aiua-11120	288	9	94	94	NUM
aiua-11120	288	10	,	,	PUNCT
aiua-11120	288	11	4	4	NUM
aiua-11120	288	12	treatment	treatment	NOUN
aiua-11120	288	13	of	of	ADP
aiua-11120	288	14	overactive	overactive	ADJ
aiua-11120	288	15	neurogenic	neurogenic	ADJ
aiua-11120	288	16	bladder	bladder	NOUN
aiua-11120	288	17	pelvic	pelvic	ADJ
aiua-11120	288	18	floor	floor	NOUN
aiua-11120	288	19	muscle	muscle	NOUN
aiua-11120	288	20	training	training	NOUN
aiua-11120	288	21	(	(	PUNCT
aiua-11120	288	22	pfmt	pfmt	NOUN
aiua-11120	288	23	)	)	PUNCT
aiua-11120	288	24	and	and	CCONJ
aiua-11120	288	25	non	non	ADJ
aiua-11120	288	26	-	-	ADJ
aiua-11120	288	27	invasive	invasive	ADJ
aiua-11120	288	28	electrical	electrical	ADJ
aiua-11120	288	29	stimulation	stimulation	NOUN
aiua-11120	288	30	a	a	DET
aiua-11120	288	31	recent	recent	ADJ
aiua-11120	288	32	metanalysis	metanalysis	NOUN
aiua-11120	288	33	addressed	address	VERB
aiua-11120	288	34	studies	study	NOUN
aiua-11120	288	35	that	that	PRON
aiua-11120	288	36	evaluated	evaluate	VERB
aiua-11120	288	37	pfmt	pfmt	NOUN
aiua-11120	288	38	in	in	ADP
aiua-11120	288	39	multiple	multiple	ADJ
aiua-11120	288	40	sclerosis	sclerosis	NOUN
aiua-11120	288	41	patients	patient	NOUN
aiua-11120	288	42	with	with	ADP
aiua-11120	288	43	luts	luts	PROPN
aiua-11120	288	44	in	in	ADP
aiua-11120	288	45	the	the	DET
aiua-11120	288	46	period	period	NOUN
aiua-11120	288	47	between	between	ADP
aiua-11120	288	48	1990	1990	NUM
aiua-11120	288	49	and	and	CCONJ
aiua-11120	288	50	2019	2019	NUM
aiua-11120	288	51	.	.	PUNCT
aiua-11120	289	1	kajbafvala	kajbafvala	PROPN
aiua-11120	289	2	et	et	PROPN
aiua-11120	289	3	al	al	PROPN
aiua-11120	289	4	.	.	PROPN
aiua-11120	290	1	(	(	PUNCT
aiua-11120	290	2	5	5	X
aiua-11120	290	3	)	)	PUNCT
aiua-11120	290	4	found	find	VERB
aiua-11120	290	5	that	that	SCONJ
aiua-11120	290	6	pfmt	pfmt	NOUN
aiua-11120	290	7	significantly	significantly	ADV
aiua-11120	290	8	reduced	reduce	VERB
aiua-11120	290	9	urinary	urinary	ADJ
aiua-11120	290	10	incontinence	incontinence	NOUN
aiua-11120	290	11	episodes	episode	NOUN
aiua-11120	290	12	and	and	CCONJ
aiua-11120	290	13	neurogenic	neurogenic	ADJ
aiua-11120	290	14	bladder	bladder	NOUN
aiua-11120	290	15	symptoms	symptom	NOUN
aiua-11120	290	16	measured	measure	VERB
aiua-11120	290	17	according	accord	VERB
aiua-11120	290	18	to	to	ADP
aiua-11120	290	19	oab	oab	PROPN
aiua-11120	290	20	-	-	PUNCT
aiua-11120	290	21	vs	vs	ADP
aiua-11120	290	22	scores	score	NOUN
aiua-11120	290	23	.	.	PUNCT
aiua-11120	291	1	according	accord	VERB
aiua-11120	291	2	to	to	ADP
aiua-11120	291	3	the	the	DET
aiua-11120	291	4	perfect	perfect	ADJ
aiua-11120	291	5	scheme	scheme	NOUN
aiua-11120	291	6	for	for	ADP
aiua-11120	291	7	assessment	assessment	NOUN
aiua-11120	291	8	of	of	ADP
aiua-11120	291	9	pelvic	pelvic	ADJ
aiua-11120	291	10	floor	floor	NOUN
aiua-11120	291	11	muscle	muscle	NOUN
aiua-11120	291	12	function	function	NOUN
aiua-11120	291	13	,	,	PUNCT
aiua-11120	291	14	pfmt	pfmt	NOUN
aiua-11120	291	15	increased	increase	VERB
aiua-11120	291	16	the	the	DET
aiua-11120	291	17	overall	overall	ADJ
aiua-11120	291	18	endurance	endurance	NOUN
aiua-11120	291	19	and	and	CCONJ
aiua-11120	291	20	power	power	NOUN
aiua-11120	291	21	of	of	ADP
aiua-11120	291	22	the	the	DET
aiua-11120	291	23	pelvic	pelvic	ADJ
aiua-11120	291	24	floor	floor	NOUN
aiua-11120	291	25	musculature	musculature	NOUN
aiua-11120	291	26	.	.	PUNCT
aiua-11120	292	1	one	one	NUM
aiua-11120	292	2	metanalysis	metanalysis	NOUN
aiua-11120	292	3	by	by	ADP
aiua-11120	292	4	vecchio	vecchio	PROPN
aiua-11120	292	5	and	and	CCONJ
aiua-11120	292	6	coworkers	coworker	NOUN
aiua-11120	292	7	evaluated	evaluate	VERB
aiua-11120	292	8	the	the	DET
aiua-11120	292	9	effectiveness	effectiveness	NOUN
aiua-11120	292	10	of	of	ADP
aiua-11120	292	11	peripheral	peripheral	ADJ
aiua-11120	292	12	tibial	tibial	ADJ
aiua-11120	292	13	nerve	nerve	NOUN
aiua-11120	292	14	stimulation	stimulation	NOUN
aiua-11120	292	15	(	(	PUNCT
aiua-11120	292	16	ptns	ptns	NOUN
aiua-11120	292	17	)	)	PUNCT
aiua-11120	292	18	and	and	CCONJ
aiua-11120	292	19	pelvic	pelvic	ADJ
aiua-11120	292	20	floor	floor	NOUN
aiua-11120	292	21	muscle	muscle	NOUN
aiua-11120	292	22	training	training	NOUN
aiua-11120	292	23	(	(	PUNCT
aiua-11120	292	24	pfmt	pfmt	NOUN
aiua-11120	292	25	)	)	PUNCT
aiua-11120	292	26	for	for	ADP
aiua-11120	292	27	bladder	bladder	NOUN
aiua-11120	292	28	dysfunction	dysfunction	NOUN
aiua-11120	292	29	in	in	ADP
aiua-11120	292	30	ms	ms	PROPN
aiua-11120	292	31	,	,	PUNCT
aiua-11120	292	32	on	on	ADP
aiua-11120	292	33	the	the	DET
aiua-11120	292	34	basis	basis	NOUN
aiua-11120	292	35	of	of	ADP
aiua-11120	292	36	data	datum	NOUN
aiua-11120	292	37	retrieved	retrieve	VERB
aiua-11120	292	38	up	up	ADP
aiua-11120	292	39	to	to	ADP
aiua-11120	292	40	october	october	PROPN
aiua-11120	292	41	2021	2021	NUM
aiua-11120	292	42	(	(	PUNCT
aiua-11120	292	43	6	6	NUM
aiua-11120	292	44	)	)	PUNCT
aiua-11120	292	45	.	.	PUNCT
aiua-11120	293	1	the	the	DET
aiua-11120	293	2	authors	author	NOUN
aiua-11120	293	3	found	find	VERB
aiua-11120	293	4	no	no	DET
aiua-11120	293	5	significant	significant	ADJ
aiua-11120	293	6	differences	difference	NOUN
aiua-11120	293	7	in	in	ADP
aiua-11120	293	8	voided	void	VERB
aiua-11120	293	9	volume	volume	NOUN
aiua-11120	293	10	after	after	ADP
aiua-11120	293	11	pfmt	pfmt	NOUN
aiua-11120	293	12	.	.	PUNCT
aiua-11120	294	1	however	however	ADV
aiua-11120	294	2	,	,	PUNCT
aiua-11120	294	3	according	accord	VERB
aiua-11120	294	4	to	to	ADP
aiua-11120	294	5	the	the	DET
aiua-11120	294	6	perfect	perfect	ADJ
aiua-11120	294	7	scheme	scheme	NOUN
aiua-11120	294	8	assessed	assess	VERB
aiua-11120	294	9	at	at	ADP
aiua-11120	294	10	3	3	NUM
aiua-11120	294	11	months	month	NOUN
aiua-11120	294	12	,	,	PUNCT
aiua-11120	294	13	endurance	endurance	NOUN
aiua-11120	294	14	and	and	CCONJ
aiua-11120	294	15	fast	fast	ADJ
aiua-11120	294	16	contraction	contraction	NOUN
aiua-11120	294	17	of	of	ADP
aiua-11120	294	18	pelvic	pelvic	ADJ
aiua-11120	294	19	floor	floor	NOUN
aiua-11120	294	20	muscles	muscle	NOUN
aiua-11120	294	21	were	be	AUX
aiua-11120	294	22	significantly	significantly	ADV
aiua-11120	294	23	improved	improve	VERB
aiua-11120	294	24	(	(	PUNCT
aiua-11120	294	25	p	p	X
aiua-11120	294	26	=	=	NOUN
aiua-11120	294	27	0.002	0.002	NUM
aiua-11120	294	28	)	)	PUNCT
aiua-11120	294	29	.	.	PUNCT
aiua-11120	295	1	papers	paper	NOUN
aiua-11120	295	2	on	on	ADP
aiua-11120	295	3	pfmt	pfmt	NOUN
aiua-11120	295	4	(	(	PUNCT
aiua-11120	295	5	without	without	ADP
aiua-11120	295	6	or	or	CCONJ
aiua-11120	295	7	with	with	ADP
aiua-11120	295	8	electrostimulation	electrostimulation	NOUN
aiua-11120	295	9	)	)	PUNCT
aiua-11120	295	10	in	in	ADP
aiua-11120	295	11	patients	patient	NOUN
aiua-11120	295	12	with	with	ADP
aiua-11120	295	13	ms	ms	NOUN
aiua-11120	295	14	which	which	PRON
aiua-11120	295	15	were	be	AUX
aiua-11120	295	16	retrieved	retrieve	VERB
aiua-11120	295	17	in	in	ADP
aiua-11120	295	18	our	our	PRON
aiua-11120	295	19	review	review	NOUN
aiua-11120	295	20	were	be	AUX
aiua-11120	295	21	also	also	ADV
aiua-11120	295	22	previously	previously	ADV
aiua-11120	295	23	included	include	VERB
aiua-11120	295	24	in	in	ADP
aiua-11120	295	25	these	these	DET
aiua-11120	295	26	reviews	review	NOUN
aiua-11120	295	27	.	.	PUNCT
aiua-11120	296	1	we	we	PRON
aiua-11120	296	2	retrieved	retrieve	VERB
aiua-11120	296	3	four	four	NUM
aiua-11120	296	4	additional	additional	ADJ
aiua-11120	296	5	studies	study	NOUN
aiua-11120	296	6	reporting	report	VERB
aiua-11120	296	7	about	about	ADP
aiua-11120	296	8	pfmt	pfmt	NOUN
aiua-11120	296	9	in	in	ADP
aiua-11120	296	10	patients	patient	NOUN
aiua-11120	296	11	with	with	ADP
aiua-11120	296	12	pd	pd	PROPN
aiua-11120	296	13	(	(	PUNCT
aiua-11120	296	14	n	n	NOUN
aiua-11120	296	15	=	=	SYM
aiua-11120	296	16	2	2	NUM
aiua-11120	296	17	)	)	PUNCT
aiua-11120	296	18	or	or	CCONJ
aiua-11120	296	19	with	with	ADP
aiua-11120	296	20	post	post	ADJ
aiua-11120	296	21	-	-	ADJ
aiua-11120	296	22	stroke	stroke	ADJ
aiua-11120	296	23	oab	oab	PROPN
aiua-11120	296	24	(	(	PUNCT
aiua-11120	296	25	n	n	NOUN
aiua-11120	296	26	=	=	NUM
aiua-11120	296	27	2	2	NUM
aiua-11120	296	28	)	)	PUNCT
aiua-11120	296	29	.	.	PUNCT
aiua-11120	297	1	meta	meta	ADJ
aiua-11120	297	2	-	-	PUNCT
aiua-11120	297	3	analysis	analysis	NOUN
aiua-11120	297	4	of	of	ADP
aiua-11120	297	5	two	two	NUM
aiua-11120	297	6	studies	study	NOUN
aiua-11120	297	7	in	in	ADP
aiua-11120	297	8	patients	patient	NOUN
aiua-11120	297	9	with	with	ADP
aiua-11120	297	10	pd	pd	PROPN
aiua-11120	297	11	,	,	PUNCT
aiua-11120	297	12	showed	show	VERB
aiua-11120	297	13	that	that	SCONJ
aiua-11120	297	14	pfmt	pfmt	NOUN
aiua-11120	297	15	could	could	AUX
aiua-11120	297	16	improve	improve	VERB
aiua-11120	297	17	oab	oab	PROPN
aiua-11120	297	18	symptoms	symptom	NOUN
aiua-11120	297	19	in	in	ADP
aiua-11120	297	20	pd	pd	PROPN
aiua-11120	297	21	,	,	PUNCT
aiua-11120	297	22	though	though	SCONJ
aiua-11120	297	23	the	the	DET
aiua-11120	297	24	number	number	NOUN
aiua-11120	297	25	of	of	ADP
aiua-11120	297	26	episodes	episode	NOUN
aiua-11120	297	27	of	of	ADP
aiua-11120	297	28	incontinence	incontinence	NOUN
aiua-11120	297	29	was	be	AUX
aiua-11120	297	30	not	not	PART
aiua-11120	297	31	significantly	significantly	ADV
aiua-11120	297	32	decreased	decrease	VERB
aiua-11120	297	33	.	.	PUNCT
aiua-11120	298	1	in	in	ADP
aiua-11120	298	2	men	man	NOUN
aiua-11120	298	3	and	and	CCONJ
aiua-11120	298	4	women	woman	NOUN
aiua-11120	298	5	with	with	ADP
aiua-11120	298	6	post	post	ADJ
aiua-11120	298	7	-	-	ADJ
aiua-11120	298	8	stroke	stroke	ADJ
aiua-11120	298	9	oab	oab	PROPN
aiua-11120	298	10	symptom	symptom	NOUN
aiua-11120	298	11	scores	score	NOUN
aiua-11120	298	12	,	,	PUNCT
aiua-11120	298	13	bladder	bladder	NOUN
aiua-11120	298	14	diary	diary	NOUN
aiua-11120	298	15	parameters	parameter	NOUN
aiua-11120	298	16	and	and	CCONJ
aiua-11120	298	17	pelvic	pelvic	ADJ
aiua-11120	298	18	floor	floor	NOUN
aiua-11120	298	19	function	function	NOUN
aiua-11120	298	20	and	and	CCONJ
aiua-11120	298	21	strength	strength	NOUN
aiua-11120	298	22	were	be	AUX
aiua-11120	298	23	improved	improve	VERB
aiua-11120	298	24	.	.	PUNCT
aiua-11120	299	1	gaziev	gaziev	NOUN
aiua-11120	299	2	et	et	PROPN
aiua-11120	299	3	al	al	PROPN
aiua-11120	299	4	.	.	PROPN
aiua-11120	300	1	(	(	PUNCT
aiua-11120	300	2	7	7	X
aiua-11120	300	3	)	)	PUNCT
aiua-11120	300	4	reviewed	review	VERB
aiua-11120	300	5	the	the	DET
aiua-11120	300	6	efficacy	efficacy	NOUN
aiua-11120	300	7	of	of	ADP
aiua-11120	300	8	ttns	ttns	NOUN
aiua-11120	300	9	in	in	ADP
aiua-11120	300	10	the	the	DET
aiua-11120	300	11	treatment	treatment	NOUN
aiua-11120	300	12	of	of	ADP
aiua-11120	300	13	lower	low	ADJ
aiua-11120	300	14	urinary	urinary	ADJ
aiua-11120	300	15	tract	tract	NOUN
aiua-11120	300	16	dysfunction	dysfunction	NOUN
aiua-11120	300	17	,	,	PUNCT
aiua-11120	300	18	including	include	VERB
aiua-11120	300	19	overactive	overactive	ADJ
aiua-11120	300	20	bladder	bladder	NOUN
aiua-11120	300	21	.	.	PUNCT
aiua-11120	301	1	the	the	DET
aiua-11120	301	2	authors	author	NOUN
aiua-11120	301	3	found	find	VERB
aiua-11120	301	4	that	that	SCONJ
aiua-11120	301	5	ttns	ttns	NOUN
aiua-11120	301	6	was	be	AUX
aiua-11120	301	7	effective	effective	ADJ
aiua-11120	301	8	in	in	ADP
aiua-11120	301	9	37	37	NUM
aiua-11120	301	10	-	-	SYM
aiua-11120	301	11	100	100	NUM
aiua-11120	301	12	%	%	NOUN
aiua-11120	301	13	of	of	ADP
aiua-11120	301	14	patients	patient	NOUN
aiua-11120	301	15	with	with	ADP
aiua-11120	301	16	oab	oab	PROPN
aiua-11120	301	17	.	.	PROPN
aiua-11120	302	1	four	four	NUM
aiua-11120	302	2	rcts	rct	NOUN
aiua-11120	302	3	were	be	AUX
aiua-11120	302	4	retrieved	retrieve	VERB
aiua-11120	302	5	;	;	PUNCT
aiua-11120	302	6	importantly	importantly	ADV
aiua-11120	302	7	,	,	PUNCT
aiua-11120	302	8	these	these	DET
aiua-11120	302	9	studies	study	NOUN
aiua-11120	302	10	did	do	AUX
aiua-11120	302	11	not	not	PART
aiua-11120	302	12	distinguish	distinguish	VERB
aiua-11120	302	13	between	between	ADP
aiua-11120	302	14	neurogenic	neurogenic	ADJ
aiua-11120	302	15	and	and	CCONJ
aiua-11120	302	16	idiopathic	idiopathic	ADJ
aiua-11120	302	17	oab	oab	PROPN
aiua-11120	302	18	.	.	PUNCT
aiua-11120	303	1	the	the	DET
aiua-11120	303	2	above	above	ADJ
aiua-11120	303	3	cited	cite	VERB
aiua-11120	303	4	metanalysis	metanalysis	NOUN
aiua-11120	303	5	by	by	ADP
aiua-11120	303	6	vecchio	vecchio	PROPN
aiua-11120	303	7	et	et	PROPN
aiua-11120	303	8	al	al	PROPN
aiua-11120	303	9	.	.	PROPN
aiua-11120	304	1	(	(	PUNCT
aiua-11120	304	2	6	6	NUM
aiua-11120	304	3	)	)	PUNCT
aiua-11120	304	4	showed	show	VERB
aiua-11120	304	5	significant	significant	ADJ
aiua-11120	304	6	improvements	improvement	NOUN
aiua-11120	304	7	of	of	ADP
aiua-11120	304	8	daytime	daytime	ADJ
aiua-11120	304	9	frequency	frequency	NOUN
aiua-11120	304	10	,	,	PUNCT
aiua-11120	304	11	nocturia	nocturia	PROPN
aiua-11120	304	12	,	,	PUNCT
aiua-11120	304	13	urgency	urgency	NOUN
aiua-11120	304	14	incontinence	incontinence	NOUN
aiua-11120	304	15	and	and	CCONJ
aiua-11120	304	16	voided	void	VERB
aiua-11120	304	17	volume	volume	NOUN
aiua-11120	304	18	after	after	ADP
aiua-11120	304	19	three	three	NUM
aiua-11120	304	20	months	month	NOUN
aiua-11120	304	21	of	of	ADP
aiua-11120	304	22	ptns	ptns	NOUN
aiua-11120	304	23	(	(	PUNCT
aiua-11120	304	24	p	p	X
aiua-11120	304	25	<	<	X
aiua-11120	304	26	0.001	0.001	NUM
aiua-11120	304	27	)	)	PUNCT
aiua-11120	304	28	in	in	ADP
aiua-11120	304	29	patients	patient	NOUN
aiua-11120	304	30	with	with	ADP
aiua-11120	304	31	ms	ms	PROPN
aiua-11120	304	32	.	.	PROPN
aiua-11120	304	33	a	a	DET
aiua-11120	304	34	significant	significant	ADJ
aiua-11120	304	35	improvement	improvement	NOUN
aiua-11120	304	36	in	in	ADP
aiua-11120	304	37	maximum	maximum	ADJ
aiua-11120	304	38	cystometric	cystometric	ADJ
aiua-11120	304	39	capacity	capacity	NOUN
aiua-11120	304	40	was	be	AUX
aiua-11120	304	41	also	also	ADV
aiua-11120	304	42	observed	observe	VERB
aiua-11120	304	43	.	.	PUNCT
aiua-11120	305	1	our	our	PRON
aiua-11120	305	2	review	review	NOUN
aiua-11120	305	3	added	add	VERB
aiua-11120	305	4	three	three	NUM
aiua-11120	305	5	studies	study	NOUN
aiua-11120	305	6	evaluating	evaluate	VERB
aiua-11120	305	7	the	the	DET
aiua-11120	305	8	effect	effect	NOUN
aiua-11120	305	9	of	of	ADP
aiua-11120	305	10	ptns	ptns	NOUN
aiua-11120	305	11	in	in	ADP
aiua-11120	305	12	patients	patient	NOUN
aiua-11120	305	13	with	with	ADP
aiua-11120	305	14	pd	pd	PROPN
aiua-11120	305	15	or	or	CCONJ
aiua-11120	305	16	post	post	ADJ
aiua-11120	305	17	-	-	ADJ
aiua-11120	305	18	stroke	stroke	ADJ
aiua-11120	305	19	oab	oab	PROPN
aiua-11120	305	20	.	.	PROPN
aiua-11120	305	21	quantitative	quantitative	ADJ
aiua-11120	305	22	analysis	analysis	NOUN
aiua-11120	305	23	of	of	ADP
aiua-11120	305	24	two	two	NUM
aiua-11120	305	25	studies	study	NOUN
aiua-11120	305	26	comparing	compare	VERB
aiua-11120	305	27	ttns	ttns	NOUN
aiua-11120	305	28	with	with	ADP
aiua-11120	305	29	sham	sham	ADJ
aiua-11120	305	30	treatment	treatment	NOUN
aiua-11120	305	31	in	in	ADP
aiua-11120	305	32	patients	patient	NOUN
aiua-11120	305	33	with	with	ADP
aiua-11120	305	34	pd	pd	PROPN
aiua-11120	305	35	tentatively	tentatively	ADV
aiua-11120	305	36	indicates	indicate	VERB
aiua-11120	305	37	that	that	SCONJ
aiua-11120	305	38	ttns	ttns	NOUN
aiua-11120	305	39	is	be	AUX
aiua-11120	305	40	more	more	ADV
aiua-11120	305	41	effective	effective	ADJ
aiua-11120	305	42	than	than	ADP
aiua-11120	305	43	sham	sham	ADJ
aiua-11120	305	44	in	in	ADP
aiua-11120	305	45	decreasing	decrease	VERB
aiua-11120	305	46	the	the	DET
aiua-11120	305	47	number	number	NOUN
aiua-11120	305	48	of	of	ADP
aiua-11120	305	49	nocturia	nocturia	PROPN
aiua-11120	305	50	episodes	episode	NOUN
aiua-11120	305	51	.	.	PUNCT
aiua-11120	306	1	tens	ten	NOUN
aiua-11120	306	2	improved	improve	VERB
aiua-11120	306	3	urinary	urinary	ADJ
aiua-11120	306	4	symptoms	symptom	NOUN
aiua-11120	306	5	also	also	ADV
aiua-11120	306	6	in	in	ADP
aiua-11120	306	7	patients	patient	NOUN
aiua-11120	306	8	with	with	ADP
aiua-11120	306	9	post	post	ADJ
aiua-11120	306	10	-	-	ADJ
aiua-11120	306	11	ischemic	ischemic	ADJ
aiua-11120	306	12	stroke	stroke	NOUN
aiua-11120	306	13	by	by	ADP
aiua-11120	306	14	reducing	reduce	VERB
aiua-11120	306	15	urinary	urinary	ADJ
aiua-11120	306	16	urgency	urgency	NOUN
aiua-11120	306	17	and	and	CCONJ
aiua-11120	306	18	frequency	frequency	NOUN
aiua-11120	306	19	.	.	PUNCT
aiua-11120	307	1	acupuncture	acupuncture	NOUN
aiua-11120	307	2	and	and	CCONJ
aiua-11120	307	3	electroacupuncture	electroacupuncture	NOUN
aiua-11120	307	4	also	also	ADV
aiua-11120	307	5	proved	prove	VERB
aiua-11120	307	6	to	to	PART
aiua-11120	307	7	be	be	AUX
aiua-11120	307	8	effective	effective	ADJ
aiua-11120	307	9	in	in	ADP
aiua-11120	307	10	patients	patient	NOUN
aiua-11120	307	11	with	with	ADP
aiua-11120	307	12	pd	pd	PROPN
aiua-11120	307	13	and	and	CCONJ
aiua-11120	307	14	in	in	ADP
aiua-11120	307	15	post	post	ADJ
aiua-11120	307	16	-	-	ADJ
aiua-11120	307	17	stroke	stroke	ADJ
aiua-11120	307	18	patients	patient	NOUN
aiua-11120	307	19	.	.	PUNCT
aiua-11120	308	1	finally	finally	ADV
aiua-11120	308	2	,	,	PUNCT
aiua-11120	308	3	transcutaneous	transcutaneous	ADJ
aiua-11120	308	4	electrical	electrical	ADJ
aiua-11120	308	5	nerve	nerve	NOUN
aiua-11120	308	6	stimulation	stimulation	NOUN
aiua-11120	308	7	(	(	PUNCT
aiua-11120	308	8	tens	ten	NOUN
aiua-11120	308	9	)	)	PUNCT
aiua-11120	308	10	was	be	AUX
aiua-11120	308	11	successfully	successfully	ADV
aiua-11120	308	12	used	use	VERB
aiua-11120	308	13	to	to	PART
aiua-11120	308	14	treat	treat	VERB
aiua-11120	308	15	post	post	ADJ
aiua-11120	308	16	-	-	ADJ
aiua-11120	308	17	stroke	stroke	ADJ
aiua-11120	308	18	neurogenic	neurogenic	ADJ
aiua-11120	308	19	oab	oab	PROPN
aiua-11120	308	20	.	.	PUNCT
aiua-11120	308	21	treatment	treatment	NOUN
aiua-11120	308	22	improved	improve	VERB
aiua-11120	308	23	voiding	void	VERB
aiua-11120	308	24	diary	diary	ADJ
aiua-11120	308	25	parameters	parameter	NOUN
aiua-11120	308	26	and	and	CCONJ
aiua-11120	308	27	urodynamic	urodynamic	ADJ
aiua-11120	308	28	findings	finding	NOUN
aiua-11120	308	29	and	and	CCONJ
aiua-11120	308	30	showed	show	VERB
aiua-11120	308	31	to	to	PART
aiua-11120	308	32	be	be	AUX
aiua-11120	308	33	superior	superior	ADJ
aiua-11120	308	34	to	to	ADP
aiua-11120	308	35	anticholinergics	anticholinergic	NOUN
aiua-11120	308	36	.	.	PUNCT
aiua-11120	309	1	sacral	sacral	ADJ
aiua-11120	309	2	neuromodulation	neuromodulation	NOUN
aiua-11120	309	3	a	a	DET
aiua-11120	309	4	systematic	systematic	ADJ
aiua-11120	309	5	review	review	NOUN
aiua-11120	309	6	evaluated	evaluate	VERB
aiua-11120	309	7	the	the	DET
aiua-11120	309	8	results	result	NOUN
aiua-11120	309	9	of	of	ADP
aiua-11120	309	10	studies	study	NOUN
aiua-11120	309	11	on	on	ADP
aiua-11120	309	12	sacral	sacral	ADJ
aiua-11120	309	13	neuromodulation	neuromodulation	NOUN
aiua-11120	309	14	(	(	PUNCT
aiua-11120	309	15	snm	snm	PROPN
aiua-11120	309	16	)	)	PUNCT
aiua-11120	309	17	in	in	ADP
aiua-11120	309	18	patients	patient	NOUN
aiua-11120	309	19	with	with	ADP
aiua-11120	309	20	neurogenic	neurogenic	ADJ
aiua-11120	309	21	lower	low	ADJ
aiua-11120	309	22	urinary	urinary	ADJ
aiua-11120	309	23	tract	tract	NOUN
aiua-11120	309	24	dysfunction	dysfunction	NOUN
aiua-11120	309	25	.	.	PUNCT
aiua-11120	310	1	data	datum	NOUN
aiua-11120	310	2	published	publish	VERB
aiua-11120	310	3	between	between	ADP
aiua-11120	310	4	1998	1998	NUM
aiua-11120	310	5	to	to	ADP
aiua-11120	310	6	march	march	PROPN
aiua-11120	310	7	2020	2020	NUM
aiua-11120	310	8	were	be	AUX
aiua-11120	310	9	retrieved	retrieve	VERB
aiua-11120	310	10	.	.	PUNCT
aiua-11120	311	1	the	the	DET
aiua-11120	311	2	review	review	NOUN
aiua-11120	311	3	included	include	VERB
aiua-11120	311	4	retrospective	retrospective	ADJ
aiua-11120	311	5	or	or	CCONJ
aiua-11120	311	6	prospective	prospective	ADJ
aiua-11120	311	7	clinical	clinical	ADJ
aiua-11120	311	8	studies	study	NOUN
aiua-11120	311	9	,	,	PUNCT
aiua-11120	311	10	cohort	cohort	NOUN
aiua-11120	311	11	studies	study	NOUN
aiua-11120	311	12	,	,	PUNCT
aiua-11120	311	13	and	and	CCONJ
aiua-11120	311	14	case	case	NOUN
aiua-11120	311	15	reports	report	VERB
aiua-11120	311	16	.	.	PUNCT
aiua-11120	312	1	a	a	DET
aiua-11120	312	2	meta	meta	ADJ
aiua-11120	312	3	-	-	PUNCT
aiua-11120	312	4	analysis	analysis	NOUN
aiua-11120	312	5	of	of	ADP
aiua-11120	312	6	21	21	NUM
aiua-11120	312	7	studies	study	NOUN
aiua-11120	312	8	demonstrated	demonstrate	VERB
aiua-11120	312	9	a	a	DET
aiua-11120	312	10	66.2	66.2	NUM
aiua-11120	312	11	%	%	NOUN
aiua-11120	312	12	success	success	NOUN
aiua-11120	312	13	rate	rate	NOUN
aiua-11120	312	14	of	of	ADP
aiua-11120	312	15	snm	snm	PROPN
aiua-11120	312	16	test	test	NOUN
aiua-11120	312	17	stimulation	stimulation	NOUN
aiua-11120	312	18	;	;	PUNCT
aiua-11120	312	19	another	another	DET
aiua-11120	312	20	meta	meta	ADJ
aiua-11120	312	21	-	-	PUNCT
aiua-11120	312	22	analysis	analysis	NOUN
aiua-11120	312	23	of	of	ADP
aiua-11120	312	24	24	24	NUM
aiua-11120	312	25	studies	study	NOUN
aiua-11120	312	26	reported	report	VERB
aiua-11120	312	27	a	a	DET
aiua-11120	312	28	84.2	84.2	NUM
aiua-11120	312	29	%	%	NOUN
aiua-11120	312	30	success	success	NOUN
aiua-11120	312	31	rate	rate	NOUN
aiua-11120	312	32	of	of	ADP
aiua-11120	312	33	permanent	permanent	ADJ
aiua-11120	312	34	smn	smn	NOUN
aiua-11120	312	35	.	.	PUNCT
aiua-11120	313	1	loss	loss	NOUN
aiua-11120	313	2	of	of	ADP
aiua-11120	313	3	effectiveness	effectiveness	NOUN
aiua-11120	313	4	,	,	PUNCT
aiua-11120	313	5	infection	infection	NOUN
aiua-11120	313	6	,	,	PUNCT
aiua-11120	313	7	pain	pain	NOUN
aiua-11120	313	8	at	at	ADP
aiua-11120	313	9	implant	implant	ADJ
aiua-11120	313	10	site	site	NOUN
aiua-11120	313	11	,	,	PUNCT
aiua-11120	313	12	and	and	CCONJ
aiua-11120	313	13	lead	lead	NOUN
aiua-11120	313	14	migration	migration	NOUN
aiua-11120	313	15	were	be	AUX
aiua-11120	313	16	observed	observe	VERB
aiua-11120	313	17	in	in	ADP
aiua-11120	313	18	4.7	4.7	NUM
aiua-11120	313	19	%	%	NOUN
aiua-11120	313	20	,	,	PUNCT
aiua-11120	313	21	3.6	3.6	NUM
aiua-11120	313	22	%	%	NOUN
aiua-11120	313	23	,	,	PUNCT
aiua-11120	313	24	3.2	3.2	NUM
aiua-11120	313	25	%	%	NOUN
aiua-11120	313	26	,	,	PUNCT
aiua-11120	313	27	and	and	CCONJ
aiua-11120	313	28	3.2	3.2	NUM
aiua-11120	313	29	%	%	NOUN
aiua-11120	313	30	of	of	ADP
aiua-11120	313	31	cases	case	NOUN
aiua-11120	313	32	,	,	PUNCT
aiua-11120	313	33	respectively	respectively	ADV
aiua-11120	313	34	.	.	PUNCT
aiua-11120	314	1	the	the	DET
aiua-11120	314	2	clinical	clinical	ADJ
aiua-11120	314	3	effect	effect	NOUN
aiua-11120	314	4	of	of	ADP
aiua-11120	314	5	smn	smn	PROPN
aiua-11120	314	6	for	for	ADP
aiua-11120	314	7	neurogenic	neurogenic	ADJ
aiua-11120	314	8	lower	low	ADJ
aiua-11120	314	9	urinary	urinary	ADJ
aiua-11120	314	10	tract	tract	NOUN
aiua-11120	314	11	dysfunction	dysfunction	NOUN
aiua-11120	314	12	was	be	AUX
aiua-11120	314	13	comparable	comparable	ADJ
aiua-11120	314	14	to	to	ADP
aiua-11120	314	15	the	the	DET
aiua-11120	314	16	outcomes	outcome	NOUN
aiua-11120	314	17	obtained	obtain	VERB
aiua-11120	314	18	in	in	ADP
aiua-11120	314	19	idiopathic	idiopathic	ADJ
aiua-11120	314	20	populations	population	NOUN
aiua-11120	314	21	.	.	PUNCT
aiua-11120	315	1	conclusions	conclusion	NOUN
aiua-11120	315	2	although	although	SCONJ
aiua-11120	315	3	all	all	DET
aiua-11120	315	4	treatments	treatment	NOUN
aiua-11120	315	5	have	have	AUX
aiua-11120	315	6	proven	prove	VERB
aiua-11120	315	7	efficacy	efficacy	NOUN
aiua-11120	315	8	,	,	PUNCT
aiua-11120	315	9	there	there	PRON
aiua-11120	315	10	is	be	VERB
aiua-11120	315	11	no	no	DET
aiua-11120	315	12	therapy	therapy	NOUN
aiua-11120	315	13	that	that	PRON
aiua-11120	315	14	can	can	AUX
aiua-11120	315	15	be	be	AUX
aiua-11120	315	16	considered	consider	VERB
aiua-11120	315	17	clearly	clearly	ADV
aiua-11120	315	18	superior	superior	ADJ
aiua-11120	315	19	to	to	ADP
aiua-11120	315	20	the	the	DET
aiua-11120	315	21	others	other	NOUN
aiua-11120	315	22	.	.	PUNCT
aiua-11120	316	1	in	in	ADP
aiua-11120	316	2	fact	fact	NOUN
aiua-11120	316	3	,	,	PUNCT
aiua-11120	316	4	the	the	DET
aiua-11120	316	5	treatment	treatment	NOUN
aiua-11120	316	6	of	of	ADP
aiua-11120	316	7	neurological	neurological	ADJ
aiua-11120	316	8	bladder	bladder	NOUN
aiua-11120	316	9	must	must	AUX
aiua-11120	316	10	be	be	AUX
aiua-11120	316	11	tailored	tailor	VERB
aiua-11120	316	12	to	to	ADP
aiua-11120	316	13	the	the	DET
aiua-11120	316	14	individual	individual	ADJ
aiua-11120	316	15	patient	patient	NOUN
aiua-11120	316	16	,	,	PUNCT
aiua-11120	316	17	and	and	CCONJ
aiua-11120	316	18	often	often	ADV
aiua-11120	316	19	requires	require	VERB
aiua-11120	316	20	the	the	DET
aiua-11120	316	21	combination	combination	NOUN
aiua-11120	316	22	of	of	ADP
aiua-11120	316	23	different	different	ADJ
aiua-11120	316	24	forms	form	NOUN
aiua-11120	316	25	of	of	ADP
aiua-11120	316	26	complementary	complementary	ADJ
aiua-11120	316	27	treatment	treatment	NOUN
aiua-11120	316	28	.	.	PUNCT
aiua-11120	317	1	combination	combination	NOUN
aiua-11120	317	2	of	of	ADP
aiua-11120	317	3	different	different	ADJ
aiua-11120	317	4	pharmacological	pharmacological	ADJ
aiua-11120	317	5	treatments	treatment	NOUN
aiua-11120	317	6	,	,	PUNCT
aiua-11120	317	7	or	or	CCONJ
aiua-11120	317	8	associating	associate	VERB
aiua-11120	317	9	pharmacological	pharmacological	ADJ
aiua-11120	317	10	treatments	treatment	NOUN
aiua-11120	317	11	and	and	CCONJ
aiua-11120	317	12	non	non	ADJ
aiua-11120	317	13	-	-	ADJ
aiua-11120	317	14	pharmacological	pharmacological	ADJ
aiua-11120	317	15	treatments	treatment	NOUN
aiua-11120	317	16	,	,	PUNCT
aiua-11120	317	17	can	can	AUX
aiua-11120	317	18	allow	allow	VERB
aiua-11120	317	19	reduction	reduction	NOUN
aiua-11120	317	20	of	of	ADP
aiua-11120	317	21	the	the	DET
aiua-11120	317	22	dosage	dosage	NOUN
aiua-11120	317	23	of	of	ADP
aiua-11120	317	24	drugs	drug	NOUN
aiua-11120	317	25	,	,	PUNCT
aiua-11120	317	26	thus	thus	ADV
aiua-11120	317	27	minimizing	minimize	VERB
aiua-11120	317	28	the	the	DET
aiua-11120	317	29	side	side	NOUN
aiua-11120	317	30	effects	effect	NOUN
aiua-11120	317	31	which	which	PRON
aiua-11120	317	32	represent	represent	VERB
aiua-11120	317	33	a	a	DET
aiua-11120	317	34	limitation	limitation	NOUN
aiua-11120	317	35	of	of	ADP
aiua-11120	317	36	their	their	PRON
aiua-11120	317	37	usage	usage	NOUN
aiua-11120	317	38	in	in	ADP
aiua-11120	317	39	therapy	therapy	NOUN
aiua-11120	317	40	.	.	PUNCT
aiua-11120	318	1	a	a	DET
aiua-11120	318	2	caveat	caveat	NOUN
aiua-11120	318	3	:	:	PUNCT
aiua-11120	318	4	evidence	evidence	NOUN
aiua-11120	318	5	from	from	ADP
aiua-11120	318	6	our	our	PRON
aiua-11120	318	7	quantitative	quantitative	ADJ
aiua-11120	318	8	analysis	analysis	NOUN
aiua-11120	318	9	is	be	AUX
aiua-11120	318	10	fragmentary	fragmentary	ADJ
aiua-11120	318	11	and	and	CCONJ
aiua-11120	318	12	does	do	AUX
aiua-11120	318	13	not	not	PART
aiua-11120	318	14	allow	allow	VERB
aiua-11120	318	15	to	to	PART
aiua-11120	318	16	draw	draw	VERB
aiua-11120	318	17	robust	robust	ADJ
aiua-11120	318	18	conclusions	conclusion	NOUN
aiua-11120	318	19	.	.	PUNCT
aiua-11120	319	1	our	our	PRON
aiua-11120	319	2	data	datum	NOUN
aiua-11120	319	3	are	be	AUX
aiua-11120	319	4	only	only	ADV
aiua-11120	319	5	provisional	provisional	ADJ
aiua-11120	319	6	and	and	CCONJ
aiua-11120	319	7	should	should	AUX
aiua-11120	319	8	be	be	AUX
aiua-11120	319	9	considered	consider	VERB
aiua-11120	319	10	with	with	ADP
aiua-11120	319	11	caution	caution	NOUN
aiua-11120	319	12	,	,	PUNCT
aiua-11120	319	13	due	due	ADP
aiua-11120	319	14	to	to	ADP
aiua-11120	319	15	the	the	DET
aiua-11120	319	16	few	few	ADJ
aiua-11120	319	17	studies	study	NOUN
aiua-11120	319	18	included	include	VERB
aiua-11120	319	19	in	in	ADP
aiua-11120	319	20	metaanalysis	metaanalysis	NOUN
aiua-11120	319	21	and	and	CCONJ
aiua-11120	319	22	to	to	ADP
aiua-11120	319	23	the	the	DET
aiua-11120	319	24	small	small	ADJ
aiua-11120	319	25	number	number	NOUN
aiua-11120	319	26	of	of	ADP
aiua-11120	319	27	patients	patient	NOUN
aiua-11120	319	28	included	include	VERB
aiua-11120	319	29	in	in	ADP
aiua-11120	319	30	each	each	DET
aiua-11120	319	31	study	study	NOUN
aiua-11120	319	32	.	.	PUNCT
aiua-11120	320	1	references	reference	NOUN
aiua-11120	320	2	1	1	NUM
aiua-11120	320	3	.	.	X
aiua-11120	320	4	przydacz	przydacz	NOUN
aiua-11120	320	5	m	m	PROPN
aiua-11120	320	6	,	,	PUNCT
aiua-11120	320	7	chlosta	chlosta	NOUN
aiua-11120	320	8	m	m	PROPN
aiua-11120	320	9	,	,	PUNCT
aiua-11120	320	10	golabek	golabek	PROPN
aiua-11120	320	11	t	t	PROPN
aiua-11120	320	12	,	,	PUNCT
aiua-11120	320	13	chlosta	chlosta	NOUN
aiua-11120	320	14	p.	p.	NOUN
aiua-11120	320	15	population	population	NOUN
aiua-11120	320	16	-	-	PUNCT
aiua-11120	320	17	based	base	VERB
aiua-11120	320	18	study	study	NOUN
aiua-11120	320	19	of	of	ADP
aiua-11120	320	20	prevalence	prevalence	NOUN
aiua-11120	320	21	,	,	PUNCT
aiua-11120	320	22	bother	bother	VERB
aiua-11120	320	23	and	and	CCONJ
aiua-11120	320	24	behavior	behavior	NOUN
aiua-11120	320	25	related	relate	VERB
aiua-11120	320	26	to	to	ADP
aiua-11120	320	27	treatment	treatment	NOUN
aiua-11120	320	28	for	for	ADP
aiua-11120	320	29	lower	low	ADJ
aiua-11120	320	30	urinary	urinary	ADJ
aiua-11120	320	31	tract	tract	NOUN
aiua-11120	320	32	symptoms	symptom	NOUN
aiua-11120	320	33	and	and	CCONJ
aiua-11120	320	34	overactive	overactive	ADJ
aiua-11120	320	35	bladder	bladder	NOUN
aiua-11120	320	36	among	among	ADP
aiua-11120	320	37	polish	polish	ADJ
aiua-11120	320	38	neurogenic	neurogenic	ADJ
aiua-11120	320	39	patients	patient	NOUN
aiua-11120	320	40	.	.	PUNCT
aiua-11120	321	1	brain	brain	NOUN
aiua-11120	321	2	sci	sci	PROPN
aiua-11120	321	3	2021	2021	NUM
aiua-11120	321	4	;	;	PUNCT
aiua-11120	321	5	11:712	11:712	NUM
aiua-11120	321	6	.	.	PUNCT
aiua-11120	322	1	2	2	X
aiua-11120	322	2	.	.	X
aiua-11120	322	3	madhuvrata	madhuvrata	NOUN
aiua-11120	322	4	p	p	NOUN
aiua-11120	322	5	,	,	PUNCT
aiua-11120	322	6	singh	singh	PROPN
aiua-11120	322	7	m	m	PROPN
aiua-11120	322	8	,	,	PUNCT
aiua-11120	322	9	hasafa	hasafa	PROPN
aiua-11120	322	10	z	z	PROPN
aiua-11120	322	11	,	,	PUNCT
aiua-11120	322	12	abdel	abdel	PROPN
aiua-11120	322	13	-	-	PUNCT
aiua-11120	322	14	fattah	fattah	PROPN
aiua-11120	322	15	m.	m.	NOUN
aiua-11120	322	16	anticholinergic	anticholinergic	ADJ
aiua-11120	322	17	drugs	drug	NOUN
aiua-11120	322	18	for	for	ADP
aiua-11120	322	19	adult	adult	NOUN
aiua-11120	322	20	neurogenic	neurogenic	ADJ
aiua-11120	322	21	detrusor	detrusor	NOUN
aiua-11120	322	22	overactivity	overactivity	NOUN
aiua-11120	322	23	:	:	PUNCT
aiua-11120	322	24	a	a	DET
aiua-11120	322	25	systematic	systematic	ADJ
aiua-11120	322	26	review	review	NOUN
aiua-11120	322	27	and	and	CCONJ
aiua-11120	322	28	meta	meta	ADJ
aiua-11120	322	29	-	-	PUNCT
aiua-11120	322	30	analysis	analysis	NOUN
aiua-11120	322	31	eur	eur	NOUN
aiua-11120	322	32	urol	urol	NOUN
aiua-11120	322	33	2012	2012	NUM
aiua-11120	322	34	;	;	PUNCT
aiua-11120	322	35	62:816	62:816	NUM
aiua-11120	322	36	-	-	SYM
aiua-11120	322	37	830	830	NUM
aiua-11120	322	38	.	.	PUNCT
aiua-11120	323	1	3	3	X
aiua-11120	323	2	.	.	X
aiua-11120	323	3	nicholas	nicholas	PROPN
aiua-11120	323	4	rs	rs	PROPN
aiua-11120	323	5	,	,	PUNCT
aiua-11120	323	6	friede	friede	PROPN
aiua-11120	323	7	t	t	PROPN
aiua-11120	323	8	,	,	PUNCT
aiua-11120	323	9	hollis	hollis	PROPN
aiua-11120	323	10	s	s	PROPN
aiua-11120	323	11	,	,	PUNCT
aiua-11120	323	12	young	young	ADJ
aiua-11120	323	13	ca	ca	NOUN
aiua-11120	323	14	.	.	PUNCT
aiua-11120	324	1	anticholinergics	anticholinergic	NOUN
aiua-11120	324	2	for	for	ADP
aiua-11120	324	3	urinary	urinary	ADJ
aiua-11120	324	4	symptoms	symptom	NOUN
aiua-11120	324	5	in	in	ADP
aiua-11120	324	6	multiple	multiple	ADJ
aiua-11120	324	7	sclerosis	sclerosis	NOUN
aiua-11120	324	8	.	.	PUNCT
aiua-11120	325	1	cochrane	cochrane	NOUN
aiua-11120	325	2	database	database	NOUN
aiua-11120	325	3	of	of	ADP
aiua-11120	325	4	systematic	systematic	ADJ
aiua-11120	325	5	reviews	review	NOUN
aiua-11120	325	6	2009	2009	NUM
aiua-11120	325	7	,	,	PUNCT
aiua-11120	325	8	issue	issue	NOUN
aiua-11120	325	9	1	1	NUM
aiua-11120	325	10	.	.	PUNCT
aiua-11120	325	11	art	art	NOUN
aiua-11120	325	12	.	.	PUNCT
aiua-11120	326	1	no	no	INTJ
aiua-11120	326	2	.	.	PUNCT
aiua-11120	326	3	:	:	PUNCT
aiua-11120	327	1	cd004193	cd004193	PROPN
aiua-11120	327	2	4	4	NUM
aiua-11120	327	3	.	.	PUNCT
aiua-11120	327	4	shen	shen	PROPN
aiua-11120	328	1	s	s	PROPN
aiua-11120	328	2	-	-	PUNCT
aiua-11120	328	3	h	h	PROPN
aiua-11120	328	4	,	,	PUNCT
aiua-11120	328	5	jia	jia	PROPN
aiua-11120	328	6	x	x	PROPN
aiua-11120	328	7	,	,	PUNCT
aiua-11120	328	8	peng	peng	PROPN
aiua-11120	328	9	l	l	PROPN
aiua-11120	328	10	,	,	PUNCT
aiua-11120	328	11	et	et	PROPN
aiua-11120	328	12	al	al	PROPN
aiua-11120	328	13	.	.	PROPN
aiua-11120	329	1	intravesical	intravesical	ADJ
aiua-11120	329	2	oxybutynin	oxybutynin	PROPN
aiua-11120	329	3	therapy	therapy	NOUN
aiua-11120	329	4	for	for	ADP
aiua-11120	329	5	patients	patient	NOUN
aiua-11120	329	6	with	with	ADP
aiua-11120	329	7	neurogenic	neurogenic	ADJ
aiua-11120	329	8	detrusor	detrusor	NOUN
aiua-11120	329	9	overactivity	overactivity	NOUN
aiua-11120	329	10	:	:	PUNCT
aiua-11120	329	11	a	a	DET
aiua-11120	329	12	systematic	systematic	ADJ
aiua-11120	329	13	review	review	NOUN
aiua-11120	329	14	and	and	CCONJ
aiua-11120	329	15	meta	meta	VERB
aiua-11120	329	16	analysis	analysis	NOUN
aiua-11120	329	17	5	5	NUM
aiua-11120	329	18	.	.	PUNCT
aiua-11120	329	19	kajbafvala	kajbafvala	PROPN
aiua-11120	329	20	m	m	PROPN
aiua-11120	329	21	,	,	PUNCT
aiua-11120	329	22	ashnagar	ashnagar	PROPN
aiua-11120	329	23	z	z	PROPN
aiua-11120	329	24	,	,	PUNCT
aiua-11120	329	25	lucio	lucio	PROPN
aiua-11120	329	26	a	a	PROPN
aiua-11120	329	27	,	,	PUNCT
aiua-11120	329	28	et	et	PROPN
aiua-11120	329	29	al	al	PROPN
aiua-11120	329	30	.	.	PROPN
aiua-11120	329	31	pelvic	pelvic	ADJ
aiua-11120	329	32	floor	floor	NOUN
aiua-11120	329	33	muscle	muscle	NOUN
aiua-11120	329	34	training	training	NOUN
aiua-11120	329	35	in	in	ADP
aiua-11120	329	36	multiple	multiple	ADJ
aiua-11120	329	37	sclerosis	sclerosis	NOUN
aiua-11120	329	38	patients	patient	NOUN
aiua-11120	329	39	with	with	ADP
aiua-11120	329	40	lower	low	ADJ
aiua-11120	329	41	urinary	urinary	ADJ
aiua-11120	329	42	tract	tract	NOUN
aiua-11120	329	43	dysfunction	dysfunction	NOUN
aiua-11120	329	44	:	:	PUNCT
aiua-11120	329	45	a	a	DET
aiua-11120	329	46	systematic	systematic	ADJ
aiua-11120	329	47	review	review	NOUN
aiua-11120	329	48	and	and	CCONJ
aiua-11120	329	49	meta	meta	ADJ
aiua-11120	329	50	-	-	PUNCT
aiua-11120	329	51	analysis	analysis	NOUN
aiua-11120	329	52	.	.	PUNCT
aiua-11120	330	1	mult	mult	PROPN
aiua-11120	330	2	scler	scler	PROPN
aiua-11120	330	3	relat	relat	PROPN
aiua-11120	330	4	disord	disord	PROPN
aiua-11120	330	5	.	.	PUNCT
aiua-11120	331	1	2022	2022	NUM
aiua-11120	331	2	;	;	PUNCT
aiua-11120	331	3	59:103559	59:103559	NUM
aiua-11120	331	4	.	.	NOUN
aiua-11120	332	1	6	6	NUM
aiua-11120	332	2	.	.	X
aiua-11120	332	3	vecchio	vecchio	PROPN
aiua-11120	332	4	m	m	PROPN
aiua-11120	332	5	,	,	PUNCT
aiua-11120	332	6	chiaramonte	chiaramonte	PROPN
aiua-11120	332	7	r	r	NOUN
aiua-11120	332	8	,	,	PUNCT
aiua-11120	332	9	di	di	X
aiua-11120	332	10	benedetto	benedetto	PROPN
aiua-11120	332	11	p.	p.	PROPN
aiua-11120	332	12	management	management	NOUN
aiua-11120	332	13	of	of	ADP
aiua-11120	332	14	bladder	bladder	NOUN
aiua-11120	332	15	dysfunction	dysfunction	NOUN
aiua-11120	332	16	in	in	ADP
aiua-11120	332	17	multiple	multiple	ADJ
aiua-11120	332	18	sclerosis	sclerosis	NOUN
aiua-11120	332	19	:	:	PUNCT
aiua-11120	332	20	a	a	DET
aiua-11120	332	21	systematic	systematic	ADJ
aiua-11120	332	22	review	review	NOUN
aiua-11120	332	23	and	and	CCONJ
aiua-11120	332	24	meta	meta	ADJ
aiua-11120	332	25	-	-	PUNCT
aiua-11120	332	26	analysis	analysis	NOUN
aiua-11120	332	27	of	of	ADP
aiua-11120	332	28	studies	study	NOUN
aiua-11120	332	29	regarding	regard	VERB
aiua-11120	332	30	bladder	bladder	NOUN
aiua-11120	332	31	rehabilitation	rehabilitation	NOUN
aiua-11120	332	32	.	.	PUNCT
aiua-11120	333	1	european	european	ADJ
aiua-11120	333	2	journal	journal	PROPN
aiua-11120	333	3	of	of	ADP
aiua-11120	333	4	physical	physical	ADJ
aiua-11120	333	5	and	and	CCONJ
aiua-11120	333	6	rehabilitation	rehabilitation	NOUN
aiua-11120	333	7	medicine	medicine	NOUN
aiua-11120	333	8	2022	2022	NUM
aiua-11120	333	9	;	;	PUNCT
aiua-11120	333	10	58:387	58:387	NUM
aiua-11120	333	11	-	-	SYM
aiua-11120	333	12	96	96	NUM
aiua-11120	333	13	.	.	PUNCT
aiua-11120	334	1	7	7	X
aiua-11120	334	2	.	.	X
aiua-11120	334	3	gaziev	gaziev	NOUN
aiua-11120	334	4	g	g	NOUN
aiua-11120	334	5	,	,	PUNCT
aiua-11120	334	6	topazio	topazio	PROPN
aiua-11120	334	7	l	l	NOUN
aiua-11120	334	8	,	,	PUNCT
aiua-11120	334	9	iacovelli	iacovelli	PROPN
aiua-11120	334	10	v	v	NOUN
aiua-11120	334	11	,	,	PUNCT
aiua-11120	334	12	et	et	PROPN
aiua-11120	334	13	al	al	PROPN
aiua-11120	334	14	.	.	PROPN
aiua-11120	335	1	percutaneous	percutaneous	ADJ
aiua-11120	335	2	tibial	tibial	ADJ
aiua-11120	335	3	nerve	nerve	NOUN
aiua-11120	335	4	stimulation	stimulation	NOUN
aiua-11120	335	5	(	(	PUNCT
aiua-11120	335	6	ptns	ptns	NOUN
aiua-11120	335	7	)	)	PUNCT
aiua-11120	335	8	efficacy	efficacy	NOUN
aiua-11120	335	9	in	in	ADP
aiua-11120	335	10	the	the	DET
aiua-11120	335	11	treatment	treatment	NOUN
aiua-11120	335	12	of	of	ADP
aiua-11120	335	13	lower	low	ADJ
aiua-11120	335	14	urinary	urinary	ADJ
aiua-11120	335	15	tract	tract	NOUN
aiua-11120	335	16	dysfunctions	dysfunction	NOUN
aiua-11120	335	17	:	:	PUNCT
aiua-11120	335	18	a	a	DET
aiua-11120	335	19	systematic	systematic	ADJ
aiua-11120	335	20	review	review	NOUN
aiua-11120	335	21	.	.	PUNCT
aiua-11120	336	1	bmc	bmc	PROPN
aiua-11120	336	2	urol	urol	PROPN
aiua-11120	336	3	.	.	PUNCT
aiua-11120	337	1	2013	2013	NUM
aiua-11120	337	2	;	;	PUNCT
aiua-11120	337	3	13:61	13:61	NUM
aiua-11120	337	4	.	.	X
aiua-11120	338	1	8	8	X
aiua-11120	338	2	.	.	PUNCT
aiua-11120	339	1	van	van	PROPN
aiua-11120	339	2	ophoven	ophoven	VERB
aiua-11120	339	3	a	a	PRON
aiua-11120	339	4	,	,	PUNCT
aiua-11120	339	5	engelberg	engelberg	PROPN
aiua-11120	339	6	s	s	PROPN
aiua-11120	339	7	,	,	PUNCT
aiua-11120	339	8	lilley	lilley	PROPN
aiua-11120	339	9	h	h	PROPN
aiua-11120	339	10	,	,	PUNCT
aiua-11120	339	11	sievert	sievert	ADJ
aiua-11120	339	12	kd	kd	PROPN
aiua-11120	339	13	.	.	PUNCT
aiua-11120	340	1	systematic	systematic	PROPN
aiua-11120	340	2	literature	literature	PROPN
aiua-11120	340	3	review	review	NOUN
aiua-11120	340	4	and	and	CCONJ
aiua-11120	340	5	meta	meta	NOUN
aiua-11120	340	6	-	-	PUNCT
aiua-11120	340	7	analysis	analysis	NOUN
aiua-11120	340	8	of	of	ADP
aiua-11120	340	9	sacral	sacral	ADJ
aiua-11120	340	10	neuromodulation	neuromodulation	NOUN
aiua-11120	340	11	(	(	PUNCT
aiua-11120	340	12	snm	snm	PROPN
aiua-11120	340	13	)	)	PUNCT
aiua-11120	340	14	in	in	ADP
aiua-11120	340	15	patients	patient	NOUN
aiua-11120	340	16	with	with	ADP
aiua-11120	340	17	neurogenic	neurogenic	ADJ
aiua-11120	340	18	lower	low	ADJ
aiua-11120	340	19	urinary	urinary	ADJ
aiua-11120	340	20	tract	tract	NOUN
aiua-11120	340	21	dysfunction	dysfunction	NOUN
aiua-11120	340	22	archivio	archivio	NOUN
aiua-11120	340	23	italiano	italiano	NOUN
aiua-11120	340	24	di	di	X
aiua-11120	340	25	urologia	urologia	PROPN
aiua-11120	340	26	e	e	PROPN
aiua-11120	340	27	andrologia	andrologia	PROPN
aiua-11120	340	28	2022	2022	NUM
aiua-11120	340	29	;	;	PUNCT
aiua-11120	340	30	94	94	NUM
aiua-11120	340	31	,	,	PUNCT
aiua-11120	340	32	4	4	NUM
aiua-11120	340	33	r.	r.	NOUN
aiua-11120	340	34	bapir	bapir	NOUN
aiua-11120	340	35	,	,	PUNCT
aiua-11120	340	36	k.	k.	PROPN
aiua-11120	340	37	hassan	hassan	PROPN
aiua-11120	340	38	bhatti	bhatti	PROPN
aiua-11120	340	39	,	,	PUNCT
aiua-11120	340	40	ahmed	ahmed	PROPN
aiua-11120	340	41	eliwa	eliwa	PROPN
aiua-11120	340	42	,	,	PUNCT
aiua-11120	340	43	et	et	PROPN
aiua-11120	340	44	al	al	PROPN
aiua-11120	340	45	.	.	PROPN
aiua-11120	341	1	504	504	NUM
aiua-11120	341	2	(	(	PUNCT
aiua-11120	341	3	nlutd	nlutd	NOUN
aiua-11120	341	4	):	):	PUNCT
aiua-11120	341	5	over	over	ADP
aiua-11120	341	6	20	20	NUM
aiua-11120	341	7	years	year	NOUN
aiua-11120	341	8	'	'	PART
aiua-11120	341	9	experience	experience	NOUN
aiua-11120	341	10	and	and	CCONJ
aiua-11120	341	11	future	future	ADJ
aiua-11120	341	12	directions	direction	NOUN
aiua-11120	341	13	.	.	PUNCT
aiua-11120	342	1	adv	adv	INTJ
aiua-11120	342	2	ther	ther	ADV
aiua-11120	342	3	.	.	PUNCT
aiua-11120	343	1	2021	2021	NUM
aiua-11120	343	2	;	;	PUNCT
aiua-11120	343	3	38:1987	38:1987	NUM
aiua-11120	343	4	-	-	SYM
aiua-11120	343	5	2006	2006	NUM
aiua-11120	343	6	.	.	PUNCT
aiua-11120	344	1	9	9	X
aiua-11120	344	2	.	.	PUNCT
aiua-11120	344	3	duthie	duthie	PROPN
aiua-11120	344	4	jb	jb	PROPN
aiua-11120	344	5	,	,	PUNCT
aiua-11120	344	6	vincent	vincent	PROPN
aiua-11120	344	7	m	m	PROPN
aiua-11120	344	8	,	,	PUNCT
aiua-11120	344	9	herbison	herbison	PROPN
aiua-11120	344	10	gp	gp	NOUN
aiua-11120	344	11	,	,	PUNCT
aiua-11120	344	12	et	et	PROPN
aiua-11120	344	13	al	al	PROPN
aiua-11120	344	14	.	.	PUNCT
aiua-11120	344	15	botulinum	botulinum	ADJ
aiua-11120	344	16	toxin	toxin	NOUN
aiua-11120	344	17	injections	injection	NOUN
aiua-11120	344	18	for	for	ADP
aiua-11120	344	19	adults	adult	NOUN
aiua-11120	344	20	with	with	ADP
aiua-11120	344	21	overactive	overactive	ADJ
aiua-11120	344	22	bladder	bladder	NOUN
aiua-11120	344	23	syndrome	syndrome	NOUN
aiua-11120	344	24	.	.	PUNCT
aiua-11120	345	1	cochrane	cochrane	NOUN
aiua-11120	345	2	database	database	NOUN
aiua-11120	345	3	of	of	ADP
aiua-11120	345	4	systematic	systematic	ADJ
aiua-11120	345	5	reviews	review	NOUN
aiua-11120	345	6	2011	2011	NUM
aiua-11120	345	7	,	,	PUNCT
aiua-11120	345	8	issue	issue	NOUN
aiua-11120	345	9	12	12	NUM
aiua-11120	345	10	.	.	PUNCT
aiua-11120	346	1	art	art	NOUN
aiua-11120	346	2	.	.	PUNCT
aiua-11120	347	1	no	no	INTJ
aiua-11120	347	2	.	.	PUNCT
aiua-11120	347	3	:	:	PUNCT
aiua-11120	348	1	cd005493	cd005493	PROPN
aiua-11120	348	2	.	.	PUNCT
aiua-11120	349	1	10	10	NUM
aiua-11120	349	2	.	.	PUNCT
aiua-11120	350	1	zhang	zhang	PROPN
aiua-11120	350	2	r	r	PROPN
aiua-11120	350	3	,	,	PUNCT
aiua-11120	350	4	xu	xu	PROPN
aiua-11120	350	5	y	y	PROPN
aiua-11120	350	6	,	,	PUNCT
aiua-11120	350	7	yang	yang	PROPN
aiua-11120	350	8	s	s	PROPN
aiua-11120	350	9	,	,	PUNCT
aiua-11120	350	10	et	et	PROPN
aiua-11120	350	11	al	al	PROPN
aiua-11120	350	12	.	.	PROPN
aiua-11120	350	13	onabotulinumtoxina	onabotulinumtoxina	PROPN
aiua-11120	350	14	for	for	ADP
aiua-11120	350	15	neurogenic	neurogenic	ADJ
aiua-11120	350	16	detrusor	detrusor	NOUN
aiua-11120	350	17	overactivity	overactivity	NOUN
aiua-11120	350	18	and	and	CCONJ
aiua-11120	350	19	dose	dose	NOUN
aiua-11120	350	20	differences	difference	NOUN
aiua-11120	350	21	:	:	PUNCT
aiua-11120	350	22	a	a	DET
aiua-11120	350	23	systematic	systematic	ADJ
aiua-11120	350	24	review	review	NOUN
aiua-11120	350	25	.	.	PUNCT
aiua-11120	351	1	int	int	PROPN
aiua-11120	351	2	braz	braz	PROPN
aiua-11120	351	3	j	j	PROPN
aiua-11120	351	4	urol	urol	PROPN
aiua-11120	351	5	.	.	PROPN
aiua-11120	352	1	2015	2015	NUM
aiua-11120	352	2	;	;	PUNCT
aiua-11120	352	3	41:207	41:207	NOUN
aiua-11120	352	4	-	-	SYM
aiua-11120	352	5	19	19	NUM
aiua-11120	352	6	.	.	NOUN
aiua-11120	352	7	11	11	NUM
aiua-11120	352	8	.	.	PUNCT
aiua-11120	353	1	zhou	zhou	PROPN
aiua-11120	353	2	x	x	PROPN
aiua-11120	353	3	,	,	PUNCT
aiua-11120	353	4	yan	yan	PROPN
aiua-11120	353	5	hl	hl	PROPN
aiua-11120	353	6	,	,	PUNCT
aiua-11120	353	7	cui	cui	PROPN
aiua-11120	353	8	ys	ys	PROPN
aiua-11120	353	9	,	,	PUNCT
aiua-11120	353	10	et	et	PROPN
aiua-11120	353	11	al	al	PROPN
aiua-11120	353	12	.	.	PROPN
aiua-11120	353	13	efficacy	efficacy	NOUN
aiua-11120	353	14	and	and	CCONJ
aiua-11120	353	15	safety	safety	NOUN
aiua-11120	353	16	of	of	ADP
aiua-11120	353	17	onabotulinumtoxina	onabotulinumtoxina	PROPN
aiua-11120	353	18	in	in	ADP
aiua-11120	353	19	treating	treat	VERB
aiua-11120	353	20	neurogenic	neurogenic	ADJ
aiua-11120	353	21	detrusor	detrusor	NOUN
aiua-11120	353	22	overactivity	overactivity	NOUN
aiua-11120	353	23	:	:	PUNCT
aiua-11120	353	24	a	a	DET
aiua-11120	353	25	systematic	systematic	ADJ
aiua-11120	353	26	review	review	NOUN
aiua-11120	353	27	and	and	CCONJ
aiua-11120	353	28	meta	meta	ADJ
aiua-11120	353	29	-	-	PUNCT
aiua-11120	353	30	analysis	analysis	NOUN
aiua-11120	353	31	.	.	PUNCT
aiua-11120	354	1	chin	chin	PROPN
aiua-11120	354	2	med	med	PROPN
aiua-11120	354	3	j	j	PROPN
aiua-11120	354	4	(	(	PUNCT
aiua-11120	354	5	engl	engl	PROPN
aiua-11120	354	6	)	)	PUNCT
aiua-11120	354	7	.	.	PUNCT
aiua-11120	355	1	2015	2015	NUM
aiua-11120	355	2	;	;	PUNCT
aiua-11120	355	3	128:9638	128:9638	NUM
aiua-11120	355	4	.	.	PROPN
aiua-11120	355	5	12	12	NUM
aiua-11120	355	6	.	.	PUNCT
aiua-11120	356	1	mehta	mehta	PROPN
aiua-11120	356	2	s	s	PROPN
aiua-11120	356	3	,	,	PUNCT
aiua-11120	356	4	hill	hill	PROPN
aiua-11120	356	5	d	d	PROPN
aiua-11120	356	6	,	,	PUNCT
aiua-11120	356	7	mcintyre	mcintyre	PROPN
aiua-11120	356	8	a	a	PROPN
aiua-11120	356	9	,	,	PUNCT
aiua-11120	356	10	et	et	PROPN
aiua-11120	356	11	al	al	PROPN
aiua-11120	356	12	.	.	PUNCT
aiua-11120	357	1	meta	meta	VERB
aiua-11120	357	2	-	-	PUNCT
aiua-11120	357	3	analysis	analysis	NOUN
aiua-11120	357	4	of	of	ADP
aiua-11120	357	5	botulinum	botulinum	ADJ
aiua-11120	357	6	toxin	toxin	NOUN
aiua-11120	357	7	a	a	DET
aiua-11120	357	8	detrusor	detrusor	NOUN
aiua-11120	357	9	injections	injection	NOUN
aiua-11120	357	10	in	in	ADP
aiua-11120	357	11	the	the	DET
aiua-11120	357	12	treatment	treatment	NOUN
aiua-11120	357	13	of	of	ADP
aiua-11120	357	14	neurogenic	neurogenic	ADJ
aiua-11120	357	15	detrusor	detrusor	NOUN
aiua-11120	357	16	overactivity	overactivity	NOUN
aiua-11120	357	17	after	after	ADP
aiua-11120	357	18	spinal	spinal	PROPN
aiua-11120	357	19	cord	cord	NOUN
aiua-11120	357	20	injury	injury	NOUN
aiua-11120	357	21	.	.	PUNCT
aiua-11120	358	1	arch	arch	ADJ
aiua-11120	358	2	phys	phy	NOUN
aiua-11120	358	3	med	me	VERB
aiua-11120	358	4	rehabil	rehabil	NOUN
aiua-11120	358	5	.	.	PUNCT
aiua-11120	359	1	2013	2013	NUM
aiua-11120	359	2	;	;	PUNCT
aiua-11120	359	3	94:1473	94:1473	NUM
aiua-11120	359	4	-	-	SYM
aiua-11120	359	5	81	81	NUM
aiua-11120	359	6	.	.	PUNCT
aiua-11120	360	1	13	13	NUM
aiua-11120	360	2	.	.	PUNCT
aiua-11120	361	1	wu	wu	PROPN
aiua-11120	361	2	sj	sj	PROPN
aiua-11120	361	3	,	,	PUNCT
aiua-11120	361	4	xu	xu	PROPN
aiua-11120	361	5	yq	yq	PROPN
aiua-11120	361	6	,	,	PUNCT
aiua-11120	361	7	gao	gao	PROPN
aiua-11120	361	8	zy	zy	PROPN
aiua-11120	361	9	,	,	PUNCT
aiua-11120	361	10	et	et	PROPN
aiua-11120	361	11	al	al	PROPN
aiua-11120	361	12	.	.	PUNCT
aiua-11120	362	1	clinical	clinical	ADJ
aiua-11120	362	2	outcomes	outcome	NOUN
aiua-11120	362	3	of	of	ADP
aiua-11120	362	4	botulinum	botulinum	ADJ
aiua-11120	362	5	toxin	toxin	NOUN
aiua-11120	362	6	a	a	DET
aiua-11120	362	7	management	management	NOUN
aiua-11120	362	8	for	for	ADP
aiua-11120	362	9	neurogenic	neurogenic	ADJ
aiua-11120	362	10	detrusor	detrusor	NOUN
aiua-11120	362	11	overactivity	overactivity	NOUN
aiua-11120	362	12	:	:	PUNCT
aiua-11120	362	13	meta	meta	ADJ
aiua-11120	362	14	-	-	PUNCT
aiua-11120	362	15	analysis	analysis	NOUN
aiua-11120	362	16	.	.	PUNCT
aiua-11120	363	1	ren	ren	PROPN
aiua-11120	363	2	fail	fail	VERB
aiua-11120	363	3	.	.	PUNCT
aiua-11120	364	1	2019	2019	NUM
aiua-11120	364	2	;	;	PUNCT
aiua-11120	364	3	41:937	41:937	NUM
aiua-11120	364	4	-	-	SYM
aiua-11120	364	5	945	945	NUM
aiua-11120	364	6	.	.	NOUN
aiua-11120	364	7	14	14	NUM
aiua-11120	364	8	.	.	PUNCT
aiua-11120	365	1	ni	ni	PROPN
aiua-11120	365	2	j	j	PROPN
aiua-11120	365	3	,	,	PUNCT
aiua-11120	365	4	wang	wang	PROPN
aiua-11120	365	5	x	x	PROPN
aiua-11120	365	6	,	,	PUNCT
aiua-11120	365	7	cao	cao	PROPN
aiua-11120	365	8	n	n	AUX
aiua-11120	365	9	,	,	PUNCT
aiua-11120	365	10	et	et	PROPN
aiua-11120	365	11	al	al	PROPN
aiua-11120	365	12	.	.	PROPN
aiua-11120	365	13	is	be	AUX
aiua-11120	365	14	repeat	repeat	VERB
aiua-11120	365	15	botulinum	botulinum	ADJ
aiua-11120	365	16	toxin	toxin	NOUN
aiua-11120	365	17	a	a	DET
aiua-11120	365	18	injection	injection	NOUN
aiua-11120	365	19	valuable	valuable	ADJ
aiua-11120	365	20	for	for	ADP
aiua-11120	365	21	neurogenic	neurogenic	ADJ
aiua-11120	365	22	detrusor	detrusor	NOUN
aiua-11120	365	23	overactivity	overactivity	NOUN
aiua-11120	365	24	-	-	PUNCT
aiua-11120	365	25	a	a	DET
aiua-11120	365	26	systematic	systematic	ADJ
aiua-11120	365	27	review	review	NOUN
aiua-11120	365	28	and	and	CCONJ
aiua-11120	365	29	meta	meta	ADJ
aiua-11120	365	30	-	-	PUNCT
aiua-11120	365	31	analysis	analysis	NOUN
aiua-11120	365	32	.	.	PUNCT
aiua-11120	366	1	neurourol	neurourol	PROPN
aiua-11120	366	2	urodyn	urodyn	NOUN
aiua-11120	366	3	.	.	PUNCT
aiua-11120	367	1	2018	2018	NUM
aiua-11120	367	2	;	;	PUNCT
aiua-11120	367	3	37:542	37:542	NUM
aiua-11120	367	4	-	-	SYM
aiua-11120	367	5	553	553	NUM
aiua-11120	367	6	.	.	NOUN
aiua-11120	368	1	15	15	NUM
aiua-11120	368	2	.	.	PUNCT
aiua-11120	369	1	jo	jo	PROPN
aiua-11120	369	2	jk	jk	PROPN
aiua-11120	369	3	,	,	PUNCT
aiua-11120	369	4	kim	kim	PROPN
aiua-11120	369	5	kn	kn	PROPN
aiua-11120	369	6	,	,	PUNCT
aiua-11120	369	7	kim	kim	PROPN
aiua-11120	369	8	dw	dw	PROPN
aiua-11120	369	9	,	,	PUNCT
aiua-11120	369	10	et	et	PROPN
aiua-11120	369	11	al	al	PROPN
aiua-11120	369	12	.	.	PUNCT
aiua-11120	370	1	the	the	DET
aiua-11120	370	2	effect	effect	NOUN
aiua-11120	370	3	of	of	ADP
aiua-11120	370	4	onabotulinumtoxina	onabotulinumtoxina	PROPN
aiua-11120	370	5	according	accord	VERB
aiua-11120	370	6	to	to	ADP
aiua-11120	370	7	site	site	NOUN
aiua-11120	370	8	of	of	ADP
aiua-11120	370	9	injection	injection	NOUN
aiua-11120	370	10	in	in	ADP
aiua-11120	370	11	patients	patient	NOUN
aiua-11120	370	12	with	with	ADP
aiua-11120	370	13	overactive	overactive	ADJ
aiua-11120	370	14	bladder	bladder	NOUN
aiua-11120	370	15	:	:	PUNCT
aiua-11120	370	16	a	a	DET
aiua-11120	370	17	systematic	systematic	ADJ
aiua-11120	370	18	review	review	NOUN
aiua-11120	370	19	and	and	CCONJ
aiua-11120	370	20	meta	meta	ADJ
aiua-11120	370	21	-	-	PUNCT
aiua-11120	370	22	analysis	analysis	NOUN
aiua-11120	370	23	.	.	PUNCT
aiua-11120	371	1	world	world	PROPN
aiua-11120	371	2	j	j	PROPN
aiua-11120	371	3	urol	urol	PROPN
aiua-11120	371	4	.	.	PROPN
aiua-11120	371	5	2018	2018	NUM
aiua-11120	371	6	;	;	PUNCT
aiua-11120	371	7	36:305	36:305	NUM
aiua-11120	371	8	-	-	SYM
aiua-11120	371	9	317	317	NUM
aiua-11120	371	10	.	.	PUNCT
aiua-11120	372	1	16	16	NUM
aiua-11120	372	2	.	.	PUNCT
aiua-11120	373	1	moher	moher	PROPN
aiua-11120	373	2	d	d	PROPN
aiua-11120	373	3	,	,	PUNCT
aiua-11120	373	4	liberati	liberati	PROPN
aiua-11120	373	5	a	a	PRON
aiua-11120	373	6	,	,	PUNCT
aiua-11120	373	7	tetzlaff	tetzlaff	PROPN
aiua-11120	373	8	j	j	PROPN
aiua-11120	373	9	,	,	PUNCT
aiua-11120	373	10	et	et	PROPN
aiua-11120	373	11	al	al	PROPN
aiua-11120	373	12	.	.	PROPN
aiua-11120	373	13	preferred	preferred	ADJ
aiua-11120	373	14	reporting	reporting	NOUN
aiua-11120	373	15	items	item	NOUN
aiua-11120	373	16	for	for	ADP
aiua-11120	373	17	systematic	systematic	ADJ
aiua-11120	373	18	reviews	review	NOUN
aiua-11120	373	19	and	and	CCONJ
aiua-11120	373	20	meta	meta	NOUN
aiua-11120	373	21	-	-	PUNCT
aiua-11120	373	22	analyses	analysis	NOUN
aiua-11120	373	23	:	:	PUNCT
aiua-11120	373	24	the	the	DET
aiua-11120	373	25	prisma	prisma	PROPN
aiua-11120	373	26	statement	statement	NOUN
aiua-11120	373	27	.	.	PUNCT
aiua-11120	374	1	plos	plos	PROPN
aiua-11120	374	2	med	med	PROPN
aiua-11120	374	3	.	.	PROPN
aiua-11120	374	4	2009	2009	NUM
aiua-11120	374	5	;	;	PUNCT
aiua-11120	374	6	6	6	NUM
aiua-11120	374	7	:	:	SYM
aiua-11120	374	8	e1000097	e1000097	PROPN
aiua-11120	374	9	.	.	PROPN
aiua-11120	374	10	17	17	NUM
aiua-11120	374	11	.	.	PUNCT
aiua-11120	375	1	sterne	sterne	PROPN
aiua-11120	375	2	jac	jac	PROPN
aiua-11120	375	3	,	,	PUNCT
aiua-11120	375	4	savovic	savovic	PROPN
aiua-11120	375	5	j	j	PROPN
aiua-11120	375	6	,	,	PUNCT
aiua-11120	375	7	page	page	NOUN
aiua-11120	375	8	mj	mj	PROPN
aiua-11120	375	9	,	,	PUNCT
aiua-11120	375	10	et	et	PROPN
aiua-11120	375	11	al	al	PROPN
aiua-11120	375	12	.	.	PROPN
aiua-11120	375	13	rob	rob	PROPN
aiua-11120	376	1	2	2	NUM
aiua-11120	376	2	:	:	PUNCT
aiua-11120	376	3	a	a	DET
aiua-11120	376	4	revised	revise	VERB
aiua-11120	376	5	tool	tool	NOUN
aiua-11120	376	6	for	for	ADP
aiua-11120	376	7	assessing	assess	VERB
aiua-11120	376	8	risk	risk	NOUN
aiua-11120	376	9	of	of	ADP
aiua-11120	376	10	bias	bias	NOUN
aiua-11120	376	11	in	in	ADP
aiua-11120	376	12	randomised	randomised	ADJ
aiua-11120	376	13	trials	trial	NOUN
aiua-11120	376	14	.	.	PUNCT
aiua-11120	377	1	bmj	bmj	PROPN
aiua-11120	377	2	2019	2019	NUM
aiua-11120	377	3	;	;	PUNCT
aiua-11120	377	4	366	366	NUM
aiua-11120	377	5	:	:	PUNCT
aiua-11120	377	6	l4898	l4898	PROPN
aiua-11120	377	7	.	.	PUNCT
aiua-11120	378	1	18	18	NUM
aiua-11120	378	2	.	.	PUNCT
aiua-11120	379	1	zesiewicz	zesiewicz	PROPN
aiua-11120	379	2	ta	ta	PROPN
aiua-11120	379	3	,	,	PUNCT
aiua-11120	379	4	evatt	evatt	PROPN
aiua-11120	379	5	m	m	PROPN
aiua-11120	379	6	,	,	PUNCT
aiua-11120	379	7	vaughan	vaughan	PROPN
aiua-11120	379	8	c	c	PROPN
aiua-11120	379	9	,	,	PUNCT
aiua-11120	379	10	et	et	PROPN
aiua-11120	379	11	al	al	PROPN
aiua-11120	379	12	.	.	PROPN
aiua-11120	379	13	randomized	randomize	VERB
aiua-11120	379	14	,	,	PUNCT
aiua-11120	379	15	controlled	control	VERB
aiua-11120	379	16	pilot	pilot	NOUN
aiua-11120	379	17	trial	trial	NOUN
aiua-11120	379	18	of	of	ADP
aiua-11120	379	19	solifenacin	solifenacin	PROPN
aiua-11120	379	20	succinate	succinate	NOUN
aiua-11120	379	21	for	for	ADP
aiua-11120	379	22	overactive	overactive	ADJ
aiua-11120	379	23	bladder	bladder	NOUN
aiua-11120	379	24	in	in	ADP
aiua-11120	379	25	parkinson	parkinson	NOUN
aiua-11120	379	26	's	's	PART
aiua-11120	379	27	disease	disease	NOUN
aiua-11120	379	28	.	.	PUNCT
aiua-11120	380	1	parkinsonism	parkinsonism	PROPN
aiua-11120	380	2	relat	relat	PROPN
aiua-11120	380	3	disord	disord	PROPN
aiua-11120	380	4	.	.	PUNCT
aiua-11120	381	1	2015	2015	NUM
aiua-11120	381	2	;	;	PUNCT
aiua-11120	381	3	21:514	21:514	NUM
aiua-11120	381	4	-	-	SYM
aiua-11120	381	5	20	20	NUM
aiua-11120	381	6	.	.	NOUN
aiua-11120	382	1	19	19	NUM
aiua-11120	382	2	.	.	PUNCT
aiua-11120	382	3	yonguc	yonguc	PROPN
aiua-11120	382	4	t	t	PROPN
aiua-11120	382	5	,	,	PUNCT
aiua-11120	382	6	sefik	sefik	NOUN
aiua-11120	382	7	e	e	NOUN
aiua-11120	382	8	,	,	PUNCT
aiua-11120	382	9	inci	inci	PROPN
aiua-11120	382	10	i	i	PROPN
aiua-11120	382	11	,	,	PUNCT
aiua-11120	382	12	et	et	PROPN
aiua-11120	382	13	al	al	PROPN
aiua-11120	382	14	.	.	PROPN
aiua-11120	382	15	randomized	randomize	VERB
aiua-11120	382	16	,	,	PUNCT
aiua-11120	382	17	controlled	control	VERB
aiua-11120	382	18	trial	trial	NOUN
aiua-11120	382	19	of	of	ADP
aiua-11120	382	20	fesoterodine	fesoterodine	NOUN
aiua-11120	382	21	fumarate	fumarate	NOUN
aiua-11120	382	22	for	for	ADP
aiua-11120	382	23	overactive	overactive	ADJ
aiua-11120	382	24	bladder	bladder	NOUN
aiua-11120	382	25	in	in	ADP
aiua-11120	382	26	parkinson	parkinson	NOUN
aiua-11120	382	27	's	's	PART
aiua-11120	382	28	disease	disease	NOUN
aiua-11120	382	29	.	.	PUNCT
aiua-11120	383	1	world	world	PROPN
aiua-11120	383	2	j	j	PROPN
aiua-11120	383	3	urol	urol	PROPN
aiua-11120	383	4	.	.	PUNCT
aiua-11120	384	1	2020	2020	NUM
aiua-11120	384	2	;	;	PUNCT
aiua-11120	384	3	38:2013	38:2013	NUM
aiua-11120	384	4	-	-	SYM
aiua-11120	384	5	2019	2019	NUM
aiua-11120	384	6	.	.	PUNCT
aiua-11120	385	1	20	20	NUM
aiua-11120	385	2	.	.	X
aiua-11120	385	3	amarenco	amarenco	PROPN
aiua-11120	385	4	g	g	PROPN
aiua-11120	385	5	,	,	PUNCT
aiua-11120	385	6	sutory	sutory	NOUN
aiua-11120	385	7	m	m	PROPN
aiua-11120	385	8	,	,	PUNCT
aiua-11120	385	9	zachoval	zachoval	PROPN
aiua-11120	385	10	r	r	PROPN
aiua-11120	385	11	,	,	PUNCT
aiua-11120	385	12	et	et	PROPN
aiua-11120	385	13	al	al	PROPN
aiua-11120	385	14	.	.	PUNCT
aiua-11120	386	1	solifenacin	solifenacin	PROPN
aiua-11120	386	2	is	be	AUX
aiua-11120	386	3	effective	effective	ADJ
aiua-11120	386	4	and	and	CCONJ
aiua-11120	386	5	well	well	ADV
aiua-11120	386	6	tolerated	tolerate	VERB
aiua-11120	386	7	in	in	ADP
aiua-11120	386	8	patients	patient	NOUN
aiua-11120	386	9	with	with	ADP
aiua-11120	386	10	neurogenic	neurogenic	ADJ
aiua-11120	386	11	detrusor	detrusor	NOUN
aiua-11120	386	12	overactivity	overactivity	NOUN
aiua-11120	386	13	:	:	PUNCT
aiua-11120	386	14	results	result	NOUN
aiua-11120	386	15	from	from	ADP
aiua-11120	386	16	the	the	DET
aiua-11120	386	17	double	double	ADJ
aiua-11120	386	18	-	-	PUNCT
aiua-11120	386	19	blind	blind	ADJ
aiua-11120	386	20	,	,	PUNCT
aiua-11120	386	21	randomized	randomize	VERB
aiua-11120	386	22	,	,	PUNCT
aiua-11120	386	23	activeand	activeand	CCONJ
aiua-11120	386	24	placebo	placebo	NOUN
aiua-11120	386	25	-	-	PUNCT
aiua-11120	386	26	controlled	control	VERB
aiua-11120	386	27	sonic	sonic	ADJ
aiua-11120	386	28	urodynamic	urodynamic	ADJ
aiua-11120	386	29	study	study	NOUN
aiua-11120	386	30	.	.	PUNCT
aiua-11120	387	1	neurourol	neurourol	PROPN
aiua-11120	387	2	urodyn	urodyn	PROPN
aiua-11120	387	3	.	.	PROPN
aiua-11120	388	1	2017	2017	NUM
aiua-11120	388	2	;	;	PUNCT
aiua-11120	388	3	36:414	36:414	NUM
aiua-11120	388	4	-	-	SYM
aiua-11120	388	5	421	421	NUM
aiua-11120	388	6	.	.	PUNCT
aiua-11120	389	1	21	21	NUM
aiua-11120	389	2	.	.	PUNCT
aiua-11120	390	1	lackner	lackner	PROPN
aiua-11120	390	2	te	te	PROPN
aiua-11120	390	3	,	,	PUNCT
aiua-11120	390	4	wyman	wyman	PROPN
aiua-11120	390	5	jf	jf	PROPN
aiua-11120	390	6	,	,	PUNCT
aiua-11120	390	7	mccarthy	mccarthy	PROPN
aiua-11120	390	8	tc	tc	PROPN
aiua-11120	390	9	,	,	PUNCT
aiua-11120	390	10	et	et	PROPN
aiua-11120	390	11	al	al	PROPN
aiua-11120	390	12	.	.	PROPN
aiua-11120	390	13	randomized	randomize	VERB
aiua-11120	390	14	,	,	PUNCT
aiua-11120	390	15	placebo	placebo	NOUN
aiua-11120	390	16	-	-	PUNCT
aiua-11120	390	17	controlled	control	VERB
aiua-11120	390	18	trial	trial	NOUN
aiua-11120	390	19	of	of	ADP
aiua-11120	390	20	the	the	DET
aiua-11120	390	21	cognitive	cognitive	ADJ
aiua-11120	390	22	effect	effect	NOUN
aiua-11120	390	23	,	,	PUNCT
aiua-11120	390	24	safety	safety	NOUN
aiua-11120	390	25	,	,	PUNCT
aiua-11120	390	26	and	and	CCONJ
aiua-11120	390	27	tolerability	tolerability	NOUN
aiua-11120	390	28	of	of	ADP
aiua-11120	390	29	oral	oral	ADJ
aiua-11120	390	30	extended	extend	VERB
aiua-11120	390	31	-	-	PUNCT
aiua-11120	390	32	release	release	NOUN
aiua-11120	390	33	oxybutynin	oxybutynin	NOUN
aiua-11120	390	34	in	in	ADP
aiua-11120	390	35	cognitively	cognitively	ADV
aiua-11120	390	36	impaired	impair	VERB
aiua-11120	390	37	nursing	nursing	NOUN
aiua-11120	390	38	home	home	NOUN
aiua-11120	390	39	residents	resident	NOUN
aiua-11120	390	40	with	with	ADP
aiua-11120	390	41	urge	urge	ADJ
aiua-11120	390	42	urinary	urinary	ADJ
aiua-11120	390	43	incontinence	incontinence	NOUN
aiua-11120	390	44	.	.	PUNCT
aiua-11120	391	1	j	j	PROPN
aiua-11120	391	2	am	be	AUX
aiua-11120	391	3	geriatr	geriatr	ADJ
aiua-11120	391	4	soc	soc	NOUN
aiua-11120	391	5	.	.	PUNCT
aiua-11120	391	6	2008	2008	NUM
aiua-11120	391	7	;	;	PUNCT
aiua-11120	391	8	56:862	56:862	NUM
aiua-11120	391	9	-	-	SYM
aiua-11120	391	10	70	70	NUM
aiua-11120	391	11	.	.	PUNCT
aiua-11120	392	1	22	22	NUM
aiua-11120	392	2	.	.	PUNCT
aiua-11120	392	3	menarini	menarini	PROPN
aiua-11120	392	4	m	m	PROPN
aiua-11120	392	5	,	,	PUNCT
aiua-11120	392	6	del	del	PROPN
aiua-11120	392	7	popolo	popolo	PROPN
aiua-11120	392	8	g	g	PROPN
aiua-11120	392	9	,	,	PUNCT
aiua-11120	392	10	di	di	X
aiua-11120	392	11	benedetto	benedetto	PROPN
aiua-11120	392	12	p	p	PROPN
aiua-11120	392	13	,	,	PUNCT
aiua-11120	392	14	et	et	PROPN
aiua-11120	392	15	al	al	PROPN
aiua-11120	392	16	.	.	PUNCT
aiua-11120	392	17	trospium	trospium	PROPN
aiua-11120	392	18	chloride	chloride	NOUN
aiua-11120	392	19	in	in	ADP
aiua-11120	392	20	patients	patient	NOUN
aiua-11120	392	21	with	with	ADP
aiua-11120	392	22	neurogenic	neurogenic	ADJ
aiua-11120	392	23	detrusor	detrusor	NOUN
aiua-11120	392	24	overactivity	overactivity	NOUN
aiua-11120	392	25	:	:	PUNCT
aiua-11120	392	26	is	be	AUX
aiua-11120	392	27	dose	dose	VERB
aiua-11120	392	28	titration	titration	NOUN
aiua-11120	392	29	of	of	ADP
aiua-11120	392	30	benefit	benefit	NOUN
aiua-11120	392	31	to	to	ADP
aiua-11120	392	32	the	the	DET
aiua-11120	392	33	patients	patient	NOUN
aiua-11120	392	34	?	?	PUNCT
aiua-11120	393	1	int	int	PROPN
aiua-11120	394	1	j	j	PROPN
aiua-11120	394	2	clin	clin	PROPN
aiua-11120	394	3	pharmacol	pharmacol	PROPN
aiua-11120	394	4	ther	ther	ADV
aiua-11120	394	5	.	.	PUNCT
aiua-11120	395	1	2006	2006	NUM
aiua-11120	395	2	;	;	PUNCT
aiua-11120	395	3	44:623	44:623	NUM
aiua-11120	395	4	-	-	SYM
aiua-11120	395	5	32	32	NUM
aiua-11120	395	6	.	.	PUNCT
aiua-11120	396	1	23	23	NUM
aiua-11120	396	2	.	.	PUNCT
aiua-11120	396	3	fader	fader	PROPN
aiua-11120	396	4	m	m	PROPN
aiua-11120	396	5	,	,	PUNCT
aiua-11120	396	6	glickman	glickman	PROPN
aiua-11120	396	7	s	s	PROPN
aiua-11120	396	8	,	,	PUNCT
aiua-11120	396	9	haggar	haggar	NOUN
aiua-11120	396	10	v	v	NOUN
aiua-11120	396	11	,	,	PUNCT
aiua-11120	396	12	et	et	PROPN
aiua-11120	396	13	al	al	PROPN
aiua-11120	396	14	.	.	PROPN
aiua-11120	396	15	intravesical	intravesical	ADJ
aiua-11120	396	16	atropine	atropine	NOUN
aiua-11120	396	17	compared	compare	VERB
aiua-11120	396	18	to	to	ADP
aiua-11120	396	19	oral	oral	ADJ
aiua-11120	396	20	oxybutynin	oxybutynin	NOUN
aiua-11120	396	21	for	for	ADP
aiua-11120	396	22	neurogenic	neurogenic	ADJ
aiua-11120	396	23	detrusor	detrusor	NOUN
aiua-11120	396	24	overactivity	overactivity	NOUN
aiua-11120	396	25	:	:	PUNCT
aiua-11120	396	26	a	a	DET
aiua-11120	396	27	doubleblind	doubleblind	NOUN
aiua-11120	396	28	,	,	PUNCT
aiua-11120	396	29	randomized	randomize	VERB
aiua-11120	396	30	crossover	crossover	ADP
aiua-11120	396	31	trial	trial	NOUN
aiua-11120	396	32	.	.	PUNCT
aiua-11120	397	1	j	j	PROPN
aiua-11120	397	2	urol	urol	PROPN
aiua-11120	397	3	.	.	PUNCT
aiua-11120	397	4	2007	2007	NUM
aiua-11120	397	5	;	;	PUNCT
aiua-11120	398	1	177:208	177:208	ADV
aiua-11120	398	2	-	-	PUNCT
aiua-11120	398	3	13	13	NUM
aiua-11120	398	4	.	.	X
aiua-11120	398	5	24	24	NUM
aiua-11120	398	6	.	.	PUNCT
aiua-11120	398	7	schröder	schröder	PROPN
aiua-11120	398	8	a	a	NOUN
aiua-11120	398	9	,	,	PUNCT
aiua-11120	398	10	albrecht	albrecht	PROPN
aiua-11120	398	11	u	u	PROPN
aiua-11120	398	12	,	,	PUNCT
aiua-11120	398	13	schnitker	schnitker	PROPN
aiua-11120	398	14	j	j	PROPN
aiua-11120	398	15	,	,	PUNCT
aiua-11120	398	16	et	et	PROPN
aiua-11120	398	17	al	al	PROPN
aiua-11120	398	18	.	.	PROPN
aiua-11120	398	19	efficacy	efficacy	PROPN
aiua-11120	398	20	,	,	PUNCT
aiua-11120	398	21	safety	safety	NOUN
aiua-11120	398	22	,	,	PUNCT
aiua-11120	398	23	and	and	CCONJ
aiua-11120	398	24	tolerability	tolerability	NOUN
aiua-11120	398	25	of	of	ADP
aiua-11120	398	26	intravesically	intravesically	ADV
aiua-11120	398	27	administered	administer	VERB
aiua-11120	398	28	0.1	0.1	NUM
aiua-11120	398	29	%	%	NOUN
aiua-11120	398	30	oxybutynin	oxybutynin	ADJ
aiua-11120	398	31	hydrochloride	hydrochloride	NOUN
aiua-11120	398	32	solution	solution	NOUN
aiua-11120	398	33	in	in	ADP
aiua-11120	398	34	adult	adult	NOUN
aiua-11120	398	35	patients	patient	NOUN
aiua-11120	398	36	with	with	ADP
aiua-11120	398	37	neurogenic	neurogenic	ADJ
aiua-11120	398	38	bladder	bladder	NOUN
aiua-11120	398	39	:	:	PUNCT
aiua-11120	398	40	a	a	DET
aiua-11120	398	41	randomized	randomized	ADJ
aiua-11120	398	42	,	,	PUNCT
aiua-11120	398	43	prospective	prospective	ADJ
aiua-11120	398	44	,	,	PUNCT
aiua-11120	398	45	controlled	control	VERB
aiua-11120	398	46	multi	multi	ADJ
aiua-11120	398	47	-	-	ADJ
aiua-11120	398	48	center	center	ADJ
aiua-11120	398	49	trial	trial	NOUN
aiua-11120	398	50	.	.	PUNCT
aiua-11120	399	1	neurourol	neurourol	PROPN
aiua-11120	399	2	urodyn	urodyn	PROPN
aiua-11120	399	3	.	.	PUNCT
aiua-11120	400	1	2016	2016	NUM
aiua-11120	400	2	;	;	PUNCT
aiua-11120	400	3	35:582	35:582	NUM
aiua-11120	400	4	-	-	SYM
aiua-11120	400	5	8	8	NUM
aiua-11120	400	6	.	.	X
aiua-11120	401	1	25	25	NUM
aiua-11120	401	2	.	.	PUNCT
aiua-11120	401	3	stöhrer	stöhrer	PROPN
aiua-11120	401	4	m	m	PROPN
aiua-11120	401	5	,	,	PUNCT
aiua-11120	401	6	mürtz	mürtz	NOUN
aiua-11120	401	7	g	g	PROPN
aiua-11120	401	8	,	,	PUNCT
aiua-11120	401	9	kramer	kramer	PROPN
aiua-11120	401	10	g	g	PROPN
aiua-11120	401	11	,	,	PUNCT
aiua-11120	401	12	et	et	PROPN
aiua-11120	401	13	al	al	PROPN
aiua-11120	401	14	.	.	PROPN
aiua-11120	401	15	efficacy	efficacy	NOUN
aiua-11120	401	16	and	and	CCONJ
aiua-11120	401	17	tolerability	tolerability	NOUN
aiua-11120	401	18	of	of	ADP
aiua-11120	401	19	propiverine	propiverine	ADJ
aiua-11120	401	20	hydrochloride	hydrochloride	NOUN
aiua-11120	401	21	extended	extend	VERB
aiua-11120	401	22	-	-	PUNCT
aiua-11120	401	23	release	release	NOUN
aiua-11120	401	24	compared	compare	VERB
aiua-11120	401	25	with	with	ADP
aiua-11120	401	26	immediaterelease	immediaterelease	NOUN
aiua-11120	401	27	in	in	ADP
aiua-11120	401	28	patients	patient	NOUN
aiua-11120	401	29	with	with	ADP
aiua-11120	401	30	neurogenic	neurogenic	ADJ
aiua-11120	401	31	detrusor	detrusor	NOUN
aiua-11120	401	32	overactivity	overactivity	NOUN
aiua-11120	401	33	.	.	PUNCT
aiua-11120	402	1	spinal	spinal	ADJ
aiua-11120	402	2	cord	cord	NOUN
aiua-11120	402	3	.	.	PUNCT
aiua-11120	403	1	2013	2013	NUM
aiua-11120	403	2	;	;	PUNCT
aiua-11120	403	3	51:419	51:419	NUM
aiua-11120	403	4	-	-	SYM
aiua-11120	403	5	23	23	NUM
aiua-11120	403	6	.	.	PUNCT
aiua-11120	404	1	26	26	NUM
aiua-11120	404	2	.	.	PUNCT
aiua-11120	404	3	stöhrer	stöhrer	PROPN
aiua-11120	404	4	m	m	PROPN
aiua-11120	404	5	,	,	PUNCT
aiua-11120	404	6	mürtz	mürtz	NOUN
aiua-11120	404	7	g	g	PROPN
aiua-11120	404	8	,	,	PUNCT
aiua-11120	404	9	kramer	kramer	PROPN
aiua-11120	404	10	g	g	PROPN
aiua-11120	404	11	,	,	PUNCT
aiua-11120	404	12	et	et	PROPN
aiua-11120	404	13	al	al	PROPN
aiua-11120	404	14	.	.	PROPN
aiua-11120	404	15	propiverine	propiverine	PROPN
aiua-11120	404	16	compared	compare	VERB
aiua-11120	404	17	to	to	ADP
aiua-11120	404	18	oxybutynin	oxybutynin	PROPN
aiua-11120	404	19	in	in	ADP
aiua-11120	404	20	neurogenic	neurogenic	ADJ
aiua-11120	404	21	detrusor	detrusor	NOUN
aiua-11120	404	22	overactivity	overactivity	NOUN
aiua-11120	404	23	--	--	PUNCT
aiua-11120	404	24	results	result	NOUN
aiua-11120	404	25	of	of	ADP
aiua-11120	404	26	a	a	DET
aiua-11120	404	27	randomized	randomized	ADJ
aiua-11120	404	28	,	,	PUNCT
aiua-11120	404	29	double	double	ADJ
aiua-11120	404	30	-	-	PUNCT
aiua-11120	404	31	blind	blind	ADJ
aiua-11120	404	32	,	,	PUNCT
aiua-11120	404	33	multicenter	multicenter	ADJ
aiua-11120	404	34	clinical	clinical	ADJ
aiua-11120	404	35	study	study	NOUN
aiua-11120	404	36	.	.	PUNCT
aiua-11120	405	1	eur	eur	PROPN
aiua-11120	405	2	urol	urol	PROPN
aiua-11120	405	3	.	.	PUNCT
aiua-11120	406	1	2007	2007	NUM
aiua-11120	406	2	;	;	PUNCT
aiua-11120	406	3	51:23542	51:23542	NUM
aiua-11120	406	4	.	.	PROPN
aiua-11120	407	1	27	27	NUM
aiua-11120	407	2	.	.	PUNCT
aiua-11120	408	1	cho	cho	PROPN
aiua-11120	408	2	sy	sy	PROPN
aiua-11120	408	3	,	,	PUNCT
aiua-11120	408	4	jeong	jeong	PROPN
aiua-11120	408	5	sj	sj	PROPN
aiua-11120	408	6	,	,	PUNCT
aiua-11120	408	7	lee	lee	PROPN
aiua-11120	408	8	s	s	PROPN
aiua-11120	408	9	,	,	PUNCT
aiua-11120	408	10	et	et	PROPN
aiua-11120	408	11	al	al	PROPN
aiua-11120	408	12	.	.	PROPN
aiua-11120	408	13	mirabegron	mirabegron	PROPN
aiua-11120	409	1	for	for	ADP
aiua-11120	409	2	treatment	treatment	NOUN
aiua-11120	409	3	of	of	ADP
aiua-11120	409	4	overactive	overactive	ADJ
aiua-11120	409	5	bladder	bladder	NOUN
aiua-11120	409	6	symptoms	symptom	NOUN
aiua-11120	409	7	in	in	ADP
aiua-11120	409	8	patients	patient	NOUN
aiua-11120	409	9	with	with	ADP
aiua-11120	409	10	parkinson	parkinson	NOUN
aiua-11120	409	11	's	's	PART
aiua-11120	409	12	disease	disease	NOUN
aiua-11120	409	13	:	:	PUNCT
aiua-11120	409	14	a	a	DET
aiua-11120	409	15	doubleblind	doubleblind	NOUN
aiua-11120	409	16	,	,	PUNCT
aiua-11120	409	17	randomized	randomize	VERB
aiua-11120	409	18	placebo	placebo	NOUN
aiua-11120	409	19	-	-	PUNCT
aiua-11120	409	20	controlled	control	VERB
aiua-11120	409	21	trial	trial	NOUN
aiua-11120	409	22	(	(	PUNCT
aiua-11120	409	23	parkinson	parkinson	NOUN
aiua-11120	409	24	's	's	PART
aiua-11120	409	25	disease	disease	NOUN
aiua-11120	409	26	overactive	overactive	ADJ
aiua-11120	409	27	bladder	bladder	NOUN
aiua-11120	409	28	mirabegron	mirabegron	NOUN
aiua-11120	409	29	,	,	PUNCT
aiua-11120	409	30	padomi	padomi	NOUN
aiua-11120	409	31	study	study	NOUN
aiua-11120	409	32	)	)	PUNCT
aiua-11120	409	33	.	.	PUNCT
aiua-11120	410	1	neurourol	neurourol	PROPN
aiua-11120	410	2	urodyn	urodyn	PROPN
aiua-11120	410	3	.	.	PUNCT
aiua-11120	411	1	2021	2021	NUM
aiua-11120	411	2	;	;	PUNCT
aiua-11120	411	3	40:286	40:286	PROPN
aiua-11120	411	4	-	-	SYM
aiua-11120	411	5	294	294	NUM
aiua-11120	411	6	.	.	PUNCT
aiua-11120	412	1	28	28	NUM
aiua-11120	412	2	.	.	PUNCT
aiua-11120	413	1	moussa	moussa	PROPN
aiua-11120	413	2	m	m	PROPN
aiua-11120	413	3	,	,	PUNCT
aiua-11120	413	4	chakra	chakra	PROPN
aiua-11120	413	5	ma	ma	PROPN
aiua-11120	413	6	,	,	PUNCT
aiua-11120	413	7	dabboucy	dabboucy	PROPN
aiua-11120	413	8	b	b	PROPN
aiua-11120	413	9	,	,	PUNCT
aiua-11120	413	10	et	et	PROPN
aiua-11120	413	11	al	al	PROPN
aiua-11120	413	12	.	.	PUNCT
aiua-11120	414	1	the	the	DET
aiua-11120	414	2	safety	safety	NOUN
aiua-11120	414	3	and	and	CCONJ
aiua-11120	414	4	effectiveness	effectiveness	NOUN
aiua-11120	414	5	of	of	ADP
aiua-11120	414	6	mirabegron	mirabegron	PROPN
aiua-11120	414	7	in	in	ADP
aiua-11120	414	8	parkinson	parkinson	NOUN
aiua-11120	414	9	's	's	PART
aiua-11120	414	10	disease	disease	NOUN
aiua-11120	414	11	patients	patient	NOUN
aiua-11120	414	12	with	with	ADP
aiua-11120	414	13	overactive	overactive	ADJ
aiua-11120	414	14	bladder	bladder	NOUN
aiua-11120	414	15	:	:	PUNCT
aiua-11120	414	16	a	a	DET
aiua-11120	414	17	randomized	randomized	ADJ
aiua-11120	414	18	controlled	control	VERB
aiua-11120	414	19	trial	trial	NOUN
aiua-11120	414	20	.	.	PUNCT
aiua-11120	415	1	scand	scand	PROPN
aiua-11120	415	2	j	j	PROPN
aiua-11120	415	3	urol	urol	PROPN
aiua-11120	415	4	.	.	PUNCT
aiua-11120	415	5	2022	2022	NUM
aiua-11120	415	6	;	;	PUNCT
aiua-11120	415	7	56:66	56:66	NUM
aiua-11120	415	8	-	-	SYM
aiua-11120	415	9	72	72	NUM
aiua-11120	415	10	.	.	PUNCT
aiua-11120	415	11	29	29	NUM
aiua-11120	415	12	.	.	PUNCT
aiua-11120	416	1	ray	ray	PROPN
aiua-11120	416	2	s	s	PROPN
aiua-11120	416	3	,	,	PUNCT
aiua-11120	416	4	burdick	burdick	PROPN
aiua-11120	416	5	d	d	PROPN
aiua-11120	416	6	,	,	PUNCT
aiua-11120	416	7	griffith	griffith	PROPN
aiua-11120	416	8	a	a	PRON
aiua-11120	416	9	,	,	PUNCT
aiua-11120	416	10	agarwal	agarwal	PROPN
aiua-11120	416	11	p.	p.	PROPN
aiua-11120	416	12	preliminary	preliminary	ADJ
aiua-11120	416	13	report	report	NOUN
aiua-11120	416	14	on	on	ADP
aiua-11120	416	15	the	the	DET
aiua-11120	416	16	maestro	maestro	ADJ
aiua-11120	416	17	study	study	NOUN
aiua-11120	416	18	:	:	PUNCT
aiua-11120	416	19	a	a	DET
aiua-11120	416	20	pilot	pilot	NOUN
aiua-11120	416	21	study	study	NOUN
aiua-11120	416	22	of	of	ADP
aiua-11120	416	23	mirabegron	mirabegron	PROPN
aiua-11120	416	24	and	and	CCONJ
aiua-11120	416	25	behavioral	behavioral	ADJ
aiua-11120	416	26	modification	modification	NOUN
aiua-11120	416	27	including	include	VERB
aiua-11120	416	28	pelvic	pelvic	ADJ
aiua-11120	416	29	floor	floor	NOUN
aiua-11120	416	30	exercise	exercise	NOUN
aiua-11120	416	31	for	for	ADP
aiua-11120	416	32	overactive	overactive	ADJ
aiua-11120	416	33	bladder	bladder	NOUN
aiua-11120	416	34	in	in	ADP
aiua-11120	416	35	parkinson	parkinson	NOUN
aiua-11120	416	36	's	's	PART
aiua-11120	416	37	disease	disease	NOUN
aiua-11120	416	38	movement	movement	NOUN
aiua-11120	416	39	disorders	disorder	NOUN
aiua-11120	416	40	.	.	PUNCT
aiua-11120	417	1	2017	2017	NUM
aiua-11120	417	2	;	;	PUNCT
aiua-11120	418	1	32(suppl	32(suppl	NUM
aiua-11120	418	2	2):945	2):945	NUM
aiua-11120	418	3	-	-	SYM
aiua-11120	418	4	946	946	NUM
aiua-11120	418	5	.	.	PUNCT
aiua-11120	418	6	30	30	NUM
aiua-11120	418	7	.	.	PUNCT
aiua-11120	419	1	krhut	krhut	PROPN
aiua-11120	419	2	j	j	PROPN
aiua-11120	419	3	,	,	PUNCT
aiua-11120	419	4	borovicka	borovicka	PROPN
aiua-11120	419	5	v	v	PROPN
aiua-11120	419	6	,	,	PUNCT
aiua-11120	419	7	bilkova	bilkova	X
aiua-11120	419	8	k	k	X
aiua-11120	419	9	,	,	PUNCT
aiua-11120	419	10	et	et	PROPN
aiua-11120	419	11	al	al	PROPN
aiua-11120	419	12	.	.	PROPN
aiua-11120	419	13	mirabegron	mirabegron	PROPN
aiua-11120	420	1	in	in	ADP
aiua-11120	420	2	the	the	DET
aiua-11120	420	3	treatment	treatment	NOUN
aiua-11120	420	4	of	of	ADP
aiua-11120	420	5	neurogenic	neurogenic	ADJ
aiua-11120	420	6	detrusor	detrusor	NOUN
aiua-11120	420	7	overactivity	overactivity	NOUN
aiua-11120	420	8	due	due	ADP
aiua-11120	420	9	to	to	ADP
aiua-11120	420	10	spinal	spinal	ADJ
aiua-11120	420	11	cord	cord	NOUN
aiua-11120	420	12	injury	injury	NOUN
aiua-11120	420	13	and	and	CCONJ
aiua-11120	420	14	multiple	multiple	ADJ
aiua-11120	420	15	sclerosis	sclerosis	NOUN
aiua-11120	420	16	international	international	ADJ
aiua-11120	420	17	journal	journal	NOUN
aiua-11120	420	18	of	of	ADP
aiua-11120	420	19	urology	urology	NOUN
aiua-11120	420	20	2017	2017	NUM
aiua-11120	420	21	;	;	PUNCT
aiua-11120	420	22	24(suppl	24(suppl	NUM
aiua-11120	420	23	1):18	1):18	NUM
aiua-11120	420	24	-	-	SYM
aiua-11120	420	25	19	19	NUM
aiua-11120	420	26	.	.	PUNCT
aiua-11120	420	27	31	31	NUM
aiua-11120	420	28	.	.	PUNCT
aiua-11120	420	29	welk	welk	PROPN
aiua-11120	420	30	b	b	PROPN
aiua-11120	420	31	,	,	PUNCT
aiua-11120	420	32	hickling	hickling	NOUN
aiua-11120	420	33	d	d	NOUN
aiua-11120	420	34	,	,	PUNCT
aiua-11120	420	35	mckibbon	mckibbon	PROPN
aiua-11120	420	36	m	m	PROPN
aiua-11120	420	37	,	,	PUNCT
aiua-11120	420	38	et	et	PROPN
aiua-11120	420	39	al	al	PROPN
aiua-11120	420	40	.	.	PUNCT
aiua-11120	421	1	a	a	DET
aiua-11120	421	2	pilot	pilot	NOUN
aiua-11120	421	3	randomized	randomize	VERB
aiua-11120	421	4	-	-	PUNCT
aiua-11120	421	5	controlled	control	VERB
aiua-11120	421	6	trial	trial	NOUN
aiua-11120	421	7	of	of	ADP
aiua-11120	421	8	the	the	DET
aiua-11120	421	9	urodynamic	urodynamic	ADJ
aiua-11120	421	10	efficacy	efficacy	NOUN
aiua-11120	421	11	of	of	ADP
aiua-11120	421	12	mirabegron	mirabegron	PROPN
aiua-11120	421	13	for	for	ADP
aiua-11120	421	14	patients	patient	NOUN
aiua-11120	421	15	with	with	ADP
aiua-11120	421	16	neurogenic	neurogenic	ADJ
aiua-11120	421	17	lower	low	ADJ
aiua-11120	421	18	urinary	urinary	ADJ
aiua-11120	421	19	tract	tract	NOUN
aiua-11120	421	20	dysfunction	dysfunction	NOUN
aiua-11120	421	21	.	.	PUNCT
aiua-11120	422	1	neurourol	neurourol	PROPN
aiua-11120	422	2	urodyn	urodyn	PROPN
aiua-11120	422	3	.	.	PUNCT
aiua-11120	423	1	2018	2018	NUM
aiua-11120	423	2	;	;	PUNCT
aiua-11120	423	3	37:2810	37:2810	NOUN
aiua-11120	423	4	-	-	SYM
aiua-11120	423	5	2817	2817	NUM
aiua-11120	423	6	.	.	PUNCT
aiua-11120	424	1	32	32	NUM
aiua-11120	424	2	.	.	PUNCT
aiua-11120	425	1	vasudeva	vasudeva	PROPN
aiua-11120	425	2	p	p	PROPN
aiua-11120	425	3	,	,	PUNCT
aiua-11120	425	4	kumar	kumar	PROPN
aiua-11120	425	5	a	a	PROPN
aiua-11120	425	6	,	,	PUNCT
aiua-11120	425	7	yadav	yadav	PROPN
aiua-11120	425	8	s	s	PROPN
aiua-11120	425	9	,	,	PUNCT
aiua-11120	425	10	et	et	PROPN
aiua-11120	425	11	al	al	PROPN
aiua-11120	425	12	.	.	PROPN
aiua-11120	425	13	neurological	neurological	ADJ
aiua-11120	425	14	safety	safety	NOUN
aiua-11120	425	15	and	and	CCONJ
aiua-11120	425	16	efficacy	efficacy	NOUN
aiua-11120	425	17	of	of	ADP
aiua-11120	425	18	darifenacin	darifenacin	PROPN
aiua-11120	425	19	and	and	CCONJ
aiua-11120	425	20	mirabegron	mirabegron	PROPN
aiua-11120	425	21	for	for	ADP
aiua-11120	425	22	the	the	DET
aiua-11120	425	23	treatment	treatment	NOUN
aiua-11120	425	24	of	of	ADP
aiua-11120	425	25	overactive	overactive	ADJ
aiua-11120	425	26	bladder	bladder	NOUN
aiua-11120	425	27	in	in	ADP
aiua-11120	425	28	patients	patient	NOUN
aiua-11120	425	29	with	with	ADP
aiua-11120	425	30	history	history	NOUN
aiua-11120	425	31	of	of	ADP
aiua-11120	425	32	cerebrovascular	cerebrovascular	ADJ
aiua-11120	425	33	accident	accident	NOUN
aiua-11120	425	34	:	:	PUNCT
aiua-11120	425	35	a	a	DET
aiua-11120	425	36	prospective	prospective	ADJ
aiua-11120	425	37	study	study	NOUN
aiua-11120	425	38	.	.	PUNCT
aiua-11120	426	1	neurourol	neurourol	PROPN
aiua-11120	426	2	urodyn	urodyn	PROPN
aiua-11120	426	3	.	.	PUNCT
aiua-11120	427	1	2021	2021	NUM
aiua-11120	427	2	;	;	PUNCT
aiua-11120	427	3	40:2041	40:2041	X
aiua-11120	427	4	-	-	SYM
aiua-11120	427	5	2047	2047	NUM
aiua-11120	427	6	.	.	PUNCT
aiua-11120	428	1	33	33	NUM
aiua-11120	428	2	.	.	PUNCT
aiua-11120	428	3	nardulli	nardulli	PROPN
aiua-11120	428	4	r	r	NOUN
aiua-11120	428	5	,	,	PUNCT
aiua-11120	428	6	losavio	losavio	NOUN
aiua-11120	428	7	e	e	NOUN
aiua-11120	428	8	,	,	PUNCT
aiua-11120	428	9	ranieri	ranieri	PROPN
aiua-11120	428	10	m	m	PROPN
aiua-11120	428	11	,	,	PUNCT
aiua-11120	428	12	et	et	PROPN
aiua-11120	428	13	al	al	PROPN
aiua-11120	428	14	.	.	PROPN
aiua-11120	428	15	combined	combine	VERB
aiua-11120	428	16	antimuscarinics	antimuscarinic	NOUN
aiua-11120	428	17	for	for	ADP
aiua-11120	428	18	treatment	treatment	NOUN
aiua-11120	428	19	of	of	ADP
aiua-11120	428	20	neurogenic	neurogenic	ADJ
aiua-11120	428	21	overactive	overactive	ADJ
aiua-11120	428	22	bladder	bladder	NOUN
aiua-11120	428	23	.	.	PUNCT
aiua-11120	429	1	int	int	PROPN
aiua-11120	430	1	j	j	PROPN
aiua-11120	430	2	immunopathol	immunopathol	PROPN
aiua-11120	430	3	pharmacol	pharmacol	PROPN
aiua-11120	430	4	.	.	PROPN
aiua-11120	430	5	2012	2012	NUM
aiua-11120	430	6	;	;	PUNCT
aiua-11120	430	7	25(1	25(1	NUM
aiua-11120	430	8	suppl):35s-41s	suppl):35s-41	NOUN
aiua-11120	430	9	.	.	PUNCT
aiua-11120	431	1	34	34	NUM
aiua-11120	431	2	.	.	PUNCT
aiua-11120	432	1	sakakibara	sakakibara	PROPN
aiua-11120	432	2	r	r	PROPN
aiua-11120	432	3	,	,	PUNCT
aiua-11120	432	4	ito	ito	PROPN
aiua-11120	432	5	t	t	PROPN
aiua-11120	432	6	,	,	PUNCT
aiua-11120	432	7	uchiyama	uchiyama	PROPN
aiua-11120	432	8	t	t	PROPN
aiua-11120	432	9	,	,	PUNCT
aiua-11120	432	10	et	et	PROPN
aiua-11120	432	11	al	al	PROPN
aiua-11120	432	12	.	.	PUNCT
aiua-11120	432	13	effects	effect	NOUN
aiua-11120	432	14	of	of	ADP
aiua-11120	432	15	milnacipran	milnacipran	NOUN
aiua-11120	432	16	and	and	CCONJ
aiua-11120	432	17	paroxetine	paroxetine	NOUN
aiua-11120	432	18	on	on	ADP
aiua-11120	432	19	overactive	overactive	ADJ
aiua-11120	432	20	bladder	bladder	NOUN
aiua-11120	432	21	due	due	ADP
aiua-11120	432	22	to	to	ADP
aiua-11120	432	23	neurologic	neurologic	ADJ
aiua-11120	432	24	diseases	disease	NOUN
aiua-11120	432	25	:	:	PUNCT
aiua-11120	432	26	a	a	DET
aiua-11120	432	27	urodynamic	urodynamic	ADJ
aiua-11120	432	28	assessment	assessment	NOUN
aiua-11120	432	29	.	.	PUNCT
aiua-11120	433	1	urol	urol	PROPN
aiua-11120	433	2	int	int	PROPN
aiua-11120	433	3	.	.	PUNCT
aiua-11120	433	4	2008	2008	NUM
aiua-11120	433	5	;	;	PUNCT
aiua-11120	433	6	81:335	81:335	NUM
aiua-11120	433	7	-	-	SYM
aiua-11120	433	8	9	9	NUM
aiua-11120	433	9	.	.	NOUN
aiua-11120	433	10	35	35	NUM
aiua-11120	433	11	.	.	PUNCT
aiua-11120	434	1	freeman	freeman	PROPN
aiua-11120	434	2	rm	rm	PROPN
aiua-11120	434	3	,	,	PUNCT
aiua-11120	434	4	adekanmi	adekanmi	PROPN
aiua-11120	434	5	o	o	PROPN
aiua-11120	434	6	,	,	PUNCT
aiua-11120	434	7	waterfield	waterfield	PROPN
aiua-11120	434	8	mr	mr	PROPN
aiua-11120	434	9	,	,	PUNCT
aiua-11120	434	10	et	et	PROPN
aiua-11120	434	11	al	al	PROPN
aiua-11120	434	12	.	.	PUNCT
aiua-11120	435	1	the	the	DET
aiua-11120	435	2	effect	effect	NOUN
aiua-11120	435	3	of	of	ADP
aiua-11120	435	4	cannabis	cannabis	NOUN
aiua-11120	435	5	on	on	ADP
aiua-11120	435	6	urge	urge	ADJ
aiua-11120	435	7	incontinence	incontinence	NOUN
aiua-11120	435	8	in	in	ADP
aiua-11120	435	9	patients	patient	NOUN
aiua-11120	435	10	with	with	ADP
aiua-11120	435	11	multiple	multiple	ADJ
aiua-11120	435	12	sclerosis	sclerosis	NOUN
aiua-11120	435	13	:	:	PUNCT
aiua-11120	435	14	a	a	DET
aiua-11120	435	15	multicentre	multicentre	NOUN
aiua-11120	435	16	,	,	PUNCT
aiua-11120	435	17	randomised	randomise	VERB
aiua-11120	435	18	placebo	placebo	NOUN
aiua-11120	435	19	-	-	PUNCT
aiua-11120	435	20	controlled	control	VERB
aiua-11120	435	21	trial	trial	NOUN
aiua-11120	435	22	(	(	PUNCT
aiua-11120	435	23	cams	cams	NOUN
aiua-11120	435	24	-	-	PUNCT
aiua-11120	435	25	luts	luts	PROPN
aiua-11120	435	26	)	)	PUNCT
aiua-11120	435	27	.	.	PUNCT
aiua-11120	436	1	int	int	NOUN
aiua-11120	437	1	urogynecol	urogynecol	ADJ
aiua-11120	437	2	j	j	PROPN
aiua-11120	437	3	pelvic	pelvic	ADJ
aiua-11120	437	4	floor	floor	NOUN
aiua-11120	437	5	dysfunct	dysfunct	ADJ
aiua-11120	437	6	.	.	PUNCT
aiua-11120	438	1	2006	2006	NUM
aiua-11120	438	2	;	;	PUNCT
aiua-11120	438	3	17:636	17:636	NUM
aiua-11120	438	4	-	-	SYM
aiua-11120	438	5	41	41	NUM
aiua-11120	438	6	.	.	PUNCT
aiua-11120	439	1	36	36	NUM
aiua-11120	439	2	.	.	X
aiua-11120	439	3	kavia	kavia	PROPN
aiua-11120	439	4	rb	rb	PROPN
aiua-11120	439	5	,	,	PUNCT
aiua-11120	440	1	de	de	X
aiua-11120	440	2	ridder	ridder	PROPN
aiua-11120	440	3	d	d	PROPN
aiua-11120	440	4	,	,	PUNCT
aiua-11120	440	5	constantinescu	constantinescu	PROPN
aiua-11120	440	6	cs	cs	PROPN
aiua-11120	440	7	,	,	PUNCT
aiua-11120	440	8	et	et	PROPN
aiua-11120	440	9	al	al	PROPN
aiua-11120	440	10	.	.	PROPN
aiua-11120	440	11	randomized	randomize	VERB
aiua-11120	440	12	controlled	control	VERB
aiua-11120	440	13	trial	trial	NOUN
aiua-11120	440	14	of	of	ADP
aiua-11120	440	15	sativex	sativex	NOUN
aiua-11120	440	16	to	to	PART
aiua-11120	440	17	treat	treat	VERB
aiua-11120	440	18	detrusor	detrusor	NOUN
aiua-11120	440	19	overactivity	overactivity	NOUN
aiua-11120	440	20	in	in	ADP
aiua-11120	440	21	multiple	multiple	ADJ
aiua-11120	440	22	sclerosis	sclerosis	NOUN
aiua-11120	440	23	.	.	PUNCT
aiua-11120	441	1	mult	mult	PROPN
aiua-11120	441	2	scler	scler	NOUN
aiua-11120	441	3	.	.	PUNCT
aiua-11120	442	1	2010	2010	NUM
aiua-11120	442	2	;	;	PUNCT
aiua-11120	442	3	16:1349	16:1349	NUM
aiua-11120	442	4	-	-	SYM
aiua-11120	442	5	59	59	NUM
aiua-11120	442	6	.	.	PUNCT
aiua-11120	443	1	37	37	NUM
aiua-11120	443	2	.	.	X
aiua-11120	443	3	de	de	PROPN
aiua-11120	443	4	sèze	sèze	PROPN
aiua-11120	443	5	m	m	PROPN
aiua-11120	443	6	,	,	PUNCT
aiua-11120	443	7	wiart	wiart	PROPN
aiua-11120	443	8	l	l	PROPN
aiua-11120	443	9	,	,	PUNCT
aiua-11120	443	10	joseph	joseph	PROPN
aiua-11120	443	11	p	p	PROPN
aiua-11120	443	12	-	-	PUNCT
aiua-11120	443	13	a	a	NOUN
aiua-11120	443	14	,	,	PUNCT
aiua-11120	443	15	et	et	PROPN
aiua-11120	443	16	al	al	PROPN
aiua-11120	443	17	.	.	PUNCT
aiua-11120	443	18	capsaicin	capsaicin	PROPN
aiua-11120	443	19	and	and	CCONJ
aiua-11120	443	20	neurogenic	neurogenic	ADJ
aiua-11120	443	21	detrusor	detrusor	NOUN
aiua-11120	443	22	hyperreflexia	hyperreflexia	NOUN
aiua-11120	443	23	:	:	PUNCT
aiua-11120	443	24	a	a	DET
aiua-11120	443	25	double	double	ADJ
aiua-11120	443	26	-	-	PUNCT
aiua-11120	443	27	blind	blind	ADJ
aiua-11120	443	28	placebocontrolled	placebocontrolle	VERB
aiua-11120	443	29	study	study	NOUN
aiua-11120	443	30	in	in	ADP
aiua-11120	443	31	20	20	NUM
aiua-11120	443	32	patients	patient	NOUN
aiua-11120	443	33	with	with	ADP
aiua-11120	443	34	spinal	spinal	ADJ
aiua-11120	443	35	cord	cord	NOUN
aiua-11120	443	36	lesions	lesion	NOUN
aiua-11120	443	37	neurourology	neurourology	NOUN
aiua-11120	443	38	and	and	CCONJ
aiua-11120	443	39	urodynamics	urodynamic	NOUN
aiua-11120	443	40	.	.	PUNCT
aiua-11120	444	1	1998	1998	NUM
aiua-11120	444	2	;	;	PUNCT
aiua-11120	444	3	17:5	17:5	NUM
aiua-11120	444	4	(	(	PUNCT
aiua-11120	444	5	513	513	NUM
aiua-11120	444	6	-	-	SYM
aiua-11120	444	7	523	523	NUM
aiua-11120	444	8	)	)	PUNCT
aiua-11120	444	9	.	.	PUNCT
aiua-11120	445	1	cited	cite	VERB
aiua-11120	445	2	by	by	ADP
aiua-11120	445	3	:	:	PUNCT
aiua-11120	445	4	97	97	NUM
aiua-11120	445	5	.	.	NOUN
aiua-11120	445	6	38	38	NUM
aiua-11120	445	7	.	.	X
aiua-11120	445	8	de	de	PROPN
aiua-11120	445	9	sèze	sèze	PROPN
aiua-11120	445	10	m	m	PROPN
aiua-11120	445	11	,	,	PUNCT
aiua-11120	445	12	gallien	gallien	PROPN
aiua-11120	445	13	p	p	PROPN
aiua-11120	445	14	,	,	PUNCT
aiua-11120	445	15	denys	denys	PROPN
aiua-11120	445	16	p	p	PROPN
aiua-11120	445	17	,	,	PUNCT
aiua-11120	445	18	et	et	PROPN
aiua-11120	445	19	al	al	PROPN
aiua-11120	445	20	.	.	PROPN
aiua-11120	446	1	intravesical	intravesical	PROPN
aiua-11120	446	2	glucidic	glucidic	PROPN
aiua-11120	446	3	capsaicin	capsaicin	PROPN
aiua-11120	446	4	versus	versus	ADP
aiua-11120	446	5	glucidic	glucidic	ADJ
aiua-11120	446	6	solvent	solvent	PROPN
aiua-11120	446	7	in	in	ADP
aiua-11120	446	8	neurogenic	neurogenic	ADJ
aiua-11120	446	9	detrusor	detrusor	NOUN
aiua-11120	446	10	overactivity	overactivity	NOUN
aiua-11120	446	11	:	:	PUNCT
aiua-11120	446	12	a	a	DET
aiua-11120	446	13	double	double	ADJ
aiua-11120	446	14	blind	blind	NOUN
aiua-11120	446	15	controlled	control	VERB
aiua-11120	446	16	randomized	randomized	ADJ
aiua-11120	446	17	study	study	NOUN
aiua-11120	446	18	.	.	PUNCT
aiua-11120	447	1	neurourol	neurourol	PROPN
aiua-11120	447	2	urodyn	urodyn	PROPN
aiua-11120	447	3	.	.	PUNCT
aiua-11120	448	1	2006	2006	NUM
aiua-11120	448	2	;	;	PUNCT
aiua-11120	448	3	25:752	25:752	NUM
aiua-11120	448	4	-	-	SYM
aiua-11120	448	5	7	7	NUM
aiua-11120	448	6	.	.	NOUN
aiua-11120	448	7	39	39	NUM
aiua-11120	448	8	.	.	PUNCT
aiua-11120	449	1	lazzeri	lazzeri	PROPN
aiua-11120	449	2	m	m	PROPN
aiua-11120	449	3	,	,	PUNCT
aiua-11120	449	4	calò	calò	PROPN
aiua-11120	449	5	g	g	PROPN
aiua-11120	449	6	,	,	PUNCT
aiua-11120	449	7	spinelli	spinelli	PROPN
aiua-11120	449	8	m	m	PROPN
aiua-11120	449	9	,	,	PUNCT
aiua-11120	449	10	et	et	PROPN
aiua-11120	449	11	al	al	PROPN
aiua-11120	449	12	.	.	PROPN
aiua-11120	450	1	daily	daily	PROPN
aiua-11120	450	2	intravesical	intravesical	ADJ
aiua-11120	450	3	instillation	instillation	NOUN
aiua-11120	450	4	of	of	ADP
aiua-11120	450	5	1	1	NUM
aiua-11120	450	6	mg	mg	ADV
aiua-11120	450	7	nociceptin	nociceptin	ADV
aiua-11120	450	8	/	/	SYM
aiua-11120	450	9	orphanin	orphanin	PROPN
aiua-11120	450	10	fq	fq	PROPN
aiua-11120	450	11	for	for	ADP
aiua-11120	450	12	the	the	DET
aiua-11120	450	13	control	control	NOUN
aiua-11120	450	14	of	of	ADP
aiua-11120	450	15	neurogenic	neurogenic	ADJ
aiua-11120	450	16	detrusor	detrusor	NOUN
aiua-11120	450	17	overactivity	overactivity	NOUN
aiua-11120	450	18	:	:	PUNCT
aiua-11120	450	19	a	a	DET
aiua-11120	450	20	multicenter	multicenter	NOUN
aiua-11120	450	21	,	,	PUNCT
aiua-11120	450	22	placebo	placebo	NOUN
aiua-11120	450	23	controlled	control	VERB
aiua-11120	450	24	,	,	PUNCT
aiua-11120	450	25	randomized	randomize	VERB
aiua-11120	450	26	exploratory	exploratory	ADJ
aiua-11120	450	27	study	study	NOUN
aiua-11120	450	28	.	.	PUNCT
aiua-11120	451	1	j	j	PROPN
aiua-11120	451	2	urol	urol	PROPN
aiua-11120	451	3	.	.	PUNCT
aiua-11120	452	1	2006	2006	NUM
aiua-11120	452	2	;	;	PUNCT
aiua-11120	452	3	176:2098	176:2098	NUM
aiua-11120	452	4	-	-	SYM
aiua-11120	452	5	102	102	NUM
aiua-11120	452	6	.	.	PUNCT
aiua-11120	453	1	40	40	NUM
aiua-11120	453	2	.	.	PUNCT
aiua-11120	453	3	del	del	PROPN
aiua-11120	453	4	popolo	popolo	PROPN
aiua-11120	453	5	g	g	PROPN
aiua-11120	453	6	,	,	PUNCT
aiua-11120	453	7	denys	denys	PROPN
aiua-11120	453	8	p	p	PROPN
aiua-11120	453	9	,	,	PUNCT
aiua-11120	453	10	keppenne	keppenne	PROPN
aiua-11120	453	11	v	v	PROPN
aiua-11120	453	12	,	,	PUNCT
aiua-11120	453	13	et	et	PROPN
aiua-11120	453	14	al	al	PROPN
aiua-11120	453	15	.	.	PROPN
aiua-11120	453	16	efficacy	efficacy	NOUN
aiua-11120	453	17	and	and	CCONJ
aiua-11120	453	18	safety	safety	NOUN
aiua-11120	453	19	of	of	ADP
aiua-11120	453	20	onabotulinumtoxina	onabotulinumtoxina	PROPN
aiua-11120	453	21	100u	100u	NUM
aiua-11120	453	22	for	for	ADP
aiua-11120	453	23	treatment	treatment	NOUN
aiua-11120	453	24	of	of	ADP
aiua-11120	453	25	urinary	urinary	ADJ
aiua-11120	453	26	incontinence	incontinence	NOUN
aiua-11120	453	27	due	due	ADP
aiua-11120	453	28	to	to	ADP
aiua-11120	453	29	neurogenic	neurogenic	ADJ
aiua-11120	453	30	detrusor	detrusor	NOUN
aiua-11120	453	31	overactivity	overactivity	NOUN
aiua-11120	453	32	in	in	ADP
aiua-11120	453	33	non	non	ADJ
aiua-11120	453	34	-	-	ADJ
aiua-11120	453	35	catheterising	catheterising	ADJ
aiua-11120	453	36	multiple	multiple	ADJ
aiua-11120	453	37	sclerosis	sclerosis	NOUN
aiua-11120	453	38	patients	patient	NOUN
aiua-11120	453	39	neurourology	neurourology	NOUN
aiua-11120	453	40	and	and	CCONJ
aiua-11120	453	41	urodynamics	urodynamic	NOUN
aiua-11120	453	42	.	.	PUNCT
aiua-11120	453	43	2016	2016	NUM
aiua-11120	453	44	;	;	PUNCT
aiua-11120	453	45	35(suppl	35(suppl	NUM
aiua-11120	453	46	3):s53	3):s53	NUM
aiua-11120	453	47	-	-	SYM
aiua-11120	453	48	s54	s54	NOUN
aiua-11120	453	49	.	.	PUNCT
aiua-11120	454	1	41	41	NUM
aiua-11120	454	2	.	.	PUNCT
aiua-11120	455	1	chancellor	chancellor	NOUN
aiua-11120	455	2	mb	mb	PROPN
aiua-11120	455	3	,	,	PUNCT
aiua-11120	455	4	patel	patel	PROPN
aiua-11120	455	5	v	v	PROPN
aiua-11120	455	6	,	,	PUNCT
aiua-11120	455	7	leng	leng	PROPN
aiua-11120	455	8	ww	ww	PROPN
aiua-11120	455	9	,	,	PUNCT
aiua-11120	455	10	et	et	PROPN
aiua-11120	455	11	al	al	PROPN
aiua-11120	455	12	.	.	PROPN
aiua-11120	455	13	onabotulinumtoxina	onabotulinumtoxina	PROPN
aiua-11120	455	14	improves	improve	VERB
aiua-11120	455	15	quality	quality	NOUN
aiua-11120	455	16	of	of	ADP
aiua-11120	455	17	life	life	NOUN
aiua-11120	455	18	in	in	ADP
aiua-11120	455	19	patients	patient	NOUN
aiua-11120	455	20	with	with	ADP
aiua-11120	455	21	neurogenic	neurogenic	ADJ
aiua-11120	455	22	detrusor	detrusor	NOUN
aiua-11120	455	23	overactivity	overactivity	NOUN
aiua-11120	455	24	.	.	PUNCT
aiua-11120	455	25	neurology	neurology	NOUN
aiua-11120	455	26	.	.	PUNCT
aiua-11120	456	1	2013	2013	NUM
aiua-11120	456	2	;	;	PUNCT
aiua-11120	456	3	81:841	81:841	NUM
aiua-11120	456	4	-	-	SYM
aiua-11120	456	5	8	8	NUM
aiua-11120	456	6	42	42	NUM
aiua-11120	456	7	.	.	PUNCT
aiua-11120	457	1	cruz	cruz	PROPN
aiua-11120	457	2	f	f	PROPN
aiua-11120	457	3	,	,	PUNCT
aiua-11120	457	4	herschorn	herschorn	PROPN
aiua-11120	457	5	s	s	PROPN
aiua-11120	457	6	,	,	PUNCT
aiua-11120	457	7	aliotta	aliotta	NOUN
aiua-11120	457	8	p	p	NOUN
aiua-11120	457	9	,	,	PUNCT
aiua-11120	457	10	et	et	PROPN
aiua-11120	457	11	al	al	PROPN
aiua-11120	457	12	.	.	PROPN
aiua-11120	457	13	efficacy	efficacy	NOUN
aiua-11120	457	14	and	and	CCONJ
aiua-11120	457	15	safety	safety	NOUN
aiua-11120	457	16	of	of	ADP
aiua-11120	457	17	onabotulinumtoxina	onabotulinumtoxina	PROPN
aiua-11120	457	18	in	in	ADP
aiua-11120	457	19	patients	patient	NOUN
aiua-11120	457	20	with	with	ADP
aiua-11120	457	21	urinary	urinary	ADJ
aiua-11120	457	22	incontinence	incontinence	NOUN
aiua-11120	457	23	due	due	ADP
aiua-11120	457	24	to	to	ADP
aiua-11120	457	25	neu505archivio	neu505archivio	PROPN
aiua-11120	457	26	italiano	italiano	PROPN
aiua-11120	457	27	di	di	PROPN
aiua-11120	457	28	urologia	urologia	PROPN
aiua-11120	457	29	e	e	PROPN
aiua-11120	457	30	andrologia	andrologia	PROPN
aiua-11120	457	31	2022	2022	NUM
aiua-11120	457	32	;	;	PUNCT
aiua-11120	457	33	94	94	NUM
aiua-11120	457	34	,	,	PUNCT
aiua-11120	457	35	4	4	NUM
aiua-11120	457	36	treatment	treatment	NOUN
aiua-11120	457	37	of	of	ADP
aiua-11120	457	38	overactive	overactive	ADJ
aiua-11120	457	39	neurogenic	neurogenic	ADJ
aiua-11120	457	40	bladder	bladder	NOUN
aiua-11120	457	41	rogenic	rogenic	NOUN
aiua-11120	457	42	detrusor	detrusor	NOUN
aiua-11120	457	43	overactivity	overactivity	NOUN
aiua-11120	457	44	:	:	PUNCT
aiua-11120	457	45	a	a	DET
aiua-11120	457	46	randomised	randomised	ADJ
aiua-11120	457	47	,	,	PUNCT
aiua-11120	457	48	double	double	ADJ
aiua-11120	457	49	-	-	PUNCT
aiua-11120	457	50	blind	blind	ADJ
aiua-11120	457	51	,	,	PUNCT
aiua-11120	457	52	placebo	placebo	NOUN
aiua-11120	457	53	-	-	PUNCT
aiua-11120	457	54	controlled	control	VERB
aiua-11120	457	55	trial	trial	NOUN
aiua-11120	457	56	.	.	PUNCT
aiua-11120	458	1	eur	eur	PROPN
aiua-11120	458	2	urol	urol	PROPN
aiua-11120	458	3	.	.	PUNCT
aiua-11120	459	1	2011	2011	NUM
aiua-11120	459	2	;	;	PUNCT
aiua-11120	459	3	60:742	60:742	NUM
aiua-11120	459	4	-	-	SYM
aiua-11120	459	5	50	50	NUM
aiua-11120	459	6	.	.	PUNCT
aiua-11120	460	1	43	43	NUM
aiua-11120	460	2	.	.	PUNCT
aiua-11120	461	1	denys	denys	PROPN
aiua-11120	461	2	p	p	PROPN
aiua-11120	461	3	,	,	PUNCT
aiua-11120	461	4	del	del	PROPN
aiua-11120	461	5	popolo	popolo	PROPN
aiua-11120	461	6	g	g	PROPN
aiua-11120	461	7	,	,	PUNCT
aiua-11120	461	8	amarenco	amarenco	PROPN
aiua-11120	461	9	g	g	PROPN
aiua-11120	461	10	,	,	PUNCT
aiua-11120	461	11	et	et	PROPN
aiua-11120	461	12	al	al	PROPN
aiua-11120	461	13	.	.	PROPN
aiua-11120	461	14	efficacy	efficacy	NOUN
aiua-11120	461	15	and	and	CCONJ
aiua-11120	461	16	safety	safety	NOUN
aiua-11120	461	17	of	of	ADP
aiua-11120	461	18	two	two	NUM
aiua-11120	461	19	administration	administration	NOUN
aiua-11120	461	20	modes	mode	NOUN
aiua-11120	461	21	of	of	ADP
aiua-11120	461	22	an	an	DET
aiua-11120	461	23	intra	intra	ADJ
aiua-11120	461	24	-	-	ADJ
aiua-11120	461	25	detrusor	detrusor	ADJ
aiua-11120	461	26	injection	injection	NOUN
aiua-11120	461	27	of	of	ADP
aiua-11120	461	28	750	750	NUM
aiua-11120	461	29	units	unit	NOUN
aiua-11120	461	30	dysport	dysport	NOUN
aiua-11120	461	31	®	®	PROPN
aiua-11120	461	32	(	(	PUNCT
aiua-11120	461	33	abobotulinumtoxina	abobotulinumtoxina	ADJ
aiua-11120	461	34	)	)	PUNCT
aiua-11120	461	35	in	in	ADP
aiua-11120	461	36	patients	patient	NOUN
aiua-11120	461	37	suffering	suffer	VERB
aiua-11120	461	38	from	from	ADP
aiua-11120	461	39	refractory	refractory	NOUN
aiua-11120	461	40	neurogenic	neurogenic	ADJ
aiua-11120	461	41	detrusor	detrusor	NOUN
aiua-11120	461	42	overactivity	overactivity	NOUN
aiua-11120	461	43	(	(	PUNCT
aiua-11120	461	44	ndo	ndo	INTJ
aiua-11120	461	45	):	):	PUNCT
aiua-11120	461	46	a	a	DET
aiua-11120	461	47	randomised	randomised	ADJ
aiua-11120	461	48	placebo	placebo	NOUN
aiua-11120	461	49	-	-	PUNCT
aiua-11120	461	50	controlled	control	VERB
aiua-11120	461	51	phase	phase	NOUN
aiua-11120	461	52	iia	iia	NOUN
aiua-11120	461	53	study	study	NOUN
aiua-11120	461	54	.	.	PUNCT
aiua-11120	462	1	neurourol	neurourol	PROPN
aiua-11120	462	2	urodyn	urodyn	PROPN
aiua-11120	462	3	.	.	PROPN
aiua-11120	463	1	2017	2017	NUM
aiua-11120	463	2	;	;	PUNCT
aiua-11120	463	3	36:457	36:457	NUM
aiua-11120	463	4	-	-	SYM
aiua-11120	463	5	462	462	NUM
aiua-11120	463	6	.	.	PROPN
aiua-11120	463	7	44	44	NUM
aiua-11120	463	8	.	.	PUNCT
aiua-11120	464	1	ehren	ehren	PROPN
aiua-11120	464	2	i	i	PROPN
aiua-11120	464	3	,	,	PUNCT
aiua-11120	464	4	volz	volz	PROPN
aiua-11120	464	5	d	d	PROPN
aiua-11120	464	6	,	,	PUNCT
aiua-11120	464	7	farrelly	farrelly	PROPN
aiua-11120	464	8	e	e	PROPN
aiua-11120	464	9	,	,	PUNCT
aiua-11120	464	10	et	et	PROPN
aiua-11120	464	11	al	al	PROPN
aiua-11120	464	12	.	.	PROPN
aiua-11120	464	13	efficacy	efficacy	NOUN
aiua-11120	464	14	and	and	CCONJ
aiua-11120	464	15	impact	impact	NOUN
aiua-11120	464	16	of	of	ADP
aiua-11120	464	17	botulinum	botulinum	ADJ
aiua-11120	464	18	toxin	toxin	NOUN
aiua-11120	464	19	a	a	PRON
aiua-11120	464	20	on	on	ADP
aiua-11120	464	21	quality	quality	NOUN
aiua-11120	464	22	of	of	ADP
aiua-11120	464	23	life	life	NOUN
aiua-11120	464	24	in	in	ADP
aiua-11120	464	25	patients	patient	NOUN
aiua-11120	464	26	with	with	ADP
aiua-11120	464	27	neurogenic	neurogenic	ADJ
aiua-11120	464	28	detrusor	detrusor	NOUN
aiua-11120	464	29	overactivity	overactivity	NOUN
aiua-11120	464	30	:	:	PUNCT
aiua-11120	464	31	a	a	DET
aiua-11120	464	32	randomised	randomised	ADJ
aiua-11120	464	33	,	,	PUNCT
aiua-11120	464	34	placebo	placebo	NOUN
aiua-11120	464	35	-	-	PUNCT
aiua-11120	464	36	controlled	control	VERB
aiua-11120	464	37	,	,	PUNCT
aiua-11120	464	38	double	double	ADJ
aiua-11120	464	39	-	-	PUNCT
aiua-11120	464	40	blind	blind	ADJ
aiua-11120	464	41	study	study	NOUN
aiua-11120	464	42	.	.	PUNCT
aiua-11120	465	1	scand	scand	PROPN
aiua-11120	465	2	j	j	PROPN
aiua-11120	465	3	urol	urol	PROPN
aiua-11120	465	4	nephrol	nephrol	PROPN
aiua-11120	465	5	.	.	PUNCT
aiua-11120	466	1	2007	2007	NUM
aiua-11120	466	2	;	;	PUNCT
aiua-11120	466	3	41:335	41:335	NOUN
aiua-11120	466	4	-	-	SYM
aiua-11120	466	5	40	40	NUM
aiua-11120	466	6	.	.	PUNCT
aiua-11120	467	1	45	45	NUM
aiua-11120	467	2	.	.	PUNCT
aiua-11120	468	1	ginsberg	ginsberg	PROPN
aiua-11120	468	2	d	d	PROPN
aiua-11120	468	3	,	,	PUNCT
aiua-11120	468	4	gousse	gousse	NOUN
aiua-11120	468	5	a	a	PRON
aiua-11120	468	6	,	,	PUNCT
aiua-11120	468	7	keppenne	keppenne	ADJ
aiua-11120	468	8	v	v	PROPN
aiua-11120	468	9	,	,	PUNCT
aiua-11120	468	10	et	et	PROPN
aiua-11120	468	11	al	al	PROPN
aiua-11120	468	12	.	.	PROPN
aiua-11120	468	13	phase	phase	NOUN
aiua-11120	468	14	3	3	NUM
aiua-11120	468	15	efficacy	efficacy	NOUN
aiua-11120	468	16	and	and	CCONJ
aiua-11120	468	17	tolerability	tolerability	NOUN
aiua-11120	468	18	study	study	NOUN
aiua-11120	468	19	of	of	ADP
aiua-11120	468	20	onabotulinumtoxina	onabotulinumtoxina	PROPN
aiua-11120	468	21	for	for	ADP
aiua-11120	468	22	urinary	urinary	ADJ
aiua-11120	468	23	incontinence	incontinence	NOUN
aiua-11120	468	24	from	from	ADP
aiua-11120	468	25	neurogenic	neurogenic	ADJ
aiua-11120	468	26	detrusor	detrusor	NOUN
aiua-11120	468	27	overactivity	overactivity	NOUN
aiua-11120	468	28	.	.	PUNCT
aiua-11120	469	1	j	j	PROPN
aiua-11120	469	2	urol	urol	PROPN
aiua-11120	469	3	.	.	PUNCT
aiua-11120	469	4	2012	2012	NUM
aiua-11120	469	5	;	;	PUNCT
aiua-11120	469	6	187:2131	187:2131	X
aiua-11120	469	7	-	-	SYM
aiua-11120	469	8	9	9	NUM
aiua-11120	469	9	.	.	NOUN
aiua-11120	469	10	46	46	NUM
aiua-11120	469	11	.	.	PUNCT
aiua-11120	470	1	herschorn	herschorn	PROPN
aiua-11120	470	2	s	s	PROPN
aiua-11120	470	3	,	,	PUNCT
aiua-11120	470	4	gajewski	gajewski	PROPN
aiua-11120	470	5	j	j	PROPN
aiua-11120	470	6	,	,	PUNCT
aiua-11120	470	7	ethans	ethans	PROPN
aiua-11120	470	8	k	k	PROPN
aiua-11120	470	9	,	,	PUNCT
aiua-11120	470	10	et	et	PROPN
aiua-11120	470	11	al	al	PROPN
aiua-11120	470	12	.	.	PROPN
aiua-11120	470	13	efficacy	efficacy	PROPN
aiua-11120	470	14	of	of	ADP
aiua-11120	470	15	botulinum	botulinum	ADJ
aiua-11120	470	16	toxin	toxin	NOUN
aiua-11120	470	17	a	a	DET
aiua-11120	470	18	injection	injection	NOUN
aiua-11120	470	19	for	for	ADP
aiua-11120	470	20	neurogenic	neurogenic	ADJ
aiua-11120	470	21	detrusor	detrusor	NOUN
aiua-11120	470	22	overactivity	overactivity	NOUN
aiua-11120	470	23	and	and	CCONJ
aiua-11120	470	24	urinary	urinary	ADJ
aiua-11120	470	25	incontinence	incontinence	NOUN
aiua-11120	470	26	:	:	PUNCT
aiua-11120	470	27	a	a	DET
aiua-11120	470	28	randomized	randomized	ADJ
aiua-11120	470	29	,	,	PUNCT
aiua-11120	470	30	double	double	ADJ
aiua-11120	470	31	-	-	PUNCT
aiua-11120	470	32	blind	blind	ADJ
aiua-11120	470	33	trial	trial	NOUN
aiua-11120	470	34	.	.	PUNCT
aiua-11120	471	1	j	j	PROPN
aiua-11120	471	2	urol	urol	PROPN
aiua-11120	471	3	.	.	PUNCT
aiua-11120	472	1	2011	2011	NUM
aiua-11120	472	2	;	;	PUNCT
aiua-11120	472	3	185:2229	185:2229	NUM
aiua-11120	472	4	-	-	SYM
aiua-11120	472	5	35	35	NUM
aiua-11120	472	6	.	.	PUNCT
aiua-11120	473	1	47	47	NUM
aiua-11120	473	2	.	.	PUNCT
aiua-11120	474	1	honda	honda	PROPN
aiua-11120	474	2	m	m	PROPN
aiua-11120	474	3	,	,	PUNCT
aiua-11120	474	4	yokoyama	yokoyama	PROPN
aiua-11120	474	5	o	o	NOUN
aiua-11120	474	6	,	,	PUNCT
aiua-11120	474	7	takahashi	takahashi	PROPN
aiua-11120	474	8	r	r	PROPN
aiua-11120	474	9	,	,	PUNCT
aiua-11120	474	10	et	et	PROPN
aiua-11120	474	11	al	al	PROPN
aiua-11120	474	12	.	.	PUNCT
aiua-11120	474	13	botulinum	botulinum	ADJ
aiua-11120	474	14	toxin	toxin	NOUN
aiua-11120	474	15	injections	injection	NOUN
aiua-11120	474	16	for	for	ADP
aiua-11120	474	17	japanese	japanese	ADJ
aiua-11120	474	18	patients	patient	NOUN
aiua-11120	474	19	with	with	ADP
aiua-11120	474	20	urinary	urinary	ADJ
aiua-11120	474	21	incontinence	incontinence	NOUN
aiua-11120	474	22	caused	cause	VERB
aiua-11120	474	23	by	by	ADP
aiua-11120	474	24	neurogenic	neurogenic	ADJ
aiua-11120	474	25	detrusor	detrusor	NOUN
aiua-11120	474	26	overactivity	overactivity	NOUN
aiua-11120	474	27	:	:	PUNCT
aiua-11120	474	28	clinical	clinical	ADJ
aiua-11120	474	29	evaluation	evaluation	NOUN
aiua-11120	474	30	of	of	ADP
aiua-11120	474	31	onabotulinumtoxina	onabotulinumtoxina	PROPN
aiua-11120	474	32	in	in	ADP
aiua-11120	474	33	a	a	DET
aiua-11120	474	34	randomized	randomized	ADJ
aiua-11120	474	35	,	,	PUNCT
aiua-11120	474	36	placebo	placebo	NOUN
aiua-11120	474	37	-	-	PUNCT
aiua-11120	474	38	controlled	control	VERB
aiua-11120	474	39	,	,	PUNCT
aiua-11120	474	40	double	double	ADJ
aiua-11120	474	41	-	-	PUNCT
aiua-11120	474	42	blind	blind	ADJ
aiua-11120	474	43	trial	trial	NOUN
aiua-11120	474	44	with	with	ADP
aiua-11120	474	45	an	an	DET
aiua-11120	474	46	openlabel	openlabel	NOUN
aiua-11120	474	47	extension	extension	NOUN
aiua-11120	474	48	.	.	PUNCT
aiua-11120	475	1	int	int	PROPN
aiua-11120	475	2	j	j	PROPN
aiua-11120	475	3	urol	urol	PROPN
aiua-11120	475	4	.	.	PUNCT
aiua-11120	475	5	2021	2021	NUM
aiua-11120	475	6	;	;	PUNCT
aiua-11120	475	7	28	28	NUM
aiua-11120	475	8	:	:	PUNCT
aiua-11120	475	9	906	906	NUM
aiua-11120	475	10	-	-	SYM
aiua-11120	475	11	912	912	NUM
aiua-11120	475	12	.	.	PUNCT
aiua-11120	476	1	48	48	NUM
aiua-11120	476	2	.	.	PUNCT
aiua-11120	477	1	sussman	sussman	PROPN
aiua-11120	477	2	d	d	PROPN
aiua-11120	477	3	,	,	PUNCT
aiua-11120	477	4	patel	patel	PROPN
aiua-11120	477	5	v	v	PROPN
aiua-11120	477	6	,	,	PUNCT
aiua-11120	477	7	del	del	PROPN
aiua-11120	477	8	popolo	popolo	PROPN
aiua-11120	477	9	g	g	PROPN
aiua-11120	477	10	,	,	PUNCT
aiua-11120	477	11	et	et	PROPN
aiua-11120	477	12	al	al	PROPN
aiua-11120	477	13	.	.	PROPN
aiua-11120	477	14	treatment	treatment	NOUN
aiua-11120	477	15	satisfaction	satisfaction	NOUN
aiua-11120	477	16	and	and	CCONJ
aiua-11120	477	17	improvement	improvement	NOUN
aiua-11120	477	18	in	in	ADP
aiua-11120	477	19	health	health	NOUN
aiua-11120	477	20	-	-	PUNCT
aiua-11120	477	21	related	relate	VERB
aiua-11120	477	22	quality	quality	NOUN
aiua-11120	477	23	of	of	ADP
aiua-11120	477	24	life	life	NOUN
aiua-11120	477	25	with	with	ADP
aiua-11120	477	26	onabotulinumtoxina	onabotulinumtoxina	PROPN
aiua-11120	477	27	in	in	ADP
aiua-11120	477	28	patients	patient	NOUN
aiua-11120	477	29	with	with	ADP
aiua-11120	477	30	urinary	urinary	ADJ
aiua-11120	477	31	incontinence	incontinence	NOUN
aiua-11120	477	32	due	due	ADP
aiua-11120	477	33	to	to	ADP
aiua-11120	477	34	neurogenic	neurogenic	ADJ
aiua-11120	477	35	detrusor	detrusor	NOUN
aiua-11120	477	36	overactivity	overactivity	NOUN
aiua-11120	477	37	.	.	PUNCT
aiua-11120	478	1	neurourol	neurourol	PROPN
aiua-11120	478	2	urodyn	urodyn	PROPN
aiua-11120	478	3	.	.	PUNCT
aiua-11120	479	1	2013	2013	NUM
aiua-11120	479	2	;	;	PUNCT
aiua-11120	479	3	32:242	32:242	NUM
aiua-11120	479	4	-	-	SYM
aiua-11120	479	5	9	9	NUM
aiua-11120	479	6	.	.	NUM
aiua-11120	479	7	49	49	NUM
aiua-11120	479	8	.	.	PUNCT
aiua-11120	480	1	kennelly	kennelly	PROPN
aiua-11120	480	2	m	m	PROPN
aiua-11120	480	3	,	,	PUNCT
aiua-11120	480	4	cruz	cruz	PROPN
aiua-11120	480	5	f	f	PROPN
aiua-11120	480	6	,	,	PUNCT
aiua-11120	480	7	herschorn	herschorn	PROPN
aiua-11120	480	8	s	s	PROPN
aiua-11120	480	9	,	,	PUNCT
aiua-11120	480	10	et	et	PROPN
aiua-11120	480	11	al	al	PROPN
aiua-11120	480	12	.	.	PROPN
aiua-11120	480	13	efficacy	efficacy	NOUN
aiua-11120	480	14	and	and	CCONJ
aiua-11120	480	15	safety	safety	NOUN
aiua-11120	480	16	of	of	ADP
aiua-11120	480	17	abobotulinumtoxina	abobotulinumtoxina	PROPN
aiua-11120	480	18	in	in	ADP
aiua-11120	480	19	patients	patient	NOUN
aiua-11120	480	20	with	with	ADP
aiua-11120	480	21	neurogenic	neurogenic	ADJ
aiua-11120	480	22	detrusor	detrusor	NOUN
aiua-11120	480	23	overactivity	overactivity	NOUN
aiua-11120	480	24	incontinence	incontinence	NOUN
aiua-11120	480	25	performing	perform	VERB
aiua-11120	480	26	regular	regular	ADJ
aiua-11120	480	27	clean	clean	ADJ
aiua-11120	480	28	intermittent	intermittent	ADJ
aiua-11120	480	29	catheterization	catheterization	NOUN
aiua-11120	480	30	:	:	PUNCT
aiua-11120	480	31	pooled	pool	VERB
aiua-11120	480	32	results	result	NOUN
aiua-11120	480	33	from	from	ADP
aiua-11120	480	34	two	two	NUM
aiua-11120	480	35	phase	phase	NOUN
aiua-11120	480	36	3	3	NUM
aiua-11120	480	37	randomized	randomize	VERB
aiua-11120	480	38	studies	study	NOUN
aiua-11120	480	39	(	(	PUNCT
aiua-11120	480	40	content1	content1	NOUN
aiua-11120	480	41	and	and	CCONJ
aiua-11120	480	42	content2	content2	PROPN
aiua-11120	480	43	)	)	PUNCT
aiua-11120	480	44	european	european	ADJ
aiua-11120	480	45	urology	urology	NOUN
aiua-11120	480	46	2022	2022	NUM
aiua-11120	480	47	50	50	NUM
aiua-11120	480	48	.	.	PUNCT
aiua-11120	481	1	grise	grise	PROPN
aiua-11120	481	2	p	p	NOUN
aiua-11120	481	3	,	,	PUNCT
aiua-11120	481	4	ruffion	ruffion	NOUN
aiua-11120	481	5	a	a	NOUN
aiua-11120	481	6	,	,	PUNCT
aiua-11120	481	7	denys	denys	PROPN
aiua-11120	481	8	p	p	PROPN
aiua-11120	481	9	,	,	PUNCT
aiua-11120	481	10	et	et	PROPN
aiua-11120	481	11	al	al	PROPN
aiua-11120	481	12	.	.	PROPN
aiua-11120	481	13	efficacy	efficacy	NOUN
aiua-11120	481	14	and	and	CCONJ
aiua-11120	481	15	tolerability	tolerability	NOUN
aiua-11120	481	16	of	of	ADP
aiua-11120	481	17	botulinum	botulinum	ADJ
aiua-11120	481	18	toxin	toxin	NOUN
aiua-11120	481	19	type	type	NOUN
aiua-11120	481	20	a	a	PRON
aiua-11120	481	21	in	in	ADP
aiua-11120	481	22	patients	patient	NOUN
aiua-11120	481	23	with	with	ADP
aiua-11120	481	24	neurogenic	neurogenic	ADJ
aiua-11120	481	25	detrusor	detrusor	NOUN
aiua-11120	481	26	overactivity	overactivity	NOUN
aiua-11120	481	27	and	and	CCONJ
aiua-11120	481	28	without	without	ADP
aiua-11120	481	29	concomitant	concomitant	ADJ
aiua-11120	481	30	anticholinergic	anticholinergic	ADJ
aiua-11120	481	31	therapy	therapy	NOUN
aiua-11120	481	32	:	:	PUNCT
aiua-11120	481	33	comparison	comparison	NOUN
aiua-11120	481	34	of	of	ADP
aiua-11120	481	35	two	two	NUM
aiua-11120	481	36	doses	dose	NOUN
aiua-11120	481	37	eur	eur	PROPN
aiua-11120	481	38	urol	urol	PROPN
aiua-11120	481	39	.	.	PUNCT
aiua-11120	482	1	2010	2010	NUM
aiua-11120	482	2	;	;	PUNCT
aiua-11120	482	3	58:759	58:759	NUM
aiua-11120	482	4	-	-	PUNCT
aiua-11120	482	5	766	766	NUM
aiua-11120	482	6	.	.	NOUN
aiua-11120	483	1	51	51	NUM
aiua-11120	483	2	.	.	PUNCT
aiua-11120	484	1	schurch	schurch	PROPN
aiua-11120	484	2	b	b	PROPN
aiua-11120	484	3	,	,	PUNCT
aiua-11120	484	4	de	de	PROPN
aiua-11120	484	5	sèze	sèze	PROPN
aiua-11120	484	6	m	m	PROPN
aiua-11120	484	7	,	,	PUNCT
aiua-11120	484	8	denys	denys	PROPN
aiua-11120	484	9	p	p	PROPN
aiua-11120	484	10	,	,	PUNCT
aiua-11120	484	11	et	et	PROPN
aiua-11120	484	12	al	al	PROPN
aiua-11120	484	13	.	.	PUNCT
aiua-11120	485	1	botulinum	botulinum	ADJ
aiua-11120	485	2	toxin	toxin	NOUN
aiua-11120	485	3	type	type	NOUN
aiua-11120	485	4	a	a	PRON
aiua-11120	485	5	is	be	AUX
aiua-11120	485	6	a	a	DET
aiua-11120	485	7	safe	safe	ADJ
aiua-11120	485	8	and	and	CCONJ
aiua-11120	485	9	effective	effective	ADJ
aiua-11120	485	10	treatment	treatment	NOUN
aiua-11120	485	11	for	for	ADP
aiua-11120	485	12	neurogenic	neurogenic	ADJ
aiua-11120	485	13	urinary	urinary	ADJ
aiua-11120	485	14	incontinence	incontinence	NOUN
aiua-11120	485	15	:	:	PUNCT
aiua-11120	485	16	results	result	NOUN
aiua-11120	485	17	of	of	ADP
aiua-11120	485	18	a	a	DET
aiua-11120	485	19	single	single	ADJ
aiua-11120	485	20	treatment	treatment	NOUN
aiua-11120	485	21	,	,	PUNCT
aiua-11120	485	22	randomized	randomize	VERB
aiua-11120	485	23	,	,	PUNCT
aiua-11120	485	24	placebo	placebo	NOUN
aiua-11120	485	25	controlled	control	VERB
aiua-11120	485	26	6	6	NUM
aiua-11120	485	27	-	-	PUNCT
aiua-11120	485	28	month	month	NOUN
aiua-11120	485	29	study	study	NOUN
aiua-11120	485	30	j	j	PROPN
aiua-11120	485	31	urol	urol	PROPN
aiua-11120	485	32	.	.	PUNCT
aiua-11120	486	1	2005	2005	NUM
aiua-11120	486	2	;	;	PUNCT
aiua-11120	486	3	174:196	174:196	NUM
aiua-11120	486	4	-	-	SYM
aiua-11120	486	5	200	200	NUM
aiua-11120	486	6	.	.	PUNCT
aiua-11120	487	1	52	52	NUM
aiua-11120	487	2	.	.	PUNCT
aiua-11120	488	1	schurch	schurch	PROPN
aiua-11120	488	2	b	b	PROPN
aiua-11120	488	3	,	,	PUNCT
aiua-11120	488	4	denys	denys	PROPN
aiua-11120	488	5	p	p	PROPN
aiua-11120	488	6	,	,	PUNCT
aiua-11120	488	7	kozma	kozma	PROPN
aiua-11120	488	8	cm	cm	PROPN
aiua-11120	488	9	,	,	PUNCT
aiua-11120	488	10	et	et	PROPN
aiua-11120	488	11	al	al	PROPN
aiua-11120	488	12	.	.	PUNCT
aiua-11120	489	1	botulinum	botulinum	ADJ
aiua-11120	489	2	toxin	toxin	PROPN
aiua-11120	489	3	a	a	PRON
aiua-11120	489	4	improves	improve	VERB
aiua-11120	489	5	the	the	DET
aiua-11120	489	6	quality	quality	NOUN
aiua-11120	489	7	of	of	ADP
aiua-11120	489	8	life	life	NOUN
aiua-11120	489	9	of	of	ADP
aiua-11120	489	10	patients	patient	NOUN
aiua-11120	489	11	with	with	ADP
aiua-11120	489	12	neurogenic	neurogenic	ADJ
aiua-11120	489	13	urinary	urinary	ADJ
aiua-11120	489	14	incontinence	incontinence	NOUN
aiua-11120	489	15	.	.	PUNCT
aiua-11120	490	1	eur	eur	PROPN
aiua-11120	490	2	urol	urol	PROPN
aiua-11120	490	3	.	.	PUNCT
aiua-11120	491	1	2007	2007	NUM
aiua-11120	491	2	;	;	PUNCT
aiua-11120	491	3	52:850	52:850	NUM
aiua-11120	491	4	-	-	SYM
aiua-11120	491	5	8	8	NUM
aiua-11120	491	6	.	.	X
aiua-11120	491	7	53	53	NUM
aiua-11120	491	8	.	.	PUNCT
aiua-11120	492	1	abdel	abdel	PROPN
aiua-11120	492	2	-	-	PUNCT
aiua-11120	492	3	meguid	meguid	PROPN
aiua-11120	492	4	ta	ta	PROPN
aiua-11120	492	5	.	.	PUNCT
aiua-11120	493	1	botulinum	botulinum	ADJ
aiua-11120	493	2	toxin	toxin	PROPN
aiua-11120	493	3	-	-	PUNCT
aiua-11120	493	4	a	a	DET
aiua-11120	493	5	injections	injection	NOUN
aiua-11120	493	6	into	into	ADP
aiua-11120	493	7	neurogenic	neurogenic	ADJ
aiua-11120	493	8	overactive	overactive	ADJ
aiua-11120	493	9	bladder	bladder	NOUN
aiua-11120	493	10	--	--	PUNCT
aiua-11120	493	11	to	to	PART
aiua-11120	493	12	include	include	VERB
aiua-11120	493	13	or	or	CCONJ
aiua-11120	493	14	exclude	exclude	VERB
aiua-11120	493	15	the	the	DET
aiua-11120	493	16	trigone	trigone	NOUN
aiua-11120	493	17	?	?	PUNCT
aiua-11120	494	1	a	a	DET
aiua-11120	494	2	prospective	prospective	ADJ
aiua-11120	494	3	,	,	PUNCT
aiua-11120	494	4	randomized	randomize	VERB
aiua-11120	494	5	,	,	PUNCT
aiua-11120	494	6	controlled	control	VERB
aiua-11120	494	7	trial	trial	NOUN
aiua-11120	494	8	.	.	PUNCT
aiua-11120	495	1	j	j	PROPN
aiua-11120	495	2	urol	urol	PROPN
aiua-11120	495	3	.	.	PUNCT
aiua-11120	496	1	2010	2010	NUM
aiua-11120	496	2	;	;	PUNCT
aiua-11120	496	3	184:2423	184:2423	X
aiua-11120	496	4	-	-	SYM
aiua-11120	496	5	8	8	NUM
aiua-11120	496	6	.	.	PUNCT
aiua-11120	497	1	54	54	NUM
aiua-11120	497	2	.	.	PUNCT
aiua-11120	498	1	hui	hui	PROPN
aiua-11120	498	2	c	c	PROPN
aiua-11120	498	3	,	,	PUNCT
aiua-11120	498	4	keji	keji	PROPN
aiua-11120	498	5	x	x	PROPN
aiua-11120	498	6	,	,	PUNCT
aiua-11120	498	7	chonghe	chonghe	PROPN
aiua-11120	498	8	j	j	PROPN
aiua-11120	498	9	,	,	PUNCT
aiua-11120	498	10	et	et	PROPN
aiua-11120	498	11	al	al	PROPN
aiua-11120	498	12	.	.	PROPN
aiua-11120	498	13	combined	combine	VERB
aiua-11120	498	14	detrusor	detrusor	NOUN
aiua-11120	498	15	-	-	PUNCT
aiua-11120	498	16	trigone	trigone	NOUN
aiua-11120	498	17	btx	btx	NOUN
aiua-11120	498	18	-	-	PUNCT
aiua-11120	498	19	a	a	DET
aiua-11120	498	20	injections	injection	NOUN
aiua-11120	498	21	for	for	ADP
aiua-11120	498	22	urinary	urinary	ADJ
aiua-11120	498	23	incontinence	incontinence	NOUN
aiua-11120	498	24	secondary	secondary	ADJ
aiua-11120	498	25	to	to	ADP
aiua-11120	498	26	neurogenic	neurogenic	ADJ
aiua-11120	498	27	detrusor	detrusor	NOUN
aiua-11120	498	28	overactivity	overactivity	NOUN
aiua-11120	498	29	.	.	PUNCT
aiua-11120	499	1	spinal	spinal	ADJ
aiua-11120	499	2	cord	cord	NOUN
aiua-11120	499	3	.	.	PUNCT
aiua-11120	500	1	2016	2016	NUM
aiua-11120	500	2	;	;	PUNCT
aiua-11120	500	3	54:46	54:46	NUM
aiua-11120	500	4	-	-	SYM
aiua-11120	500	5	50	50	NUM
aiua-11120	500	6	.	.	PUNCT
aiua-11120	501	1	55	55	NUM
aiua-11120	501	2	.	.	PUNCT
aiua-11120	502	1	grise	grise	PROPN
aiua-11120	502	2	p	p	NOUN
aiua-11120	502	3	,	,	PUNCT
aiua-11120	502	4	ruffion	ruffion	NOUN
aiua-11120	502	5	a	a	NOUN
aiua-11120	502	6	,	,	PUNCT
aiua-11120	502	7	denys	denys	PROPN
aiua-11120	502	8	p	p	PROPN
aiua-11120	502	9	,	,	PUNCT
aiua-11120	502	10	et	et	PROPN
aiua-11120	502	11	al	al	PROPN
aiua-11120	502	12	.	.	PROPN
aiua-11120	502	13	efficacy	efficacy	NOUN
aiua-11120	502	14	and	and	CCONJ
aiua-11120	502	15	tolerability	tolerability	NOUN
aiua-11120	502	16	of	of	ADP
aiua-11120	502	17	botulinum	botulinum	ADJ
aiua-11120	502	18	toxin	toxin	NOUN
aiua-11120	502	19	type	type	NOUN
aiua-11120	502	20	a	a	PRON
aiua-11120	502	21	in	in	ADP
aiua-11120	502	22	patients	patient	NOUN
aiua-11120	502	23	with	with	ADP
aiua-11120	502	24	neurogenic	neurogenic	ADJ
aiua-11120	502	25	detrusor	detrusor	NOUN
aiua-11120	502	26	overactivity	overactivity	NOUN
aiua-11120	502	27	and	and	CCONJ
aiua-11120	502	28	without	without	ADP
aiua-11120	502	29	concomitant	concomitant	ADJ
aiua-11120	502	30	anticholinergic	anticholinergic	ADJ
aiua-11120	502	31	therapy	therapy	NOUN
aiua-11120	502	32	:	:	PUNCT
aiua-11120	502	33	comparison	comparison	NOUN
aiua-11120	502	34	of	of	ADP
aiua-11120	502	35	two	two	NUM
aiua-11120	502	36	doses	dose	NOUN
aiua-11120	502	37	eur	eur	PROPN
aiua-11120	502	38	urol	urol	PROPN
aiua-11120	502	39	.	.	PUNCT
aiua-11120	503	1	2010	2010	NUM
aiua-11120	503	2	;	;	PUNCT
aiua-11120	503	3	58:759	58:759	NUM
aiua-11120	503	4	-	-	PUNCT
aiua-11120	503	5	766	766	NUM
aiua-11120	503	6	.	.	X
aiua-11120	504	1	56	56	NUM
aiua-11120	504	2	.	.	PUNCT
aiua-11120	504	3	araujo	araujo	PROPN
aiua-11120	504	4	tg	tg	PROPN
aiua-11120	504	5	,	,	PUNCT
aiua-11120	504	6	schmidt	schmidt	PROPN
aiua-11120	504	7	ap	ap	PROPN
aiua-11120	504	8	,	,	PUNCT
aiua-11120	504	9	sanches	sanches	PROPN
aiua-11120	504	10	prs	prs	PROPN
aiua-11120	504	11	,	,	PUNCT
aiua-11120	504	12	et	et	PROPN
aiua-11120	504	13	al	al	PROPN
aiua-11120	504	14	.	.	PUNCT
aiua-11120	505	1	transcutaneous	transcutaneous	ADJ
aiua-11120	505	2	tibial	tibial	ADJ
aiua-11120	505	3	nerve	nerve	NOUN
aiua-11120	505	4	home	home	NOUN
aiua-11120	505	5	stimulation	stimulation	NOUN
aiua-11120	505	6	for	for	ADP
aiua-11120	505	7	overactive	overactive	ADJ
aiua-11120	505	8	bladder	bladder	NOUN
aiua-11120	505	9	in	in	ADP
aiua-11120	505	10	women	woman	NOUN
aiua-11120	505	11	with	with	ADP
aiua-11120	505	12	parkinson	parkinson	NOUN
aiua-11120	505	13	's	's	PART
aiua-11120	505	14	disease	disease	NOUN
aiua-11120	505	15	:	:	PUNCT
aiua-11120	505	16	a	a	DET
aiua-11120	505	17	randomized	randomized	ADJ
aiua-11120	505	18	clinical	clinical	ADJ
aiua-11120	505	19	trial	trial	NOUN
aiua-11120	505	20	.	.	PUNCT
aiua-11120	506	1	neurourol	neurourol	PROPN
aiua-11120	506	2	urodyn	urodyn	PROPN
aiua-11120	506	3	.	.	PUNCT
aiua-11120	507	1	2021	2021	NUM
aiua-11120	507	2	;	;	PUNCT
aiua-11120	507	3	40:538	40:538	NUM
aiua-11120	507	4	-	-	SYM
aiua-11120	507	5	548	548	NUM
aiua-11120	507	6	.	.	PUNCT
aiua-11120	508	1	57	57	NUM
aiua-11120	508	2	.	.	PUNCT
aiua-11120	509	1	perissinotto	perissinotto	PROPN
aiua-11120	509	2	mc	mc	PROPN
aiua-11120	509	3	,	,	PUNCT
aiua-11120	509	4	d’ancona	d’ancona	NOUN
aiua-11120	509	5	ca	can	AUX
aiua-11120	509	6	,	,	PUNCT
aiua-11120	509	7	lucio	lucio	PROPN
aiua-11120	509	8	a	a	PROPN
aiua-11120	509	9	,	,	PUNCT
aiua-11120	509	10	et	et	PROPN
aiua-11120	509	11	al	al	PROPN
aiua-11120	509	12	.	.	PUNCT
aiua-11120	510	1	transcutaneous	transcutaneous	ADJ
aiua-11120	510	2	tibial	tibial	ADJ
aiua-11120	510	3	nerve	nerve	NOUN
aiua-11120	510	4	stimulation	stimulation	NOUN
aiua-11120	510	5	in	in	ADP
aiua-11120	510	6	the	the	DET
aiua-11120	510	7	treatment	treatment	NOUN
aiua-11120	510	8	of	of	ADP
aiua-11120	510	9	lower	low	ADJ
aiua-11120	510	10	urinary	urinary	ADJ
aiua-11120	510	11	tract	tract	NOUN
aiua-11120	510	12	symptoms	symptom	NOUN
aiua-11120	510	13	and	and	CCONJ
aiua-11120	510	14	its	its	PRON
aiua-11120	510	15	impact	impact	NOUN
aiua-11120	510	16	on	on	ADP
aiua-11120	510	17	health	health	NOUN
aiua-11120	510	18	-	-	PUNCT
aiua-11120	510	19	related	relate	VERB
aiua-11120	510	20	quality	quality	NOUN
aiua-11120	510	21	of	of	ADP
aiua-11120	510	22	life	life	NOUN
aiua-11120	510	23	in	in	ADP
aiua-11120	510	24	patients	patient	NOUN
aiua-11120	510	25	with	with	ADP
aiua-11120	510	26	parkinson	parkinson	NOUN
aiua-11120	510	27	disease	disease	NOUN
aiua-11120	510	28	:	:	PUNCT
aiua-11120	510	29	a	a	DET
aiua-11120	510	30	randomized	randomized	ADJ
aiua-11120	510	31	controlled	control	VERB
aiua-11120	510	32	trial	trial	NOUN
aiua-11120	510	33	.	.	PUNCT
aiua-11120	511	1	j	j	PROPN
aiua-11120	511	2	wound	wind	VERB
aiua-11120	511	3	ostomy	ostomy	NOUN
aiua-11120	511	4	continence	continence	NOUN
aiua-11120	511	5	nurs	nur	VERB
aiua-11120	511	6	.	.	PUNCT
aiua-11120	512	1	2015	2015	NUM
aiua-11120	512	2	;	;	PUNCT
aiua-11120	512	3	42:94	42:94	NUM
aiua-11120	512	4	-	-	SYM
aiua-11120	512	5	9	9	NUM
aiua-11120	512	6	.	.	X
aiua-11120	512	7	58	58	NUM
aiua-11120	512	8	.	.	PUNCT
aiua-11120	513	1	monteiro	monteiro	PROPN
aiua-11120	513	2	és	és	PROPN
aiua-11120	513	3	,	,	PUNCT
aiua-11120	513	4	de	de	PROPN
aiua-11120	513	5	carvalho	carvalho	PROPN
aiua-11120	513	6	lb	lb	NOUN
aiua-11120	513	7	,	,	PUNCT
aiua-11120	513	8	fukujima	fukujima	PROPN
aiua-11120	513	9	mm	mm	PROPN
aiua-11120	513	10	,	,	PUNCT
aiua-11120	513	11	et	et	PROPN
aiua-11120	513	12	al	al	PROPN
aiua-11120	513	13	.	.	PUNCT
aiua-11120	513	14	electrical	electrical	ADJ
aiua-11120	513	15	stimulation	stimulation	NOUN
aiua-11120	513	16	of	of	ADP
aiua-11120	513	17	the	the	DET
aiua-11120	513	18	posterior	posterior	ADJ
aiua-11120	513	19	tibialis	tibialis	NOUN
aiua-11120	513	20	nerve	nerve	NOUN
aiua-11120	513	21	improves	improve	VERB
aiua-11120	513	22	symptoms	symptom	NOUN
aiua-11120	513	23	of	of	ADP
aiua-11120	513	24	poststroke	poststroke	ADJ
aiua-11120	513	25	neurogenic	neurogenic	ADJ
aiua-11120	513	26	overactive	overactive	ADJ
aiua-11120	513	27	bladder	bladder	NOUN
aiua-11120	513	28	in	in	ADP
aiua-11120	513	29	men	man	NOUN
aiua-11120	513	30	:	:	PUNCT
aiua-11120	513	31	a	a	DET
aiua-11120	513	32	randomized	randomized	ADJ
aiua-11120	513	33	controlled	control	VERB
aiua-11120	513	34	trial	trial	NOUN
aiua-11120	513	35	.	.	PUNCT
aiua-11120	514	1	urology	urology	NOUN
aiua-11120	514	2	.	.	PUNCT
aiua-11120	515	1	2014	2014	NUM
aiua-11120	515	2	;	;	PUNCT
aiua-11120	515	3	84:509	84:509	NUM
aiua-11120	515	4	-	-	SYM
aiua-11120	515	5	14	14	NUM
aiua-11120	515	6	.	.	PUNCT
aiua-11120	516	1	59	59	NUM
aiua-11120	516	2	.	.	PUNCT
aiua-11120	517	1	gaspard	gaspard	PROPN
aiua-11120	517	2	l	l	PROPN
aiua-11120	517	3	,	,	PUNCT
aiua-11120	517	4	tombal	tombal	PROPN
aiua-11120	517	5	b	b	SYM
aiua-11120	517	6	,	,	PUNCT
aiua-11120	517	7	opsomer	opsomer	PROPN
aiua-11120	517	8	rj	rj	PROPN
aiua-11120	517	9	,	,	PUNCT
aiua-11120	517	10	et	et	PROPN
aiua-11120	517	11	al	al	PROPN
aiua-11120	517	12	.	.	PROPN
aiua-11120	517	13	kinésithérapie	kinésithérapie	PROPN
aiua-11120	518	1	et	et	PROPN
aiua-11120	518	2	symptômes	symptômes	PROPN
aiua-11120	518	3	du	du	PROPN
aiua-11120	518	4	bas	bas	PROPN
aiua-11120	518	5	appareil	appareil	PROPN
aiua-11120	518	6	urinaire	urinaire	PROPN
aiua-11120	518	7	chez	chez	PROPN
aiua-11120	518	8	des	des	PROPN
aiua-11120	518	9	patients	patients	PROPN
aiua-11120	518	10	atteints	atteints	PROPN
aiua-11120	518	11	de	de	X
aiua-11120	518	12	la	la	X
aiua-11120	518	13	sclérose	sclérose	PROPN
aiua-11120	518	14	en	en	PROPN
aiua-11120	518	15	plaques	plaque	NOUN
aiua-11120	518	16	:	:	PUNCT
aiua-11120	518	17	étude	étude	PROPN
aiua-11120	518	18	contrôlée	contrôlée	NOUN
aiua-11120	518	19	randomisée	randomisée	NOUN
aiua-11120	518	20	[	[	X
aiua-11120	518	21	physiotherapy	physiotherapy	NOUN
aiua-11120	518	22	and	and	CCONJ
aiua-11120	518	23	neurogenic	neurogenic	ADJ
aiua-11120	518	24	lower	low	ADJ
aiua-11120	518	25	urinary	urinary	ADJ
aiua-11120	518	26	tract	tract	NOUN
aiua-11120	518	27	dysfunction	dysfunction	NOUN
aiua-11120	518	28	in	in	ADP
aiua-11120	518	29	multiple	multiple	ADJ
aiua-11120	518	30	sclerosis	sclerosis	NOUN
aiua-11120	518	31	patients	patient	NOUN
aiua-11120	518	32	:	:	PUNCT
aiua-11120	518	33	a	a	DET
aiua-11120	518	34	randomized	randomized	ADJ
aiua-11120	518	35	controlled	control	VERB
aiua-11120	518	36	trial	trial	NOUN
aiua-11120	518	37	]	]	PUNCT
aiua-11120	518	38	.	.	PUNCT
aiua-11120	519	1	prog	prog	PROPN
aiua-11120	519	2	urol	urol	PROPN
aiua-11120	519	3	.	.	PUNCT
aiua-11120	519	4	2014	2014	NUM
aiua-11120	519	5	;	;	PUNCT
aiua-11120	519	6	24:697	24:697	NUM
aiua-11120	519	7	-	-	SYM
aiua-11120	519	8	707	707	NUM
aiua-11120	519	9	.	.	PUNCT
aiua-11120	519	10	60	60	NUM
aiua-11120	519	11	.	.	PUNCT
aiua-11120	520	1	zonic	zonic	NOUN
aiua-11120	520	2	-	-	PUNCT
aiua-11120	520	3	imamovic	imamovic	PROPN
aiua-11120	520	4	m	m	PROPN
aiua-11120	520	5	,	,	PUNCT
aiua-11120	520	6	imamovic	imamovic	PROPN
aiua-11120	520	7	s	s	PROPN
aiua-11120	520	8	,	,	PUNCT
aiua-11120	520	9	cickušic	cickušic	NOUN
aiua-11120	520	10	a	a	X
aiua-11120	520	11	,	,	PUNCT
aiua-11120	520	12	et	et	PROPN
aiua-11120	520	13	al	al	PROPN
aiua-11120	520	14	.	.	PUNCT
aiua-11120	520	15	effects	effect	NOUN
aiua-11120	520	16	of	of	ADP
aiua-11120	520	17	treating	treat	VERB
aiua-11120	520	18	an	an	DET
aiua-11120	520	19	overactive	overactive	ADJ
aiua-11120	520	20	urinary	urinary	ADJ
aiua-11120	520	21	bladder	bladder	NOUN
aiua-11120	520	22	in	in	ADP
aiua-11120	520	23	patients	patient	NOUN
aiua-11120	520	24	with	with	ADP
aiua-11120	520	25	multiple	multiple	ADJ
aiua-11120	520	26	sclerosis	sclerosis	NOUN
aiua-11120	520	27	.	.	PUNCT
aiua-11120	521	1	acta	acta	PROPN
aiua-11120	521	2	med	med	PROPN
aiua-11120	521	3	acad	acad	PROPN
aiua-11120	521	4	.	.	PUNCT
aiua-11120	522	1	2019	2019	NUM
aiua-11120	522	2	;	;	PUNCT
aiua-11120	522	3	48:271	48:271	NUM
aiua-11120	522	4	-	-	SYM
aiua-11120	522	5	277	277	NUM
aiua-11120	522	6	.	.	PUNCT
aiua-11120	523	1	61	61	NUM
aiua-11120	523	2	.	.	PUNCT
aiua-11120	524	1	eftekhar	eftekhar	PROPN
aiua-11120	524	2	t	t	PROPN
aiua-11120	524	3	,	,	PUNCT
aiua-11120	524	4	teimoory	teimoory	PROPN
aiua-11120	524	5	n	n	NUM
aiua-11120	524	6	,	,	PUNCT
aiua-11120	524	7	miri	miri	PROPN
aiua-11120	524	8	e	e	PROPN
aiua-11120	524	9	,	,	PUNCT
aiua-11120	524	10	et	et	PROPN
aiua-11120	524	11	al	al	PROPN
aiua-11120	524	12	.	.	PUNCT
aiua-11120	524	13	posterior	posterior	ADJ
aiua-11120	524	14	tibial	tibial	ADJ
aiua-11120	524	15	nerve	nerve	NOUN
aiua-11120	524	16	stimulation	stimulation	NOUN
aiua-11120	524	17	for	for	ADP
aiua-11120	524	18	treating	treat	VERB
aiua-11120	524	19	neurologic	neurologic	ADJ
aiua-11120	524	20	bladder	bladder	NOUN
aiua-11120	524	21	in	in	ADP
aiua-11120	524	22	women	woman	NOUN
aiua-11120	524	23	:	:	PUNCT
aiua-11120	524	24	a	a	DET
aiua-11120	524	25	randomized	randomized	ADJ
aiua-11120	524	26	clinical	clinical	ADJ
aiua-11120	524	27	trial	trial	NOUN
aiua-11120	524	28	.	.	PUNCT
aiua-11120	525	1	acta	acta	PROPN
aiua-11120	525	2	med	med	PROPN
aiua-11120	525	3	iran	iran	PROPN
aiua-11120	525	4	.	.	PUNCT
aiua-11120	526	1	2014	2014	NUM
aiua-11120	526	2	;	;	PUNCT
aiua-11120	526	3	52:816	52:816	NUM
aiua-11120	526	4	-	-	SYM
aiua-11120	526	5	21	21	NUM
aiua-11120	526	6	.	.	PUNCT
aiua-11120	527	1	62	62	NUM
aiua-11120	527	2	.	.	PUNCT
aiua-11120	528	1	chen	chen	PROPN
aiua-11120	528	2	yl	yl	PROPN
aiua-11120	528	3	,	,	PUNCT
aiua-11120	528	4	feng	feng	PROPN
aiua-11120	528	5	wj	wj	PROPN
aiua-11120	528	6	,	,	PUNCT
aiua-11120	528	7	zhang	zhang	PROPN
aiua-11120	528	8	xl	xl	PROPN
aiua-11120	528	9	.	.	PUNCT
aiua-11120	528	10	parkinson	parkinson	PROPN
aiua-11120	528	11	's	's	PART
aiua-11120	528	12	disease	disease	NOUN
aiua-11120	528	13	combined	combine	VERB
aiua-11120	528	14	with	with	ADP
aiua-11120	528	15	overactive	overactive	ADJ
aiua-11120	528	16	bladder	bladder	NOUN
aiua-11120	528	17	syndrome	syndrome	NOUN
aiua-11120	528	18	treated	treat	VERB
aiua-11120	528	19	with	with	ADP
aiua-11120	528	20	acupuncture	acupuncture	NOUN
aiua-11120	528	21	and	and	CCONJ
aiua-11120	528	22	medication	medication	NOUN
aiua-11120	528	23	.	.	PUNCT
aiua-11120	529	1	zhongguo	zhongguo	PROPN
aiua-11120	529	2	zhen	zhen	PROPN
aiua-11120	529	3	jiu	jiu	PROPN
aiua-11120	529	4	.	.	PROPN
aiua-11120	529	5	2012	2012	NUM
aiua-11120	529	6	;	;	PUNCT
aiua-11120	529	7	32:215	32:215	NUM
aiua-11120	529	8	-	-	SYM
aiua-11120	529	9	8	8	NUM
aiua-11120	529	10	.	.	PUNCT
aiua-11120	529	11	63	63	NUM
aiua-11120	529	12	.	.	PUNCT
aiua-11120	530	1	chen	chen	PROPN
aiua-11120	530	2	h	h	PROPN
aiua-11120	530	3	,	,	PUNCT
aiua-11120	530	4	wang	wang	PROPN
aiua-11120	530	5	c	c	PROPN
aiua-11120	530	6	,	,	PUNCT
aiua-11120	530	7	zhou	zhou	PROPN
aiua-11120	530	8	m	m	PROPN
aiua-11120	530	9	,	,	PUNCT
aiua-11120	530	10	et	et	PROPN
aiua-11120	530	11	al	al	PROPN
aiua-11120	530	12	.	.	PROPN
aiua-11120	530	13	electroacupuncture	electroacupuncture	PROPN
aiua-11120	530	14	for	for	ADP
aiua-11120	530	15	post	post	ADJ
aiua-11120	530	16	-	-	ADJ
aiua-11120	530	17	stroke	stroke	ADJ
aiua-11120	530	18	overactive	overactive	ADJ
aiua-11120	530	19	bladder	bladder	NOUN
aiua-11120	530	20	:	:	PUNCT
aiua-11120	530	21	a	a	DET
aiua-11120	530	22	multi	multi	ADJ
aiua-11120	530	23	-	-	ADJ
aiua-11120	530	24	centre	centre	ADJ
aiua-11120	530	25	pilot	pilot	NOUN
aiua-11120	530	26	randomized	randomize	VERB
aiua-11120	530	27	controlled	control	VERB
aiua-11120	530	28	trial	trial	NOUN
aiua-11120	530	29	.	.	PUNCT
aiua-11120	531	1	acupunct	acupunct	PROPN
aiua-11120	531	2	med	med	PROPN
aiua-11120	531	3	.	.	PUNCT
aiua-11120	531	4	2021	2021	NUM
aiua-11120	531	5	;	;	PUNCT
aiua-11120	531	6	39:175	39:175	PROPN
aiua-11120	531	7	-	-	SYM
aiua-11120	531	8	183	183	NUM
aiua-11120	531	9	.	.	NOUN
aiua-11120	532	1	64	64	NUM
aiua-11120	532	2	.	.	PUNCT
aiua-11120	533	1	guo	guo	PROPN
aiua-11120	533	2	zf	zf	PROPN
aiua-11120	533	3	,	,	PUNCT
aiua-11120	533	4	liu	liu	PROPN
aiua-11120	533	5	y	y	PROPN
aiua-11120	533	6	,	,	PUNCT
aiua-11120	533	7	hu	hu	PROPN
aiua-11120	533	8	gh	gh	PROPN
aiua-11120	533	9	,	,	PUNCT
aiua-11120	533	10	et	et	PROPN
aiua-11120	533	11	al	al	PROPN
aiua-11120	533	12	.	.	PUNCT
aiua-11120	534	1	transcutaneous	transcutaneous	ADJ
aiua-11120	534	2	electrical	electrical	ADJ
aiua-11120	534	3	nerve	nerve	NOUN
aiua-11120	534	4	stimulation	stimulation	NOUN
aiua-11120	534	5	in	in	ADP
aiua-11120	534	6	the	the	DET
aiua-11120	534	7	treatment	treatment	NOUN
aiua-11120	534	8	of	of	ADP
aiua-11120	534	9	patients	patient	NOUN
aiua-11120	534	10	with	with	ADP
aiua-11120	534	11	poststroke	poststroke	ADJ
aiua-11120	534	12	urinary	urinary	ADJ
aiua-11120	534	13	incontinence	incontinence	NOUN
aiua-11120	534	14	.	.	PUNCT
aiua-11120	535	1	clin	clin	PROPN
aiua-11120	535	2	interv	interv	VERB
aiua-11120	535	3	aging	age	VERB
aiua-11120	535	4	.	.	PUNCT
aiua-11120	535	5	2014	2014	NUM
aiua-11120	535	6	;	;	PUNCT
aiua-11120	535	7	9:851	9:851	NOUN
aiua-11120	535	8	-	-	SYM
aiua-11120	535	9	6	6	NUM
aiua-11120	535	10	.	.	NOUN
aiua-11120	535	11	65	65	NUM
aiua-11120	535	12	.	.	PUNCT
aiua-11120	536	1	guo	guo	PROPN
aiua-11120	536	2	gy	gy	PROPN
aiua-11120	536	3	,	,	PUNCT
aiua-11120	536	4	kang	kang	PROPN
aiua-11120	536	5	yg	yg	PROPN
aiua-11120	536	6	.	.	PROPN
aiua-11120	536	7	effectiveness	effectiveness	NOUN
aiua-11120	536	8	of	of	ADP
aiua-11120	536	9	neuromuscular	neuromuscular	ADJ
aiua-11120	536	10	electrical	electrical	ADJ
aiua-11120	536	11	stimulation	stimulation	NOUN
aiua-11120	536	12	therapy	therapy	NOUN
aiua-11120	536	13	in	in	ADP
aiua-11120	536	14	patients	patient	NOUN
aiua-11120	536	15	with	with	ADP
aiua-11120	536	16	urinary	urinary	ADJ
aiua-11120	536	17	incontinence	incontinence	NOUN
aiua-11120	536	18	after	after	ADP
aiua-11120	536	19	stroke	stroke	NOUN
aiua-11120	536	20	:	:	PUNCT
aiua-11120	536	21	a	a	DET
aiua-11120	536	22	randomized	randomize	VERB
aiua-11120	536	23	sham	sham	NOUN
aiua-11120	536	24	controlled	control	VERB
aiua-11120	536	25	trial	trial	NOUN
aiua-11120	536	26	.	.	PUNCT
aiua-11120	537	1	medicine	medicine	NOUN
aiua-11120	537	2	(	(	PUNCT
aiua-11120	537	3	baltimore	baltimore	PROPN
aiua-11120	537	4	)	)	PUNCT
aiua-11120	537	5	.	.	PUNCT
aiua-11120	538	1	2018	2018	NUM
aiua-11120	538	2	;	;	PUNCT
aiua-11120	538	3	97	97	NUM
aiua-11120	538	4	:	:	PUNCT
aiua-11120	538	5	e13702	e13702	NOUN
aiua-11120	538	6	.	.	PROPN
aiua-11120	539	1	66	66	NUM
aiua-11120	539	2	.	.	PUNCT
aiua-11120	540	1	liu	liu	PROPN
aiua-11120	540	2	y	y	PROPN
aiua-11120	540	3	,	,	PUNCT
aiua-11120	540	4	xu	xu	PROPN
aiua-11120	540	5	g	g	PROPN
aiua-11120	540	6	,	,	PUNCT
aiua-11120	540	7	luo	luo	PROPN
aiua-11120	540	8	m	m	PROPN
aiua-11120	540	9	,	,	PUNCT
aiua-11120	540	10	teng	teng	PROPN
aiua-11120	540	11	hf	hf	PROPN
aiua-11120	540	12	.	.	PUNCT
aiua-11120	541	1	effects	effect	NOUN
aiua-11120	541	2	of	of	ADP
aiua-11120	541	3	transcutaneous	transcutaneous	ADJ
aiua-11120	541	4	electrical	electrical	ADJ
aiua-11120	541	5	nerve	nerve	NOUN
aiua-11120	541	6	stimulation	stimulation	NOUN
aiua-11120	541	7	at	at	ADP
aiua-11120	541	8	two	two	NUM
aiua-11120	541	9	frequencies	frequency	NOUN
aiua-11120	541	10	on	on	ADP
aiua-11120	541	11	urinary	urinary	ADJ
aiua-11120	541	12	incontinence	incontinence	NOUN
aiua-11120	541	13	in	in	ADP
aiua-11120	541	14	poststroke	poststroke	NOUN
aiua-11120	541	15	patients	patient	NOUN
aiua-11120	541	16	:	:	PUNCT
aiua-11120	541	17	a	a	DET
aiua-11120	541	18	randomized	randomized	ADJ
aiua-11120	541	19	controlled	control	VERB
aiua-11120	541	20	trial	trial	NOUN
aiua-11120	541	21	.	.	PUNCT
aiua-11120	542	1	am	be	AUX
aiua-11120	542	2	j	j	PROPN
aiua-11120	542	3	phys	phy	NOUN
aiua-11120	542	4	med	me	VERB
aiua-11120	542	5	rehabil	rehabil	NOUN
aiua-11120	542	6	.	.	PUNCT
aiua-11120	543	1	2016	2016	NUM
aiua-11120	543	2	;	;	PUNCT
aiua-11120	543	3	95:183	95:183	NUM
aiua-11120	543	4	-	-	SYM
aiua-11120	543	5	93	93	NUM
aiua-11120	543	6	.	.	PUNCT
aiua-11120	544	1	67	67	NUM
aiua-11120	544	2	.	.	PUNCT
aiua-11120	545	1	liu	liu	PROPN
aiua-11120	545	2	y	y	PROPN
aiua-11120	545	3	,	,	PUNCT
aiua-11120	545	4	xu	xu	PROPN
aiua-11120	546	1	g	g	PROPN
aiua-11120	546	2	,	,	PUNCT
aiua-11120	546	3	geng	geng	PROPN
aiua-11120	546	4	j.	j.	PROPN
aiua-11120	546	5	efficacy	efficacy	PROPN
aiua-11120	546	6	of	of	ADP
aiua-11120	546	7	transcutaneous	transcutaneous	ADJ
aiua-11120	546	8	electrical	electrical	ADJ
aiua-11120	546	9	nerve	nerve	NOUN
aiua-11120	546	10	stimulation	stimulation	NOUN
aiua-11120	546	11	in	in	ADP
aiua-11120	546	12	the	the	DET
aiua-11120	546	13	management	management	NOUN
aiua-11120	546	14	of	of	ADP
aiua-11120	546	15	neurogenic	neurogenic	ADJ
aiua-11120	546	16	overactive	overactive	ADJ
aiua-11120	546	17	bladder	bladder	NOUN
aiua-11120	546	18	:	:	PUNCT
aiua-11120	546	19	a	a	DET
aiua-11120	546	20	randomized	randomized	ADJ
aiua-11120	546	21	controlled	control	VERB
aiua-11120	546	22	trial	trial	NOUN
aiua-11120	546	23	.	.	PUNCT
aiua-11120	547	1	am	be	AUX
aiua-11120	547	2	j	j	PROPN
aiua-11120	547	3	phys	phy	NOUN
aiua-11120	547	4	med	me	VERB
aiua-11120	547	5	rehabil	rehabil	NOUN
aiua-11120	547	6	.	.	PUNCT
aiua-11120	548	1	2022	2022	NUM
aiua-11120	548	2	;	;	PUNCT
aiua-11120	548	3	101:2	101:2	NUM
aiua-11120	548	4	-	-	SYM
aiua-11120	548	5	10	10	NUM
aiua-11120	548	6	.	.	PUNCT
aiua-11120	549	1	68	68	NUM
aiua-11120	549	2	.	.	PUNCT
aiua-11120	550	1	mcdonald	mcdonald	PROPN
aiua-11120	550	2	c	c	PROPN
aiua-11120	550	3	,	,	PUNCT
aiua-11120	550	4	rees	rees	PROPN
aiua-11120	550	5	j	j	PROPN
aiua-11120	550	6	,	,	PUNCT
aiua-11120	550	7	winge	winge	VERB
aiua-11120	550	8	k	k	PROPN
aiua-11120	550	9	,	,	PUNCT
aiua-11120	550	10	et	et	PROPN
aiua-11120	550	11	al	al	PROPN
aiua-11120	550	12	.	.	PUNCT
aiua-11120	551	1	bladder	bladder	NOUN
aiua-11120	551	2	training	training	NOUN
aiua-11120	551	3	for	for	ADP
aiua-11120	551	4	urinary	urinary	ADJ
aiua-11120	551	5	tract	tract	NOUN
aiua-11120	551	6	symptoms	symptom	NOUN
aiua-11120	551	7	in	in	ADP
aiua-11120	551	8	parkinson	parkinson	NOUN
aiua-11120	551	9	disease	disease	NOUN
aiua-11120	551	10	:	:	PUNCT
aiua-11120	551	11	a	a	DET
aiua-11120	551	12	randomized	randomized	ADJ
aiua-11120	551	13	controlled	control	VERB
aiua-11120	551	14	trial	trial	NOUN
aiua-11120	551	15	.	.	PUNCT
aiua-11120	552	1	neurology	neurology	NOUN
aiua-11120	552	2	.	.	PUNCT
aiua-11120	553	1	2020	2020	NUM
aiua-11120	553	2	;	;	PUNCT
aiua-11120	553	3	94	94	NUM
aiua-11120	553	4	:	:	PUNCT
aiua-11120	553	5	e1427	e1427	NOUN
aiua-11120	553	6	-	-	PUNCT
aiua-11120	553	7	e1433	e1433	NOUN
aiua-11120	553	8	.	.	PUNCT
aiua-11120	554	1	69	69	NUM
aiua-11120	554	2	.	.	PUNCT
aiua-11120	555	1	vaughan	vaughan	PROPN
aiua-11120	555	2	cp	cp	PROPN
aiua-11120	555	3	,	,	PUNCT
aiua-11120	555	4	burgio	burgio	PROPN
aiua-11120	555	5	kl	kl	PROPN
aiua-11120	555	6	,	,	PUNCT
aiua-11120	555	7	goode	goode	PROPN
aiua-11120	555	8	ps	ps	PROPN
aiua-11120	555	9	,	,	PUNCT
aiua-11120	555	10	et	et	PROPN
aiua-11120	555	11	al	al	PROPN
aiua-11120	555	12	.	.	PUNCT
aiua-11120	556	1	behavioral	behavioral	ADJ
aiua-11120	556	2	therapy	therapy	NOUN
aiua-11120	556	3	for	for	ADP
aiua-11120	556	4	urinary	urinary	ADJ
aiua-11120	556	5	symptoms	symptom	NOUN
aiua-11120	556	6	in	in	ADP
aiua-11120	556	7	parkinson	parkinson	NOUN
aiua-11120	556	8	's	's	PART
aiua-11120	556	9	disease	disease	NOUN
aiua-11120	556	10	:	:	PUNCT
aiua-11120	556	11	a	a	DET
aiua-11120	556	12	randomized	randomized	ADJ
aiua-11120	556	13	clinical	clinical	ADJ
aiua-11120	556	14	trial	trial	NOUN
aiua-11120	556	15	.	.	PUNCT
aiua-11120	557	1	neurourol	neurourol	PROPN
aiua-11120	557	2	urodyn	urodyn	PROPN
aiua-11120	557	3	.	.	PUNCT
aiua-11120	558	1	2019	2019	NUM
aiua-11120	558	2	;	;	PUNCT
aiua-11120	558	3	38:1737	38:1737	X
aiua-11120	558	4	-	-	SYM
aiua-11120	558	5	1744	1744	NUM
aiua-11120	558	6	.	.	PUNCT
aiua-11120	559	1	70	70	NUM
aiua-11120	559	2	.	.	PUNCT
aiua-11120	559	3	tibaek	tibaek	PROPN
aiua-11120	559	4	s	s	PROPN
aiua-11120	559	5	,	,	PUNCT
aiua-11120	559	6	gard	gard	NOUN
aiua-11120	559	7	g	g	PROPN
aiua-11120	559	8	,	,	PUNCT
aiua-11120	559	9	jensen	jensen	PROPN
aiua-11120	559	10	r.	r.	PROPN
aiua-11120	559	11	pelvic	pelvic	PROPN
aiua-11120	559	12	floor	floor	NOUN
aiua-11120	559	13	muscle	muscle	NOUN
aiua-11120	559	14	training	training	NOUN
aiua-11120	559	15	is	be	AUX
aiua-11120	559	16	effective	effective	ADJ
aiua-11120	559	17	in	in	ADP
aiua-11120	559	18	women	woman	NOUN
aiua-11120	559	19	with	with	ADP
aiua-11120	559	20	urinary	urinary	ADJ
aiua-11120	559	21	incontinence	incontinence	NOUN
aiua-11120	559	22	after	after	ADP
aiua-11120	559	23	stroke	stroke	NOUN
aiua-11120	559	24	:	:	PUNCT
aiua-11120	559	25	a	a	DET
aiua-11120	559	26	randomised	randomised	ADJ
aiua-11120	559	27	,	,	PUNCT
aiua-11120	559	28	controlled	control	VERB
aiua-11120	559	29	and	and	CCONJ
aiua-11120	559	30	blinded	blinded	ADJ
aiua-11120	559	31	study	study	NOUN
aiua-11120	559	32	.	.	PUNCT
aiua-11120	560	1	neurourol	neurourol	PROPN
aiua-11120	560	2	urodyn	urodyn	PROPN
aiua-11120	560	3	.	.	PUNCT
aiua-11120	561	1	2005	2005	NUM
aiua-11120	561	2	;	;	PUNCT
aiua-11120	561	3	24:348	24:348	NUM
aiua-11120	561	4	-	-	SYM
aiua-11120	561	5	57	57	NUM
aiua-11120	561	6	.	.	PUNCT
aiua-11120	562	1	71	71	NUM
aiua-11120	562	2	.	.	PUNCT
aiua-11120	563	1	tibaek	tibaek	PROPN
aiua-11120	563	2	s	s	PROPN
aiua-11120	563	3	,	,	PUNCT
aiua-11120	563	4	gard	gard	NOUN
aiua-11120	563	5	g	g	PROPN
aiua-11120	563	6	,	,	PUNCT
aiua-11120	563	7	dehlendorff	dehlendorff	PROPN
aiua-11120	563	8	c	c	X
aiua-11120	563	9	,	,	PUNCT
aiua-11120	563	10	et	et	PROPN
aiua-11120	563	11	al	al	PROPN
aiua-11120	563	12	.	.	PROPN
aiua-11120	563	13	is	be	AUX
aiua-11120	563	14	pelvic	pelvic	ADJ
aiua-11120	563	15	floor	floor	NOUN
aiua-11120	563	16	muscle	muscle	NOUN
aiua-11120	563	17	training	training	NOUN
aiua-11120	563	18	effective	effective	ADJ
aiua-11120	563	19	for	for	ADP
aiua-11120	563	20	men	man	NOUN
aiua-11120	563	21	with	with	ADP
aiua-11120	563	22	poststroke	poststroke	PROPN
aiua-11120	563	23	lower	low	ADJ
aiua-11120	563	24	urinary	urinary	ADJ
aiua-11120	563	25	tract	tract	NOUN
aiua-11120	563	26	symptoms	symptom	NOUN
aiua-11120	563	27	?	?	PUNCT
aiua-11120	564	1	a	a	DET
aiua-11120	564	2	single	single	ADJ
aiua-11120	564	3	-	-	PUNCT
aiua-11120	564	4	blinded	blind	VERB
aiua-11120	564	5	randomized	randomize	VERB
aiua-11120	564	6	,	,	PUNCT
aiua-11120	564	7	controlled	control	VERB
aiua-11120	564	8	trial	trial	NOUN
aiua-11120	564	9	.	.	PUNCT
aiua-11120	565	1	am	be	AUX
aiua-11120	565	2	j	j	PROPN
aiua-11120	565	3	mens	mens	PROPN
aiua-11120	565	4	health	health	NOUN
aiua-11120	565	5	.	.	PUNCT
aiua-11120	566	1	2017	2017	NUM
aiua-11120	566	2	;	;	PUNCT
aiua-11120	566	3	11:1460	11:1460	NUM
aiua-11120	566	4	-	-	SYM
aiua-11120	566	5	1471	1471	NUM
aiua-11120	566	6	.	.	PUNCT
aiua-11120	567	1	72	72	NUM
aiua-11120	567	2	.	.	PUNCT
aiua-11120	568	1	khan	khan	PROPN
aiua-11120	568	2	f	f	PROPN
aiua-11120	568	3	,	,	PUNCT
aiua-11120	568	4	pallant	pallant	PROPN
aiua-11120	568	5	jf	jf	PROPN
aiua-11120	568	6	,	,	PUNCT
aiua-11120	568	7	pallant	pallant	VERB
aiua-11120	568	8	ji	ji	PROPN
aiua-11120	568	9	,	,	PUNCT
aiua-11120	568	10	et	et	PROPN
aiua-11120	568	11	al	al	PROPN
aiua-11120	568	12	.	.	PUNCT
aiua-11120	569	1	a	a	DET
aiua-11120	569	2	randomised	randomised	ADJ
aiua-11120	569	3	controlled	control	VERB
aiua-11120	569	4	trial	trial	NOUN
aiua-11120	569	5	:	:	PUNCT
aiua-11120	569	6	outcomes	outcome	NOUN
aiua-11120	569	7	of	of	ADP
aiua-11120	569	8	bladder	bladder	NOUN
aiua-11120	569	9	rehabilitation	rehabilitation	NOUN
aiua-11120	569	10	in	in	ADP
aiua-11120	569	11	persons	person	NOUN
aiua-11120	569	12	with	with	ADP
aiua-11120	569	13	multiple	multiple	ADJ
aiua-11120	569	14	sclerosis	sclerosis	NOUN
aiua-11120	569	15	journal	journal	PROPN
aiua-11120	569	16	of	of	ADP
aiua-11120	569	17	neurology	neurology	NOUN
aiua-11120	569	18	,	,	PUNCT
aiua-11120	569	19	neurosurgery	neurosurgery	NOUN
aiua-11120	569	20	and	and	CCONJ
aiua-11120	569	21	psychiatry	psychiatry	NOUN
aiua-11120	569	22	.	.	PUNCT
aiua-11120	570	1	2010	2010	NUM
aiua-11120	570	2	;	;	PUNCT
aiua-11120	570	3	81:9	81:9	NUM
aiua-11120	570	4	(	(	PUNCT
aiua-11120	570	5	10331038	10331038	NUM
aiua-11120	570	6	)	)	PUNCT
aiua-11120	570	7	.	.	PUNCT
aiua-11120	571	1	73	73	NUM
aiua-11120	571	2	.	.	PUNCT
aiua-11120	572	1	lúcio	lúcio	PROPN
aiua-11120	572	2	ac	ac	PROPN
aiua-11120	572	3	,	,	PUNCT
aiua-11120	572	4	perissinoto	perissinoto	NOUN
aiua-11120	572	5	mc	mc	PROPN
aiua-11120	572	6	,	,	PUNCT
aiua-11120	572	7	natalin	natalin	PROPN
aiua-11120	572	8	ra	ra	PROPN
aiua-11120	572	9	,	,	PUNCT
aiua-11120	572	10	et	et	PROPN
aiua-11120	572	11	al	al	PROPN
aiua-11120	572	12	.	.	PUNCT
aiua-11120	573	1	a	a	DET
aiua-11120	573	2	comparative	comparative	ADJ
aiua-11120	573	3	study	study	NOUN
aiua-11120	573	4	of	of	ADP
aiua-11120	573	5	pelvic	pelvic	ADJ
aiua-11120	573	6	floor	floor	NOUN
aiua-11120	573	7	muscle	muscle	NOUN
aiua-11120	573	8	training	training	NOUN
aiua-11120	573	9	in	in	ADP
aiua-11120	573	10	women	woman	NOUN
aiua-11120	573	11	with	with	ADP
aiua-11120	573	12	multiple	multiple	ADJ
aiua-11120	573	13	sclerosis	sclerosis	NOUN
aiua-11120	573	14	:	:	PUNCT
aiua-11120	573	15	its	its	PRON
aiua-11120	573	16	impact	impact	NOUN
aiua-11120	573	17	on	on	ADP
aiua-11120	573	18	lower	low	ADJ
aiua-11120	573	19	urinary	urinary	ADJ
aiua-11120	573	20	tract	tract	NOUN
aiua-11120	573	21	symptoms	symptom	NOUN
aiua-11120	573	22	and	and	CCONJ
aiua-11120	573	23	quality	quality	NOUN
aiua-11120	573	24	of	of	ADP
aiua-11120	573	25	life	life	NOUN
aiua-11120	573	26	.	.	PUNCT
aiua-11120	574	1	clinics	clinic	NOUN
aiua-11120	574	2	(	(	PUNCT
aiua-11120	574	3	sao	sao	PROPN
aiua-11120	574	4	paulo	paulo	PROPN
aiua-11120	574	5	)	)	PUNCT
aiua-11120	574	6	.	.	PUNCT
aiua-11120	575	1	2011	2011	NUM
aiua-11120	575	2	;	;	PUNCT
aiua-11120	575	3	66:1563	66:1563	X
aiua-11120	575	4	-	-	SYM
aiua-11120	575	5	8	8	NUM
aiua-11120	575	6	.	.	X
aiua-11120	576	1	74	74	NUM
aiua-11120	576	2	.	.	PUNCT
aiua-11120	577	1	botini	botini	PROPN
aiua-11120	577	2	d	d	PROPN
aiua-11120	577	3	,	,	PUNCT
aiua-11120	577	4	lucio	lucio	PROPN
aiua-11120	577	5	a	a	PROPN
aiua-11120	577	6	,	,	PUNCT
aiua-11120	577	7	domingos	domingos	PROPN
aiua-11120	577	8	j	j	PROPN
aiua-11120	577	9	,	,	PUNCT
aiua-11120	577	10	et	et	PROPN
aiua-11120	577	11	al	al	PROPN
aiua-11120	577	12	.	.	PROPN
aiua-11120	577	13	pelvic	pelvic	ADJ
aiua-11120	577	14	floor	floor	NOUN
aiua-11120	577	15	muscle	muscle	NOUN
aiua-11120	577	16	training	training	NOUN
aiua-11120	577	17	in	in	ADP
aiua-11120	577	18	the	the	DET
aiua-11120	577	19	treatment	treatment	NOUN
aiua-11120	577	20	of	of	ADP
aiua-11120	577	21	lower	low	ADJ
aiua-11120	577	22	urinary	urinary	ADJ
aiua-11120	577	23	tract	tract	NOUN
aiua-11120	577	24	symptoms	symptom	NOUN
aiua-11120	577	25	in	in	ADP
aiua-11120	577	26	women	woman	NOUN
aiua-11120	577	27	with	with	ADP
aiua-11120	577	28	multiple	multiple	ADJ
aiua-11120	577	29	archivio	archivio	NOUN
aiua-11120	577	30	italiano	italiano	X
aiua-11120	577	31	di	di	X
aiua-11120	577	32	urologia	urologia	PROPN
aiua-11120	577	33	e	e	PROPN
aiua-11120	577	34	andrologia	andrologia	PROPN
aiua-11120	577	35	2022	2022	NUM
aiua-11120	577	36	;	;	PUNCT
aiua-11120	577	37	94	94	NUM
aiua-11120	577	38	,	,	PUNCT
aiua-11120	577	39	4	4	NUM
aiua-11120	577	40	r.	r.	NOUN
aiua-11120	577	41	bapir	bapir	NOUN
aiua-11120	577	42	,	,	PUNCT
aiua-11120	577	43	k.	k.	PROPN
aiua-11120	577	44	hassan	hassan	PROPN
aiua-11120	577	45	bhatti	bhatti	PROPN
aiua-11120	577	46	,	,	PUNCT
aiua-11120	577	47	ahmed	ahmed	PROPN
aiua-11120	577	48	eliwa	eliwa	PROPN
aiua-11120	577	49	,	,	PUNCT
aiua-11120	577	50	et	et	PROPN
aiua-11120	577	51	al	al	PROPN
aiua-11120	577	52	.	.	PROPN
aiua-11120	577	53	506	506	NUM
aiua-11120	577	54	sclerosis	sclerosis	NOUN
aiua-11120	577	55	and	and	CCONJ
aiua-11120	577	56	myelopathy	myelopathy	ADJ
aiua-11120	577	57	associated	associate	VERB
aiua-11120	577	58	with	with	ADP
aiua-11120	577	59	htlv	htlv	PROPN
aiua-11120	577	60	-	-	PUNCT
aiua-11120	577	61	i	i	PROPN
aiua-11120	577	62	(	(	PUNCT
aiua-11120	577	63	ham	ham	NOUN
aiua-11120	577	64	/	/	SYM
aiua-11120	577	65	tsp	tsp	NOUN
aiua-11120	577	66	):	):	PUNCT
aiua-11120	577	67	a	a	DET
aiua-11120	577	68	randomized	randomized	ADJ
aiua-11120	577	69	controlled	control	VERB
aiua-11120	577	70	trial	trial	NOUN
aiua-11120	577	71	neurourology	neurourology	NOUN
aiua-11120	577	72	and	and	CCONJ
aiua-11120	577	73	urodynamics	urodynamic	NOUN
aiua-11120	577	74	.	.	PUNCT
aiua-11120	577	75	2019	2019	NUM
aiua-11120	577	76	;	;	PUNCT
aiua-11120	577	77	38	38	NUM
aiua-11120	577	78	(	(	PUNCT
aiua-11120	577	79	suppl	suppl	PROPN
aiua-11120	577	80	3):s455-	3):s455-	NUM
aiua-11120	577	81	.	.	PROPN
aiua-11120	578	1	75	75	NUM
aiua-11120	578	2	.	.	PUNCT
aiua-11120	579	1	ferreira	ferreira	PROPN
aiua-11120	579	2	ap	ap	PROPN
aiua-11120	579	3	,	,	PUNCT
aiua-11120	579	4	pegorare	pegorare	PROPN
aiua-11120	579	5	ab	ab	PROPN
aiua-11120	579	6	,	,	PUNCT
aiua-11120	579	7	salgado	salgado	PROPN
aiua-11120	579	8	pr	pr	PROPN
aiua-11120	579	9	,	,	PUNCT
aiua-11120	579	10	et	et	PROPN
aiua-11120	579	11	al	al	PROPN
aiua-11120	579	12	.	.	PROPN
aiua-11120	579	13	impact	impact	NOUN
aiua-11120	579	14	of	of	ADP
aiua-11120	579	15	a	a	DET
aiua-11120	579	16	pelvic	pelvic	ADJ
aiua-11120	579	17	floor	floor	NOUN
aiua-11120	579	18	training	training	NOUN
aiua-11120	579	19	program	program	NOUN
aiua-11120	579	20	among	among	ADP
aiua-11120	579	21	women	woman	NOUN
aiua-11120	579	22	with	with	ADP
aiua-11120	579	23	multiple	multiple	ADJ
aiua-11120	579	24	sclerosis	sclerosis	NOUN
aiua-11120	579	25	:	:	PUNCT
aiua-11120	579	26	a	a	DET
aiua-11120	579	27	controlled	control	VERB
aiua-11120	579	28	clinical	clinical	ADJ
aiua-11120	579	29	trial	trial	NOUN
aiua-11120	579	30	.	.	PUNCT
aiua-11120	580	1	am	be	AUX
aiua-11120	580	2	j	j	PROPN
aiua-11120	580	3	phys	phy	NOUN
aiua-11120	580	4	med	me	VERB
aiua-11120	580	5	rehabil	rehabil	NOUN
aiua-11120	580	6	.	.	PUNCT
aiua-11120	581	1	2016	2016	NUM
aiua-11120	581	2	;	;	PUNCT
aiua-11120	581	3	95:1	95:1	NUM
aiua-11120	581	4	-	-	SYM
aiua-11120	581	5	8	8	NUM
aiua-11120	581	6	.	.	NUM
aiua-11120	582	1	76	76	NUM
aiua-11120	582	2	.	.	PUNCT
aiua-11120	583	1	silva	silva	PROPN
aiua-11120	583	2	ferreira	ferreira	PROPN
aiua-11120	583	3	ap	ap	PROPN
aiua-11120	583	4	,	,	PUNCT
aiua-11120	583	5	de	de	PROPN
aiua-11120	583	6	souza	souza	PROPN
aiua-11120	583	7	pegorare	pegorare	PROPN
aiua-11120	583	8	abg	abg	PROPN
aiua-11120	583	9	,	,	PUNCT
aiua-11120	583	10	miotto	miotto	PROPN
aiua-11120	583	11	junior	junior	PROPN
aiua-11120	583	12	a	a	PROPN
aiua-11120	583	13	,	,	PUNCT
aiua-11120	583	14	et	et	PROPN
aiua-11120	583	15	al	al	PROPN
aiua-11120	583	16	.	.	PUNCT
aiua-11120	584	1	a	a	DET
aiua-11120	584	2	controlled	control	VERB
aiua-11120	584	3	clinical	clinical	ADJ
aiua-11120	584	4	trial	trial	NOUN
aiua-11120	584	5	on	on	ADP
aiua-11120	584	6	the	the	DET
aiua-11120	584	7	effects	effect	NOUN
aiua-11120	584	8	of	of	ADP
aiua-11120	584	9	exercise	exercise	NOUN
aiua-11120	584	10	on	on	ADP
aiua-11120	584	11	lower	low	ADJ
aiua-11120	584	12	urinary	urinary	ADJ
aiua-11120	584	13	tract	tract	NOUN
aiua-11120	584	14	symptoms	symptom	NOUN
aiua-11120	584	15	in	in	ADP
aiua-11120	584	16	women	woman	NOUN
aiua-11120	584	17	with	with	ADP
aiua-11120	584	18	multiple	multiple	ADJ
aiua-11120	584	19	sclerosis	sclerosis	NOUN
aiua-11120	584	20	.	.	PUNCT
aiua-11120	585	1	am	be	AUX
aiua-11120	585	2	j	j	PROPN
aiua-11120	585	3	phys	phy	NOUN
aiua-11120	585	4	med	me	VERB
aiua-11120	585	5	rehabil	rehabil	NOUN
aiua-11120	585	6	.	.	PUNCT
aiua-11120	586	1	2019	2019	NUM
aiua-11120	586	2	;	;	PUNCT
aiua-11120	586	3	98:777	98:777	NUM
aiua-11120	586	4	-	-	SYM
aiua-11120	586	5	782	782	NUM
aiua-11120	586	6	.	.	PUNCT
aiua-11120	587	1	77	77	NUM
aiua-11120	587	2	.	.	PUNCT
aiua-11120	588	1	lúcio	lúcio	PROPN
aiua-11120	588	2	a	a	PRON
aiua-11120	588	3	,	,	PUNCT
aiua-11120	588	4	d’ancona	d’ancona	NOUN
aiua-11120	588	5	ca	can	AUX
aiua-11120	588	6	,	,	PUNCT
aiua-11120	588	7	perissinotto	perissinotto	PROPN
aiua-11120	588	8	mc	mc	PROPN
aiua-11120	588	9	,	,	PUNCT
aiua-11120	588	10	et	et	PROPN
aiua-11120	588	11	al	al	PROPN
aiua-11120	588	12	.	.	PROPN
aiua-11120	588	13	pelvic	pelvic	ADJ
aiua-11120	588	14	floor	floor	NOUN
aiua-11120	588	15	muscle	muscle	NOUN
aiua-11120	588	16	training	training	NOUN
aiua-11120	588	17	with	with	ADP
aiua-11120	588	18	and	and	CCONJ
aiua-11120	588	19	without	without	ADP
aiua-11120	588	20	electrical	electrical	ADJ
aiua-11120	588	21	stimulation	stimulation	NOUN
aiua-11120	588	22	in	in	ADP
aiua-11120	588	23	the	the	DET
aiua-11120	588	24	treatment	treatment	NOUN
aiua-11120	588	25	of	of	ADP
aiua-11120	588	26	lower	low	ADJ
aiua-11120	588	27	urinary	urinary	ADJ
aiua-11120	588	28	tract	tract	NOUN
aiua-11120	588	29	symptoms	symptom	NOUN
aiua-11120	588	30	in	in	ADP
aiua-11120	588	31	women	woman	NOUN
aiua-11120	588	32	with	with	ADP
aiua-11120	588	33	multiple	multiple	ADJ
aiua-11120	588	34	sclerosis	sclerosis	NOUN
aiua-11120	588	35	.	.	PUNCT
aiua-11120	589	1	j	j	PROPN
aiua-11120	589	2	wound	wind	VERB
aiua-11120	589	3	ostomy	ostomy	NOUN
aiua-11120	589	4	continence	continence	NOUN
aiua-11120	589	5	nurs	nur	VERB
aiua-11120	589	6	.	.	PUNCT
aiua-11120	590	1	2016	2016	NUM
aiua-11120	590	2	;	;	PUNCT
aiua-11120	590	3	43:414	43:414	NUM
aiua-11120	590	4	-	-	SYM
aiua-11120	590	5	9	9	NUM
aiua-11120	590	6	.	.	NUM
aiua-11120	590	7	78	78	NUM
aiua-11120	590	8	.	.	PUNCT
aiua-11120	591	1	witte	witte	PROPN
aiua-11120	591	2	lp	lp	PROPN
aiua-11120	591	3	,	,	PUNCT
aiua-11120	591	4	odekerken	odekerken	ADJ
aiua-11120	591	5	vjj	vjj	PROPN
aiua-11120	591	6	,	,	PUNCT
aiua-11120	591	7	boel	boel	PROPN
aiua-11120	591	8	ja	ja	PROPN
aiua-11120	591	9	,	,	PUNCT
aiua-11120	591	10	et	et	PROPN
aiua-11120	591	11	al	al	PROPN
aiua-11120	591	12	.	.	PROPN
aiua-11120	591	13	does	do	AUX
aiua-11120	591	14	deep	deep	ADJ
aiua-11120	591	15	brain	brain	NOUN
aiua-11120	591	16	stimulation	stimulation	NOUN
aiua-11120	591	17	improve	improve	VERB
aiua-11120	591	18	lower	low	ADJ
aiua-11120	591	19	urinary	urinary	ADJ
aiua-11120	591	20	tract	tract	NOUN
aiua-11120	591	21	symptoms	symptom	NOUN
aiua-11120	591	22	in	in	ADP
aiua-11120	591	23	parkinson	parkinson	NOUN
aiua-11120	591	24	's	's	PART
aiua-11120	591	25	disease	disease	NOUN
aiua-11120	591	26	?	?	PUNCT
aiua-11120	592	1	neurourol	neurourol	PROPN
aiua-11120	592	2	urodyn	urodyn	NOUN
aiua-11120	592	3	.	.	PUNCT
aiua-11120	593	1	2018	2018	NUM
aiua-11120	593	2	;	;	PUNCT
aiua-11120	593	3	37:354	37:354	NUM
aiua-11120	593	4	-	-	SYM
aiua-11120	593	5	359	359	NUM
aiua-11120	593	6	.	.	PUNCT
aiua-11120	594	1	79	79	NUM
aiua-11120	594	2	.	.	PUNCT
aiua-11120	595	1	moussa	moussa	PROPN
aiua-11120	595	2	m	m	PROPN
aiua-11120	595	3	,	,	PUNCT
aiua-11120	595	4	abou	abou	PROPN
aiua-11120	595	5	chakra	chakra	PROPN
aiua-11120	595	6	m	m	PROPN
aiua-11120	595	7	,	,	PUNCT
aiua-11120	595	8	dabboucy	dabboucy	PROPN
aiua-11120	595	9	b	b	PROPN
aiua-11120	595	10	,	,	PUNCT
aiua-11120	595	11	et	et	PROPN
aiua-11120	595	12	al	al	PROPN
aiua-11120	595	13	.	.	PROPN
aiua-11120	595	14	single	single	ADJ
aiua-11120	595	15	intradetrusor	intradetrusor	NOUN
aiua-11120	595	16	injection	injection	NOUN
aiua-11120	595	17	of	of	ADP
aiua-11120	595	18	autologous	autologous	ADJ
aiua-11120	595	19	adipose	adipose	NOUN
aiua-11120	595	20	-	-	PUNCT
aiua-11120	595	21	derived	derive	VERB
aiua-11120	595	22	stem	stem	NOUN
aiua-11120	595	23	cells	cell	NOUN
aiua-11120	595	24	in	in	ADP
aiua-11120	595	25	parkinson	parkinson	NOUN
aiua-11120	595	26	's	's	PART
aiua-11120	595	27	disease	disease	NOUN
aiua-11120	595	28	patients	patient	NOUN
aiua-11120	595	29	with	with	ADP
aiua-11120	595	30	overactive	overactive	ADJ
aiua-11120	595	31	bladder	bladder	NOUN
aiua-11120	595	32	:	:	PUNCT
aiua-11120	595	33	a	a	DET
aiua-11120	595	34	pilot	pilot	NOUN
aiua-11120	595	35	study	study	NOUN
aiua-11120	595	36	neurourology	neurourology	NOUN
aiua-11120	595	37	and	and	CCONJ
aiua-11120	595	38	urodynamics	urodynamic	NOUN
aiua-11120	595	39	.	.	PUNCT
aiua-11120	595	40	2021	2021	NUM
aiua-11120	595	41	;	;	PUNCT
aiua-11120	595	42	40(suppl	40(suppl	NUM
aiua-11120	595	43	2):s93	2):s93	NUM
aiua-11120	595	44	-	-	PUNCT
aiua-11120	595	45	s95	s95	NOUN
aiua-11120	595	46	.	.	PUNCT
aiua-11120	596	1	80	80	NUM
aiua-11120	596	2	.	.	PUNCT
aiua-11120	597	1	hebjorn	hebjorn	ADJ
aiua-11120	597	2	s.	s.	PROPN
aiua-11120	597	3	treatment	treatment	NOUN
aiua-11120	597	4	of	of	ADP
aiua-11120	597	5	detrusor	detrusor	NOUN
aiua-11120	597	6	hyperreflexia	hyperreflexia	NOUN
aiua-11120	597	7	in	in	ADP
aiua-11120	597	8	multiple	multiple	ADJ
aiua-11120	597	9	sclerosis	sclerosis	NOUN
aiua-11120	597	10	:	:	PUNCT
aiua-11120	597	11	a	a	DET
aiua-11120	597	12	double	double	ADJ
aiua-11120	597	13	-	-	PUNCT
aiua-11120	597	14	blind	blind	ADJ
aiua-11120	597	15	,	,	PUNCT
aiua-11120	597	16	crossover	crossover	VERB
aiua-11120	597	17	clinical	clinical	ADJ
aiua-11120	597	18	trial	trial	NOUN
aiua-11120	597	19	comparing	compare	VERB
aiua-11120	597	20	methantheline	methantheline	NOUN
aiua-11120	597	21	bromide	bromide	NOUN
aiua-11120	597	22	(	(	PUNCT
aiua-11120	597	23	banthine	banthine	PROPN
aiua-11120	597	24	)	)	PUNCT
aiua-11120	597	25	,	,	PUNCT
aiua-11120	597	26	flavoxate	flavoxate	ADJ
aiua-11120	597	27	chloride	chloride	NOUN
aiua-11120	597	28	(	(	PUNCT
aiua-11120	597	29	urispas	urispas	NOUN
aiua-11120	597	30	)	)	PUNCT
aiua-11120	597	31	and	and	CCONJ
aiua-11120	597	32	meladrazine	meladrazine	ADJ
aiua-11120	597	33	tartrate	tartrate	NOUN
aiua-11120	597	34	(	(	PUNCT
aiua-11120	597	35	lisidonil	lisidonil	NOUN
aiua-11120	597	36	)	)	PUNCT
aiua-11120	597	37	.	.	PUNCT
aiua-11120	598	1	urol	urol	PROPN
aiua-11120	598	2	int	int	PROPN
aiua-11120	598	3	.	.	PUNCT
aiua-11120	599	1	1977	1977	NUM
aiua-11120	599	2	;	;	PUNCT
aiua-11120	599	3	32:209	32:209	NUM
aiua-11120	599	4	-	-	SYM
aiua-11120	599	5	17	17	NUM
aiua-11120	599	6	.	.	PUNCT
aiua-11120	600	1	81	81	NUM
aiua-11120	600	2	.	.	PUNCT
aiua-11120	601	1	gajewski	gajewski	VERB
aiua-11120	601	2	jb	jb	PROPN
aiua-11120	601	3	,	,	PUNCT
aiua-11120	601	4	awad	awad	PROPN
aiua-11120	601	5	sa	sa	PROPN
aiua-11120	601	6	.	.	PUNCT
aiua-11120	602	1	oxybutynin	oxybutynin	PROPN
aiua-11120	602	2	versus	versus	ADP
aiua-11120	602	3	propantheline	propantheline	NOUN
aiua-11120	602	4	in	in	ADP
aiua-11120	602	5	patients	patient	NOUN
aiua-11120	602	6	with	with	ADP
aiua-11120	602	7	multiple	multiple	ADJ
aiua-11120	602	8	sclerosis	sclerosis	NOUN
aiua-11120	602	9	and	and	CCONJ
aiua-11120	602	10	detrusor	detrusor	NOUN
aiua-11120	602	11	hyperreflexia	hyperreflexia	PROPN
aiua-11120	602	12	.	.	PUNCT
aiua-11120	603	1	j	j	PROPN
aiua-11120	603	2	urol	urol	PROPN
aiua-11120	603	3	.	.	PUNCT
aiua-11120	603	4	1986	1986	NUM
aiua-11120	603	5	;	;	PUNCT
aiua-11120	603	6	135:966	135:966	X
aiua-11120	603	7	-	-	SYM
aiua-11120	603	8	68	68	NUM
aiua-11120	603	9	.	.	PUNCT
aiua-11120	604	1	82	82	NUM
aiua-11120	604	2	.	.	PUNCT
aiua-11120	604	3	fader	fader	PROPN
aiua-11120	604	4	m	m	PROPN
aiua-11120	604	5	,	,	PUNCT
aiua-11120	604	6	glickman	glickman	PROPN
aiua-11120	604	7	s	s	PROPN
aiua-11120	604	8	,	,	PUNCT
aiua-11120	604	9	haggar	haggar	NOUN
aiua-11120	604	10	v	v	NOUN
aiua-11120	604	11	,	,	PUNCT
aiua-11120	604	12	et	et	PROPN
aiua-11120	604	13	al	al	PROPN
aiua-11120	604	14	.	.	PROPN
aiua-11120	604	15	intravesical	intravesical	ADJ
aiua-11120	604	16	atropine	atropine	NOUN
aiua-11120	604	17	compared	compare	VERB
aiua-11120	604	18	to	to	ADP
aiua-11120	604	19	oral	oral	ADJ
aiua-11120	604	20	oxybutynin	oxybutynin	NOUN
aiua-11120	604	21	for	for	ADP
aiua-11120	604	22	neurogenic	neurogenic	ADJ
aiua-11120	604	23	detrusor	detrusor	NOUN
aiua-11120	604	24	overactivity	overactivity	NOUN
aiua-11120	604	25	:	:	PUNCT
aiua-11120	604	26	a	a	DET
aiua-11120	604	27	double	double	ADJ
aiua-11120	604	28	-	-	PUNCT
aiua-11120	604	29	blind	blind	ADJ
aiua-11120	604	30	,	,	PUNCT
aiua-11120	604	31	randomized	randomize	VERB
aiua-11120	604	32	crossover	crossover	ADP
aiua-11120	604	33	trial	trial	NOUN
aiua-11120	604	34	.	.	PUNCT
aiua-11120	605	1	j	j	PROPN
aiua-11120	605	2	urol	urol	PROPN
aiua-11120	605	3	.	.	PUNCT
aiua-11120	605	4	2007	2007	NUM
aiua-11120	605	5	;	;	PUNCT
aiua-11120	605	6	177:208	177:208	ADV
aiua-11120	605	7	-	-	SYM
aiua-11120	605	8	13	13	NUM
aiua-11120	605	9	.	.	PUNCT
aiua-11120	605	10	83	83	NUM
aiua-11120	605	11	.	.	PUNCT
aiua-11120	606	1	novara	novara	PROPN
aiua-11120	606	2	g	g	PROPN
aiua-11120	606	3	,	,	PUNCT
aiua-11120	606	4	galfano	galfano	VERB
aiua-11120	606	5	a	a	PRON
aiua-11120	606	6	,	,	PUNCT
aiua-11120	606	7	secco	secco	PROPN
aiua-11120	606	8	s	s	PART
aiua-11120	606	9	,	,	PUNCT
aiua-11120	606	10	et	et	PROPN
aiua-11120	606	11	al	al	PROPN
aiua-11120	606	12	.	.	PUNCT
aiua-11120	607	1	a	a	DET
aiua-11120	607	2	systematic	systematic	ADJ
aiua-11120	607	3	review	review	NOUN
aiua-11120	607	4	and	and	CCONJ
aiua-11120	607	5	metaanalysis	metaanalysis	NOUN
aiua-11120	607	6	of	of	ADP
aiua-11120	607	7	randomized	randomized	ADJ
aiua-11120	607	8	controlled	control	VERB
aiua-11120	607	9	trials	trial	NOUN
aiua-11120	607	10	with	with	ADP
aiua-11120	607	11	antimuscarinic	antimuscarinic	ADJ
aiua-11120	607	12	drugs	drug	NOUN
aiua-11120	607	13	for	for	ADP
aiua-11120	607	14	overactive	overactive	ADJ
aiua-11120	607	15	bladder	bladder	NOUN
aiua-11120	607	16	.	.	PUNCT
aiua-11120	608	1	eur	eur	PROPN
aiua-11120	608	2	urol	urol	PROPN
aiua-11120	608	3	.	.	PUNCT
aiua-11120	608	4	2008	2008	NUM
aiua-11120	608	5	;	;	PUNCT
aiua-11120	608	6	54:740	54:740	NUM
aiua-11120	608	7	-	-	SYM
aiua-11120	608	8	63	63	NUM
aiua-11120	608	9	.	.	PUNCT
aiua-11120	608	10	84	84	NUM
aiua-11120	608	11	.	.	PUNCT
aiua-11120	609	1	rossanese	rossanese	PROPN
aiua-11120	609	2	m	m	PROPN
aiua-11120	609	3	,	,	PUNCT
aiua-11120	609	4	novara	novara	PROPN
aiua-11120	609	5	g	g	PROPN
aiua-11120	609	6	,	,	PUNCT
aiua-11120	609	7	challacombe	challacombe	ADJ
aiua-11120	609	8	b	b	NOUN
aiua-11120	609	9	,	,	PUNCT
aiua-11120	609	10	et	et	PROPN
aiua-11120	609	11	al	al	PROPN
aiua-11120	609	12	.	.	PROPN
aiua-11120	610	1	critical	critical	ADJ
aiua-11120	610	2	analysis	analysis	NOUN
aiua-11120	610	3	of	of	ADP
aiua-11120	610	4	phase	phase	NOUN
aiua-11120	610	5	ii	ii	PROPN
aiua-11120	610	6	and	and	CCONJ
aiua-11120	610	7	iii	iii	NUM
aiua-11120	610	8	randomised	randomised	ADJ
aiua-11120	610	9	control	control	NOUN
aiua-11120	610	10	trials	trial	NOUN
aiua-11120	610	11	(	(	PUNCT
aiua-11120	610	12	rcts	rct	NOUN
aiua-11120	610	13	)	)	PUNCT
aiua-11120	610	14	evaluating	evaluating	NOUN
aiua-11120	610	15	efficacy	efficacy	NOUN
aiua-11120	610	16	and	and	CCONJ
aiua-11120	610	17	tolerability	tolerability	NOUN
aiua-11120	610	18	of	of	ADP
aiua-11120	610	19	a	a	DET
aiua-11120	610	20	β3	β3	ADJ
aiua-11120	610	21	-	-	PUNCT
aiua-11120	610	22	adrenoceptor	adrenoceptor	NOUN
aiua-11120	610	23	agonist	agonist	NOUN
aiua-11120	610	24	(	(	PUNCT
aiua-11120	610	25	mirabegron	mirabegron	PROPN
aiua-11120	610	26	)	)	PUNCT
aiua-11120	610	27	for	for	ADP
aiua-11120	610	28	overactive	overactive	ADJ
aiua-11120	610	29	bladder	bladder	NOUN
aiua-11120	610	30	(	(	PUNCT
aiua-11120	610	31	oab	oab	PROPN
aiua-11120	610	32	)	)	PUNCT
aiua-11120	610	33	.	.	PUNCT
aiua-11120	611	1	bju	bju	NOUN
aiua-11120	611	2	int	int	PROPN
aiua-11120	611	3	.	.	PUNCT
aiua-11120	612	1	2015	2015	NUM
aiua-11120	612	2	;	;	PUNCT
aiua-11120	612	3	115:32	115:32	NUM
aiua-11120	612	4	-	-	SYM
aiua-11120	612	5	40	40	NUM
aiua-11120	612	6	.	.	PUNCT
aiua-11120	612	7	85	85	NUM
aiua-11120	612	8	.	.	PUNCT
aiua-11120	613	1	chapple	chapple	PROPN
aiua-11120	613	2	cr	cr	PROPN
aiua-11120	613	3	,	,	PUNCT
aiua-11120	613	4	kaplan	kaplan	PROPN
aiua-11120	613	5	sa	sa	PROPN
aiua-11120	613	6	,	,	PUNCT
aiua-11120	613	7	mitcheson	mitcheson	PROPN
aiua-11120	613	8	d	d	NOUN
aiua-11120	613	9	,	,	PUNCT
aiua-11120	613	10	et	et	PROPN
aiua-11120	613	11	al	al	PROPN
aiua-11120	613	12	.	.	PROPN
aiua-11120	614	1	mirabegron	mirabegron	PROPN
aiua-11120	614	2	50	50	NUM
aiua-11120	614	3	mg	mg	NOUN
aiua-11120	614	4	once	once	ADV
aiua-11120	614	5	-	-	PUNCT
aiua-11120	614	6	daily	daily	ADJ
aiua-11120	614	7	for	for	ADP
aiua-11120	614	8	the	the	DET
aiua-11120	614	9	treatment	treatment	NOUN
aiua-11120	614	10	of	of	ADP
aiua-11120	614	11	symptoms	symptom	NOUN
aiua-11120	614	12	of	of	ADP
aiua-11120	614	13	overactive	overactive	ADJ
aiua-11120	614	14	bladder	bladder	NOUN
aiua-11120	614	15	:	:	PUNCT
aiua-11120	614	16	an	an	DET
aiua-11120	614	17	overview	overview	NOUN
aiua-11120	614	18	of	of	ADP
aiua-11120	614	19	efficacy	efficacy	NOUN
aiua-11120	614	20	and	and	CCONJ
aiua-11120	614	21	tolerability	tolerability	NOUN
aiua-11120	614	22	over	over	ADP
aiua-11120	614	23	12	12	NUM
aiua-11120	614	24	weeks	week	NOUN
aiua-11120	614	25	and	and	CCONJ
aiua-11120	614	26	1	1	NUM
aiua-11120	614	27	year	year	NOUN
aiua-11120	614	28	.	.	PUNCT
aiua-11120	615	1	int	int	PROPN
aiua-11120	615	2	j	j	PROPN
aiua-11120	615	3	urol	urol	PROPN
aiua-11120	615	4	.	.	PUNCT
aiua-11120	616	1	2014	2014	NUM
aiua-11120	616	2	;	;	PUNCT
aiua-11120	616	3	21:960	21:960	NUM
aiua-11120	616	4	-	-	SYM
aiua-11120	616	5	967	967	NUM
aiua-11120	616	6	.	.	PUNCT
aiua-11120	617	1	86	86	NUM
aiua-11120	617	2	.	.	PUNCT
aiua-11120	618	1	rosa	rosa	PROPN
aiua-11120	618	2	gm	gm	PROPN
aiua-11120	618	3	,	,	PUNCT
aiua-11120	618	4	ferrero	ferrero	PROPN
aiua-11120	618	5	s	s	PROPN
aiua-11120	618	6	,	,	PUNCT
aiua-11120	618	7	nitti	nitti	PROPN
aiua-11120	618	8	vw	vw	PROPN
aiua-11120	618	9	,	,	PUNCT
aiua-11120	618	10	et	et	PROPN
aiua-11120	618	11	al	al	PROPN
aiua-11120	618	12	.	.	PUNCT
aiua-11120	619	1	cardiovascular	cardiovascular	ADJ
aiua-11120	619	2	safety	safety	NOUN
aiua-11120	619	3	of	of	ADP
aiua-11120	619	4	β3adrenoceptor	β3adrenoceptor	PROPN
aiua-11120	619	5	agonists	agonist	NOUN
aiua-11120	619	6	for	for	ADP
aiua-11120	619	7	the	the	DET
aiua-11120	619	8	treatment	treatment	NOUN
aiua-11120	619	9	of	of	ADP
aiua-11120	619	10	patients	patient	NOUN
aiua-11120	619	11	with	with	ADP
aiua-11120	619	12	overactive	overactive	ADJ
aiua-11120	619	13	bladder	bladder	NOUN
aiua-11120	619	14	syndrome	syndrome	NOUN
aiua-11120	619	15	.	.	PUNCT
aiua-11120	620	1	eur	eur	PROPN
aiua-11120	620	2	urol	urol	PROPN
aiua-11120	620	3	.	.	PUNCT
aiua-11120	620	4	2016	2016	NUM
aiua-11120	620	5	;	;	PUNCT
aiua-11120	620	6	69:311	69:311	NUM
aiua-11120	620	7	-	-	SYM
aiua-11120	620	8	323	323	NUM
aiua-11120	620	9	.	.	PUNCT
aiua-11120	621	1	correspondence	correspondence	NOUN
aiua-11120	621	2	rawa	rawa	PROPN
aiua-11120	621	3	bapir	bapir	PROPN
aiua-11120	621	4	dr.rawa@yahoo.com	dr.rawa@yahoo.com	VERB
aiua-11120	621	5	smart	smart	ADJ
aiua-11120	621	6	health	health	NOUN
aiua-11120	621	7	tower	tower	NOUN
aiua-11120	621	8	,	,	PUNCT
aiua-11120	621	9	sulaymaniyah	sulaymaniyah	NOUN
aiua-11120	621	10	,	,	PUNCT
aiua-11120	621	11	kurdistan	kurdistan	ADJ
aiua-11120	621	12	region	region	NOUN
aiua-11120	621	13	,	,	PUNCT
aiua-11120	621	14	iraq	iraq	PROPN
aiua-11120	621	15	kamran	kamran	PROPN
aiua-11120	621	16	hassan	hassan	PROPN
aiua-11120	621	17	bhatti	bhatti	PROPN
aiua-11120	621	18	kamibhatti92@gmail.com	kamibhatti92@gmail.com	PROPN
aiua-11120	621	19	urology	urology	NOUN
aiua-11120	621	20	department	department	PROPN
aiua-11120	621	21	,	,	PUNCT
aiua-11120	621	22	hmc	hmc	PROPN
aiua-11120	621	23	,	,	PUNCT
aiua-11120	621	24	hamad	hamad	PROPN
aiua-11120	621	25	medical	medical	PROPN
aiua-11120	621	26	corporation	corporation	PROPN
aiua-11120	621	27	,	,	PUNCT
aiua-11120	621	28	qatar	qatar	PROPN
aiua-11120	621	29	ahmed	ahmed	PROPN
aiua-11120	621	30	eliwa	eliwa	PROPN
aiua-11120	621	31	ahmedeliwafarag@gmail.com	ahmedeliwafarag@gmail.com	PROPN
aiua-11120	621	32	department	department	PROPN
aiua-11120	621	33	of	of	ADP
aiua-11120	621	34	urology	urology	NOUN
aiua-11120	621	35	,	,	PUNCT
aiua-11120	621	36	zagazig	zagazig	PROPN
aiua-11120	621	37	university	university	PROPN
aiua-11120	621	38	,	,	PUNCT
aiua-11120	621	39	zagazig	zagazig	PROPN
aiua-11120	621	40	,	,	PUNCT
aiua-11120	621	41	sharkia	sharkia	PROPN
aiua-11120	621	42	,	,	PUNCT
aiua-11120	621	43	egypt	egypt	PROPN
aiua-11120	621	44	herney	herney	PROPN
aiua-11120	621	45	andrés	andrés	PROPN
aiua-11120	621	46	garcía	garcía	PROPN
aiua-11120	621	47	-	-	PUNCT
aiua-11120	621	48	perdomo	perdomo	NOUN
aiua-11120	621	49	herney.garcia@correounivalle.edu.co	herney.garcia@correounivalle.edu.co	PROPN
aiua-11120	621	50	universidad	universidad	PROPN
aiua-11120	621	51	del	del	PROPN
aiua-11120	621	52	valle	valle	PROPN
aiua-11120	621	53	,	,	PUNCT
aiua-11120	621	54	cali	cali	PROPN
aiua-11120	621	55	,	,	PUNCT
aiua-11120	621	56	colombia	colombia	PROPN
aiua-11120	621	57	nazim	nazim	PROPN
aiua-11120	621	58	gherabi	gherabi	PROPN
aiua-11120	621	59	,	,	PUNCT
aiua-11120	621	60	md	md	PROPN
aiua-11120	621	61	ngherabi@gmail.com	ngherabi@gmail.com	PROPN
aiua-11120	621	62	faculty	faculty	NOUN
aiua-11120	621	63	of	of	ADP
aiua-11120	621	64	medicine	medicine	NOUN
aiua-11120	621	65	algiers	algiers	PROPN
aiua-11120	621	66	1	1	NUM
aiua-11120	621	67	,	,	PUNCT
aiua-11120	621	68	algiers	algiers	PROPN
aiua-11120	621	69	,	,	PUNCT
aiua-11120	621	70	algeria	algeria	PROPN
aiua-11120	621	71	derek	derek	PROPN
aiua-11120	621	72	hennessey	hennessey	PROPN
aiua-11120	621	73	,	,	PUNCT
aiua-11120	621	74	md	md	PROPN
aiua-11120	621	75	derek.hennessey@gmail.com	derek.hennessey@gmail.com	PROPN
aiua-11120	621	76	department	department	PROPN
aiua-11120	621	77	of	of	ADP
aiua-11120	621	78	urology	urology	NOUN
aiua-11120	621	79	,	,	PUNCT
aiua-11120	621	80	mercy	mercy	NOUN
aiua-11120	621	81	university	university	NOUN
aiua-11120	621	82	hospital	hospital	NOUN
aiua-11120	621	83	,	,	PUNCT
aiua-11120	621	84	cork	cork	NOUN
aiua-11120	621	85	,	,	PUNCT
aiua-11120	621	86	ireland	ireland	PROPN
aiua-11120	621	87	vittorio	vittorio	PROPN
aiua-11120	621	88	magri	magri	PROPN
aiua-11120	621	89	,	,	PUNCT
aiua-11120	621	90	md	md	PROPN
aiua-11120	621	91	vittorio.magri@virgilio.it	vittorio.magri@virgilio.it	PROPN
aiua-11120	621	92	asst	asst	PROPN
aiua-11120	621	93	nord	nord	PROPN
aiua-11120	621	94	milano	milano	PROPN
aiua-11120	621	95	,	,	PUNCT
aiua-11120	621	96	milan	milan	PROPN
aiua-11120	621	97	,	,	PUNCT
aiua-11120	621	98	italy	italy	PROPN
aiua-11120	621	99	panagiotis	panagiotis	PROPN
aiua-11120	621	100	mourmouris	mourmouris	PROPN
aiua-11120	621	101	,	,	PUNCT
aiua-11120	621	102	md	md	PROPN
aiua-11120	621	103	thodoros13@yahoo.com	thodoros13@yahoo.com	PROPN
aiua-11120	621	104	2nd	2nd	PROPN
aiua-11120	621	105	department	department	PROPN
aiua-11120	621	106	of	of	ADP
aiua-11120	621	107	urology	urology	NOUN
aiua-11120	621	108	,	,	PUNCT
aiua-11120	621	109	national	national	ADJ
aiua-11120	621	110	and	and	CCONJ
aiua-11120	621	111	kapodistrian	kapodistrian	ADJ
aiua-11120	621	112	university	university	PROPN
aiua-11120	621	113	of	of	ADP
aiua-11120	621	114	athens	athens	PROPN
aiua-11120	621	115	,	,	PUNCT
aiua-11120	621	116	sismanoglio	sismanoglio	PROPN
aiua-11120	621	117	hospital	hospital	PROPN
aiua-11120	621	118	,	,	PUNCT
aiua-11120	621	119	athens	athens	PROPN
aiua-11120	621	120	,	,	PUNCT
aiua-11120	621	121	greece	greece	PROPN
aiua-11120	621	122	adama	adama	PROPN
aiua-11120	621	123	ouattara	ouattara	PROPN
aiua-11120	621	124	,	,	PUNCT
aiua-11120	621	125	md	md	PROPN
aiua-11120	621	126	adamsouat1@hotmail.com	adamsouat1@hotmail.com	X
aiua-11120	621	127	division	division	NOUN
aiua-11120	621	128	of	of	ADP
aiua-11120	621	129	urology	urology	NOUN
aiua-11120	621	130	,	,	PUNCT
aiua-11120	621	131	souro	souro	NOUN
aiua-11120	621	132	sanou	sanou	PROPN
aiua-11120	621	133	university	university	NOUN
aiua-11120	621	134	teaching	teaching	NOUN
aiua-11120	621	135	hospital	hospital	NOUN
aiua-11120	621	136	,	,	PUNCT
aiua-11120	621	137	bobodioulasso	bobodioulasso	NOUN
aiua-11120	621	138	,	,	PUNCT
aiua-11120	621	139	burkina	burkina	PROPN
aiua-11120	621	140	faso	faso	PROPN
aiua-11120	621	141	gianpaolo	gianpaolo	PROPN
aiua-11120	621	142	perletti	perletti	PROPN
aiua-11120	621	143	,	,	PUNCT
aiua-11120	621	144	dr	dr	PROPN
aiua-11120	621	145	.	.	PROPN
aiua-11120	621	146	biol	biol	PROPN
aiua-11120	621	147	.	.	PUNCT
aiua-11120	622	1	sci	sci	PROPN
aiua-11120	622	2	.	.	PROPN
aiua-11120	622	3	m.	m.	PROPN
aiua-11120	622	4	clin	clin	PROPN
aiua-11120	622	5	.	.	PUNCT
aiua-11120	623	1	pharmacol	pharmacol	PROPN
aiua-11120	623	2	.	.	PUNCT
aiua-11120	624	1	gianpaolo.perletti@uninsubria.it	gianpaolo.perletti@uninsubria.it	PROPN
aiua-11120	624	2	department	department	PROPN
aiua-11120	624	3	of	of	ADP
aiua-11120	624	4	biotechnology	biotechnology	NOUN
aiua-11120	624	5	and	and	CCONJ
aiua-11120	624	6	life	life	NOUN
aiua-11120	624	7	sciences	science	NOUN
aiua-11120	624	8	,	,	PUNCT
aiua-11120	624	9	section	section	NOUN
aiua-11120	624	10	of	of	ADP
aiua-11120	624	11	medical	medical	ADJ
aiua-11120	624	12	and	and	CCONJ
aiua-11120	624	13	surgical	surgical	ADJ
aiua-11120	624	14	sciences	science	NOUN
aiua-11120	624	15	,	,	PUNCT
aiua-11120	624	16	university	university	NOUN
aiua-11120	624	17	of	of	ADP
aiua-11120	624	18	insubria	insubria	PROPN
aiua-11120	624	19	,	,	PUNCT
aiua-11120	624	20	varese	varese	PROPN
aiua-11120	624	21	,	,	PUNCT
aiua-11120	624	22	italy	italy	PROPN
aiua-11120	624	23	joseph	joseph	PROPN
aiua-11120	624	24	philipraj	philipraj	PROPN
aiua-11120	624	25	,	,	PUNCT
aiua-11120	624	26	md	md	PROPN
aiua-11120	624	27	josephphilipraj@gmail.com	josephphilipraj@gmail.com	PROPN
aiua-11120	624	28	department	department	PROPN
aiua-11120	624	29	of	of	ADP
aiua-11120	624	30	urology	urology	NOUN
aiua-11120	624	31	,	,	PUNCT
aiua-11120	624	32	mahatma	mahatma	PROPN
aiua-11120	624	33	gandhi	gandhi	PROPN
aiua-11120	624	34	medical	medical	PROPN
aiua-11120	624	35	college	college	PROPN
aiua-11120	624	36	and	and	CCONJ
aiua-11120	624	37	research	research	PROPN
aiua-11120	624	38	institute	institute	PROPN
aiua-11120	624	39	,	,	PUNCT
aiua-11120	624	40	sri	sri	PROPN
aiua-11120	624	41	balaji	balaji	PROPN
aiua-11120	624	42	vidyapeeth	vidyapeeth	PROPN
aiua-11120	624	43	,	,	PUNCT
aiua-11120	624	44	puducherry	puducherry	PROPN
aiua-11120	624	45	,	,	PUNCT
aiua-11120	624	46	india	india	PROPN
aiua-11120	624	47	konstantinos	konstantinos	PROPN
aiua-11120	624	48	stamatiou	stamatiou	PROPN
aiua-11120	624	49	,	,	PUNCT
aiua-11120	624	50	md	md	PROPN
aiua-11120	624	51	stamatiouk@gmail.com	stamatiouk@gmail.com	PROPN
aiua-11120	624	52	department	department	PROPN
aiua-11120	624	53	of	of	ADP
aiua-11120	624	54	urology	urology	NOUN
aiua-11120	624	55	,	,	PUNCT
aiua-11120	624	56	tzaneio	tzaneio	PROPN
aiua-11120	624	57	general	general	ADJ
aiua-11120	624	58	hospital	hospital	NOUN
aiua-11120	624	59	,	,	PUNCT
aiua-11120	624	60	18536	18536	NUM
aiua-11120	624	61	piraeus	piraeus	NOUN
aiua-11120	624	62	,	,	PUNCT
aiua-11120	624	63	greece	greece	PROPN
aiua-11120	624	64	alberto	alberto	PROPN
aiua-11120	624	65	trinchieri	trinchieri	PROPN
aiua-11120	624	66	,	,	PUNCT
aiua-11120	624	67	md	md	PROPN
aiua-11120	624	68	alberto.trinchieri@gmail.com	alberto.trinchieri@gmail.com	PROPN
aiua-11120	624	69	urology	urology	NOUN
aiua-11120	624	70	school	school	NOUN
aiua-11120	624	71	,	,	PUNCT
aiua-11120	624	72	university	university	PROPN
aiua-11120	624	73	of	of	ADP
aiua-11120	624	74	milan	milan	PROPN
aiua-11120	624	75	,	,	PUNCT
aiua-11120	624	76	milan	milan	PROPN
aiua-11120	624	77	(	(	PUNCT
aiua-11120	624	78	italy	italy	PROPN
aiua-11120	624	79	)	)	PUNCT
aiua-11120	624	80	noor	noor	PROPN
aiua-11120	624	81	buchholz	buchholz	PROPN
aiua-11120	624	82	,	,	PUNCT
aiua-11120	624	83	md	md	PROPN
aiua-11120	624	84	noor.buchholz@gmail.com	noor.buchholz@gmail.com	PROPN
aiua-11120	624	85	sobeh	sobeh	NOUN
aiua-11120	624	86	's	's	PART
aiua-11120	624	87	vascular	vascular	ADJ
aiua-11120	624	88	and	and	CCONJ
aiua-11120	624	89	medical	medical	ADJ
aiua-11120	624	90	center	center	NOUN
aiua-11120	624	91	,	,	PUNCT
aiua-11120	624	92	dubai	dubai	PROPN
aiua-11120	624	93	health	health	PROPN
aiua-11120	624	94	care	care	PROPN
aiua-11120	624	95	city	city	PROPN
aiua-11120	624	96	,	,	PUNCT
aiua-11120	624	97	dubai	dubai	PROPN
aiua-11120	624	98	,	,	PUNCT
aiua-11120	624	99	united	united	PROPN
aiua-11120	624	100	arab	arab	PROPN
aiua-11120	624	101	emirates	emirates	PROPN